Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_019112.4(ABCA7):c.3641G>A (p.Trp1214Ter)	ABCA7	W1214*	Alzheimer disease, type 9|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000225545	19	1054255	19	1054256	225545	227448	rs201060968	NC_000019.10:1054255:G:A
NM_020297.4(ABCC9):c.448A>G (p.Ile150Val)	ABCC9	I150V	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487606	12	22069996	12	21917062	487606	480711	rs1555117063	NC_000012.12:21917061:T:C
NM_020297.4(ABCC9):c.2019+2T>C	ABCC9		Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487597	12	22035698	12	21882764	487597	480710	rs1555100687	NC_000012.12:21882763:A:G
NM_001103.4(ACTN2):c.2075T>A (p.Ile692Asn)	ACTN2	I692N, I484N	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487588	1	236918419	1	236755119	487588	480672	rs1553304459	NC_000001.11:236755118:T:A
NM_000669.5(ADH1C):c.232G>T (p.Gly78Ter)	ADH1C	G78*	Parkinson disease, mitochondrial	risk factor(Last reviewed: Jan 1, 2005)	no assertion criteria provided	VCV000018181	4	100268190	4	99347033	18181	33220	rs283413	NC_000004.12:99347032:C:A
NM_000674.3(ADORA1):c.835G>A (p.Gly279Ser)	ADORA1	G279S, G163S, G211S	not provided	Uncertain significance(Last reviewed: Feb 22, 2017)	no assertion criteria provided	VCV000375733	1	203134882	1	203165754	375733	362618	rs748346254	NC_000001.11:203165753:G:A
NM_005751.5(AKAP9):c.10591C>G (p.Gln3531Glu)	AKAP9	Q3523E, Q3531E, Q1746E	Wolff-Parkinson-White pattern|Long QT syndrome	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000487601	7	91727092	7	92097778	487601	480699	rs767137372	NC_000007.14:92097777:C:G
NM_005751.5(AKAP9):c.11297G>A (p.Arg3766Gln)	AKAP9	R3758Q, R3766Q, R1981Q	Wolff-Parkinson-White pattern|Long QT syndrome	Uncertain significance(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV000487596	7	91732107	7	92102793	487596	480700	rs137892407	NC_000007.14:92102792:G:A
NM_001148.6(ANK2):c.1427A>G (p.Gln476Arg)	ANK2	Q455R, Q476R, Q462R, Q491R, Q381R, Q410R, Q406R, Q447R, Q464R, Q472R, Q485R, Q493R	Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000487619	4	114186093	4	113264937	487619	480686	rs1203193073	NC_000004.12:113264936:A:G
NM_001148.6(ANK2):c.742G>A (p.Val248Met)	ANK2	V227M, V248M, V244M, V263M, V219M, V234M, V236M, V257M, V265M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487591	4	114161689	4	113240533	487591	480685	rs752395758	NC_000004.12:113240532:G:A
NM_001148.6(ANK2):c.11692A>G (p.Lys3898Glu)	ANK2	K1804E, K1813E, K3898E, K1742E, K1747E, K1758E, K1759E, K1792E, K1817E, K1822E, K1856E, K1001E, K1713E, K1726E, K1766E, K1780E, K1811E, K1812E, K1685E, K1718E, K1738E, K1751E, K1770E, K1779E, K1791E, K1803E, K1806E, K1823E, K1827E, K1834E, K1843E, K1858E, K989E, K996E, K1796E, K1828E, K1839E, K1652E, K1735E, K1740E, K1749E, K1755E, K1761E, K1768E, K1771E, K1808E, K1859E, K2698E, K3820E, K3968E, K3976E, K644E	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487587	4	114294327	4	113373171	487587	480687	rs1554597130	NC_000004.12:113373170:A:G
NM_177924.5(ASAH1):c.1004C>T (p.Thr335Met)	ASAH1	T270M, T329M, T351M, T335M	Farber lipogranulomatosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2020)	criteria provided, conflicting interpretations	VCV000691802	8	17916887	8	18059378	691802	679517	rs147233112	NC_000008.11:18059377:G:A
NM_022089.4(ATP13A2):c.2939G>A (p.Arg980His)	ATP13A2	R936H, R975H, R980H	not provided	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, single submitter	VCV001303171	1	17313685	1	16987190	1303171	1293449		NC_000001.11:16987189:C:T
NM_022089.4(ATP13A2):c.1195+66A>G	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001192485	1	17323449	1	16996954	1192485	1182343		NC_000001.11:16996953:T:C
NM_022089.4(ATP13A2):c.1234T>C (p.Leu412=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001159508	1	17322953	1	16996458	1159508	1130586		NC_000001.11:16996457:A:G
NM_022089.4(ATP13A2):c.1869C>T (p.Ser623=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 5, 2020)	criteria provided, single submitter	VCV001156514	1	17318874	1	16992379	1156514	1130583		NC_000001.11:16992378:G:A
NM_022089.4(ATP13A2):c.1398C>T (p.Thr466=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001153583	1	17322615	1	16996120	1153583	1130584		NC_000001.11:16996119:G:A
NM_022089.4(ATP13A2):c.1137C>G (p.Leu379=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV001149175	1	17323573	1	16997078	1149175	1130588		NC_000001.11:16997077:G:C
NM_022089.4(ATP13A2):c.2796C>T (p.Ser932=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV001148890	1	17314696	1	16988201	1148890	1130581		NC_000001.11:16988200:G:A
NM_022089.4(ATP13A2):c.2133T>C (p.Thr711=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 24, 2019)	criteria provided, single submitter	VCV001145104	1	17318347	1	16991852	1145104	1130582		NC_000001.11:16991851:A:G
NM_022089.4(ATP13A2):c.1353+8T>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001144737	1	17322741	1	16996246	1144737	1130585		NC_000001.11:16996245:A:G
NM_022089.4(ATP13A2):c.1167G>A (p.Pro389=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001142649	1	17323543	1	16997048	1142649	1130587		NC_000001.11:16997047:C:T
NM_022089.4(ATP13A2):c.270C>T (p.Ile90=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001133514	1	17331887	1	17005392	1133514	1109686		NC_000001.11:17005391:G:A
NM_022089.4(ATP13A2):c.1170C>T (p.His390=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001129464	1	17323540	1	16997045	1129464	1109684		NC_000001.11:16997044:G:A
NM_022089.4(ATP13A2):c.2454C>T (p.Pro818=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001129340	1	17316457	1	16989962	1129340	1109683		NC_000001.11:16989961:G:A
NM_022089.4(ATP13A2):c.3501C>T (p.Ala1167=)	ATP13A2	R1067*	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001128805	1	17312758	1	16986263	1128805	1109680		NC_000001.11:16986262:G:A
NM_022089.4(ATP13A2):c.2742G>A (p.Glu914=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001126234	1	17314837	1	16988342	1126234	1109682		NC_000001.11:16988341:C:T
NM_022089.4(ATP13A2):c.2820C>T (p.Tyr940=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001124581	1	17314672	1	16988177	1124581	1109681		NC_000001.11:16988176:G:A
NM_022089.4(ATP13A2):c.471C>T (p.Val157=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001124202	1	17331193	1	17004698	1124202	1109685		NC_000001.11:17004697:G:A
NM_022089.4(ATP13A2):c.699G>T (p.Val233=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001115474	1	17328535	1	17002040	1115474	1088162		NC_000001.11:17002039:C:A
NM_022089.4(ATP13A2):c.2685G>A (p.Leu895=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV001111167	1	17314894	1	16988399	1111167	1088158		NC_000001.11:16988398:C:T
NM_022089.4(ATP13A2):c.822G>A (p.Ser274=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001110896	1	17326913	1	17000418	1110896	1088161		NC_000001.11:17000417:C:T
NM_022089.4(ATP13A2):c.2397C>T (p.Ala799=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001109189	1	17316637	1	16990142	1109189	1088159		NC_000001.11:16990141:G:A
NM_022089.4(ATP13A2):c.1341C>T (p.Leu447=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV001104646	1	17322761	1	16996266	1104646	1088160		NC_000001.11:16996265:G:A
NM_022089.4(ATP13A2):c.2943G>A (p.Thr981=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV001103624	1	17313681	1	16987186	1103624	1088157		NC_000001.11:16987185:C:T
NM_022089.4(ATP13A2):c.3207G>A (p.Ala1069=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001102648	1	17313328	1	16986833	1102648	1088156		NC_000001.11:16986832:C:T
NM_022089.4(ATP13A2):c.723T>C (p.Tyr241=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001098141	1	17327012	1	17000517	1098141	1066436		NC_000001.11:17000516:A:G
NM_022089.4(ATP13A2):c.3321G>A (p.Ala1107=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001097983	1	17313042	1	16986547	1097983	1066430		NC_000001.11:16986546:C:T
NM_022089.4(ATP13A2):c.2994C>T (p.Ser998=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001090349	1	17313630	1	16987135	1090349	1066431		NC_000001.11:16987134:G:A
NM_022089.4(ATP13A2):c.1755G>A (p.Leu585=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001089057	1	17319071	1	16992576	1089057	1066434		NC_000001.11:16992575:C:T
NM_022089.4(ATP13A2):c.244C>T (p.Leu82=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001088122	1	17331913	1	17005418	1088122	1066437		NC_000001.11:17005417:G:A
NM_022089.4(ATP13A2):c.2082A>G (p.Pro694=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001080278	1	17318548	1	16992053	1080278	1066433		NC_000001.11:16992052:T:C
NM_022089.4(ATP13A2):c.1218C>T (p.Gly406=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV001078242	1	17322969	1	16996474	1078242	1066435		NC_000001.11:16996473:G:A
NM_022089.4(ATP13A2):c.2580A>G (p.Thr860=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001077368	1	17316215	1	16989720	1077368	1066432		NC_000001.11:16989719:T:C
NM_022089.4(ATP13A2):c.3136G>T (p.Glu1046Ter)	ATP13A2	E1002*, E1041*, E1046*	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001075283	1	17313399	1	16986904	1075283	1058471		NC_000001.11:16986903:C:A
NM_022089.4(ATP13A2):c.1649C>A (p.Pro550His)	ATP13A2	P545H, P550H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV001062357	1	17320224	1	16993729	1062357	1039599		NC_000001.11:16993728:G:T
NM_022089.4(ATP13A2):c.2270C>T (p.Ala757Val)	ATP13A2	A752V, A757V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001061042	1	17316764	1	16990269	1061042	1039597		NC_000001.11:16990268:G:A
NM_022089.4(ATP13A2):c.2771G>A (p.Arg924His)	ATP13A2	R880H, R919H, R924H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001056992	1	17314721	1	16988226	1056992	1039596		NC_000001.11:16988225:C:T
NM_022089.4(ATP13A2):c.778G>A (p.Ala260Thr)	ATP13A2	A255T, A260T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001056624	1	17326957	1	17000462	1056624	1039602		NC_000001.11:17000461:C:T
NM_022089.4(ATP13A2):c.1925C>T (p.Ala642Val)	ATP13A2	A637V, A642V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001056319	1	17318818	1	16992323	1056319	1039598		NC_000001.11:16992322:G:A
NM_022089.4(ATP13A2):c.1064C>T (p.Thr355Met)	ATP13A2	T350M, T355M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001052718	1	17323646	1	16997151	1052718	1039601		NC_000001.11:16997150:G:A
NM_022089.4(ATP13A2):c.1384C>G (p.Leu462Val)	ATP13A2	L457V, L462V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001051520	1	17322629	1	16996134	1051520	1039600		NC_000001.11:16996133:G:C
NM_022089.4(ATP13A2):c.2978C>G (p.Pro993Arg)	ATP13A2	P949R, P988R, P993R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001051144	1	17313646	1	16987151	1051144	1039595		NC_000001.11:16987150:G:C
NM_022089.4(ATP13A2):c.1957G>A (p.Val653Ile)	ATP13A2	V653I, V648I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001046235	1	17318786	1	16992291	1046235	1022752		NC_000001.11:16992290:C:T
NM_022089.4(ATP13A2):c.212G>C (p.Trp71Ser)	ATP13A2	W71S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001045786	1	17331945	1	17005450	1045786	1022754		NC_000001.11:17005449:C:G
NM_022089.4(ATP13A2):c.2309A>G (p.Gln770Arg)	ATP13A2	Q770R, Q765R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001042540	1	17316725	1	16990230	1042540	1022751		NC_000001.11:16990229:T:C
NM_022089.4(ATP13A2):c.1466G>T (p.Arg489Leu)	ATP13A2	R489L, R484L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001042103	1	17322547	1	16996052	1042103	1022753		NC_000001.11:16996051:C:A
NM_022089.4(ATP13A2):c.2859+5G>C	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001034961	1	17314628	1	16988133	1034961	1022750		NC_000001.11:16988132:C:G
NM_022089.4(ATP13A2):c.2525C>G (p.Pro842Arg)	ATP13A2	P842R, P837R	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV001031328	1	17316386	1	16989891	1031328	1019222		NC_000001.11:16989890:G:C
NM_022089.4(ATP13A2):c.265G>A (p.Val89Ile)	ATP13A2	V89I	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001029841	1	17331892	1	17005397	1029841	1015586		NC_000001.11:17005396:C:T
NM_022089.4(ATP13A2):c.2529+1G>A	ATP13A2		Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001029840	1	17316381	1	16989886	1029840	1015584		NC_000001.11:16989885:C:T
NM_022089.4(ATP13A2):c.1843A>G (p.Met615Val)	ATP13A2	M610V, M615V	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV001028752	1	17318983	1	16992488	1028752	1015585		NC_000001.11:16992487:T:C
NM_022089.4(ATP13A2):c.2663C>T (p.Ala888Val)	ATP13A2	A844V, A883V, A888V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV001025917	1	17314916	1	16988421	1025917	1002291		NC_000001.11:16988420:G:A
NM_022089.4(ATP13A2):c.1591C>G (p.Leu531Val)	ATP13A2	L526V, L531V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV001019440	1	17320282	1	16993787	1019440	1002292		NC_000001.11:16993786:G:C
NM_022089.4(ATP13A2):c.348C>G (p.Ser116Arg)	ATP13A2	S116R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001015771	1	17331316	1	17004821	1015771	1002294		NC_000001.11:17004820:G:C
NM_022089.4(ATP13A2):c.841C>G (p.Gln281Glu)	ATP13A2	Q276E, Q281E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV001015312	1	17326807	1	17000312	1015312	1002293		NC_000001.11:17000311:G:C
NM_022089.4(ATP13A2):c.3040G>A (p.Gly1014Ser)	ATP13A2	G1009S, G1014S, G970S	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV001014208	1	17313584	1	16987089	1014208	1002290		NC_000001.11:16987088:C:T
NM_022089.4(ATP13A2):c.722A>G (p.Tyr241Cys)	ATP13A2	Y236C, Y241C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV001008650	1	17327013	1	17000518	1008650	987035		NC_000001.11:17000517:T:C
NM_022089.4(ATP13A2):c.2544C>T (p.Gly848=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001007416	1	17316251	1	16989756	1007416	987034		NC_000001.11:16989755:G:A
NM_022089.4(ATP13A2):c.3458G>A (p.Arg1153Gln)	ATP13A2	R1148Q, R1153Q	ATP13A2-related disorders|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000973287	1	17312801	1	16986306	973287	961498		NC_000001.11:16986305:C:T
NM_022089.4(ATP13A2):c.1321A>T (p.Ile441Phe)	ATP13A2	I441F, I436F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV000971324	1	17322781	1	16996286	971324	952139		NC_000001.11:16996285:T:A
NM_022089.4(ATP13A2):c.3439C>T (p.Arg1147Cys)	ATP13A2	A1046V, R1147C, R1142C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000970791	1	17312820	1	16986325	970791	952138		NC_000001.11:16986324:G:A
NM_022089.4(ATP13A2):c.1465C>T (p.Arg489Trp)	ATP13A2	R484W, R489W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000962412	1	17322548	1	16996053	962412	941569		NC_000001.11:16996052:G:A
NM_022089.4(ATP13A2):c.994G>A (p.Ala332Thr)	ATP13A2	A332T, A327T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000958400	1	17326551	1	17000056	958400	941571		NC_000001.11:17000055:C:T
NM_022089.4(ATP13A2):c.2218C>G (p.Arg740Gly)	ATP13A2	R740G, R735G	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000957849	1	17318262	1	16991767	957849	941568		NC_000001.11:16991766:G:C
NM_022089.4(ATP13A2):c.668T>C (p.Ile223Thr)	ATP13A2	I218T, I223T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 8, 2019)	criteria provided, single submitter	VCV000957471	1	17328566	1	17002071	957471	941572		NC_000001.11:17002070:A:G
NM_022089.4(ATP13A2):c.1306G>A (p.Ala436Thr)	ATP13A2	A431T, A436T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000954358	1	17322881	1	16996386	954358	941570		NC_000001.11:16996385:C:T
NM_022089.4(ATP13A2):c.1864G>T (p.Val622Phe)	ATP13A2	V617F, V622F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000952741	1	17318879	1	16992384	952741	921740		NC_000001.11:16992383:C:A
NM_022089.4(ATP13A2):c.157G>A (p.Val53Met)	ATP13A2	V53M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000952316	1	17332000	1	17005505	952316	921741		NC_000001.11:17005504:C:T
NM_022089.4(ATP13A2):c.2422C>G (p.Gln808Glu)	ATP13A2	Q808E, Q803E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000949336	1	17316489	1	16989994	949336	921739		NC_000001.11:16989993:G:C
NM_022089.4(ATP13A2):c.3042C>T (p.Gly1014=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000940709	1	17313582	1	16987087	940709	930152		NC_000001.11:16987086:G:A
NM_022089.4(ATP13A2):c.2326G>C (p.Val776Leu)	ATP13A2	V776L, V771L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV000936424	1	17316708	1	16990213	936424	930153		NC_000001.11:16990212:C:G
NM_022089.4(ATP13A2):c.1880G>A (p.Arg627His)	ATP13A2	R627H, R622H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|none provided	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000935221	1	17318863	1	16992368	935221	930154		NC_000001.11:16992367:C:T
NM_022089.4(ATP13A2):c.1658G>A (p.Arg553Gln)	ATP13A2	R548Q, R553Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000934675	1	17320215	1	16993720	934675	930155		NC_000001.11:16993719:C:T
NM_022089.4(ATP13A2):c.515G>A (p.Arg172His)	ATP13A2	R167H, R172H	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876420	1	17330869	1	17004374	876420	862773		NC_000001.11:17004373:C:T
NM_022089.4(ATP13A2):c.601C>T (p.Arg201Cys)	ATP13A2	R196C, R201C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000876419	1	17328825	1	17002330	876419	862772		NC_000001.11:17002329:G:A
NM_022089.4(ATP13A2):c.706-14C>T	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876418	1	17327043	1	17000548	876418	865031		NC_000001.11:17000547:G:A
NM_022089.4(ATP13A2):c.840G>T (p.Lys280Asn)	ATP13A2	K275N, K280N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876417	1	17326895	1	17000400	876417	862771		NC_000001.11:17000399:C:A
NM_022089.4(ATP13A2):c.1774G>A (p.Asp592Asn)	ATP13A2	D587N, D592N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876375	1	17319052	1	16992557	876375	862768		NC_000001.11:16992556:C:T
NM_022089.4(ATP13A2):c.1870G>A (p.Val624Ile)	ATP13A2	V619I, V624I	Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 22, 2020)	criteria provided, conflicting interpretations	VCV000876374	1	17318873	1	16992378	876374	862767		NC_000001.11:16992377:C:T
NM_022089.4(ATP13A2):c.2927T>G (p.Val976Gly)	ATP13A2	V932G, V976G, V971G	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876341	1	17313697	1	16987202	876341	862760		NC_000001.11:16987201:A:C
NM_022089.4(ATP13A2):c.3112G>A (p.Ala1038Thr)	ATP13A2	A1038T, A994T, A1033T	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876340	1	17313423	1	16986928	876340	862759		NC_000001.11:16986927:C:T
NM_022089.4(ATP13A2):c.*182C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876292	1	17312534	1	16986039	876292	862755		NC_000001.11:16986038:G:A
NM_022089.4(ATP13A2):c.*231G>A	ATP13A2	V1158M	Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000876291	1	17312485	1	16985990	876291	862754		NC_000001.11:16985989:C:T
NM_022089.4(ATP13A2):c.2190G>T (p.Pro730=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876256	1	17318290	1	16991795	876256	862766		NC_000001.11:16991794:C:A
NM_022089.4(ATP13A2):c.3235+15G>A	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876202	1	17313285	1	16986790	876202	865029		NC_000001.11:16986789:C:T
NM_022089.4(ATP13A2):c.1112G>A (p.Arg371Gln)	ATP13A2	R366Q, R371Q	not provided|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000875386	1	17323598	1	16997103	875386	862770		NC_000001.11:16997102:C:T
NM_022089.4(ATP13A2):c.1307-14C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875335	1	17322809	1	16996314	875335	865030		NC_000001.11:16996313:G:A
NM_022089.4(ATP13A2):c.2439C>T (p.Thr813=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000875296	1	17316472	1	16989977	875296	862765		NC_000001.11:16989976:G:A
NM_022089.4(ATP13A2):c.2440G>A (p.Val814Met)	ATP13A2	V809M, V814M	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875295	1	17316471	1	16989976	875295	862764		NC_000001.11:16989975:C:T
NM_022089.4(ATP13A2):c.2517G>C (p.Lys839Asn)	ATP13A2	K839N, K834N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875294	1	17316394	1	16989899	875294	862763		NC_000001.11:16989898:C:G
NM_022089.4(ATP13A2):c.2558G>A (p.Arg853His)	ATP13A2	R848H, R809H, R853H	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875293	1	17316237	1	16989742	875293	862762		NC_000001.11:16989741:C:T
NM_022089.4(ATP13A2):c.-171G>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874518	1	17338404	1	17011909	874518	862775		NC_000001.11:17011908:C:G
NM_022089.4(ATP13A2):c.-99G>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874468	1	17338332	1	17011837	874468	862774		NC_000001.11:17011836:C:G
NM_022089.4(ATP13A2):c.1387G>C (p.Asp463His)	ATP13A2	D458H, D463H	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874423	1	17322626	1	16996131	874423	862769		NC_000001.11:16996130:C:G
NM_022089.4(ATP13A2):c.2770C>T (p.Arg924Cys)	ATP13A2	R880C, R919C, R924C	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874374	1	17314722	1	16988227	874374	862761		NC_000001.11:16988226:G:A
NM_022089.4(ATP13A2):c.*9C>A	ATP13A2	H1084N	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000874315	1	17312707	1	16986212	874315	862758		NC_000001.11:16986211:G:T
NM_022089.4(ATP13A2):c.*58A>G	ATP13A2	D1100G	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874314	1	17312658	1	16986163	874314	862757		NC_000001.11:16986162:T:C
NM_022089.4(ATP13A2):c.*140C>G	ATP13A2		Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000874313	1	17312576	1	16986081	874313	862756		NC_000001.11:16986080:G:C
NM_022089.4(ATP13A2):c.558-1G>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic	criteria provided, single submitter	VCV000873473	1	17328869	1	17002374	873473	861603		NC_000001.11:17002373:C:A
NM_022089.4(ATP13A2):c.1847A>C (p.Glu616Ala)	ATP13A2	E616A, E611A	not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000872233	1	17318896	1	16992401	872233	858872		NC_000001.11:16992400:T:G
NM_022089.4(ATP13A2):c.955G>C (p.Val319Leu)	ATP13A2	V319L, V314L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000862331	1	17326590	1	17000095	862331	822984		NC_000001.11:17000094:C:G
NM_022089.4(ATP13A2):c.407C>T (p.Ala136Val)	ATP13A2	A136V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV000856542	1	17331257	1	17004762	856542	822989		NC_000001.11:17004761:G:A
NM_022089.4(ATP13A2):c.3518C>T (p.Pro1173Leu)	ATP13A2	P1173L, P1168L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000856355	1	17312741	1	16986246	856355	822981		NC_000001.11:16986245:G:A
NM_022089.4(ATP13A2):c.1102A>G (p.Thr368Ala)	ATP13A2	T363A, T368A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000856243	1	17323608	1	16997113	856243	822983		NC_000001.11:16997112:T:C
NM_022089.4(ATP13A2):c.1845+1G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000854703	1	17318980	1	16992485	854703	851237		NC_000001.11:16992484:C:T
NM_022089.4(ATP13A2):c.461C>T (p.Ala154Val)	ATP13A2	A154V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 8, 2019)	criteria provided, single submitter	VCV000854384	1	17331203	1	17004708	854384	822987		NC_000001.11:17004707:G:A
NM_022089.4(ATP13A2):c.595C>T (p.Arg199Cys)	ATP13A2	R194C, R199C	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 11, 2019)	criteria provided, single submitter	VCV000845963	1	17328831	1	17002336	845963	822986		NC_000001.11:17002335:G:A
NM_022089.4(ATP13A2):c.146G>T (p.Gly49Val)	ATP13A2	G49V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000845664	1	17332011	1	17005516	845664	822992		NC_000001.11:17005515:C:A
NM_022089.4(ATP13A2):c.3538A>T (p.Arg1180Trp)	ATP13A2	E1079V, R1175W, R1180W	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000845582	1	17312721	1	16986226	845582	822980		NC_000001.11:16986225:T:A
NM_022089.4(ATP13A2):c.1105C>G (p.His369Asp)	ATP13A2	H364D, H369D	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000845242	1	17323605	1	16997110	845242	822982		NC_000001.11:16997109:G:C
NM_022089.4(ATP13A2):c.394G>A (p.Ala132Thr)	ATP13A2	A132T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000843654	1	17331270	1	17004775	843654	822990		NC_000001.11:17004774:C:T
NM_022089.4(ATP13A2):c.816C>G (p.Cys272Trp)	ATP13A2	C267W, C272W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000843251	1	17326919	1	17000424	843251	822985		NC_000001.11:17000423:G:C
NM_022089.4(ATP13A2):c.356C>T (p.Pro119Leu)	ATP13A2	P119L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000835887	1	17331308	1	17004813	835887	822991		NC_000001.11:17004812:G:A
NM_022089.4(ATP13A2):c.839A>G (p.Lys280Arg)	ATP13A2	K275R, K280R	Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000806074	1	17326896	1	17000401	806074	794490	rs148094721	NC_000001.11:17000400:T:C
NM_022089.4(ATP13A2):c.1205C>T (p.Thr402Met)	ATP13A2	T397M, T402M	Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 12, 2021)	criteria provided, conflicting interpretations	VCV000806073	1	17322982	1	16996487	806073	794489	rs763632781	NC_000001.11:16996486:G:A
NM_022089.4(ATP13A2):c.7G>C (p.Ala3Pro)	ATP13A2	A3P	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000804554	1	17338227	1	17011732	804554	792838	rs549839037	NC_000001.11:17011731:C:G
NM_022089.4(ATP13A2):c.1749+2T>G	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801452	1	17320122	1	16993627	801452	789877	rs74058364	NC_000001.11:16993626:A:C
NM_022089.4(ATP13A2):c.3384C>T (p.Phe1128=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Feb 24, 2018)	criteria provided, single submitter	VCV000784784	1	17312979	1	16986484	784784	706864	rs373514205	NC_000001.11:16986483:G:A
NM_022089.4(ATP13A2):c.42C>T (p.Thr14=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 21, 2018)	criteria provided, conflicting interpretations	VCV000778704	1	17332242	1	17005747	778704	696261	rs371850140	NC_000001.11:17005746:G:A
NM_022089.4(ATP13A2):c.2709C>G (p.Val903=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000772797	1	17314870	1	16988375	772797	696255	rs145455452	NC_000001.11:16988374:G:C
NM_022089.4(ATP13A2):c.435G>A (p.Thr145=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV000772607	1	17331229	1	17004734	772607	696260	rs201154350	NC_000001.11:17004733:C:T
NM_022089.4(ATP13A2):c.2013C>T (p.Thr671=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000772292	1	17318617	1	16992122	772292	696256	rs1176219513	NC_000001.11:16992121:G:A
NM_022089.4(ATP13A2):c.3205G>A (p.Ala1069Thr)	ATP13A2	A1069T, A1064T, A1025T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000772041	1	17313330	1	16986835	772041	696253	rs774238872	NC_000001.11:16986834:C:T
NM_022089.4(ATP13A2):c.2919A>G (p.Thr973=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000767232	1	17313705	1	16987210	767232	696254	rs149403933	NC_000001.11:16987209:T:C
NM_022089.4(ATP13A2):c.528C>T (p.Ile176=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000767061	1	17330856	1	17004361	767061	696259	rs371992028	NC_000001.11:17004360:G:A
NM_022089.4(ATP13A2):c.1079G>A (p.Gly360Glu)	ATP13A2	G355E, G360E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000766995	1	17323631	1	16997136	766995	696258	rs566918264	NC_000001.11:16997135:C:T
NM_022089.4(ATP13A2):c.636-7C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000761680	1	17328605	1	17002110	761680	774412	rs762753391	NC_000001.11:17002109:G:A
NM_022089.4(ATP13A2):c.2199G>A (p.Thr733=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000760005	1	17318281	1	16991786	760005	761324	rs1269645931	NC_000001.11:16991785:C:T
NM_022089.4(ATP13A2):c.2529+8C>T	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000750745	1	17316374	1	16989879	750745	758832	rs771708290	NC_000001.11:16989878:G:A
NM_022089.4(ATP13A2):c.1377C>T (p.Ile459=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000749465	1	17322636	1	16996141	749465	745837	rs1570823082	NC_000001.11:16996140:G:A
NM_022089.4(ATP13A2):c.2762+9G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000749013	1	17314808	1	16988313	749013	758879	rs1570769698	NC_000001.11:16988312:C:T
NM_022089.4(ATP13A2):c.2682G>A (p.Ser894=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV000743172	1	17314897	1	16988402	743172	745835	rs767921922	NC_000001.11:16988401:C:T
NM_022089.4(ATP13A2):c.69A>G (p.Thr23=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Nov 7, 2020)	criteria provided, single submitter	VCV000741503	1	17332215	1	17005720	741503	745838	rs1196381069	NC_000001.11:17005719:T:C
NM_022089.4(ATP13A2):c.823C>T (p.Leu275=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV000727989	1	17326912	1	17000417	727989	731862	rs767056514	NC_000001.11:17000416:G:A
NM_022089.4(ATP13A2):c.2061C>T (p.Val687=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000714640	1	17318569	1	16992074	714640	718381	rs370622481	NC_000001.11:16992073:G:A
NM_022089.4(ATP13A2):c.1196-9C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Oct 6, 2019)	criteria provided, single submitter	VCV000712759	1	17323000	1	16996505	712759	729937	rs747077419	NC_000001.11:16996504:G:A
NM_022089.4(ATP13A2):c.111C>T (p.Leu37=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000711585	1	17332046	1	17005551	711585	718383	rs1331180219	NC_000001.11:17005550:G:A
NM_022089.4(ATP13A2):c.1767G>A (p.Pro589=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000707755	1	17319059	1	16992564	707755	690412	rs752208167	NC_000001.11:16992563:C:T
NM_022089.4(ATP13A2):c.423C>T (p.Ala141=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 22, 2019)	criteria provided, single submitter	VCV000707726	1	17331241	1	17004746	707726	690415	rs1258288001	NC_000001.11:17004745:G:A
NM_022089.4(ATP13A2):c.106-5C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000705980	1	17332056	1	17005561	705980	695019	rs117838709	NC_000001.11:17005560:G:A
NM_022089.4(ATP13A2):c.2160G>T (p.Gly720=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000705946	1	17318320	1	16991825	705946	690410	rs61999317	NC_000001.11:16991824:C:A
NM_022089.4(ATP13A2):c.3087C>T (p.Phe1029=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000705032	1	17313448	1	16986953	705032	690409	rs184878897	NC_000001.11:16986952:G:A
NM_022089.4(ATP13A2):c.36G>A (p.Thr12=)	ATP13A2		not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 8, 2018)	criteria provided, conflicting interpretations	VCV000705000	1	17332248	1	17005753	705000	690416	rs61741838	NC_000001.11:17005752:C:T
NM_022089.4(ATP13A2):c.2252-8A>T	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000704722	1	17316790	1	16990295	704722	695016	rs759020707	NC_000001.11:16990294:T:A
NM_022089.4(ATP13A2):c.1543-9C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV000704263	1	17320339	1	16993844	704263	695017	rs563459900	NC_000001.11:16993843:G:A
NM_022089.4(ATP13A2):c.588C>T (p.Asp196=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000703969	1	17328838	1	17002343	703969	690414	rs147384248	NC_000001.11:17002342:G:A
NM_022089.4(ATP13A2):c.705+228A>G	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703790	1	17328301	1	17001806	703790	695018	rs2871776	NC_000001.11:17001805:T:C
NM_022089.4(ATP13A2):c.859G>A (p.Asp287Asn)	ATP13A2	D282N, D287N	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000689486	1	17326789	1	17000294	689486	677123	rs764560082	NC_000001.11:17000293:C:T
NM_022089.4(ATP13A2):c.431A>T (p.Asp144Val)	ATP13A2	D144V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000664804	1	17331233	1	17004738	664804	627073	rs145031260	NC_000001.11:17004737:T:A
NM_022089.4(ATP13A2):c.1017G>C (p.Met339Ile)	ATP13A2	M334I, M339I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000658891	1	17326528	1	17000033	658891	627070	rs1345269003	NC_000001.11:17000032:C:G
NM_022089.4(ATP13A2):c.658G>A (p.Val220Met)	ATP13A2	V220M, V215M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000657632	1	17328576	1	17002081	657632	627071	rs367693423	NC_000001.11:17002080:C:T
NM_022089.4(ATP13A2):c.706-3C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 5, 2018)	criteria provided, single submitter	VCV000654444	1	17327032	1	17000537	654444	650592	rs753707797	NC_000001.11:17000536:G:A
NM_022089.4(ATP13A2):c.2951C>T (p.Ala984Val)	ATP13A2	A940V, A979V, A984V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000653589	1	17313673	1	16987178	653589	627063	rs375552345	NC_000001.11:16987177:G:A
NM_022089.4(ATP13A2):c.1896G>A (p.Ser632=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000652812	1	17318847	1	16992352	652812	627065	rs575694238	NC_000001.11:16992351:C:T
NM_022089.4(ATP13A2):c.233G>A (p.Arg78Gln)	ATP13A2	R78Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 21, 2018)	criteria provided, single submitter	VCV000651864	1	17331924	1	17005429	651864	627074	rs773087322	NC_000001.11:17005428:C:T
NM_022089.4(ATP13A2):c.509G>T (p.Gly170Val)	ATP13A2	G170V, G165V	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000651385	1	17330875	1	17004380	651385	627072	rs1369312171	NC_000001.11:17004379:C:A
NM_022089.4(ATP13A2):c.212G>T (p.Trp71Leu)	ATP13A2	W71L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000649178	1	17331945	1	17005450	649178	627075	rs373607247	NC_000001.11:17005449:C:A
NM_022089.4(ATP13A2):c.1876C>T (p.His626Tyr)	ATP13A2	H626Y, H621Y	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000647413	1	17318867	1	16992372	647413	627066	rs778267471	NC_000001.11:16992371:G:A
NM_022089.4(ATP13A2):c.35C>T (p.Thr12Met)	ATP13A2	T12M	Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000646881	1	17332249	1	17005754	646881	627076	rs151117874	NC_000001.11:17005753:G:A
NM_022089.4(ATP13A2):c.1634G>A (p.Arg545His)	ATP13A2	R540H, R545H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000646609	1	17320239	1	16993744	646609	627067	rs200337290	NC_000001.11:16993743:C:T
NM_022089.4(ATP13A2):c.2828C>T (p.Thr943Ile)	ATP13A2	T938I, T899I, T943I	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000645131	1	17314664	1	16988169	645131	627064	rs1401431520	NC_000001.11:16988168:G:A
NM_022089.4(ATP13A2):c.2978C>T (p.Pro993Leu)	ATP13A2	P993L, P988L, P949L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000644097	1	17313646	1	16987151	644097	627062	rs146559160	NC_000001.11:16987150:G:A
NM_022089.4(ATP13A2):c.2995G>A (p.Val999Met)	ATP13A2	V999M, V955M, V994M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000643225	1	17313629	1	16987134	643225	627061	rs764162255	NC_000001.11:16987133:C:T
NM_022089.4(ATP13A2):c.1126T>C (p.Cys376Arg)	ATP13A2	C376R, C371R	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000642320	1	17323584	1	16997089	642320	627068	rs1570833382	NC_000001.11:16997088:A:G
NM_022089.4(ATP13A2):c.1103C>T (p.Thr368Ile)	ATP13A2	T363I, T368I	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000641968	1	17323607	1	16997112	641968	627069	rs1033088325	NC_000001.11:16997111:G:A
NM_022089.4(ATP13A2):c.2640C>T (p.Ala880=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000626064	1	17314939	1	16988444	626064	614198	rs567287489	NC_000001.11:16988443:G:A
NM_022089.4(ATP13A2):c.2746G>A (p.Val916Met)	ATP13A2	V916M, V872M, V911M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000626063	1	17314833	1	16988338	626063	614197	rs768674400	NC_000001.11:16988337:C:T
NM_022089.4(ATP13A2):c.3405+9C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000626062	1	17312949	1	16986454	626062	614196	rs374766933	NC_000001.11:16986453:G:A
NM_022089.4(ATP13A2):c.1039+6C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625890	1	17326500	1	17000005	625890	614200	rs565724504	NC_000001.11:17000004:G:A
NM_022089.4(ATP13A2):c.1542+3G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000625889	1	17322468	1	16995973	625889	614199	rs747456787	NC_000001.11:16995972:C:T
NM_022089.4(ATP13A2):c.1080G>C (p.Gly360=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2020)	criteria provided, conflicting interpretations	VCV000596731	1	17323630	1	16997135	596731	587792	rs55943100	NC_000001.11:16997134:C:G
NM_022089.4(ATP13A2):c.3258G>A (p.Ala1086=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2020)	criteria provided, conflicting interpretations	VCV000593131	1	17313105	1	16986610	593131	584195	rs377253172	NC_000001.11:16986609:C:T
NM_022089.4(ATP13A2):c.2020G>A (p.Ala674Thr)	ATP13A2	A674T, A669T	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000590155	1	17318610	1	16992115	590155	578784	rs143834546	NC_000001.11:16992114:C:T
NM_022089.4(ATP13A2):c.2151C>T (p.Ser717=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590119	1	17318329	1	16991834	590119	578779	rs544545629	NC_000001.11:16991833:G:A
NM_022089.4(ATP13A2):c.114C>T (p.Ser38=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 13, 2019)	criteria provided, conflicting interpretations	VCV000590096	1	17332043	1	17005548	590096	578804	rs368279466	NC_000001.11:17005547:G:A
NM_022089.4(ATP13A2):c.1536C>T (p.Phe512=)	ATP13A2		History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590058	1	17322477	1	16995982	590058	578811	rs536306337	NC_000001.11:16995981:G:A
NM_022089.4(ATP13A2):c.3257C>T (p.Ala1086Val)	ATP13A2	A1086V, A1081V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589979	1	17313106	1	16986611	589979	578794	rs370677966	NC_000001.11:16986610:G:A
NM_022089.4(ATP13A2):c.2221A>C (p.Arg741=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jun 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000589241	1	17318259	1	16991764	589241	578776	rs754926284	NC_000001.11:16991763:T:G
NM_022089.4(ATP13A2):c.1399G>A (p.Val467Met)	ATP13A2	V467M, V462M	History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000588886	1	17322614	1	16996119	588886	578793	rs760443267	NC_000001.11:16996118:C:T
NM_022089.4(ATP13A2):c.3342C>T (p.Thr1114=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)	criteria provided, conflicting interpretations	VCV000588527	1	17313021	1	16986526	588527	578790	rs115985012	NC_000001.11:16986525:G:A
NM_022089.4(ATP13A2):c.145G>A (p.Gly49Ser)	ATP13A2	G49S	Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588136	1	17332012	1	17005517	588136	578803	rs56379718	NC_000001.11:17005516:C:T
NM_022089.4(ATP13A2):c.3529G>A (p.Gly1177Ser)	ATP13A2	G1177S, G1172S, R1076Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 29, 2020)	criteria provided, conflicting interpretations	VCV000587913	1	17312730	1	16986235	587913	578778	rs547860186	NC_000001.11:16986234:C:T
NM_022089.4(ATP13A2):c.3222G>A (p.Pro1074=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2020)	criteria provided, conflicting interpretations	VCV000585471	1	17313313	1	16986818	585471	576436	rs372993383	NC_000001.11:16986817:C:T
NM_022089.4(ATP13A2):c.252C>T (p.His84=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000585469	1	17331905	1	17005410	585469	576441	rs554944790	NC_000001.11:17005409:G:A
NM_022089.4(ATP13A2):c.2198C>T (p.Thr733Met)	ATP13A2	T733M, T728M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000585467	1	17318282	1	16991787	585467	576438	rs201883464	NC_000001.11:16991786:G:A
NM_022089.4(ATP13A2):c.746C>T (p.Ala249Val)	ATP13A2	A249V, A244V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2020)	criteria provided, conflicting interpretations	VCV000585085	1	17326989	1	17000494	585085	576078	rs145515028	NC_000001.11:17000493:G:A
NM_022089.4(ATP13A2):c.3329A>G (p.Asn1110Ser)	ATP13A2	N1110S, N1105S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV000583336	1	17313034	1	16986539	583336	558224	rs758675397	NC_000001.11:16986538:T:C
NM_022089.4(ATP13A2):c.2T>G (p.Met1Arg)	ATP13A2	M1R	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000583076	1	17338232	1	17011737	583076	558234	rs1557729552	NC_000001.11:17011736:A:C
NM_022089.4(ATP13A2):c.656A>G (p.Asn219Ser)	ATP13A2	N219S, N214S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000582385	1	17328578	1	17002083	582385	557038	rs776406555	NC_000001.11:17002082:T:C
NM_022089.4(ATP13A2):c.649G>A (p.Gly217Ser)	ATP13A2	G217S, G212S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000582023	1	17328585	1	17002090	582023	556688	rs199961048	NC_000001.11:17002089:C:T
NM_022089.4(ATP13A2):c.574C>T (p.Arg192Cys)	ATP13A2	R192C, R187C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000579676	1	17328852	1	17002357	579676	558230	rs372857244	NC_000001.11:17002356:G:A
NM_022089.4(ATP13A2):c.385C>T (p.Arg129Trp)	ATP13A2	R129W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000579095	1	17331279	1	17004784	579095	558232	rs1318096890	NC_000001.11:17004783:G:A
NM_022089.4(ATP13A2):c.1630C>T (p.Arg544Cys)	ATP13A2	R544C, R539C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000578934	1	17320243	1	16993748	578934	556739	rs893985839	NC_000001.11:16993747:G:A
NM_022089.4(ATP13A2):c.811A>G (p.Ile271Val)	ATP13A2	I271V, I266V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000577023	1	17326924	1	17000429	577023	557034	rs561097876	NC_000001.11:17000428:T:C
NM_022089.4(ATP13A2):c.2557C>G (p.Arg853Gly)	ATP13A2	R853G, R848G, R809G	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000576357	1	17316238	1	16989743	576357	558226	rs772243999	NC_000001.11:16989742:G:C
NM_022089.4(ATP13A2):c.769T>C (p.Tyr257His)	ATP13A2	Y257H, Y252H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: May 22, 2018)	criteria provided, single submitter	VCV000572420	1	17326966	1	17000471	572420	557036	rs370403918	NC_000001.11:17000470:A:G
NM_022089.4(ATP13A2):c.813C>G (p.Ile271Met)	ATP13A2	I271M, I266M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 8, 2019)	criteria provided, single submitter	VCV000570178	1	17326922	1	17000427	570178	556686	rs1557703924	NC_000001.11:17000426:G:C
NM_022089.4(ATP13A2):c.472G>A (p.Gly158Arg)	ATP13A2	G158R	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000569020	1	17331192	1	17004697	569020	556741	rs113643181	NC_000001.11:17004696:C:T
NM_022089.4(ATP13A2):c.3314C>T (p.Pro1105Leu)	ATP13A2	P1105L, P1100L	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000568939	1	17313049	1	16986554	568939	556737	rs201756175	NC_000001.11:16986553:G:A
NM_022089.4(ATP13A2):c.3409G>A (p.Val1137Met)	ATP13A2	V1137M, V1132M, R1036H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000567500	1	17312850	1	16986355	567500	558222	rs528943677	NC_000001.11:16986354:C:T
NM_022089.4(ATP13A2):c.878T>C (p.Met293Thr)	ATP13A2	M293T, M288T	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000567424	1	17326770	1	17000275	567424	558228	rs772414750	NC_000001.11:17000274:A:G
NM_022089.4(ATP13A2):c.2972G>A (p.Arg991Gln)	ATP13A2	R991Q, R947Q, R986Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566669	1	17313652	1	16987157	566669	556682	rs145548316	NC_000001.11:16987156:C:T
NM_022089.4(ATP13A2):c.2260C>G (p.Leu754Val)	ATP13A2	L754V, L749V	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000566479	1	17316774	1	16990279	566479	556684	rs139909551	NC_000001.11:16990278:G:C
NM_022089.4(ATP13A2):c.2763-16G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000559003	1	17314745	1	16988250	559003	549506	rs114407349	NC_000001.11:16988249:C:T
NM_022089.4(ATP13A2):c.3236-30C>T	ATP13A2		Kufor-Rakeb syndrome|not provided|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000559000	1	17313157	1	16986662	559000	549503	rs2076605	NC_000001.11:16986661:G:A
NM_022089.4(ATP13A2):c.3473G>A (p.Arg1158His)	ATP13A2	R1158H, R1153H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000558999	1	17312786	1	16986291	558999	549502	rs544885605	NC_000001.11:16986290:C:T
NM_022089.4(ATP13A2):c.477+2T>G	ATP13A2		not provided|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Neurodegeneration with brain iron accumulation	Likely pathogenic(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000546591	1	17331185	1	17004690	546591	537080	rs758014228	NC_000001.11:17004689:A:C
NM_022089.4(ATP13A2):c.1711G>A (p.Asp571Asn)	ATP13A2	D571N, D566N	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 16, 2020)	criteria provided, conflicting interpretations	VCV000546326	1	17320162	1	16993667	546326	536569	rs369863178	NC_000001.11:16993666:C:T
NM_022089.4(ATP13A2):c.844A>T (p.Ser282Cys)	ATP13A2	S282C, S277C	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000533811	1	17326804	1	17000309	533811	515306	rs538497077	NC_000001.11:17000308:T:A
NM_022089.4(ATP13A2):c.2093T>C (p.Val698Ala)	ATP13A2	V698A, V693A	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533810	1	17318537	1	16992042	533810	515265	rs61734958	NC_000001.11:16992041:A:G
NM_022089.4(ATP13A2):c.2610-9T>C	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV000533809	1	17314978	1	16988483	533809	515351	rs376189607	NC_000001.11:16988482:A:G
NM_022089.4(ATP13A2):c.745G>A (p.Ala249Thr)	ATP13A2	A249T, A244T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533808	1	17326990	1	17000495	533808	515315	rs199661793	NC_000001.11:17000494:C:T
NM_022089.4(ATP13A2):c.2899G>C (p.Asp967His)	ATP13A2	D967H, D923H, D962H	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000533807	1	17313725	1	16987230	533807	515264	rs772870846	NC_000001.11:16987229:C:G
NM_022089.4(ATP13A2):c.2158G>T (p.Gly720Trp)	ATP13A2	G720W, G715W	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000533806	1	17318322	1	16991827	533806	515354	rs865939676	NC_000001.11:16991826:C:A
NM_022089.4(ATP13A2):c.3476T>C (p.Phe1159Ser)	ATP13A2	F1159S, F1154S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000533805	1	17312783	1	16986288	533805	515274	rs1553164387	NC_000001.11:16986287:A:G
NM_022089.4(ATP13A2):c.1895C>T (p.Ser632Leu)	ATP13A2	S632L, S627L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000533804	1	17318848	1	16992353	533804	515276	rs376070950	NC_000001.11:16992352:G:A
NM_022089.4(ATP13A2):c.2942C>T (p.Thr981Met)	ATP13A2	T981M, T937M, T976M	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2019)	criteria provided, conflicting interpretations	VCV000533803	1	17313682	1	16987187	533803	515262	rs148201608	NC_000001.11:16987186:G:A
NM_022089.4(ATP13A2):c.2404G>A (p.Gly802Ser)	ATP13A2	G802S, G797S	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533802	1	17316630	1	16990135	533802	515352	rs752487771	NC_000001.11:16990134:C:T
NM_022089.4(ATP13A2):c.1171G>A (p.Val391Ile)	ATP13A2	V391I, V386I	History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000500604	1	17323539	1	16997044	500604	492028	rs113105667	NC_000001.11:16997043:C:T
NM_022089.4(ATP13A2):c.*120A>T	ATP13A2	T1121S	Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493023	1	17312596	1	16986101	493023	485986	rs41273151	NC_000001.11:16986100:T:A
NM_022089.4(ATP13A2):c.777C>T (p.Tyr259=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: May 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465265	1	17326958	1	17000463	465265	447421	rs780133367	NC_000001.11:17000462:G:A
NM_022089.4(ATP13A2):c.508G>A (p.Gly170Ser)	ATP13A2	G170S, G165S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000465264	1	17330876	1	17004381	465264	447430	rs762075619	NC_000001.11:17004380:C:T
NM_022089.4(ATP13A2):c.453C>T (p.Ser151=)	ATP13A2		not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not specified	Benign/Likely benign(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465263	1	17331211	1	17004716	465263	447484	rs55979991	NC_000001.11:17004715:G:A
NM_022089.4(ATP13A2):c.3175C>T (p.Leu1059Phe)	ATP13A2	L1059F, L1015F, L1054F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000465262	1	17313360	1	16986865	465262	447270	rs764410859	NC_000001.11:16986864:G:A
NM_022089.4(ATP13A2):c.3084-10G>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000465261	1	17313461	1	16986966	465261	447277	rs368908107	NC_000001.11:16986965:C:A
NM_022089.4(ATP13A2):c.2412G>A (p.Lys804=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, single submitter	VCV000465260	1	17316622	1	16990127	465260	447410	rs978493820	NC_000001.11:16990126:C:T
NM_022089.4(ATP13A2):c.2367C>T (p.Leu789=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465259	1	17316667	1	16990172	465259	447369	rs140048110	NC_000001.11:16990171:G:A
NM_022089.4(ATP13A2):c.2348G>A (p.Arg783Gln)	ATP13A2	R783Q, R778Q	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Benign/Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465258	1	17316686	1	16990191	465258	447469	rs137955309	NC_000001.11:16990190:C:T
NM_022089.4(ATP13A2):c.2236G>A (p.Ala746Thr)	ATP13A2	A746T, A741T	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: May 22, 2017)	criteria provided, single submitter	VCV000465257	1	17318244	1	16991749	465257	447278	rs147277743	NC_000001.11:16991748:C:T
NM_022089.4(ATP13A2):c.1831C>A (p.Gln611Lys)	ATP13A2	Q611K, Q606K	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000465256	1	17318995	1	16992500	465256	447418	rs770682887	NC_000001.11:16992499:G:T
NM_022089.4(ATP13A2):c.1545G>A (p.Thr515=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000465255	1	17320328	1	16993833	465255	447279	rs373005131	NC_000001.11:16993832:C:T
NM_022089.4(ATP13A2):c.1195+7G>A	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000465254	1	17323508	1	16997013	465254	447476	rs1407939803	NC_000001.11:16997012:C:T
NM_022089.4(ATP13A2):c.1903C>T (p.Gln635Ter)	ATP13A2	Q635*, Q630*	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465252	1	17318840	1	16992345	465252	447471	rs773246271	NC_000001.11:16992344:G:A
NM_022089.4(ATP13A2):c.3472C>T (p.Arg1158Cys)	ATP13A2	R1158C, R1153C, A1057V	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000444159	1	17312787	1	16986292	444159	437799	rs201610681	NC_000001.11:16986291:G:A
NM_022089.4(ATP13A2):c.*24C>T	ATP13A2	H1089Y	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Apr 1, 2017)	criteria provided, single submitter	VCV000441003	1	17312692	1	16986197	441003	434562	rs375521810	NC_000001.11:16986196:G:A
NM_022089.4(ATP13A2):c.3277G>C (p.Val1093Leu)	ATP13A2	V1093L, V1088L	not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000387937	1	17313086	1	16986591	387937	364534	rs1057522952	NC_000001.11:16986590:C:G
NM_022089.4(ATP13A2):c.-170C>T	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293806	1	17338403	1	17011908	293806	278400	rs150122517	NC_000001.11:17011907:G:A
NM_022089.4(ATP13A2):c.-151C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000293805	1	17338384	1	17011889	293805	278429	rs886045583	NC_000001.11:17011888:G:A
NM_022089.4(ATP13A2):c.106-14C>T	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293804	1	17332065	1	17005570	293804	278416	rs199706883	NC_000001.11:17005569:G:A
NM_022089.4(ATP13A2):c.396G>A (p.Ala132=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2019)	criteria provided, conflicting interpretations	VCV000293803	1	17331268	1	17004773	293803	278414	rs140631323	NC_000001.11:17004772:C:T
NM_022089.4(ATP13A2):c.951C>T (p.Cys317=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2021)	criteria provided, conflicting interpretations	VCV000293802	1	17326594	1	17000099	293802	277554	rs148391179	NC_000001.11:17000098:G:A
NM_022089.4(ATP13A2):c.1040-6C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293801	1	17323676	1	16997181	293801	277347	rs886045582	NC_000001.11:16997180:G:A
NM_022089.4(ATP13A2):c.1065G>A (p.Thr355=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293800	1	17323645	1	16997150	293800	278396	rs750819290	NC_000001.11:16997149:C:T
NM_022089.4(ATP13A2):c.1128C>T (p.Cys376=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 9, 2021)	criteria provided, conflicting interpretations	VCV000293799	1	17323582	1	16997087	293799	278393	rs148970081	NC_000001.11:16997086:G:A
NM_022089.4(ATP13A2):c.1163G>A (p.Gly388Glu)	ATP13A2	G388E, G383E	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000293798	1	17323547	1	16997052	293798	277552	rs769588580	NC_000001.11:16997051:C:T
NM_022089.4(ATP13A2):c.1195+9C>T	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293797	1	17323506	1	16997011	293797	278392	rs117758987	NC_000001.11:16997010:G:A
NM_022089.4(ATP13A2):c.1203C>T (p.Cys401=)	ATP13A2		Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)	criteria provided, conflicting interpretations	VCV000293796	1	17322984	1	16996489	293796	277550	rs148026506	NC_000001.11:16996488:G:A
NM_022089.4(ATP13A2):c.1208C>A (p.Ala403Glu)	ATP13A2	A403E, A398E	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293795	1	17322979	1	16996484	293795	277332	rs373349384	NC_000001.11:16996483:G:T
NM_022089.4(ATP13A2):c.1244G>A (p.Arg415Gln)	ATP13A2	R415Q, R410Q	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293794	1	17322943	1	16996448	293794	278390	rs190746040	NC_000001.11:16996447:C:T
NM_022089.4(ATP13A2):c.1309C>G (p.Leu437Val)	ATP13A2	L437V, L432V	History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 4, 2021)	criteria provided, conflicting interpretations	VCV000293793	1	17322793	1	16996298	293793	277331	rs149372969	NC_000001.11:16996297:G:C
NM_022089.4(ATP13A2):c.1314C>A (p.Leu438=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293792	1	17322788	1	16996293	293792	277547	rs764435162	NC_000001.11:16996292:G:T
NM_022089.4(ATP13A2):c.1420C>G (p.Pro474Ala)	ATP13A2	P474A, P469A	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293791	1	17322593	1	16996098	293791	278389	rs530658980	NC_000001.11:16996097:G:C
NM_022089.4(ATP13A2):c.1442C>T (p.Thr481Met)	ATP13A2	T481M, T476M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293790	1	17322571	1	16996076	293790	277328	rs752000462	NC_000001.11:16996075:G:A
NM_022089.4(ATP13A2):c.1449C>T (p.Tyr483=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000293789	1	17322564	1	16996069	293789	277326	rs750600448	NC_000001.11:16996068:G:A
NM_022089.4(ATP13A2):c.1744G>A (p.Gly582Ser)	ATP13A2	G582S, G577S	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293788	1	17320129	1	16993634	293788	278388	rs886045581	NC_000001.11:16993633:C:T
NM_022089.4(ATP13A2):c.1926G>A (p.Ala642=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2020)	criteria provided, conflicting interpretations	VCV000293787	1	17318817	1	16992322	293787	278413	rs200916673	NC_000001.11:16992321:C:T
NM_022089.4(ATP13A2):c.1947C>G (p.Pro649=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000293786	1	17318796	1	16992301	293786	277544	rs369722835	NC_000001.11:16992300:G:C
NM_022089.4(ATP13A2):c.2252-11A>G	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293785	1	17316793	1	16990298	293785	277539	rs775547036	NC_000001.11:16990297:T:C
NM_022089.4(ATP13A2):c.2263C>G (p.Gln755Glu)	ATP13A2	Q755E, Q750E	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|History of neurodevelopmental disorder|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Uncertain significance(Last reviewed: Aug 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293784	1	17316771	1	16990276	293784	278382	rs200924194	NC_000001.11:16990275:G:C
NM_022089.4(ATP13A2):c.2285G>A (p.Arg762Gln)	ATP13A2	R762Q, R757Q	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000293783	1	17316749	1	16990254	293783	277323	rs766899425	NC_000001.11:16990253:C:T
NM_022089.4(ATP13A2):c.2331C>T (p.His777=)	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000293782	1	17316703	1	16990208	293782	278410	rs144708504	NC_000001.11:16990207:G:A
NM_022089.4(ATP13A2):c.2381T>C (p.Met794Thr)	ATP13A2	M794T, M789T	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293781	1	17316653	1	16990158	293781	277313	rs151222153	NC_000001.11:16990157:A:G
NM_022089.4(ATP13A2):c.2406C>T (p.Gly802=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293780	1	17316628	1	16990133	293780	277312	rs886045580	NC_000001.11:16990132:G:A
NM_022089.4(ATP13A2):c.2407G>A (p.Val803Ile)	ATP13A2	V803I, V798I	Kufor-Rakeb syndrome|not provided	Uncertain significance(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293779	1	17316627	1	16990132	293779	277311	rs747785443	NC_000001.11:16990131:C:T
NM_022089.4(ATP13A2):c.2529+9G>A	ATP13A2		Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293778	1	17316373	1	16989878	293778	277309	rs200809857	NC_000001.11:16989877:C:T
NM_022089.4(ATP13A2):c.2563G>A (p.Ala855Thr)	ATP13A2	A855T, A811T, A850T	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293777	1	17316232	1	16989737	293777	277305	rs886045579	NC_000001.11:16989736:C:T
NM_022089.4(ATP13A2):c.2609+10C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293776	1	17316176	1	16989681	293776	277532	rs759204814	NC_000001.11:16989680:G:A
NM_022089.4(ATP13A2):c.2619G>C (p.Val873=)	ATP13A2		Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 24, 2020)	criteria provided, conflicting interpretations	VCV000293775	1	17314960	1	16988465	293775	278381	rs199994961	NC_000001.11:16988464:C:G
NM_022089.4(ATP13A2):c.2808C>T (p.Tyr936=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293774	1	17314684	1	16988189	293774	277299	rs886045578	NC_000001.11:16988188:G:A
NM_022089.4(ATP13A2):c.2952G>A (p.Ala984=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293773	1	17313672	1	16987177	293773	278380	rs138212767	NC_000001.11:16987176:C:T
NM_022089.4(ATP13A2):c.3111C>T (p.Ala1037=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293772	1	17313424	1	16986929	293772	278402	rs538236343	NC_000001.11:16986928:G:A
NM_022089.4(ATP13A2):c.3193G>A (p.Val1065Met)	ATP13A2	V1065M, V1021M, V1060M	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Dec 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293771	1	17313342	1	16986847	293771	277530	rs377431904	NC_000001.11:16986846:C:T
NM_022089.4(ATP13A2):c.3258G>C (p.Ala1086=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293770	1	17313105	1	16986610	293770	278375	rs377253172	NC_000001.11:16986609:C:G
NM_022089.4(ATP13A2):c.3297C>T (p.Pro1099=)	ATP13A2		History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000293769	1	17313066	1	16986571	293769	277520	rs756650754	NC_000001.11:16986570:G:A
NM_022089.4(ATP13A2):c.3301C>T (p.Leu1101Phe)	ATP13A2	L1101F, L1096F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000293768	1	17313062	1	16986567	293768	278394	rs886045577	NC_000001.11:16986566:G:A
NM_022089.4(ATP13A2):c.3378C>T (p.Leu1126=)	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293767	1	17312985	1	16986490	293767	278370	rs773914880	NC_000001.11:16986489:G:A
NM_022089.4(ATP13A2):c.3406-14C>T	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293766	1	17312867	1	16986372	293766	277296	rs139088170	NC_000001.11:16986371:G:A
NM_022089.4(ATP13A2):c.3429C>T (p.Pro1143=)	ATP13A2	R1043C	Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2021)	criteria provided, conflicting interpretations	VCV000293765	1	17312830	1	16986335	293765	277512	rs377703085	NC_000001.11:16986334:G:A
NM_022089.4(ATP13A2):c.3539G>A (p.Arg1180Lys)	ATP13A2	R1180K, R1175K	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293764	1	17312720	1	16986225	293764	278367	rs771312962	NC_000001.11:16986224:C:T
NM_022089.4(ATP13A2):c.*124C>T	ATP13A2	P1122L	Kufor-Rakeb syndrome|not provided	Benign(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000293763	1	17312592	1	16986097	293763	277295	rs15786	NC_000001.11:16986096:G:A
NM_022089.4(ATP13A2):c.*130C>T	ATP13A2	P1124L	Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 1, 2020)	criteria provided, conflicting interpretations	VCV000293762	1	17312586	1	16986091	293762	277511	rs189334432	NC_000001.11:16986090:G:A
NM_022089.4(ATP13A2):c.*155C>T	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293761	1	17312561	1	16986066	293761	277510	rs762111359	NC_000001.11:16986065:G:A
NM_022089.4(ATP13A2):c.*158T>C	ATP13A2		Kufor-Rakeb syndrome|not provided	Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000293760	1	17312558	1	16986063	293760	278387	rs185521359	NC_000001.11:16986062:A:G
NM_022089.4(ATP13A2):c.*243A>C	ATP13A2		Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000293759	1	17312473	1	16985978	293759	278366	rs777596557	NC_000001.11:16985977:T:G
NM_022089.4(ATP13A2):c.*251A>G	ATP13A2		Kufor-Rakeb syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000293758	1	17312465	1	16985970	293758	278365	rs535432261	NC_000001.11:16985969:T:C
NM_022089.4(ATP13A2):c.841-4A>G	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 10, 2020)	criteria provided, conflicting interpretations	VCV000287582	1	17326811	1	17000316	287582	271819	rs112549590	NC_000001.11:17000315:T:C
NM_022089.4(ATP13A2):c.3235+17G>A	ATP13A2		not specified|not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261542	1	17313283	1	16986788	261542	249527	rs56146840	NC_000001.11:16986787:C:T
NM_022089.4(ATP13A2):c.1614C>T (p.Pro538=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261541	1	17320259	1	16993764	261541	249528	rs56351817	NC_000001.11:16993763:G:A
NM_022089.4(ATP13A2):c.132A>G (p.Pro44=)	ATP13A2		Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000261540	1	17332025	1	17005530	261540	249529	rs200816691	NC_000001.11:17005529:T:C
NM_022089.4(ATP13A2):c.2859G>A (p.Thr953=)	ATP13A2		not specified|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000210381	1	17314633	1	16988138	210381	206728	rs144557304	NC_000001.11:16988137:C:T
NM_022089.4(ATP13A2):c.1352G>A (p.Arg451Gln)	ATP13A2	R451Q, R446Q	not specified|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2020)	criteria provided, conflicting interpretations	VCV000210380	1	17322750	1	16996255	210380	206729	rs138546275	NC_000001.11:16996254:C:T
NM_022089.4(ATP13A2):c.106-8G>A	ATP13A2		not specified|not provided|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000210379	1	17332059	1	17005564	210379	206730	rs200587951	NC_000001.11:17005563:C:T
NM_022089.4(ATP13A2):c.943G>A (p.Gly315Arg)	ATP13A2	G315R, G310R	Kufor-Rakeb syndrome	Likely pathogenic(Last reviewed: Jan 29, 2013)	criteria provided, single submitter	VCV000209136	1	17326602	1	17000107	209136	205722	rs150519745	NC_000001.11:17000106:C:T
NM_022089.4(ATP13A2):c.1195+10G>A	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194113	1	17323505	1	16997010	194113	191276	rs55689004	NC_000001.11:16997009:C:T
NM_022089.4(ATP13A2):c.993C>T (p.Ala331=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jul 30, 2019)	criteria provided, conflicting interpretations	VCV000193926	1	17326552	1	17000057	193926	191089	rs568367953	NC_000001.11:17000056:G:A
NM_022089.4(ATP13A2):c.490C>T (p.Arg164Trp)	ATP13A2	R164W, R159W	Kufor-Rakeb syndrome	Pathogenic	no assertion criteria provided	VCV000143196	1	17330894	1	17004399	143196	152914	rs199624796	NC_000001.11:17004398:G:A
NM_022089.4(ATP13A2):c.881G>A (p.Arg294Gln)	ATP13A2	R294Q, R289Q	not specified|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128476	1	17326767	1	17000272	128476	133925	rs56367069	NC_000001.11:17000271:C:T
NM_022089.4(ATP13A2):c.3516G>A (p.Pro1172=)	ATP13A2	A1072T	not provided|not specified|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128475	1	17312743	1	16986248	128475	133924	rs3170740	NC_000001.11:16986247:C:T
NM_022089.4(ATP13A2):c.3430G>A (p.Ala1144Thr)	ATP13A2	A1144T, A1139T, R1043H	not provided|not specified|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128474	1	17312829	1	16986334	128474	133923	rs151181674	NC_000001.11:16986333:C:T
NM_022089.4(ATP13A2):c.3192C>T (p.Ala1064=)	ATP13A2		not provided|not specified|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128473	1	17313343	1	16986848	128473	133922	rs9435659	NC_000001.11:16986847:G:A
NM_022089.4(ATP13A2):c.3144C>G (p.Thr1048=)	ATP13A2		not provided|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified|Kufor-Rakeb syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128472	1	17313391	1	16986896	128472	133921	rs56126202	NC_000001.11:16986895:G:C
NM_022089.4(ATP13A2):c.3084-3C>T	ATP13A2		not provided|not specified|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128471	1	17313454	1	16986959	128471	133920	rs7531163	NC_000001.11:16986958:G:A
NM_022089.4(ATP13A2):c.2970G>A (p.Val990=)	ATP13A2		not specified|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128470	1	17313654	1	16987159	128470	133919	rs761421	NC_000001.11:16987158:C:T
NM_022089.4(ATP13A2):c.2836A>T (p.Ile946Phe)	ATP13A2	I946F, I941F, I902F	Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000128469	1	17314656	1	16988161	128469	133918	rs55708915	NC_000001.11:16988160:T:A
NM_022089.4(ATP13A2):c.2790G>A (p.Ser930=)	ATP13A2		not specified|not provided|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128468	1	17314702	1	16988207	128468	133917	rs3738815	NC_000001.11:16988206:C:T
NM_022089.4(ATP13A2):c.2724G>A (p.Ser908=)	ATP13A2		not specified|not provided|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Kufor-Rakeb syndrome	Benign/Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128467	1	17314855	1	16988360	128467	133916	rs79724242	NC_000001.11:16988359:C:T
NM_022089.4(ATP13A2):c.2637C>T (p.Gly879=)	ATP13A2		not provided|not specified|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128466	1	17314942	1	16988447	128466	133915	rs9435662	NC_000001.11:16988446:G:A
NM_022089.4(ATP13A2):c.1815C>T (p.Pro605=)	ATP13A2		not provided|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome|not specified|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128465	1	17319011	1	16992516	128465	133914	rs2076603	NC_000001.11:16992515:G:A
NM_022089.4(ATP13A2):c.1617G>T (p.Leu539=)	ATP13A2		not specified|not provided|History of neurodevelopmental disorder|Kufor-Rakeb syndrome|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128464	1	17320256	1	16993761	128464	133913	rs61739752	NC_000001.11:16993760:C:A
NM_022089.4(ATP13A2):c.1005C>T (p.Ala335=)	ATP13A2		not provided|not specified|Kufor-Rakeb syndrome|History of neurodevelopmental disorder|Spastic paraplegia 78, autosomal recessive|Kufor-Rakeb syndrome	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000128463	1	17326540	1	17000045	128463	133912	rs56290406	NC_000001.11:17000044:G:A
NM_022089.4(ATP13A2):c.1108C>T (p.Arg370Trp)	ATP13A2	R370W, R365W	Kufor-Rakeb syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000069026	1	17323602	1	16997107	69026	79917		NC_000001.11:16997106:G:A
NM_022089.4(ATP13A2):c.2629G>A (p.Gly877Arg)	ATP13A2	G877R, G833R, G872R	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Feb 1, 2011)	no assertion criteria provided	VCV000066099	1	17314950	1	16988455	66099	77001	rs144701072	NC_000001.11:16988454:C:T
NM_022089.4(ATP13A2):c.2561T>G (p.Met854Arg)	ATP13A2	M810R, M854R, M849R	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Jun 15, 2012)	no assertion criteria provided	VCV000066098	1	17316234	1	16989739	66098	77000	rs587777053	NC_000001.11:16989738:A:C
NM_022089.4(ATP13A2):c.1510G>C (p.Gly504Arg)	ATP13A2	G504R, G499R	Kufor-Rakeb syndrome	Pathogenic(Last reviewed: May 8, 2007)	no assertion criteria provided	VCV000001221	1	17322503	1	16996008	1221	16260	rs121918227	NC_000001.11:16996007:C:G
NM_022089.4(ATP13A2):c.1306+5G>A	ATP13A2		Kufor-Rakeb syndrome	Pathogenic(Last reviewed: Aug 26, 2011)	no assertion criteria provided	VCV000001219	1	17322876	1	16996381	1219	16258	rs786205056	NC_000001.11:16996380:C:T
NM_181575.5(AUP1):c.-54C>T	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000897609	2	74756810	2	74529683	897609	885477		NC_000002.12:74529682:G:A
NM_181575.5(AUP1):c.-17C>T	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000896015	2	74756773	2	74529646	896015	885476		NC_000002.12:74529645:G:A
NM_181575.5(AUP1):c.51-4C>T	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896014	2	74756630	2	74529503	896014	885475		NC_000002.12:74529502:G:A
NM_181575.5(AUP1):c.141C>T (p.Ile47=)	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000896013	2	74756536	2	74529409	896013	885474		NC_000002.12:74529408:G:A
NM_181575.5(AUP1):c.-64C>T	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337121	2	74756820	2	74529693	337121	288015	rs377647662	NC_000002.12:74529692:G:A
NM_181575.5(AUP1):c.-19C>T	AUP1|HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337120	2	74756775	2	74529648	337120	288014	rs886056340	NC_000002.12:74529647:G:A
NM_181575.5(AUP1):c.-15C>T	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337119	2	74756771	2	74529644	337119	290667	rs371791263	NC_000002.12:74529643:G:A
NM_181575.5(AUP1):c.25C>T (p.Pro9Ser)	AUP1|HTRA2	P9S	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337118	2	74756732	2	74529605	337118	290944	rs777371915	NC_000002.12:74529604:G:A
NM_181575.5(AUP1):c.90C>G (p.Leu30=)	AUP1|HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337117	2	74756587	2	74529460	337117	290941	rs376231592	NC_000002.12:74529459:G:C
NM_181575.5(AUP1):c.129C>G (p.Leu43=)	AUP1|HTRA2		not provided|Parkinson disease 13	Benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337116	2	74756548	2	74529421	337116	290936	rs1183739	NC_000002.12:74529420:G:C
NM_001709.5(BDNF):c.196G>A (p.Val66Met)	BDNF|BDNF-AS	V66M, V74M, V81M, V148M, V95M	Memory impairment, susceptibility to|not specified	Benign(Last reviewed: Jun 18, 2013)	criteria provided, multiple submitters, no conflicts	VCV000017697	11	27679916	11	27658369	17697	32736	rs6265	NC_000011.10:27658368:C:T
NM_001200.4(BMP2):c.987C>A (p.Cys329Ter)	BMP2	C329*	Short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies	Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000492937	20	6759532	20	6778885	492937	485876	rs1555786156	NC_000020.11:6778884:C:A
NM_031448.6(C19orf12):c.391A>G (p.Lys131Glu)	C19orf12	K142E, K131E, K67E	Spastic paraplegia 43, autosomal recessive|Dystonia|Adult-onset night blindness|Peripheral visual field loss|Mental deterioration|Tremor|Spastic paraplegia 43, autosomal recessive|Neurodegeneration with brain iron accumulation 4|Hereditary spastic paraplegia 5A|Neurodegeneration with brain iron accumulation 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2021)	criteria provided, conflicting interpretations	VCV000031158	19	30193654	19	29702747	31158	40115	rs146170087	NC_000019.10:29702746:T:C
NM_000719.7(CACNA1C):c.2579G>A (p.Arg860Gln)	CACNA1C	R860Q, R857Q	Wolff-Parkinson-White pattern|not provided|Timothy syndrome|Long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2021)	criteria provided, conflicting interpretations	VCV000190654	12	2702427	12	2593261	190654	188574	rs730880056	NC_000012.12:2593260:G:A
NM_000719.7(CACNA1C):c.1485C>A (p.His495Gln)	CACNA1C	H495Q, H492Q	not provided|Long QT syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190639	12	2666120	12	2556954	190639	188550	rs373335068	NC_000012.12:2556953:C:A
NM_001205293.3(CACNA1E):c.6649C>T (p.Gln2217Ter)	CACNA1E	Q2174*, Q2217*, Q2155*	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487600	1	181767677	1	181798541	487600	480669	rs766235230	NC_000001.11:181798540:C:T
NM_001232.4(CASQ2):c.2T>C (p.Met1Thr)	CASQ2	M1T	not provided|Wolff-Parkinson-White syndrome	Likely pathogenic(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000452250	1	116311161	1	115768540	452250	442590	rs1553197939	NC_000001.11:115768539:A:G
NM_001408.3(CELSR2):c.2858A>G (p.Asn953Ser)	CELSR2	N953S	Tracheoesophageal fistula	Likely pathogenic(Last reviewed: Jul 1, 2019)	no assertion criteria provided	VCV000916557	1	109795559	1	109252937	916557	904886		NC_000001.11:109252936:A:G
NM_016139.4(CHCHD2):c.238A>G (p.Ile80Val)	CHCHD2	I80V	not provided	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001303535	7	56171981	7	56104288	1303535	1293812		NC_000007.14:56104287:T:C
NM_016139.4(CHCHD2):c.300+5G>A	CHCHD2		Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218884	7	56171914	7	56104221	218884	215641	rs750014782	NC_000007.14:56104220:C:T
NM_016139.4(CHCHD2):c.434G>A (p.Arg145Gln)	CHCHD2	R145Q	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218883	7	56170571	7	56102878	218883	215640	rs752169833	NC_000007.14:56102877:C:T
NM_016139.4(CHCHD2):c.182C>T (p.Thr61Ile)	CHCHD2	T61I	Parkinson disease 22, autosomal dominant	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000218882	7	56172037	7	56104344	218882	215639	rs864309650	NC_000007.14:56104343:G:A
NM_014043.4(CHMP2B):c.85A>G (p.Ile29Val)	CHMP2B	I29V	Amyotrophic lateral sclerosis 17|not provided	Uncertain significance(Last reviewed: Apr 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021507	3	87289899	3	87240749	21507	34359	rs63750818	NC_000003.12:87240748:A:G
NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	Amyotrophic lateral sclerosis 17|not provided	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	NC_000003.12:87253797:A:C
NM_000093.5(COL5A1):c.1389G>A (p.Pro463=)	COL5A1		not provided|Arrhythmia|Arthralgia|Wolff-Parkinson-White syndrome|Hyperextensible hand joints|Joint dislocation|Joint laxity|See cases	Uncertain significance(Last reviewed: Feb 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000373924	9	137623973	9	134732127	373924	360909	rs1057518771	NC_000009.12:134732126:G:A
NM_004369.4(COL6A3):c.2195C>T (p.Thr732Met)	COL6A3	T732M, T325M, T526M	Bethlem myopathy 1|Collagen VI-related myopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2021)	criteria provided, conflicting interpretations	VCV000573112	2	238287581	2	237378938	573112	561176	rs370719148	NC_000002.12:237378937:G:A
NM_000754.4(COMT):c.472G>A (p.Val158Met)	COMT	V158M, V108M	not specified|Tramadol response|remifentanil response - Dosage, Efficacy|sufentanil response - Dosage, Efficacy|oxycodone response - Dosage, Efficacy|tramadol response - Dosage, Efficacy|nicotine response - Efficacy|methadone response - Dosage, Efficacy|morphine response - Dosage, Efficacy|opioids response - Dosage, Efficacy|CATECHOL-O-METHYLTRANSFERASE POLYMORPHISM	drug response(Last reviewed: Dec 20, 2017)	reviewed by expert panel	VCV000017591	22	19951271	22	19963748	17591	32630	rs4680	NC_000022.11:19963747:G:A
NM_000096.4(CP):c.1430C>T (p.Pro477Leu)	CP	P477L	not specified|not provided|Deficiency of ferroxidase	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000210755	3	148917570	3	149199783	210755	207061	rs35331711	NC_000003.12:149199782:G:A
NM_000787.3(DBH):c.-979T=	DBH		Dopamine beta-hydroxylase activity	association(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000001749	9	136500515	9	133635393	1749	16788	rs1611115	NC_000009.12:133635392:T:T
NM_004082.5(DCTN1):c.3746C>T (p.Thr1249Ile)	DCTN1	T1249I, T1207I, T1115I, T1224I, T1242I, T1110I, T1226I, T1232I	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis, susceptibility to|none provided|not provided|Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008402	2	74588717	2	74361590	8402	23441	rs72466496	NC_000002.12:74361589:G:A
NM_005216.5(DDOST):c.315C>T (p.Gly105=)	DDOST|PINK1		Parkinson Disease, Recessive|not specified|Congenital disorder of glycosylation type Ir|Congenital disorder of glycosylation	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295156	1	20982631	1	20656138	295156	278588	rs4704	NC_000001.11:20656137:G:A
NM_005216.5(DDOST):c.831C>T (p.Ala277=)	DDOST|PINK1		Parkinson Disease, Recessive|not specified|Congenital disorder of glycosylation type Ir|Congenital disorder of glycosylation	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000295114	1	20980231	1	20653738	295114	279913	rs6692016	NC_000001.11:20653737:G:A
NM_005216.5(DDOST):c.*40A>G	DDOST|PINK1		not provided|Congenital disorder of glycosylation type Ir|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295057	1	20978832	1	20652339	295057	279865	rs6893	NC_000001.11:20652338:T:C
NM_005216.5(DDOST):c.*457A>C	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295048	1	20978415	1	20651922	295048	279978	rs150466875	NC_000001.11:20651921:T:G
NM_005216.5(DDOST):c.*462A>G	DDOST|PINK1|PINK1-AS		Parkinson Disease, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000295047	1	20978410	1	20651917	295047	278569	rs559542	NC_000001.11:20651916:T:C
NM_032409.3(PINK1):c.*564T>G	DDOST|PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295024	1	20977748	1	20651255	295024	279966	rs1043502	NC_000001.11:20651254:T:G
NM_032409.3(PINK1):c.*415C>G	DDOST|PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: May 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295018	1	20977599	1	20651106	295018	278658	rs8064	NC_000001.11:20651105:C:G
NM_032409.3(PINK1):c.*196T>C	DDOST|PINK1|PINK1-AS		not provided|Parkinson Disease, Recessive|Congenital disorder of glycosylation|Parkinson disease 6, autosomal recessive early-onset	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295014	1	20977380	1	20650887	295014	278656	rs1043443	NC_000001.11:20650886:T:C
NM_032409.3(PINK1):c.*181C>G	DDOST|PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295013	1	20977365	1	20650872	295013	278645	rs513414	NC_000001.11:20650871:C:G
NM_032409.3(PINK1):c.1562A>C (p.Asn521Thr)	DDOST|PINK1|PINK1-AS	N521T	not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000295006	1	20977000	1	20650507	295006	279809	rs1043424	NC_000001.11:20650506:A:C
NM_001256715.2(DNAAF3):c.484C>A (p.Arg162Ser)	DNAAF3|TNNI3	R108S, R162S, R209S, R230S	Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894094	19	55673190	19	55161822	894094	882938		NC_000019.10:55161821:G:T
NM_001256715.2(DNAAF3):c.990C>T (p.Thr330=)	DNAAF3|TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894093	19	55672066	19	55160698	894093	882937		NC_000019.10:55160697:G:A
NM_001256715.2(DNAAF3):c.1093= (p.Asn365=)	DNAAF3|TNNI3		Primary ciliary dyskinesia|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|Ciliary dyskinesia, primary, 2|Dilated Cardiomyopathy, Recessive|not specified|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000369296	19	55671337	19	55159969	369296	353525	rs890872	NC_000019.10:55159968:T:T
NM_001256715.2(DNAAF3):c.1405G>A (p.Val469Met)	DNAAF3|TNNI3	V516M, V536M, V415M, V469M	Familial restrictive cardiomyopathy|Dilated Cardiomyopathy, Recessive|Hypertrophic cardiomyopathy|Primary ciliary dyskinesia|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000369295	19	55670651	19	55159283	369295	353524	rs114601492	NC_000019.10:55159282:C:T
NM_001256715.2(DNAAF3):c.531C>T (p.Gly177=)	DNAAF3|TNNI3		Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Primary ciliary dyskinesia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2020)	criteria provided, conflicting interpretations	VCV000330217	19	55673143	19	55161775	330217	334413	rs559008223	NC_000019.10:55161774:G:A
NM_001256715.2(DNAAF3):c.790-14C>T	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Ciliary dyskinesia, primary, 2|not specified|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000257695	19	55672569	19	55161201	257695	257247	rs7260371	NC_000019.10:55161200:G:A
NM_001256715.2(DNAAF3):c.666T>C (p.Ala222=)	DNAAF3|TNNI3		not specified|not provided|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Ciliary dyskinesia, primary, 2|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257694	19	55672784	19	55161416	257694	257248	rs7260320	NC_000019.10:55161415:A:G
NM_001256715.2(DNAAF3):c.529G>A (p.Gly177Ser)	DNAAF3|TNNI3	G224S, G245S, G177S, G123S	Familial restrictive cardiomyopathy|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Hypertrophic cardiomyopathy|Primary ciliary dyskinesia	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257691	19	55673145	19	55161777	257691	257251	rs58824375	NC_000019.10:55161776:C:T
NM_001256715.2(DNAAF3):c.510A>G (p.Val170=)	DNAAF3|TNNI3		Hypertrophic cardiomyopathy|not provided|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257689	19	55673164	19	55161796	257689	257252	rs56726774	NC_000019.10:55161795:T:C
NM_001256715.2(DNAAF3):c.327A>G (p.Arg109=)	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Hypertrophic cardiomyopathy|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257688	19	55673654	19	55162286	257688	257253	rs3848618	NC_000019.10:55162285:T:C
NM_001256715.2(DNAAF3):c.1248G>A (p.Val416=)	DNAAF3|TNNI3		not specified|not provided|Primary ciliary dyskinesia|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)	criteria provided, conflicting interpretations	VCV000257685	19	55670808	19	55159440	257685	257237	rs111250144	NC_000019.10:55159439:C:T
NM_001256715.2(DNAAF3):c.1239-8A>G	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|not provided|Ciliary dyskinesia, primary, 2|not specified|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000257684	19	55670825	19	55159457	257684	257238	rs28377509	NC_000019.10:55159456:T:C
NM_001256715.2(DNAAF3):c.1164-14C>T	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|not provided|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000257682	19	55670989	19	55159621	257682	257239	rs60176657	NC_000019.10:55159620:G:A
NM_001256715.2(DNAAF3):c.1056G>A (p.Pro352=)	DNAAF3|TNNI3		Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified|not provided|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Ciliary dyskinesia, primary, 2	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257680	19	55671374	19	55160006	257680	257242	rs891187	NC_000019.10:55160005:C:T
NM_001256715.2(DNAAF3):c.1001T>C (p.Leu334Pro)	DNAAF3|TNNI3	L381P, L402P, L280P, L334P	Familial restrictive cardiomyopathy|not specified|Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257679	19	55672055	19	55160687	257679	257243	rs890871	NC_000019.10:55160686:A:G
NM_001256715.2(DNAAF3):c.875A>G (p.Glu292Gly)	DNAAF3|TNNI3	E339G, E360G, E238G, E292G	not specified|not provided|Ciliary dyskinesia, primary, 2|Familial restrictive cardiomyopathy|Primary ciliary dyskinesia|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Hypertrophic cardiomyopathy	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000257676	19	55672470	19	55161102	257676	257246	rs2365725	NC_000019.10:55161101:T:C
NM_000363.5(TNNI3):c.-35C>A	DNAAF3|TNNI3		Familial restrictive cardiomyopathy|Familial restrictive cardiomyopathy 1|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|not specified|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000137687	19	55668992	19	55157624	137687	141390	rs3729707	NC_000019.10:55157623:G:T
NM_000363.5(TNNI3):c.537G>A (p.Glu179=)	DNAAF3|TNNI3		Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Primary ciliary dyskinesia|Cardiovascular phenotype|Dilated cardiomyopathy 2A|Cardiomyopathy|Hypertrophic cardiomyopathy|not specified|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000043391	19	55665410	19	55154042	43391	52561	rs3729841	NC_000019.10:55154041:C:T
NM_000363.5(TNNI3):c.25-8T>A	DNAAF3|TNNI3		not specified|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Hypertrophic cardiomyopathy|Primary ciliary dyskinesia|Cardiomyopathy|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043371	19	55668509	19	55157141	43371	52541	rs3729836	NC_000019.10:55157140:A:T
NM_000363.5(TNNI3):c.204G>T (p.Arg68=)	DNAAF3|TNNI3		not specified|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 7|not provided|Primary ciliary dyskinesia|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000043366	19	55667647	19	55156279	43366	52536	rs3729711	NC_000019.10:55156278:C:A
NM_000363.5(TNNI3):c.150+13G>A	DNAAF3|TNNI3		Primary ciliary dyskinesia|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|not provided|Cardiomyopathy|Familial restrictive cardiomyopathy|not specified|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7	Benign/Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000043362	19	55667958	19	55156590	43362	52532	rs73617692	NC_000019.10:55156589:C:T
NM_058246.4(DNAJB6):c.577A>G (p.Thr193Ala)	DNAJB6	T193A	Hereditary late onset Parkinson disease	Likely pathogenic	no assertion criteria provided	VCV000870632	7	157177659	7	157384965	870632	858794		NC_000007.14:157384964:A:G
NM_015268.4(DNAJC13):c.3872A>G (p.Glu1291Gly)	DNAJC13	E1291G, E1296G	not provided|Parkinson disease 21	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000715477	3	132213034	3	132494190	715477	720180	rs61748101	NC_000003.12:132494189:A:G
NM_015268.4(DNAJC13):c.2564A>G (p.Asn855Ser)	DNAJC13	N855S, N860S	Parkinson disease, late-onset|Essential tremor|Parkinson disease 21	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000056171	3	132196839	3	132477995	56171	70810	rs387907571	NC_000003.12:132477994:A:G
NM_001256864.2(DNAJC6):c.2010A>C (p.Pro670=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170300	1	65860687	1	65395004	1170300	1153667		NC_000001.11:65395003:A:C
NM_001256864.2(DNAJC6):c.1500G>A (p.Glu500=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not specified|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170299	1	65858145	1	65392462	1170299	1153664		NC_000001.11:65392461:G:A
NM_001256864.2(DNAJC6):c.544-9C>T	DNAJC6		Parkinson disease 19a, juvenile-onset|not specified|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170298	1	65845076	1	65379393	1170298	1153663		NC_000001.11:65379392:C:T
NM_001256864.2(DNAJC6):c.2183G>A (p.Ser728Asn)	DNAJC6	S658N, S671N, S728N	Parkinson disease 19a, juvenile-onset|not provided|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167138	1	65867519	1	65401836	1167138	1153668		NC_000001.11:65401835:G:A
NM_001256864.2(DNAJC6):c.1983T>C (p.Ser661=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167137	1	65860660	1	65394977	1167137	1153666		NC_000001.11:65394976:T:C
NM_001256864.2(DNAJC6):c.1506C>T (p.His502=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset|not specified	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV001167136	1	65858151	1	65392468	1167136	1153665		NC_000001.11:65392467:C:T
NM_001256864.2(DNAJC6):c.2799G>A (p.Val933=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV001157160	1	65877097	1	65411414	1157160	1131684		NC_000001.11:65411413:G:A
NM_001256864.2(DNAJC6):c.507A>G (p.Ser169=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV001138490	1	65831843	1	65366160	1138490	1110820		NC_000001.11:65366159:A:G
NM_001256864.2(DNAJC6):c.2687C>T (p.Thr896Met)	DNAJC6	T826M, T839M, T896M	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098747	1	65876985	1	65411302	1098747	1087475		NC_000001.11:65411301:C:T
NM_001256864.2(DNAJC6):c.2038+3A>G	DNAJC6		Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098746	1	65860718	1	65395035	1098746	1087472		NC_000001.11:65395034:A:G
NM_001256864.2(DNAJC6):c.2365C>T (p.Gln789Ter)	DNAJC6	Q719*, Q732*, Q789*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098745	1	65871690	1	65406007	1098745	1087473		NC_000001.11:65406006:C:T
NM_001256864.2(DNAJC6):c.2416C>T (p.Arg806Ter)	DNAJC6	R736*, R749*, R806*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098744	1	65871741	1	65406058	1098744	1087474		NC_000001.11:65406057:C:T
NM_001256864.2(DNAJC6):c.766C>T (p.Arg256Ter)	DNAJC6	R186*, R199*, R256*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV001098743	1	65849975	1	65384292	1098743	1087471		NC_000001.11:65384291:C:T
NM_001256864.2(DNAJC6):c.750A>T (p.Arg250=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV001081918	1	65849959	1	65384276	1081918	1067546		NC_000001.11:65384275:A:T
NM_001256864.2(DNAJC6):c.1831G>A (p.Ala611Thr)	DNAJC6	A541T, A554T, A611T	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001024855	1	65858476	1	65392793	1024855	1002989		NC_000001.11:65392792:G:A
NM_001256864.2(DNAJC6):c.101G>C (p.Gly34Ala)	DNAJC6	G34A	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001004818	1	65775529	1	65309846	1004818	987742		NC_000001.11:65309845:G:C
NM_001256864.2(DNAJC6):c.988C>T (p.Arg330Ter)	DNAJC6	R260*, R273*, R330*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Jul 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000976692	1	65851582	1	65385899	976692	964803		NC_000001.11:65385898:C:T
NM_001256864.2(DNAJC6):c.674G>A (p.Arg225Gln)	DNAJC6	R155Q, R168Q, R225Q	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000969368	1	65849883	1	65384200	969368	952507		NC_000001.11:65384199:G:A
NM_001256864.2(DNAJC6):c.2020C>T (p.Pro674Ser)	DNAJC6	P617S, P674S, P604S	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000953330	1	65860697	1	65395014	953330	942092		NC_000001.11:65395013:C:T
NM_001256864.2(DNAJC6):c.677C>T (p.Ala226Val)	DNAJC6	A169V, A156V, A226V	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000935514	1	65849886	1	65384203	935514	930653		NC_000001.11:65384202:C:T
NM_001256864.2(DNAJC6):c.2468G>A (p.Arg823His)	DNAJC6	R823H, R753H, R766H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000861071	1	65871793	1	65406110	861071	824387		NC_000001.11:65406109:G:A
NM_001256864.2(DNAJC6):c.2044A>G (p.Ser682Gly)	DNAJC6	S682G, S625G, S612G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000851922	1	65864501	1	65398818	851922	824386		NC_000001.11:65398817:A:G
NM_001256864.2(DNAJC6):c.521G>A (p.Arg174Gln)	DNAJC6	R117Q, R104Q, R174Q	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000845295	1	65831857	1	65366174	845295	824384		NC_000001.11:65366173:G:A
NM_001256864.2(DNAJC6):c.926G>A (p.Arg309His)	DNAJC6	R239H, R252H, R309H	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000844109	1	65851520	1	65385837	844109	824385		NC_000001.11:65385836:G:A
NM_001256864.2(DNAJC6):c.2310G>A (p.Ala770=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000766835	1	65871635	1	65405952	766835	696843	rs113490907	NC_000001.11:65405951:G:A
NM_001256864.2(DNAJC6):c.2298G>A (p.Ser766=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000745392	1	65871623	1	65405940	745392	746628	rs540477402	NC_000001.11:65405939:G:A
NM_001256864.2(DNAJC6):c.264G>A (p.Gly88=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000729926	1	65830388	1	65364705	729926	732562	rs139946043	NC_000001.11:65364704:G:A
NM_001256864.2(DNAJC6):c.2151C>T (p.Thr717=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000710532	1	65867487	1	65401804	710532	719054	rs145501615	NC_000001.11:65401803:C:T
NM_001256864.2(DNAJC6):c.1194-9C>G	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV000706857	1	65854930	1	65389247	706857	695062	rs370864885	NC_000001.11:65389246:C:G
NM_001256864.2(DNAJC6):c.1182A>G (p.Leu394=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000706823	1	65854087	1	65388404	706823	690665	rs148145327	NC_000001.11:65388403:A:G
NM_001256864.2(DNAJC6):c.1577A>G (p.Asn526Ser)	DNAJC6	N456S, N526S, N469S	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000706821	1	65858222	1	65392539	706821	690671	rs191459935	NC_000001.11:65392538:A:G
NM_001256864.2(DNAJC6):c.1350T>C (p.Ser450=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000706557	1	65855095	1	65389412	706557	690668	rs202109326	NC_000001.11:65389411:T:C
NM_001256864.2(DNAJC6):c.513G>A (p.Lys171=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000705664	1	65831849	1	65366166	705664	690664	rs148204207	NC_000001.11:65366165:G:A
NM_001256864.2(DNAJC6):c.1374G>A (p.Thr458=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000705046	1	65855119	1	65389436	705046	690669	rs148673423	NC_000001.11:65389435:G:A
NM_001256864.2(DNAJC6):c.186C>T (p.Asp62=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000705033	1	65775614	1	65309931	705033	690662	rs371984320	NC_000001.11:65309930:C:T
NM_001256864.2(DNAJC6):c.2254A>T (p.Thr752Ser)	DNAJC6	T682S, T695S, T752S	Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000704007	1	65871579	1	65405896	704007	690673	rs113143702	NC_000001.11:65405895:A:T
NM_001256864.2(DNAJC6):c.1492T>A (p.Cys498Ser)	DNAJC6	C441S, C428S, C498S	not provided|Parkinson disease 19a, juvenile-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000703945	1	65858137	1	65392454	703945	690670	rs145329294	NC_000001.11:65392453:T:A
NM_001256864.2(DNAJC6):c.1710G>A (p.Pro570=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset	Benign/Likely benign(Last reviewed: Feb 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000703807	1	65858355	1	65392672	703807	690672	rs7551930	NC_000001.11:65392671:G:A
NM_001256864.2(DNAJC6):c.1320A>T (p.Thr440=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Benign/Likely benign(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000702187	1	65855065	1	65389382	702187	690667	rs142136708	NC_000001.11:65389381:A:T
NM_001256864.2(DNAJC6):c.170G>T (p.Arg57Leu)	DNAJC6	R57L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000664983	1	65775598	1	65309915	664983	628246	rs747115530	NC_000001.11:65309914:G:T
NM_001256864.2(DNAJC6):c.397A>T (p.Met133Leu)	DNAJC6	M63L, M76L, M133L	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000663145	1	65831733	1	65366050	663145	628248	rs61757223	NC_000001.11:65366049:A:T
NM_001256864.2(DNAJC6):c.2228-3T>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000648740	1	65871550	1	65405867	648740	650698	rs753885398	NC_000001.11:65405866:T:C
NM_001256864.2(DNAJC6):c.175A>G (p.Ser59Gly)	DNAJC6	S59G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000641135	1	65775603	1	65309920	641135	628247	rs1296532855	NC_000001.11:65309919:A:G
NM_001256864.2(DNAJC6):c.1039A>G (p.Ile347Val)	DNAJC6	I277V, I347V, I290V	not provided|Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000623687	1	65852538	1	65386855	623687	612540	rs200712827	NC_000001.11:65386854:A:G
NM_001256864.2(DNAJC6):c.2468G>C (p.Arg823Pro)	DNAJC6	R823P, R753P, R766P	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000569095	1	65871793	1	65406110	569095	557423	rs201984806	NC_000001.11:65406109:G:C
NM_001256864.2(DNAJC6):c.996-9T>C	DNAJC6		Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000541545	1	65852486	1	65386803	541545	516230	rs187965193	NC_000001.11:65386802:T:C
NM_001256864.2(DNAJC6):c.745A>G (p.Ile249Val)	DNAJC6	I249V, I179V, I192V	not provided|Parkinson disease 19a, juvenile-onset	Benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541544	1	65849954	1	65384271	541544	516227	rs149588872	NC_000001.11:65384270:A:G
NM_001256864.2(DNAJC6):c.833A>G (p.Asp278Gly)	DNAJC6	D278G, D208G, D221G	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000541543	1	65851427	1	65385744	541543	516077	rs368290134	NC_000001.11:65385743:A:G
NM_001256864.2(DNAJC6):c.678G>A (p.Ala226=)	DNAJC6		not provided|Parkinson disease 19a, juvenile-onset|not specified	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474681	1	65849887	1	65384204	474681	448350	rs61753391	NC_000001.11:65384203:G:A
NM_001256864.2(DNAJC6):c.2838C>T (p.Tyr946=)	DNAJC6		Parkinson disease 19a, juvenile-onset	Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000474680	1	65878633	1	65412950	474680	448222	rs148209150	NC_000001.11:65412949:C:T
NM_001256864.2(DNAJC6):c.2290C>T (p.Leu764Phe)	DNAJC6	L694F, L764F, L707F	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000474679	1	65871615	1	65405932	474679	448427	rs917235831	NC_000001.11:65405931:C:T
NM_001256864.2(DNAJC6):c.2086T>C (p.Trp696Arg)	DNAJC6	W626R, W696R, W639R	Parkinson disease 19a, juvenile-onset	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000474678	1	65864543	1	65398860	474678	448369	rs1462099424	NC_000001.11:65398859:T:C
NM_001256864.2(DNAJC6):c.2025G>T (p.Ser675=)	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000474677	1	65860702	1	65395019	474677	448363	rs185245369	NC_000001.11:65395018:G:T
NM_001256864.2(DNAJC6):c.194-5G>T	DNAJC6		Parkinson disease 19a, juvenile-onset|not provided	Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000474676	1	65830313	1	65364630	474676	448345	rs753576283	NC_000001.11:65364629:G:T
NM_001256864.2(DNAJC6):c.1456C>T (p.Leu486Phe)	DNAJC6	L416F, L486F, L429F	not provided|Parkinson disease 19a, juvenile-onset	Benign/Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000445731	1	65855298	1	65389615	445731	439003	rs78141380	NC_000001.11:65389614:C:T
NM_001256864.2(DNAJC6):c.2536C>T (p.Gln846Ter)	DNAJC6	Q789*, Q776*, Q846*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000265964	1	65874368	1	65408685	265964	260693	rs886039854	NC_000001.11:65408684:C:T
NM_001256864.2(DNAJC6):c.2223A>T (p.Thr741=)	DNAJC6		Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253095	1	65867559	1	65401876	253095	247506	rs879255554	NC_000001.11:65401875:A:T
NM_001256864.2(DNAJC6):c.2779A>G (p.Arg927Gly)	DNAJC6	R927G, R857G, R870G	Parkinson disease 19b, early-onset|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000253094	1	65877077	1	65411394	253094	247505	rs879255630	NC_000001.11:65411393:A:G
NM_001256864.2(DNAJC6):c.454C>T (p.Arg152Ter)	DNAJC6	R82*, R152*, R95*	Malignant tumor of prostate|Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000219301	1	65831790	1	65366107	219301	220990	rs864622011	NC_000001.11:65366106:C:T
NM_001256864.2(DNAJC6):c.2410C>T (p.Gln804Ter)	DNAJC6	Q734*, Q747*, Q804*	Parkinson disease 19a, juvenile-onset	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088855	1	65871735	1	65406052	88855	94424	rs398122405	NC_000001.11:65406051:C:T
NM_001256864.2(DNAJC6):c.801-2A>G	DNAJC6		Parkinson disease 19a, juvenile-onset|Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	Pathogenic(Last reviewed: May 11, 2021)	no assertion criteria provided	VCV000088854	1	65851393	1	65385710	88854	94423	rs398122404	NC_000001.11:65385709:A:G
NM_130797.4(DPP6):c.1154T>C (p.Met385Thr)	DPP6	M321T, M278T, M323T, M324T, M385T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487614	7	154585806	7	154794096	487614	480698	rs369128533	NC_000007.14:154794095:T:C
NM_130797.4(DPP6):c.1091C>G (p.Pro364Arg)	DPP6	P300R, P257R, P303R, P302R, P364R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487598	7	154564607	7	154772897	487598	480697	rs756673341	NC_000007.14:154772896:C:G
NM_004415.4(DSP):c.3754G>A (p.Glu1252Lys)	DSP	E1252K	Wolff-Parkinson-White pattern|Cardiomyopathy|not provided|Dilated cardiomyopathy with woolly hair and keratoderma|Arrhythmogenic right ventricular dysplasia 8	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487613	6	7580177	6	7579944	487613	480692	rs1262533485	NC_000006.12:7579943:G:A
NM_004415.4(DSP):c.193C>T (p.His65Tyr)	DSP	H65Y	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487612	6	7555973	6	7555740	487612	480691	rs1554105605	NC_000006.12:7555739:C:T
NM_198241.3(EIF4G1):c.3824T>A (p.Leu1275His)	EIF4G1	L1275H, L1276H, L1080H, L1111H, L1188H, L1235H, L1282H	Parkinson disease 18	Uncertain significance(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV001030449	3	184045661	3	184327873	1030449	1016210		NC_000003.12:184327872:T:A
NM_198241.3(EIF4G1):c.3953+9A>G	EIF4G1		Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 18, 2021)	criteria provided, single submitter	VCV000518346	3	184045799	3	184328011	518346	508787	rs939317	NC_000003.12:184328010:A:G
NM_198241.3(EIF4G1):c.3325+16C>T	EIF4G1		Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV000518345	3	184044433	3	184326645	518345	508786	rs2293605	NC_000003.12:184326644:C:T
NM_198241.3(EIF4G1):c.1294A>G (p.Met432Val)	EIF4G1	M432V, M236V, M345V, M392V, M268V, M439V	Parkinson disease 18|not provided|not specified	Benign(Last reviewed: Jun 9, 2021)	criteria provided, single submitter	VCV000518344	3	184039666	3	184321878	518344	508785	rs2178403	NC_000003.12:184321877:A:G
NM_198241.3(EIF4G1):c.1505C>T (p.Ala502Val)	EIF4G1	A502V, A306V, A338V, A415V, A462V, A509V	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030073	3	184039877	3	184322089	30073	39028	rs111290936	NC_000003.12:184322088:C:T
NM_198241.3(EIF4G1):c.3614G>A (p.Arg1205His)	EIF4G1	R1205H, R1206H, R1165H, R1010H, R1041H, R1118H, R1212H	Parkinson disease 18	risk factor(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030072	3	184045189	3	184327401	30072	39027	rs112176450	NC_000003.12:184327400:G:A
NM_012179.4(FBXO7):c.674C>T (p.Pro225Leu)	FBXO7	P111L, P146L, P225L	Parkinson disease 15	Uncertain significance(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001301697	22	32881083	22	32485096	1301697	1291980		NC_000022.11:32485095:C:T
NM_012179.4(FBXO7):c.1495G>A (p.Gly499Ser)	FBXO7	G385S, G420S, G499S	Parkinson disease 15	Likely benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV001153556	22	32894443	22	32498456	1153556	1150108		NC_000022.11:32498455:G:A
NM_012179.4(FBXO7):c.123-10T>G	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001144336	22	32874958	22	32478971	1144336	1150107		NC_000022.11:32478970:T:G
NM_012179.4(FBXO7):c.1145-8C>T	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001137746	22	32891472	22	32495485	1137746	1129119		NC_000022.11:32495484:C:T
NM_012179.4(FBXO7):c.993G>T (p.Gly331=)	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001129864	22	32889117	22	32493130	1129864	1129118		NC_000022.11:32493129:G:T
NM_012179.4(FBXO7):c.418-7T>C	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Dec 12, 2019)	criteria provided, single submitter	VCV001125930	22	32879877	22	32483890	1125930	1129116		NC_000022.11:32483889:T:C
NM_012179.4(FBXO7):c.646-10C>T	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Apr 10, 2019)	criteria provided, single submitter	VCV001121992	22	32881045	22	32485058	1121992	1129117		NC_000022.11:32485057:C:T
NM_012179.4(FBXO7):c.1086C>T (p.Leu362=)	FBXO7		Parkinson disease 15	Likely benign(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV001084805	22	32889210	22	32493223	1084805	1085983		NC_000022.11:32493222:C:T
NM_012179.4(FBXO7):c.1546G>T (p.Asp516Tyr)	FBXO7	D437Y, D402Y, D516Y	Parkinson disease 15	Uncertain significance(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001036996	22	32894494	22	32498507	1036996	1035178		NC_000022.11:32498506:G:T
NM_012179.4(FBXO7):c.1264A>T (p.Ile422Phe)	FBXO7	I308F, I343F, I422F	Parkinson disease 15	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000971129	22	32894212	22	32498225	971129	959086		NC_000022.11:32498224:A:T
NM_012179.4(FBXO7):c.1497C>T (p.Gly499=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Aug 24, 2019)	criteria provided, single submitter	VCV000962864	22	32894445	22	32498458	962864	951460		NC_000022.11:32498457:C:T
NM_012179.4(FBXO7):c.593C>G (p.Ala198Gly)	FBXO7	A119G, A198G, A84G	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000962045	22	32880059	22	32484072	962045	951459		NC_000022.11:32484071:C:G
NM_012179.4(FBXO7):c.464C>A (p.Ala155Glu)	FBXO7	A155E, A76E, A41E	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000953199	22	32879930	22	32483943	953199	951458		NC_000022.11:32483942:C:A
NM_012179.4(FBXO7):c.32C>T (p.Thr11Ile)	FBXO7	T11I	Parkinson disease 15	Uncertain significance(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV000934590	22	32871021	22	32475034	934590	939300		NC_000022.11:32475033:C:T
NM_012179.4(FBXO7):c.968-14T>G	FBXO7		Parkinson disease 15|not provided	Benign(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000903533	22	32889078	22	32493091	903533	891820		NC_000022.11:32493090:T:G
NM_012179.4(FBXO7):c.957T>C (p.Phe319=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903532	22	32887158	22	32491171	903532	891141		NC_000022.11:32491170:T:C
NM_012179.4(FBXO7):c.447G>A (p.Glu149=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901600	22	32879913	22	32483926	901600	891140		NC_000022.11:32483925:G:A
NM_012179.4(FBXO7):c.367T>G (p.Ser123Ala)	FBXO7	S44A, S9A, S123A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901599	22	32875212	22	32479225	901599	891139		NC_000022.11:32479224:T:G
NM_012179.4(FBXO7):c.277T>G (p.Ser93Ala)	FBXO7	S93A, S14A	Parkinson disease 15	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000901598	22	32875122	22	32479135	901598	891138		NC_000022.11:32479134:T:G
NM_012179.4(FBXO7):c.155A>G (p.Tyr52Cys)	FBXO7	Y52C	Parkinson disease 15	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000901597	22	32875000	22	32479013	901597	891137		NC_000022.11:32479012:A:G
NM_012179.4(FBXO7):c.*198T>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901103	22	32894715	22	32498728	901103	891148		NC_000022.11:32498727:T:G
NM_012179.4(FBXO7):c.*104T>C	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901102	22	32894621	22	32498634	901102	891147		NC_000022.11:32498633:T:C
NM_012179.4(FBXO7):c.*82G>A	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901101	22	32894599	22	32498612	901101	891146		NC_000022.11:32498611:G:A
NM_012179.4(FBXO7):c.1552C>T (p.Arg518Trp)	FBXO7	R404W, R439W, R518W	Parkinson disease 15	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000901100	22	32894500	22	32498513	901100	891145		NC_000022.11:32498512:C:T
NM_012179.4(FBXO7):c.-97C>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901045	22	32870893	22	32474906	901045	891136		NC_000022.11:32474905:C:T
NM_012179.4(FBXO7):c.-130C>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000901044	22	32870860	22	32474873	901044	891135		NC_000022.11:32474872:C:T
NM_012179.4(FBXO7):c.1506T>C (p.Asn502=)	FBXO7		Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2019)	criteria provided, conflicting interpretations	VCV000899932	22	32894454	22	32498467	899932	891144		NC_000022.11:32498466:T:C
NM_012179.4(FBXO7):c.1332C>G (p.Ile444Met)	FBXO7	I330M, I365M, I444M	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899931	22	32894280	22	32498293	899931	891143		NC_000022.11:32498292:C:G
NM_012179.4(FBXO7):c.1266T>G (p.Ile422Met)	FBXO7	I343M, I422M, I308M	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899930	22	32894214	22	32498227	899930	891142		NC_000022.11:32498226:T:G
NM_012179.4(FBXO7):c.1198C>A (p.His400Asn)	FBXO7	H321N, H400N, H286N	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 30, 2019)	criteria provided, single submitter	VCV000860252	22	32894146	22	32498159	860252	849298		NC_000022.11:32498158:C:A
NM_012179.4(FBXO7):c.1221G>A (p.Pro407=)	FBXO7		not provided|Parkinson disease 15	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000776097	22	32894169	22	32498182	776097	705900	rs201127594	NC_000022.11:32498181:G:A
NM_012179.4(FBXO7):c.1441C>T (p.Arg481Cys)	FBXO7	R367C, R402C, R481C	Parkinson disease 15	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV000767123	22	32894389	22	32498402	767123	705903	rs148272407	NC_000022.11:32498401:C:T
NM_012179.4(FBXO7):c.1089T>C (p.Phe363=)	FBXO7		Parkinson disease 15|not provided	Likely benign(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000763225	22	32889213	22	32493226	763225	773526	rs1250777790	NC_000022.11:32493225:T:C
NM_012179.4(FBXO7):c.999C>T (p.Val333=)	FBXO7		not provided|Parkinson disease 15	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000755172	22	32889123	22	32493136	755172	773525	rs1191841298	NC_000022.11:32493135:C:T
NM_012179.4(FBXO7):c.319G>A (p.Ala107Thr)	FBXO7	A28T, A107T	not provided|Parkinson disease 15	Likely benign(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000716472	22	32875164	22	32479177	716472	729149	rs138222812	NC_000022.11:32479176:G:A
NM_012179.4(FBXO7):c.1535G>A (p.Gly512Asp)	FBXO7	G433D, G398D, G512D	not provided|Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2018)	criteria provided, conflicting interpretations	VCV000706329	22	32894483	22	32498496	706329	694718	rs142471722	NC_000022.11:32498495:G:A
NM_012179.4(FBXO7):c.291A>C (p.Ser97=)	FBXO7		not provided|Parkinson disease 15	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000705692	22	32875136	22	32479149	705692	694716	rs369892815	NC_000022.11:32479148:A:C
NM_012179.4(FBXO7):c.1385G>T (p.Ser462Ile)	FBXO7	S348I, S383I, S462I	not provided|Parkinson disease 15	Uncertain significance(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000655787	22	32894333	22	32498346	655787	649458	rs149552421	NC_000022.11:32498345:G:T
NM_012179.4(FBXO7):c.1070C>T (p.Ala357Val)	FBXO7	A243V, A357V, A278V	Parkinson disease 15	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000652909	22	32889194	22	32493207	652909	649456	rs141068487	NC_000022.11:32493206:C:T
NM_012179.4(FBXO7):c.697G>A (p.Val233Met)	FBXO7	V154M, V119M, V233M	Parkinson disease 15	Uncertain significance(Last reviewed: Jul 10, 2018)	criteria provided, single submitter	VCV000648239	22	32881106	22	32485119	648239	649455	rs1388222868	NC_000022.11:32485118:G:A
NM_012179.4(FBXO7):c.169A>G (p.Thr57Ala)	FBXO7	T57A	Parkinson disease 15	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000640301	22	32875014	22	32479027	640301	649454	rs760306475	NC_000022.11:32479026:A:G
NM_012179.4(FBXO7):c.1453G>A (p.Val485Ile)	FBXO7	V485I, V406I, V371I	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597905	22	32894401	22	32498414	597905	588966	rs141286570	NC_000022.11:32498413:G:A
NM_012179.4(FBXO7):c.601G>A (p.Val201Met)	FBXO7	V201M, V87M, V122M	Parkinson disease 15|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533897	22	32880067	22	32484080	533897	534312	rs61730783	NC_000022.11:32484079:G:A
NM_012179.4(FBXO7):c.122+272T>G	FBXO7	L12R	not provided|Parkinson disease 15	Benign(Last reviewed: Aug 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000518326	22	32871383	22	32475396	518326	508941	rs8137714	NC_000022.11:32475395:T:G
NM_012179.4(FBXO7):c.1546G>C (p.Asp516His)	FBXO7	D516H, D437H, D402H	not provided|Parkinson disease 15	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2021)	criteria provided, conflicting interpretations	VCV000444586	22	32894494	22	32498507	444586	438226	rs34316445	NC_000022.11:32498506:G:C
NM_001033024.1(FBXO7):c.*301A>G	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341324	22	32894818	22	32498831	341324	352435	rs757675819	NC_000022.11:32498830:A:G
NM_012179.4(FBXO7):c.*282A>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341323	22	32894799	22	32498812	341323	352434	rs886057423	NC_000022.11:32498811:A:T
NM_012179.4(FBXO7):c.*263A>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341322	22	32894780	22	32498793	341322	351428	rs886057422	NC_000022.11:32498792:A:G
NM_012179.4(FBXO7):c.*170C>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341321	22	32894687	22	32498700	341321	352433	rs186797068	NC_000022.11:32498699:C:G
NM_012179.4(FBXO7):c.*47A>T	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341320	22	32894564	22	32498577	341320	337913	rs367714958	NC_000022.11:32498576:A:T
NM_012179.4(FBXO7):c.1527C>A (p.Pro509=)	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341319	22	32894475	22	32498488	341319	352426	rs758609287	NC_000022.11:32498487:C:A
NM_012179.4(FBXO7):c.1505A>G (p.Asn502Ser)	FBXO7	N502S, N423S, N388S	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341318	22	32894453	22	32498466	341318	337910	rs144538200	NC_000022.11:32498465:A:G
NM_012179.4(FBXO7):c.1144+9C>T	FBXO7		Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000341317	22	32889277	22	32493290	341317	337907	rs199954341	NC_000022.11:32493289:C:T
NM_012179.4(FBXO7):c.1125A>G (p.Leu375=)	FBXO7		Parkinson disease 15	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000341316	22	32889249	22	32493262	341316	351426	rs147911892	NC_000022.11:32493261:A:G
NM_012179.4(FBXO7):c.1054G>A (p.Val352Ile)	FBXO7	V352I, V273I, V238I	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341315	22	32889178	22	32493191	341315	352421	rs762037477	NC_000022.11:32493190:G:A
NM_012179.4(FBXO7):c.949C>T (p.Leu317=)	FBXO7		Parkinson disease 15|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000341314	22	32887150	22	32491163	341314	347523	rs9726	NC_000022.11:32491162:C:T
NM_012179.4(FBXO7):c.745A>G (p.Thr249Ala)	FBXO7	T249A, T170A, T135A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341313	22	32881154	22	32485167	341313	337906	rs749742547	NC_000022.11:32485166:A:G
NM_012179.4(FBXO7):c.693C>T (p.Ser231=)	FBXO7		not specified|Parkinson disease 15|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000341312	22	32881102	22	32485115	341312	352420	rs61752254	NC_000022.11:32485114:C:T
NM_012179.4(FBXO7):c.540A>G (p.Pro180=)	FBXO7		Parkinson disease 15|not provided	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000341311	22	32880006	22	32484019	341311	351423	rs41311141	NC_000022.11:32484018:A:G
NM_012179.4(FBXO7):c.425C>G (p.Pro142Arg)	FBXO7	P142R, P28R, P63R	Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341310	22	32879891	22	32483904	341310	351422	rs886057421	NC_000022.11:32483903:C:G
NM_012179.4(FBXO7):c.358C>T (p.Pro120Ser)	FBXO7	P120S, P6S, P41S	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341309	22	32875203	22	32479216	341309	351420	rs191469599	NC_000022.11:32479215:C:T
NM_012179.4(FBXO7):c.274G>C (p.Asp92His)	FBXO7	D92H	Parkinson disease 15|not provided	Uncertain significance(Last reviewed: Mar 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341308	22	32875119	22	32479132	341308	347522	rs139135860	NC_000022.11:32479131:G:C
NM_012179.4(FBXO7):c.122+9G>A	FBXO7		Parkinson disease 15|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2020)	criteria provided, conflicting interpretations	VCV000341307	22	32871120	22	32475133	341307	347519	rs192327462	NC_000022.11:32475132:G:A
NM_012179.4(FBXO7):c.49C>G (p.Pro17Ala)	FBXO7	P17A	Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341306	22	32871038	22	32475051	341306	347518	rs886057420	NC_000022.11:32475050:C:G
NM_012179.4(FBXO7):c.-93G>A	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000341305	22	32870897	22	32474910	341305	337905	rs886057419	NC_000022.11:32474909:G:A
NM_012179.4(FBXO7):c.-118T>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341304	22	32870872	22	32474885	341304	352419	rs886057418	NC_000022.11:32474884:T:G
NM_012179.4(FBXO7):c.-168A>G	FBXO7		Parkinson disease 15	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000341303	22	32870822	22	32474835	341303	351419	rs886057417	NC_000022.11:32474834:A:G
NM_012179.4(FBXO7):c.-184C>T	FBXO7		Parkinson disease 15|not provided	Benign(Last reviewed: Aug 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341302	22	32870806	22	32474819	341302	347516	rs11538371	NC_000022.11:32474818:C:T
NM_012179.3(FBXO7):c.-197C>T	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341301	22	32870793	22	32474806	341301	347512	rs886057416	NC_000022.11:32474805:C:T
NM_012179.3(FBXO7):c.-200G>A	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341300	22	32870790	22	32474803	341300	351415	rs886057415	NC_000022.11:32474802:G:A
NM_012179.3(FBXO7):c.-221C>T	FBXO7		not provided|Parkinson Disease, Recessive	Benign(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000341299	22	32870769	22	32474782	341299	352418	rs2072814	NC_000022.11:32474781:C:T
NM_012179.3(FBXO7):c.-232G>C	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341298	22	32870758	22	32474771	341298	337898	rs886057414	NC_000022.11:32474770:G:C
NM_012179.3(FBXO7):c.-268C>G	FBXO7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000341297	22	32870722	22	32474735	341297	347509	rs540551581	NC_000022.11:32474734:C:G
NM_012179.4(FBXO7):c.260T>C (p.Ile87Thr)	FBXO7	I87T	Parkinson disease 15	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225358	22	32875105	22	32479118	225358	227415	rs780055842	NC_000022.11:32479117:T:C
NM_012179.4(FBXO7):c.345G>A (p.Met115Ile)	FBXO7	M115I, M1I, M36I	Parkinson disease 15|not provided|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000195275	22	32875190	22	32479203	195275	192436	rs11107	NC_000022.11:32479202:G:A
NM_012179.4(FBXO7):c.65C>T (p.Thr22Met)	FBXO7	T22M	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004811	22	32871054	22	32475067	4811	19850	rs121918305	NC_000022.11:32475066:C:T
NM_012179.4(FBXO7):c.1144+1G>T	FBXO7		Parkinson disease 15	Pathogenic(Last reviewed: Nov 16, 2017)	criteria provided, single submitter	VCV000004810	22	32889269	22	32493282	4810	19849	rs730880272	NC_000022.11:32493281:G:T
NM_012179.4(FBXO7):c.1492C>T (p.Arg498Ter)	FBXO7	R498*, R419*, R384*	Parkinson disease 15	Pathogenic(Last reviewed: Jan 20, 2009)	no assertion criteria provided	VCV000004809	22	32894440	22	32498453	4809	19848	rs121918304	NC_000022.11:32498452:C:T
NM_012179.4(FBXO7):c.1132C>G (p.Arg378Gly)	FBXO7	R378G, R264G, R299G	Parkinson disease 15	Pathogenic(Last reviewed: Jun 1, 2008)	no assertion criteria provided	VCV000004808	22	32889256	22	32493269	4808	19847	rs71799110	NC_000022.11:32493268:C:G
NM_019851.3(FGF20):c.*182C>T	FGF20		Parkinson disease, late-onset|not provided	Benign(Last reviewed: Jun 19, 2021)	criteria provided, single submitter	VCV000004885	8	16850399	8	16992890	4885	19924	rs12720208	NC_000008.11:16992889:G:A
NM_001110556.2(FLNA):c.6268G>C (p.Val2090Leu)	FLNA	V2082L, V2090L	Periventricular nodular heterotopia 1|Oto-palato-digital syndrome, type II|Frontometaphyseal dysplasia 1|Melnick-Needles syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000465010	X	153581251	X	154352883	465010	471375	rs968230475	NC_000023.11:154352882:C:G
NM_001458.5(FLNC):c.6748A>C (p.Met2250Leu)	FLNC|FLNC-AS1	M2250L, M2217L	Wolff-Parkinson-White pattern|Myopathy, distal, 4|Dilated Cardiomyopathy, Dominant|Cardiomyopathy, familial hypertrophic, 26|Myofibrillar myopathy, filamin C-related	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000487622	7	128494487	7	128854433	487622	480694	rs923795184	NC_000007.14:128854432:A:C
NM_001458.5(FLNC):c.3014C>T (p.Ser1005Leu)	FLNC	S1005L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487593	7	128484142	7	128844088	487593	480693	rs752448040	NC_000007.14:128844087:C:T
NM_133372.3(FNIP1):c.455+1G>A	FNIP1		Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487589	5	131055009	5	131719316	487589	480689	rs1554096246	NC_000005.10:131719315:C:T
NM_000157.4(GBA):c.1312G>C (p.Asp438His)	GBA|LOC106627981	D351H, D389H, D438H	Parkinson disease, late-onset	Likely pathogenic(Last reviewed: Jul 26, 2021)	no assertion criteria provided	VCV001319931	1	155205548	1	155235757	1319931	1310179		NC_000001.11:155235756:C:G
NM_000157.4(GBA):c.901C>T (p.Arg301Cys)	GBA|LOC106627981	R214C, R252C, R301C	not provided	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV001303549	1	155207230	1	155237439	1303549	1293826		NC_000001.11:155237438:G:A
NM_000157.4(GBA):c.644C>A (p.Ala215Asp)	GBA|LOC106627981	A128D, A166D, A215D	not provided	Uncertain significance(Last reviewed: Sep 28, 2020)	criteria provided, single submitter	VCV001303174	1	155208042	1	155238251	1303174	1293452		NC_000001.11:155238250:G:T
NM_000157.4(GBA):c.1000G>A (p.Val334Ile)	GBA|LOC106627981	V247I, V285I, V334I	not provided	Uncertain significance(Last reviewed: Mar 2, 2021)	criteria provided, single submitter	VCV001302744	1	155206260	1	155236469	1302744	1293025		NC_000001.11:155236468:C:T
NM_000157.4(GBA):c.1249T>G (p.Trp417Gly)	GBA|LOC106627981	W330G, W368G, W417G	not provided	Likely pathogenic(Last reviewed: Feb 22, 2021)	criteria provided, single submitter	VCV001211295	1	155205611	1	155235820	1211295	1201292		NC_000001.11:155235819:A:C
NM_000157.4(GBA):c.604C>T (p.Arg202Ter)	GBA|LOC106627981	R115*, R153*, R202*	Gaucher disease|Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: Sep 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV001119997	1	155208082	1	155238291	1119997	1108785		NC_000001.11:155238290:G:A
NM_000157.4(GBA):c.635C>G (p.Ser212Ter)	GBA|LOC106627981	S125*, S163*, S212*	Hereditary late onset Parkinson disease|Gaucher disease|not provided	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000996254	1	155208051	1	155238260	996254	983940		NC_000001.11:155238259:G:C
NM_000157.4(GBA):c.946C>T (p.Arg316Cys)	GBA|LOC106627981	R229C, R267C, R316C	Hereditary late onset Parkinson disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2021)	criteria provided, conflicting interpretations	VCV000813338	1	155207185	1	155237394	813338	801584	rs1264734195	NC_000001.11:155237393:G:A
NM_000157.4(GBA):c.247C>T (p.Arg83Cys)	GBA|LOC106627981	R83C	not provided	Uncertain significance(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000806230	1	155209737	1	155239946	806230	794438	rs1141812	NC_000001.11:155239945:G:A
NM_000157.4(GBA):c.1503C>G (p.Asn501Lys)	GBA|LOC106627981	N414K, N452K, N501K	Gaucher disease type II	Likely pathogenic(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000691989	1	155204988	1	155235197	691989	679732	rs755265316	NC_000001.11:155235196:G:C
NM_000157.4(GBA):c.1495G>C (p.Val499Leu)	GBA|LOC106627981	V499L, V450L, V412L	Gaucher disease type I|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000634558	1	155204996	1	155235205	634558	622301	rs369068553	NC_000001.11:155235204:C:G
NM_000157.4(GBA):c.762-1G>C	GBA|LOC106627981		Gaucher disease|Parkinson disease, late-onset	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633240	1	155207370	1	155237579	633240	621703	rs1237637353	NC_000001.11:155237578:C:G
NM_000157.4(GBA):c.653G>A (p.Trp218Ter)	GBA|LOC106627981	W218*, W169*, W131*	Thrombocytopenia|Abnormal bleeding|Hereditary late onset Parkinson disease|Gaucher disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000632834	1	155208033	1	155238242	632834	621059	rs867929413	NC_000001.11:155238241:C:T
NM_000157.4(GBA):c.1294T>A (p.Trp432Arg)	GBA|LOC106627981	W432R, W383R, W345R	Parkinson disease, late-onset	Pathogenic	no assertion criteria provided	VCV000599275	1	155205566	1	155235775	599275	590519	rs1557901552	NC_000001.11:155235774:A:T
NM_000157.4(GBA):c.1224G>A (p.Thr408=)	GBA|LOC106627981		Gaucher disease type II|Gaucher disease type I|not provided	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000503740	1	155206036	1	155236245	503740	495063	rs138498426	NC_000001.11:155236244:C:T
NM_000157.4(GBA):c.1102C>T (p.Arg368Cys)	GBA|LOC106627981	R368C, R281C, R319C	Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|Gaucher disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 22, 2021)	criteria provided, conflicting interpretations	VCV000420153	1	155206158	1	155236367	420153	404945	rs374306700	NC_000001.11:155236366:G:A
NM_000157.4(GBA):c.1220T>C (p.Ile407Thr)	GBA|LOC106627981	I407T, I358T, I320T	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Oct 5, 2015)	no assertion criteria provided	VCV000212789	1	155206040	1	155236249	212789	209422	rs1057519358	NC_000001.11:155236248:A:G
NM_000157.4(GBA):c.1277C>T (p.Pro426Leu)	GBA|LOC106627981	P426L, P339L, P377L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209104	1	155205583	1	155235792	209104	205700	rs1057519357	NC_000001.11:155235791:G:A
NM_000157.4(GBA):c.221G>C (p.Gly74Ala)	GBA|LOC106627981	G74A	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209102	1	155209763	1	155239972	209102	205701	rs371592589	NC_000001.11:155239971:C:G
NM_000157.4(GBA):c.1093G>A (p.Glu365Lys)	GBA|LOC106627981	E365K, E278K, E316K	not provided|Parkinsonism|Parkinsonism|Tremor|Rigidity|Cogwheel rigidity|Parkinsonism|Neurological speech impairment|Hyperlipidemia|Lower limb muscle weakness|Dementia|Hypertensive disorder|not specified|Hereditary late onset Parkinson disease|Gaucher disease|Gaucher disease, perinatal lethal	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000199044	1	155206167	1	155236376	199044	38432	rs2230288	NC_000001.11:155236375:C:T
NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)	GBA|LOC106627981	L483R, L434R, L396R	Gaucher disease|not provided|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093449	1	155205043	1	155235252	93449	99356	rs421016	NC_000001.11:155235251:A:C
NM_000157.4(GBA):c.1223C>T (p.Thr408Met)	GBA|LOC106627981	T408M, T359M, T321M	not provided|not specified|Parkinson disease, late-onset|Gaucher disease, perinatal lethal|Gaucher disease	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000093447	1	155206037	1	155236246	93447	99354	rs75548401	NC_000001.11:155236245:G:A
NM_000157.4(GBA):c.115+1G>A	GBA		Gaucher disease|not provided|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Lewy body dementia|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Parkinson disease, late-onset|Parkinson disease, late-onset|Gaucher disease type II|Gaucher disease type I|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: Oct 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093445	1	155210420	1	155240629	93445	99352	rs104886460	NC_000001.11:155240628:C:T
NM_000157.4(GBA):c.1444G>A (p.Asp482Asn)	GBA|LOC106627981	D395N, D433N, D482N	not specified|Parkinson disease, late-onset|not provided	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004335	1	155205047	1	155235256	4335	19374	rs75671029	NC_000001.11:155235255:C:T
NM_001005741.2(GBA):c.[880T>G;1342G>C]	GBA|LOC106627981	D448H, D361H, D399H, H294Q, H245Q, H207Q	Gaucher disease type II|Gaucher disease type III	Pathogenic(Last reviewed: Apr 1, 2005)	no assertion criteria provided	VCV000004334	1|1	155205518	1|1	155235727	4334	19332|19373	rs1064651|rs367968666	NC_000001.11:155235726:C:G|NC_000001.11:155237457:A:C
NM_000157.4(GBA):c.887G>A (p.Arg296Gln)	GBA|LOC106627981	R296Q, R209Q, R247Q	not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: Aug 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004328	1	155207244	1	155237453	4328	19367	rs78973108	NC_000001.11:155237452:C:T
NM_000157.4(GBA):c.1604G>A (p.Arg535His)	GBA|LOC106627981	R535H, R486H, R448H	Hereditary late onset Parkinson disease|not provided|Gaucher disease type I|Gaucher disease|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004311	1	155204793	1	155235002	4311	19350	rs75822236	NC_000001.11:155235001:C:T
NM_001005741.2(GBA):c.[535G>C;c.1093G>A]	LOC106627981|GBA	E365K, E278K, E316K, D179H, D130H, D92H	Gaucher disease type I	Pathogenic(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000004299	1|1	155206167	1|1	155236376	4299	38432|19338	rs2230288|rs147138516	NC_000001.11:155236375:C:T|NC_000001.11:155238569:C:G
NM_000157.4(GBA):c.764T>A (p.Phe255Tyr)	GBA|LOC106627981	F255Y, F168Y, F206Y	Parkinson disease, late-onset|not provided|Gaucher disease|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004298	1	155207367	1	155237576	4298	19337	rs74500255	NC_000001.11:155237575:A:T
NM_001005741.2(GBA):c.[1448T>C;1483G>C;1497G>C]	GBA|LOC106627981	L483P, L396P, L434P, A495P, A408P, A446P	Gaucher disease type III|Gaucher disease type I|Gaucher disease, perinatal lethal|Gaucher disease type II|Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV000004297	1|1|1	155205043	1|1|1	155235252	4297	19327|38384|38385	rs421016|rs368060|rs1135675	NC_000001.11:155235251:A:G|NC_000001.11:155235216:C:G|NC_000001.11:155235202:C:G
NM_000157.4(GBA):c.1504C>T (p.Arg502Cys)	GBA|LOC106627981	R502C, R415C, R453C	Parkinson disease, late-onset|Gaucher disease type III|not provided|Gaucher disease type II|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic(Last reviewed: May 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004295	1	155204987	1	155235196	4295	19334	rs80356771	NC_000001.11:155235195:G:A
NM_000157.4(GBA):c.1342G>C (p.Asp448His)	GBA|LOC106627981	D448H, D361H, D399H	Gaucher disease|Gaucher disease type II|Gaucher disease type III|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004293	1	155205518	1	155235727	4293	19332	rs1064651	NC_000001.11:155235726:C:G
NM_000157.4(GBA):c.1297G>T (p.Val433Leu)	GBA|LOC106627981	V433L, V384L, V346L	Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease, perinatal lethal|Gaucher disease type 3C|Parkinson disease, late-onset|Gaucher disease|Gaucher disease type I|Gaucher disease type III|not provided|Hereditary late onset Parkinson disease|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004292	1	155205563	1	155235772	4292	19331	rs80356769	NC_000001.11:155235771:C:A
NM_000157.4(GBA):c.1226A>G (p.Asn409Ser)	GBA|LOC106627981	N409S, N322S, N360S	Thrombocytopenia|Abnormal bleeding|Parkinson disease, late-onset|none provided|Gaucher disease|Gaucher disease, perinatal lethal|Akinesia|Rigidity|Hereditary late onset Parkinson disease|Gaucher disease type I|Parkinson disease|Susceptibility to Parkinson disease|Dementia, Lewy body, susceptibility to|Lewy body dementia|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Parkinson disease, late-onset|Gaucher disease type 3C|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C|not provided	Pathogenic/Likely pathogenic, risk factor(Last reviewed: Sep 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004290	1	155205634	1	155235843	4290	19329	rs76763715	NC_000001.11:155235842:T:C
NM_000157.3(GBA):c.1448T>C	GBA|LOC106627981	L483P, L396P, L434P	not provided|Parkinson disease, late-onset|Gaucher disease type III|Hypomimic face|Parkinsonism|Movement disorder|Thoracolumbar scoliosis|Resting tremor|Gaucher disease type II|Hereditary late onset Parkinson disease|Gaucher disease|Dementia, Lewy body, susceptibility to|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Gaucher disease type 3C	Pathogenic, risk factor(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004288	1	155205043	1	155235252	4288	19327	rs421016	NC_000001.11:155235251:A:G
NM_001001557.4(GDF6):c.1271A>G (p.Lys424Arg)	GDF6	K424R	Microphthalmia, isolated 4|Klippel-Feil syndrome 1, autosomal dominant|Leber congenital amaurosis 17|Microphthalmia, isolated, with coloboma 6|Klippel-Feil syndrome|Klippel-Feil syndrome 1, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008373	8	97156888	8	96144660	8373	23412	rs121909353	NC_000008.11:96144659:T:C
NM_001103146.3(GIGYF2):c.2146A>G (p.Thr716Ala)	GIGYF2	T737A, T710A, T716A	Parkinson disease 11	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001030144	2	233680385	2	232815675	1030144	1016024		NC_000002.12:232815674:A:G
NM_001103146.3(GIGYF2):c.2489A>T (p.Glu830Val)	GIGYF2	E830V, E851V, E824V	Parkinson disease 11	Uncertain significance(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV000931848	2	233684655	2	232819945	931848	918754		NC_000002.12:232819944:A:T
NM_001103146.3(GIGYF2):c.1554G>A (p.Glu518=)	GIGYF2		Parkinson disease 11|not provided	Benign/Likely benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000522283	2	233660846	2	232796136	522283	512894	rs2305138	NC_000002.12:232796135:G:A
NM_001103146.3(GIGYF2):c.3684+15G>A	GIGYF2		Parkinson disease 11|not provided	Benign(Last reviewed: Jun 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518340	2	233712296	2	232847586	518340	508781	rs6437074	NC_000002.12:232847585:G:A
NM_001103146.3(GIGYF2):c.3651G>A (p.Pro1217=)	GIGYF2		not provided|Parkinson disease 11	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518339	2	233712248	2	232847538	518339	508780	rs12328151	NC_000002.12:232847537:G:A
NM_001103146.3(GIGYF2):c.3461-9G>A	GIGYF2		Parkinson disease 11|not provided	Benign(Last reviewed: Jun 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000518337	2	233712049	2	232847339	518337	508778	rs2305137	NC_000002.12:232847338:G:A
NM_001103146.3(GIGYF2):c.2940A>G (p.Gln980=)	GIGYF2		Parkinson disease 11|not provided	Benign(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000518336	2	233708806	2	232844096	518336	508777	rs3816334	NC_000002.12:232844095:A:G
NM_001103146.3(GIGYF2):c.2378C>T (p.Ala793Val)	GIGYF2	A793V, A814V, A787V	Parkinson disease 11	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2020)	criteria provided, conflicting interpretations	VCV000216934	2	233684544	2	232819834	216934	213536	rs748538823	NC_000002.12:232819833:C:T
NM_001103146.3(GIGYF2):c.1262A>G (p.Lys421Arg)	GIGYF2	K421R, K415R, K442R	Parkinson disease 11	risk factor(Last reviewed: Sep 1, 2009)	no assertion criteria provided	VCV000000757	2	233656136	2	232791426	757	15796	rs115735611	NC_000002.12:232791425:A:G
NM_001103146.3(GIGYF2):c.832A>G (p.Ile278Val)	GIGYF2	I278V, I272V, I300V	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000756	2	233655527	2	232790817	756	15795	rs118203904	NC_000002.12:232790816:A:G
NM_001103146.3(GIGYF2):c.1818C>G (p.Asp606Glu)	GIGYF2	D606E, D627E, D600E	Parkinson disease 11	risk factor(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000000755	2	233674441	2	232809731	755	15794	rs118203903	NC_000002.12:232809730:C:G
NM_001103146.3(GIGYF2):c.1370A>C (p.Asn457Thr)	GIGYF2	N457T, N451T, N478T	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000754	2	233659545	2	232794835	754	15793	rs116074753	NC_000002.12:232794834:A:C
NM_001103146.3(GIGYF2):c.167A>G (p.Asn56Ser)	GIGYF2	N56S	Parkinson disease 11	risk factor(Last reviewed: Aug 1, 2009)	no assertion criteria provided	VCV000000753	2	233612450	2	232747740	753	15792	rs72554080	NC_000002.12:232747739:A:G
NM_181703.4(GJA5):c.895G>A (p.Glu299Lys)	GJA5	E299K	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487608	1	147230452	1	147758344	487608	480667	rs1553226803	NC_000001.11:147758343:C:T
NM_005159.5(ACTC1):c.944T>A (p.Met315Lys)	GJD2-DT|ACTC1	M315K	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487590	15	35083361	15	34791160	487590	480714	rs1555418685	NC_000015.10:34791159:A:T
NM_000404.2(GLB1):c.245C>T	GLB1	T82M, T130M, T52M, T82I	GM1 gangliosidosis type 2|Mucopolysaccharidosis, MPS-IV-B|Infantile GM1 gangliosidosis|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|not provided|Inborn genetic diseases|GM1 gangliosidosis type 3	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000000935	3	33114036	3	33072544	935	15974	rs72555393	NC_000003.12:33072543:G:A
NM_012084.4(GLUD2):c.1492T>G (p.Ser498Ala)	GLUD2	S445A, S498A	Parkinson disease, late-onset	Pathogenic(Last reviewed: Mar 1, 2010)	no assertion criteria provided	VCV000029936	X	120183030	X	121049176	29936	38891	rs9697983	NC_000023.11:121049175:T:G
NM_015141.4(GPD1L):c.775G>A (p.Gly259Arg)	GPD1L	G259R	Brugada syndrome|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000487599	3	32200524	3	32159032	487599	480683	rs146477959	NC_000003.12:32159031:G:A
NM_002087.4(GRN):c.1540G>A (p.Val514Met)	GRN	V514M	Seizures|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000587957	17	42429835	17	44352467	587957	580346	rs142926942	NC_000017.11:44352466:G:A
NM_002087.4(GRN):c.970G>A (p.Ala324Thr)	GRN	A324T	Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|not provided|not specified|Grn-related frontotemporal lobar degeneration with Tdp43 inclusions|Ceroid lipofuscinosis, neuronal, 11	Conflicting interpretations of pathogenicity(Last reviewed: Jul 29, 2020)	criteria provided, conflicting interpretations	VCV000098165	17	42428954	17	44351586	98165	104057	rs63750541	NC_000017.11:44351585:G:A
GRN, IVS0DS, G-C, +5	GRN		Grn-related frontotemporal lobar degeneration with Tdp43 inclusions	Pathogenic(Last reviewed: Oct 1, 2007)	no assertion criteria provided	VCV000016006					16006	31045		
NM_031157.4(HNRNPA1):c.1018C>G (p.Pro340Ala)	HNRNPA1	P288A, P340A	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000637023	12	54677706	12	54283922	637023	624860	rs1592173638	NC_000012.12:54283921:C:G
NM_031157.4(HNRNPA1):c.941A>T (p.Asp314Val)	HNRNPA1	D314V, D262V	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000065451	12	54677629	12	54283845	65451	76368	rs397518452	NC_000012.12:54283844:A:T
NM_002137.4(HNRNPA2B1):c.852A>G (p.Gly284=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001161696	7	26232983	7	26193363	1161696	1138705		NC_000007.14:26193362:T:C
NM_002137.4(HNRNPA2B1):c.189T>C (p.Val63=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV001155590	7	26237010	7	26197390	1155590	1138709		NC_000007.14:26197389:A:G
NM_002137.4(HNRNPA2B1):c.255A>T (p.Val85=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV001150367	7	26236944	7	26197324	1150367	1138708		NC_000007.14:26197323:T:A
NM_002137.4(HNRNPA2B1):c.659-5A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001144709	7	26235534	7	26195914	1144709	1138706		NC_000007.14:26195913:T:C
NM_002137.4(HNRNPA2B1):c.577+9A>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001143376	7	26236168	7	26196548	1143376	1138707		NC_000007.14:26196547:T:G
NM_002137.4(HNRNPA2B1):c.7-8C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001140282	7	26237360	7	26197740	1140282	1117805		NC_000007.14:26197739:G:A
NM_002137.4(HNRNPA2B1):c.659-9C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001135005	7	26235538	7	26195918	1135005	1117802		NC_000007.14:26195917:G:A
NM_002137.4(HNRNPA2B1):c.738T>C (p.Gly246=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001132450	7	26233298	7	26193678	1132450	1117801		NC_000007.14:26193677:A:G
NM_002137.4(HNRNPA2B1):c.265-7A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, single submitter	VCV001130792	7	26236644	7	26197024	1130792	1117803		NC_000007.14:26197023:T:C
NM_002137.4(HNRNPA2B1):c.240G>A (p.Glu80=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001123541	7	26236959	7	26197339	1123541	1117804		NC_000007.14:26197338:C:T
NM_002137.4(HNRNPA2B1):c.842-8T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001119401	7	26233001	7	26193381	1119401	1096266		NC_000007.14:26193380:A:G
NM_002137.4(HNRNPA2B1):c.528G>A (p.Leu176=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Feb 5, 2019)	criteria provided, single submitter	VCV001119002	7	26236226	7	26196606	1119002	1096267		NC_000007.14:26196605:C:T
NM_002137.4(HNRNPA2B1):c.475+7G>A	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV001105386	7	26236420	7	26196800	1105386	1096268		NC_000007.14:26196799:C:T
NM_002137.4(HNRNPA2B1):c.45C>T (p.Gly15=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001097353	7	26237314	7	26197694	1097353	1074636		NC_000007.14:26197693:G:A
NM_002137.4(HNRNPA2B1):c.601C>T (p.Arg201Cys)	HNRNPA2B1	R201C, R213C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001060923	7	26236078	7	26196458	1060923	1044909		NC_000007.14:26196457:G:A
NM_002137.4(HNRNPA2B1):c.505A>G (p.Asn169Asp)	HNRNPA2B1	N169D, N181D	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV001021688	7	26236249	7	26196629	1021688	1007421		NC_000007.14:26196628:T:C
NM_002137.4(HNRNPA2B1):c.14A>G (p.Lys5Arg)	HNRNPA2B1	K17R, K5R	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001010666	7	26237345	7	26197725	1010666	992287		NC_000007.14:26197724:T:C
NM_002137.4(HNRNPA2B1):c.657T>A (p.Ser219=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000967904	7	26236022	7	26196402	967904	955136		NC_000007.14:26196401:A:T
NM_002137.4(HNRNPA2B1):c.964+5T>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV000858196	7	26232866	7	26193246	858196	852084		NC_000007.14:26193245:A:C
NM_002137.4(HNRNPA2B1):c.330T>C (p.Asp110=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000772754	7	26236572	7	26196952	772754	700021	rs191937523	NC_000007.14:26196951:A:G
NM_002137.4(HNRNPA2B1):c.147A>G (p.Ser49=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000763430	7	26237052	7	26197432	763430	766244	rs773260084	NC_000007.14:26197431:T:C
NM_002137.4(HNRNPA2B1):c.658+9C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000758964	7	26236012	7	26196392	758964	775308	rs760373015	NC_000007.14:26196391:G:A
NM_002137.4(HNRNPA2B1):c.7-143T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000733173	7	26237495	7	26197875	733173	744331	rs773972068	NC_000007.14:26197874:A:G
NM_002137.4(HNRNPA2B1):c.246A>G (p.Lys82=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000706799	7	26236953	7	26197333	706799	692221	rs1428232126	NC_000007.14:26197332:T:C
NM_002137.4(HNRNPA2B1):c.984C>A (p.Gly328=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV000705959	7	26232178	7	26192558	705959	692218	rs768943063	NC_000007.14:26192557:G:T
NM_002137.4(HNRNPA2B1):c.243A>G (p.Pro81=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000704997	7	26236956	7	26197336	704997	692222	rs143134057	NC_000007.14:26197335:T:C
NM_002137.4(HNRNPA2B1):c.964+10A>G	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000704601	7	26232861	7	26193241	704601	695361	rs181705411	NC_000007.14:26193240:T:C
NM_002137.4(HNRNPA2B1):c.610G>A (p.Gly204Ser)	HNRNPA2B1	G204S, G216S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000704292	7	26236069	7	26196449	704292	692220	rs200929422	NC_000007.14:26196448:C:T
NM_002137.4(HNRNPA2B1):c.756A>C (p.Gly252=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Benign/Likely benign(Last reviewed: Dec 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000704090	7	26233280	7	26193660	704090	692219	rs199909637	NC_000007.14:26193659:T:G
NM_002137.4(HNRNPA2B1):c.659-7C>G	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Jun 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000703967	7	26235536	7	26195916	703967	695362	rs199606705	NC_000007.14:26195915:G:C
NM_002137.4(HNRNPA2B1):c.657T>C (p.Ser219=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000662036	7	26236022	7	26196402	662036	636094	rs370050080	NC_000007.14:26196401:A:G
NM_002137.4(HNRNPA2B1):c.476-3C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000659107	7	26236281	7	26196661	659107	651731	rs370807816	NC_000007.14:26196660:G:A
NM_002137.4(HNRNPA2B1):c.578-10T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000646482	7	26236111	7	26196491	646482	651725	rs199915606	NC_000007.14:26196490:A:G
NM_002137.4(HNRNPA2B1):c.659-4A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000571200	7	26235533	7	26195913	571200	564276	rs1562711082	NC_000007.14:26195912:T:C
NM_002137.4(HNRNPA2B1):c.288T>C (p.His96=)	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541430	7	26236614	7	26196994	541430	523021	rs142061533	NC_000007.14:26196993:A:G
NM_002137.4(HNRNPA2B1):c.841+6A>G	HNRNPA2B1		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000541429	7	26233189	7	26193569	541429	523261	rs144309126	NC_000007.14:26193568:T:C
NM_002137.4(HNRNPA2B1):c.633A>G (p.Pro211=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000541428	7	26236046	7	26196426	541428	523264	rs752086550	NC_000007.14:26196425:T:C
NM_002137.4(HNRNPA2B1):c.669C>T (p.Gly223=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000541426	7	26235519	7	26195899	541426	522885	rs767263210	NC_000007.14:26195898:G:A
NM_002137.4(HNRNPA2B1):c.797A>G (p.Asn266Ser)	HNRNPA2B1	N278S, N266S	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Feb 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000474504	7	26233239	7	26193619	474504	457114	rs1554331125	NC_000007.14:26193618:T:C
NM_002137.4(HNRNPA2B1):c.744C>T (p.Pro248=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000474503	7	26233292	7	26193672	474503	457301	rs141885504	NC_000007.14:26193671:G:A
NM_002137.4(HNRNPA2B1):c.721+10C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not provided	Likely benign(Last reviewed: Jun 9, 2018)	criteria provided, single submitter	VCV000474502	7	26235457	7	26195837	474502	457124	rs768374617	NC_000007.14:26195836:G:A
NM_002137.4(HNRNPA2B1):c.33C>G (p.Leu11=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000474501	7	26237326	7	26197706	474501	457125	rs774999756	NC_000007.14:26197705:G:C
NM_002137.4(HNRNPA2B1):c.315C>T (p.Gly105=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Mar 12, 2020)	criteria provided, single submitter	VCV000474500	7	26236587	7	26196967	474500	456681	rs766409233	NC_000007.14:26196966:G:A
NM_002137.4(HNRNPA2B1):c.645T>C (p.Phe215=)	HNRNPA2B1		not specified|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261955	7	26236034	7	26196414	261955	252783	rs117082250	NC_000007.14:26196413:A:G
NM_002137.4(HNRNPA2B1):c.519A>G (p.Arg173=)	HNRNPA2B1		not provided|not specified|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261954	7	26236235	7	26196615	261954	252784	rs34317198	NC_000007.14:26196614:T:C
NM_002137.4(HNRNPA2B1):c.117+4T>C	HNRNPA2B1		not provided|not specified|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000261953	7	26237238	7	26197618	261953	252785	rs41275982	NC_000007.14:26197617:A:G
NM_002137.4(HNRNPA2B1):c.869A>T (p.Asp290Val)	HNRNPA2B1	D290V, D302V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065454	7	26232966	7	26193346	65454	76371	rs397515326	NC_000007.14:26193345:T:A
NM_004134.7(HSPA9):c.1426G>A (p.Ala476Thr)	HSPA9	A476T	Anemia, sideroblastic, 4|not provided	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, single submitter	VCV000430651	5	137894331	5	138558642	430651	424181	rs145860531	NC_000005.10:138558641:C:T
NM_013247.5(HTRA2):c.77G>A (p.Gly26Glu)	HTRA2	G26E	Parkinson disease 13	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000898769	2	74757210	2	74530083	898769	885479		NC_000002.12:74530082:G:A
NM_013247.5(HTRA2):c.*267C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000897673	2	74760379	2	74533252	897673	885484		NC_000002.12:74533251:C:T
NM_145074.2(HTRA2):c.-136C>T	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000897610	2	74756998	2	74529871	897610	885478		NC_000002.12:74529870:C:T
NM_013247.5(HTRA2):c.*265C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896084	2	74760377	2	74533250	896084	885483		NC_000002.12:74533249:C:T
NM_013247.5(HTRA2):c.1079G>A (p.Arg360His)	HTRA2	R295H, R360H, R370H	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000896083	2	74759016	2	74531889	896083	885482		NC_000002.12:74531888:G:A
NM_013247.5(HTRA2):c.1056C>T (p.Ser352=)	HTRA2		Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000895799	2	74758993	2	74531866	895799	885481		NC_000002.12:74531865:C:T
NM_013247.5(HTRA2):c.1046-5C>G	HTRA2		Parkinson disease 13	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000895798	2	74758978	2	74531851	895798	887401		NC_000002.12:74531850:C:G
NM_013247.5(HTRA2):c.937C>T (p.Leu313=)	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000895797	2	74758496	2	74531369	895797	885480		NC_000002.12:74531368:C:T
NM_013247.5(HTRA2):c.510C>T (p.His170=)	HTRA2		Parkinson disease 13|not provided	Likely benign(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000741628	2	74757747	2	74530620	741628	747788	rs200747610	NC_000002.12:74530619:C:T
NM_013247.5(HTRA2):c.354G>A (p.Leu118=)	HTRA2		not provided|Parkinson disease 13	Likely benign(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000727861	2	74757487	2	74530360	727861	733580	rs199735424	NC_000002.12:74530359:G:A
NM_032603.5(LOXL3):c.*84C>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337146	2	74760649	2	74533522	337146	290952	rs886056349	NC_000002.12:74533521:G:A
NM_032603.5(LOXL3):c.*90T>C	HTRA2|LOXL3		Parkinson disease 13	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337145	2	74760643	2	74533516	337145	290732	rs114661282	NC_000002.12:74533515:A:G
NM_032603.5(LOXL3):c.*108A>T	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337144	2	74760625	2	74533498	337144	290951	rs886056348	NC_000002.12:74533497:T:A
NM_032603.5(LOXL3):c.*178A>T	HTRA2|LOXL3		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337143	2	74760555	2	74533428	337143	290725	rs71640296	NC_000002.12:74533427:T:A
NM_032603.5(LOXL3):c.*237G>T	HTRA2|LOXL3		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337142	2	74760496	2	74533369	337142	290720	rs71640295	NC_000002.12:74533368:C:A
NM_013247.5(HTRA2):c.*291G>A	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337141	2	74760403	2	74533276	337141	287311	rs886056347	NC_000002.12:74533275:G:A
NM_013247.5(HTRA2):c.*249G>C	HTRA2|LOXL3		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337140	2	74760361	2	74533234	337140	290718	rs775428682	NC_000002.12:74533233:G:C
NM_013247.5(HTRA2):c.*94C>T	HTRA2|LOXL3		Parkinson disease 13|not provided	Benign(Last reviewed: Jul 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337139	2	74760206	2	74533079	337139	288038	rs79220020	NC_000002.12:74533078:C:T
NM_013247.5(HTRA2):c.1346C>T (p.Thr449Ile)	HTRA2|LOXL3	T449I, T427I, T352I, T417I	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337138	2	74760081	2	74532954	337138	290950	rs886056346	NC_000002.12:74532953:C:T
NM_013247.5(HTRA2):c.1155C>T (p.Pro385=)	HTRA2|LOXL3		Parkinson disease 13|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000337137	2	74759785	2	74532658	337137	290715	rs150357486	NC_000002.12:74532657:C:T
NM_013247.5(HTRA2):c.1131A>G (p.Leu377=)	HTRA2|LOXL3		Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000337136	2	74759761	2	74532634	337136	290714	rs758108369	NC_000002.12:74532633:A:G
NM_013247.5(HTRA2):c.1046-13C>T	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000337135	2	74758970	2	74531843	337135	287303	rs542851656	NC_000002.12:74531842:C:T
NM_013247.5(HTRA2):c.873T>C (p.Asn291=)	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337134	2	74758199	2	74531072	337134	287302	rs775948550	NC_000002.12:74531071:T:C
NM_013247.5(HTRA2):c.825T>C (p.Val275=)	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337133	2	74758151	2	74531024	337133	290711	rs777650346	NC_000002.12:74531023:T:C
NM_013247.5(HTRA2):c.627A>G (p.Arg209=)	HTRA2		Parkinson disease 13|not provided	Likely benign(Last reviewed: Apr 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000337132	2	74757864	2	74530737	337132	288035	rs149169879	NC_000002.12:74530736:A:G
NM_013247.5(HTRA2):c.507-9C>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337131	2	74757735	2	74530608	337131	290709	rs151291127	NC_000002.12:74530607:C:A
NM_013247.5(HTRA2):c.507-10T>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337130	2	74757734	2	74530607	337130	290701	rs747756166	NC_000002.12:74530606:T:A
NM_013247.5(HTRA2):c.480C>G (p.Ala160=)	HTRA2		not provided|Parkinson disease 13	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000337129	2	74757613	2	74530486	337129	290947	rs2231248	NC_000002.12:74530485:C:G
NM_013247.5(HTRA2):c.241G>A (p.Ala81Thr)	HTRA2	A81T	Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337128	2	74757374	2	74530247	337128	287301	rs886056345	NC_000002.12:74530246:G:A
NM_013247.5(HTRA2):c.215T>C (p.Leu72Pro)	HTRA2	L72P	Parkinson disease 13|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)	criteria provided, conflicting interpretations	VCV000337127	2	74757348	2	74530221	337127	288021	rs150047108	NC_000002.12:74530220:T:C
NM_013247.4(HTRA2):c.-86G>C	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337126	2	74757048	2	74529921	337126	290700	rs886056344	NC_000002.12:74529920:G:C
NM_013247.4(HTRA2):c.-136C>G	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337125	2	74756998	2	74529871	337125	290668	rs886056343	NC_000002.12:74529870:C:G
NM_013247.4(HTRA2):c.-146G>A	HTRA2		Parkinson disease 13	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337124	2	74756988	2	74529861	337124	288016	rs569404179	NC_000002.12:74529860:G:A
NM_013247.4(HTRA2):c.-216G>A	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337123	2	74756918	2	74529791	337123	290946	rs886056342	NC_000002.12:74529790:G:A
NM_013247.4(HTRA2):c.-236G>C	HTRA2		Parkinson disease 13	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000337122	2	74756898	2	74529771	337122	287298	rs886056341	NC_000002.12:74529770:G:C
NM_013247.5(HTRA2):c.427C>G (p.Pro143Ala)	HTRA2	P143A	Parkinson disease 13	risk factor(Last reviewed: Dec 1, 2011)	no assertion criteria provided	VCV000030583	2	74757560	2	74530433	30583	39540	rs387906942	NC_000002.12:74530432:C:G
NM_013247.5(HTRA2):c.421G>T (p.Ala141Ser)	HTRA2	A141S	not provided|Parkinson disease 13	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004342	2	74757554	2	74530427	4342	19381	rs72470544	NC_000002.12:74530426:G:T
NM_013247.5(HTRA2):c.1195G>A (p.Gly399Ser)	HTRA2|LOXL3	G399S	Parkinson disease 13|not provided	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004341	2	74759825	2	74532698	4341	19380	rs72470545	NC_000002.12:74532697:G:A
NM_000202.8(IDS):c.238C>T (p.Gln80Ter)	IDS	Q80*	Mucopolysaccharidosis, MPS-II	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000633269	X	148585689	X	149504159	633269	621680	rs1569560527	NC_000023.11:149504158:G:A
NM_002230.4(JUP):c.251G>A (p.Arg84Gln)	JUP	R84Q	Wolff-Parkinson-White pattern|not provided|Arrhythmogenic right ventricular cardiomyopathy, type 12|Naxos disease	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487584	17	39925887	17	41769635	487584	480722	rs782061304	NC_000017.11:41769634:C:T
NM_002230.4(JUP):c.578T>C (p.Met193Thr)	JUP	M193T	Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 12|Naxos disease|not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222661	17	39925350	17	41769098	222661	224519	rs139496777	NC_000017.11:41769097:A:G
NM_002230.4(JUP):c.773A>G (p.Glu258Gly)	JUP	E258G	Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Jan 4, 2017)	criteria provided, single submitter	VCV000201830	17	39923767	17	41767515	201830	198498	rs794729052	NC_000017.11:41767514:T:C
NM_000238.4(KCNH2):c.2046G>C (p.Glu682Asp)	KCNH2	E342D, E682D	Arrhythmia|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487626	7	150648108	7	150951020	487626	480695	rs1338579153	NC_000007.14:150951019:C:G
NM_000238.4(KCNH2):c.1225G>A (p.Val409Met)	KCNH2	V69M, V409M	Wolff-Parkinson-White pattern|Long QT syndrome|Arrhythmia	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000456884	7	150649845	7	150952757	456884	457546	rs539146547	NC_000007.14:150952756:C:T
NM_000891.3(KCNJ2):c.49G>A (p.Asp17Asn)	KCNJ2	D17N	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487624	17	68171229	17	70175088	487624	480723	rs1331601602	NC_000017.11:70175087:G:A
NM_000218.3(KCNQ1):c.1621G>A (p.Val541Ile)	KCNQ1	V541I, V414I	Congenital long QT syndrome|Wolff-Parkinson-White pattern|Long QT syndrome 1|not provided|not specified|Arrhythmia|Long QT syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000067043	11	2797220	11	2775990	67043	77939	rs199472796	NC_000011.10:2775989:G:A
NM_000218.3(KCNQ1):c.724G>A (p.Asp242Asn)	KCNQ1	D242N, D115N	Wolff-Parkinson-White pattern|Congenital long QT syndrome|not provided|Long QT syndrome	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000053090	11	2593283	11	2572053	53090	67758	rs199472712	NC_000011.10:2572052:G:A
NM_000218.3(KCNQ1):c.1189C>T (p.Arg397Trp)	KCNQ1	R397W, R270W	Arrhythmia|short QT syndrome|not specified|not provided|Long QT syndrome|Wolff-Parkinson-White pattern|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome|Congenital long QT syndrome|Long QT syndrome 1|Familial atrial fibrillation	Conflicting interpretations of pathogenicity(Last reviewed: Apr 29, 2021)	criteria provided, conflicting interpretations	VCV000052970	11	2608860	11	2587630	52970	67638	rs199472776	NC_000011.10:2587629:C:T
NM_001105206.3(LAMA4):c.1420G>T (p.Val474Phe)	LAMA4	V467F, V474F	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487609	6	112493944	6	112172742	487609	480690	rs375981026	NC_000006.12:112172741:C:A
NM_001105206.3(LAMA4):c.2398C>T (p.Arg800Cys)	LAMA4	R793C, R800C	not provided|Dilated cardiomyopathy 1JJ|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000192119	6	112466091	6	112144889	192119	189798	rs202184174	NC_000006.12:112144888:G:A
NM_002293.4(LAMC1):c.3304C>T (p.Arg1102Cys)	LAMC1	R1102C	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487617	1	183099502	1	183130367	487617	480670	rs142883085	NC_000001.11:183130366:C:T
NM_002294.3(LAMP2):c.718C>T (p.Gln240Ter)	LAMP2	Q240*	not provided	Pathogenic(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000488987	X	119581719	X	120447864	488987	482232	rs1556101420	NC_000023.11:120447863:G:A
NM_002294.3(LAMP2):c.1075C>T (p.Gln359Ter)	LAMP2	Q359*	not provided	Likely pathogenic(Last reviewed: Aug 19, 2016)	criteria provided, single submitter	VCV000372712	X	119575603	X	120441748	372712	360562	rs1057517940	NC_000023.11:120441747:G:A
NM_002294.3(LAMP2):c.293G>A (p.Trp98Ter)	LAMP2	W98*	Danon disease|not provided	Pathogenic(Last reviewed: Apr 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000044423	X	119589316	X	120455461	44423	53590	rs397516740	NC_000023.11:120455460:C:T
NM_002294.3(LAMP2):c.520C>T (p.Gln174Ter)	LAMP2	Q174*	Danon disease	Pathogenic(Last reviewed: Aug 17, 2017)	criteria provided, single submitter	VCV000009981	X	119582861	X	120449006	9981	25020	rs104894857	NC_000023.11:120449005:G:A
NM_007078.3(LDB3):c.2017G>A (p.Asp673Asn)	LDB3	D626N, D673N, D678N, D610N, D563N	not provided|Dilated cardiomyopathy 1C|Left ventricular noncompaction 3|Myofibrillar myopathy, ZASP-related	Uncertain significance(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004735	10	88485932	10	86726175	4735	19774	rs45514002	NC_000010.11:86726174:G:A
NM_170707.4(LMNA):c.1756G>A (p.Val586Met)	LMNA	V474M, V556M, V586M	Benign scapuloperoneal muscular dystrophy with cardiomyopathy|Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Dilated cardiomyopathy 1A|Familial partial lipodystrophy 2|Charcot-Marie-Tooth disease type 2B1|Mandibuloacral dysplasia with type A lipodystrophy|Congenital muscular dystrophy, LMNA-related|Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|not specified|not provided|Wolff-Parkinson-White pattern|Charcot-Marie-Tooth disease, type 2	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487635	1	156108336	1	156138545	487635	480668	rs758048062	NC_000001.11:156138544:G:A
NM_000157.4(GBA):c.902G>A (p.Arg301His)	LOC106627981|GBA	R301H, R252H, R214H	not provided	Uncertain significance(Last reviewed: Mar 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000592663	1	155207229	1	155237438	592663	583728	rs140955685	NC_000001.11:155237437:C:T
NM_000157.4(GBA):c.1296G>A (p.Trp432Ter)	LOC106627981|GBA	W432*, W345*, W383*	Gaucher disease|not provided	Uncertain significance(Last reviewed: Jul 1, 2017)	criteria provided, single submitter	VCV000493049	1	155205564	1	155235773	493049	486012	rs1484043383	NC_000001.11:155235772:C:T
NM_000157.4(GBA):c.1440G>C (p.Lys480Asn)	LOC106627981|GBA	K480N, K431N, K393N	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Sep 8, 2015)	no assertion criteria provided	VCV000209103	1	155205051	1	155235260	209103	205699	rs1057519356	NC_000001.11:155235259:C:G
NM_002471.4(MYH6):c.292G>A (p.Glu98Lys)	LOC114827851|MYH6	E98K	Familial hypertrophic cardiomyopathy 1|not specified|not provided|Cardiomyopathy|Cardiovascular phenotype|Familial hypertrophic cardiomyopathy 14|Dilated cardiomyopathy 1EE|Familial hypertrophic cardiomyopathy 14|Familial hypertrophic cardiomyopathy 1|Sick sinus syndrome 3, susceptibility to|Atrial septal defect 3	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000044474	14	23874889	14	23405680	44474	53641	rs140596256	NC_000014.9:23405679:C:T
NM_198578.4(LRRK2):c.4943A>G (p.Gln1648Arg)	LRRK2	Q1648R	not provided	Uncertain significance(Last reviewed: Jun 6, 2019)	criteria provided, single submitter	VCV001306222	12	40713905	12	40320103	1306222	1297491		NC_000012.12:40320102:A:G
NM_198578.4(LRRK2):c.4453T>G (p.Tyr1485Asp)	LRRK2	Y1485D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 11, 2021)	criteria provided, single submitter	VCV001199187	12	40704368	12	40310566	1199187	1189225		NC_000012.12:40310565:T:G
NM_198578.4(LRRK2):c.5080C>T (p.Leu1694=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Feb 1, 2020)	criteria provided, single submitter	VCV001169460	12	40714900	12	40321098	1169460	1156982		NC_000012.12:40321097:C:T
NM_198578.4(LRRK2):c.149G>A (p.Arg50His)	LRRK2	R50H	not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001169383	12	40619082	12	40225280	1169383	1156981		NC_000012.12:40225279:G:A
NM_198578.4(LRRK2):c.7320A>G (p.Ser2440=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001164630	12	40758782	12	40364980	1164630	1156983		NC_000012.12:40364979:A:G
NM_198578.4(LRRK2):c.3993T>G (p.Pro1331=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV001160689	12	40702302	12	40308500	1160689	1143453		NC_000012.12:40308499:T:G
NM_198578.4(LRRK2):c.1404T>C (p.His468=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001154739	12	40651165	12	40257363	1154739	1143452		NC_000012.12:40257362:T:C
NM_198578.4(LRRK2):c.4162C>A (p.Leu1388Ile)	LRRK2	L1388I	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV001152814	12	40702471	12	40308669	1152814	1143454		NC_000012.12:40308668:C:A
NM_198578.4(LRRK2):c.1288+9T>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001150013	12	40646827	12	40253025	1150013	1143451		NC_000012.12:40253024:T:A
NM_198578.4(LRRK2):c.6382-8T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001149733	12	40745333	12	40351531	1149733	1143455		NC_000012.12:40351530:T:C
NM_198578.4(LRRK2):c.6714A>T (p.Leu2238=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001148495	12	40748238	12	40354436	1148495	1143456		NC_000012.12:40354435:A:T
NM_198578.4(LRRK2):c.5838G>A (p.Val1946=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV001115510	12	40728849	12	40335047	1115510	1101132		NC_000012.12:40335046:G:A
NM_198578.4(LRRK2):c.1980A>G (p.Ala660=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV001114859	12	40671728	12	40277926	1114859	1101131		NC_000012.12:40277925:A:G
NM_198578.4(LRRK2):c.5550T>C (p.Ile1850=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001096218	12	40717002	12	40323200	1096218	1079382		NC_000012.12:40323199:T:C
NM_198578.4(LRRK2):c.4203C>T (p.Phe1401=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001093539	12	40702921	12	40309119	1093539	1079381		NC_000012.12:40309118:C:T
NM_198578.4(LRRK2):c.4132A>G (p.Ile1378Val)	LRRK2	I1378V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 13, 2020)	criteria provided, single submitter	VCV001045094	12	40702441	12	40308639	1045094	1030917		NC_000012.12:40308638:A:G
NM_198578.4(LRRK2):c.7430G>A (p.Arg2477Gln)	LRRK2	R2477Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001044075	12	40760847	12	40367045	1044075	1030918		NC_000012.12:40367044:G:A
NM_198578.4(LRRK2):c.7570A>G (p.Thr2524Ala)	LRRK2	T2524A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001043048	12	40761553	12	40367751	1043048	1030919		NC_000012.12:40367750:A:G
NM_198578.4(LRRK2):c.605A>G (p.Asn202Ser)	LRRK2	N202S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001042541	12	40634318	12	40240516	1042541	1030916		NC_000012.12:40240515:A:G
NM_198578.4(LRRK2):c.3184A>C (p.Asn1062His)	LRRK2	N1062H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001015784	12	40692132	12	40298330	1015784	1010420		NC_000012.12:40298329:A:C
NM_198578.4(LRRK2):c.3901G>A (p.Glu1301Lys)	LRRK2	E1301K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV001015545	12	40699710	12	40305908	1015545	1010421		NC_000012.12:40305907:G:A
NM_198578.4(LRRK2):c.6589A>G (p.Ser2197Gly)	LRRK2	S2197G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001011348	12	40748113	12	40354311	1011348	995182		NC_000012.12:40354310:A:G
NM_198578.4(LRRK2):c.4468G>A (p.Ala1490Thr)	LRRK2	A1490T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001007154	12	40704383	12	40310581	1007154	995181		NC_000012.12:40310580:G:A
NM_198578.4(LRRK2):c.1030G>A (p.Glu344Lys)	LRRK2	E344K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000963191	12	40645105	12	40251303	963191	948001		NC_000012.12:40251302:G:A
NM_198578.4(LRRK2):c.3935G>A (p.Gly1312Glu)	LRRK2	G1312E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000963111	12	40699744	12	40305942	963111	948003		NC_000012.12:40305941:G:A
NM_198578.4(LRRK2):c.6175T>C (p.Phe2059Leu)	LRRK2	F2059L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000961639	12	40740620	12	40346818	961639	948004		NC_000012.12:40346817:T:C
NM_198578.4(LRRK2):c.1382G>T (p.Ser461Ile)	LRRK2	S461I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV000957338	12	40651143	12	40257341	957338	948002		NC_000012.12:40257340:G:T
NM_198578.4(LRRK2):c.5827C>T (p.Arg1943Trp)	LRRK2	R1943W	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000950727	12	40728838	12	40335036	950727	926615		NC_000012.12:40335035:C:T
NM_198578.4(LRRK2):c.1211C>T (p.Ser404Phe)	LRRK2	S404F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000938921	12	40646741	12	40252939	938921	936109		NC_000012.12:40252938:C:T
NM_198578.4(LRRK2):c.2500+6T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000937316	12	40677941	12	40284139	937316	940267		NC_000012.12:40284138:T:C
NM_198578.4(LRRK2):c.6087A>G (p.Ile2029Met)	LRRK2	I2029M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 2, 2019)	criteria provided, single submitter	VCV000935665	12	40734234	12	40340432	935665	936111		NC_000012.12:40340431:A:G
NM_198578.4(LRRK2):c.2333G>A (p.Ser778Asn)	LRRK2	S778N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 25, 2019)	criteria provided, single submitter	VCV000934690	12	40677768	12	40283966	934690	936110		NC_000012.12:40283965:G:A
NM_198578.4(LRRK2):c.7475G>T (p.Cys2492Phe)	LRRK2	C2492F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000931900	12	40761458	12	40367656	931900	919431		NC_000012.12:40367655:G:T
NM_198578.4(LRRK2):c.6448G>C (p.Val2150Leu)	LRRK2	V2150L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 12, 2019)	criteria provided, single submitter	VCV000931534	12	40745407	12	40351605	931534	919430		NC_000012.12:40351604:G:C
NM_198578.4(LRRK2):c.2842C>T (p.Arg948Ter)	LRRK2	R948*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000930929	12	40688680	12	40294878	930929	919429		NC_000012.12:40294877:C:T
NM_198578.4(LRRK2):c.*1429C>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883735	12	40762996	12	40369194	883735	869800		NC_000012.12:40369193:C:G
NM_198578.4(LRRK2):c.*1402G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883734	12	40762969	12	40369167	883734	869799		NC_000012.12:40369166:G:T
NM_198578.4(LRRK2):c.*308A>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883687	12	40761875	12	40368073	883687	869790		NC_000012.12:40368072:A:C
NM_198578.4(LRRK2):c.*277A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000883686	12	40761844	12	40368042	883686	869789		NC_000012.12:40368041:A:G
NM_198578.4(LRRK2):c.5799A>T (p.Ile1933=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)	criteria provided, conflicting interpretations	VCV000883636	12	40728810	12	40335008	883636	869782		NC_000012.12:40335007:A:T
NM_198578.4(LRRK2):c.3615C>G (p.Ser1205Arg)	LRRK2	S1205R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000883595	12	40697774	12	40303972	883595	869780		NC_000012.12:40303971:C:G
NM_198578.4(LRRK2):c.1473G>T (p.Met491Ile)	LRRK2	M491I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883552	12	40653336	12	40259534	883552	869773		NC_000012.12:40259533:G:T
NM_198578.4(LRRK2):c.1260T>C (p.Asn420=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883551	12	40646790	12	40252988	883551	869772		NC_000012.12:40252987:T:C
NM_198578.4(LRRK2):c.1224T>G (p.His408Gln)	LRRK2	H408Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000883550	12	40646754	12	40252952	883550	869771		NC_000012.12:40252951:T:G
NM_198578.4(LRRK2):c.-91C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000883497	12	40618843	12	40225041	883497	869764		NC_000012.12:40225040:C:T
NM_198578.4(LRRK2):c.*1165C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 20, 2018)	criteria provided, single submitter	VCV000882942	12	40762732	12	40368930	882942	869798		NC_000012.12:40368929:C:T
NM_198578.4(LRRK2):c.*1095C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000882941	12	40762662	12	40368860	882941	869797		NC_000012.12:40368859:C:T
NM_198578.4(LRRK2):c.*1042A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000882940	12	40762609	12	40368807	882940	869796		NC_000012.12:40368806:A:G
NM_198578.4(LRRK2):c.7573T>C (p.Ser2525Pro)	LRRK2	S2525P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000882889	12	40761556	12	40367754	882889	869788		NC_000012.12:40367753:T:C
NM_198578.4(LRRK2):c.921A>G (p.Ala307=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000882757	12	40643710	12	40249908	882757	869770		NC_000012.12:40249907:A:G
NM_198578.4(LRRK2):c.839-4T>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000882756	12	40643624	12	40249822	882756	872237		NC_000012.12:40249821:T:G
NM_198578.4(LRRK2):c.*942T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881792	12	40762509	12	40368707	881792	869795		NC_000012.12:40368706:T:C
NM_198578.4(LRRK2):c.*908A>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881791	12	40762475	12	40368673	881791	869794		NC_000012.12:40368672:A:C
NM_198578.4(LRRK2):c.*769T>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881790	12	40762336	12	40368534	881790	869793		NC_000012.12:40368533:T:G
NM_198578.4(LRRK2):c.*751C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881789	12	40762318	12	40368516	881789	869792		NC_000012.12:40368515:C:A
NM_198578.4(LRRK2):c.7036T>C (p.Tyr2346His)	LRRK2	Y2346H	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881738	12	40757211	12	40363409	881738	869787		NC_000012.12:40363408:T:C
NM_198578.4(LRRK2):c.6583G>T (p.Ala2195Ser)	LRRK2	A2195S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881737	12	40748107	12	40354305	881737	869786		NC_000012.12:40354304:G:T
NM_198578.4(LRRK2):c.2864C>T (p.Ser955Leu)	LRRK2	S955L	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881647	12	40688702	12	40294900	881647	869779		NC_000012.12:40294899:C:T
NM_198578.4(LRRK2):c.2758G>A (p.Ala920Thr)	LRRK2	A920T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881646	12	40687415	12	40293613	881646	869778		NC_000012.12:40293612:G:A
NM_198578.4(LRRK2):c.2579G>A (p.Ser860Asn)	LRRK2	S860N	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881645	12	40681231	12	40287429	881645	869777		NC_000012.12:40287428:G:A
NM_198578.4(LRRK2):c.2443C>A (p.Pro815Thr)	LRRK2	P815T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881644	12	40677878	12	40284076	881644	869776		NC_000012.12:40284075:C:A
NM_198578.4(LRRK2):c.606C>T (p.Asn202=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881601	12	40634319	12	40240517	881601	869769		NC_000012.12:40240516:C:T
NM_198578.4(LRRK2):c.*497C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881346	12	40762064	12	40368262	881346	869791		NC_000012.12:40368261:C:T
NM_198578.4(LRRK2):c.6004C>G (p.Leu2002Val)	LRRK2	L2002V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881285	12	40734151	12	40340349	881285	869785		NC_000012.12:40340348:C:G
NM_198578.4(LRRK2):c.5982C>T (p.Asp1994=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881284	12	40734129	12	40340327	881284	869784		NC_000012.12:40340326:C:T
NM_198578.4(LRRK2):c.5828G>A (p.Arg1943Gln)	LRRK2	R1943Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881283	12	40728839	12	40335037	881283	869783		NC_000012.12:40335036:G:A
NM_198578.4(LRRK2):c.4317+3G>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881231	12	40703038	12	40309236	881231	872239		NC_000012.12:40309235:G:A
NM_198578.4(LRRK2):c.4165G>A (p.Val1389Ile)	LRRK2	V1389I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881230	12	40702474	12	40308672	881230	869781		NC_000012.12:40308671:G:A
NM_198578.4(LRRK2):c.2282T>C (p.Leu761Ser)	LRRK2	L761S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000881178	12	40677717	12	40283915	881178	869775		NC_000012.12:40283914:T:C
NM_198578.4(LRRK2):c.1656+6T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881177	12	40657709	12	40263907	881177	872238		NC_000012.12:40263906:T:C
NM_198578.4(LRRK2):c.1655G>A (p.Arg552Lys)	LRRK2	R552K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000881176	12	40657702	12	40263900	881176	869774		NC_000012.12:40263899:G:A
NM_198578.4(LRRK2):c.228T>C (p.Ser76=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000881131	12	40619433	12	40225631	881131	869768		NC_000012.12:40225630:T:C
NM_198578.4(LRRK2):c.215T>C (p.Met72Thr)	LRRK2	M72T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000881130	12	40619420	12	40225618	881130	869767		NC_000012.12:40225617:T:C
NM_198578.4(LRRK2):c.102G>C (p.Thr34=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881129	12	40619035	12	40225233	881129	869766		NC_000012.12:40225232:G:C
NM_198578.4(LRRK2):c.-74C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000881128	12	40618860	12	40225058	881128	869765		NC_000012.12:40225057:C:A
NM_198578.4(LRRK2):c.620T>C (p.Ile207Thr)	LRRK2	I207T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV000863118	12	40634333	12	40240531	863118	839882		NC_000012.12:40240530:T:C
NM_198578.4(LRRK2):c.309G>C (p.Gln103His)	LRRK2	Q103H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000859873	12	40626147	12	40232345	859873	839880		NC_000012.12:40232344:G:C
NM_198578.4(LRRK2):c.2025A>G (p.Ile675Met)	LRRK2	I675M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000847711	12	40671773	12	40277971	847711	839883		NC_000012.12:40277970:A:G
NM_198578.4(LRRK2):c.2513C>A (p.Thr838Lys)	LRRK2	T838K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 5, 2019)	criteria provided, single submitter	VCV000846772	12	40681165	12	40287363	846772	839884		NC_000012.12:40287362:C:A
NM_198578.4(LRRK2):c.6563G>C (p.Gly2188Ala)	LRRK2	G2188A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846126	12	40745522	12	40351720	846126	839886		NC_000012.12:40351719:G:C
NM_198578.4(LRRK2):c.4327T>G (p.Ser1443Ala)	LRRK2	S1443A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 14, 2020)	criteria provided, single submitter	VCV000844650	12	40704242	12	40310440	844650	839885		NC_000012.12:40310439:T:G
NM_198578.4(LRRK2):c.382A>G (p.Ser128Gly)	LRRK2	S128G	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 3, 2019)	criteria provided, single submitter	VCV000840701	12	40629462	12	40235660	840701	839881		NC_000012.12:40235659:A:G
NM_198578.4(LRRK2):c.825T>C (p.His275=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000804996	12	40637470	12	40243668	804996	793420	rs72546315	NC_000012.12:40243667:T:C
NM_198578.4(LRRK2):c.4827+6T>A	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000800181	12	40709108	12	40315306	800181	787873	rs550610903	NC_000012.12:40315305:T:A
NM_198578.4(LRRK2):c.3496+9T>G	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Jun 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000767350	12	40693068	12	40299266	767350	778090	rs560559629	NC_000012.12:40299265:T:G
NM_198578.4(LRRK2):c.693C>T (p.Ser231=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000766224	12	40634406	12	40240604	766224	769103	rs1592146379	NC_000012.12:40240603:C:T
NM_198578.4(LRRK2):c.4537-6T>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000765623	12	40707768	12	40313966	765623	776033	rs779382508	NC_000012.12:40313965:T:C
NM_198578.4(LRRK2):c.5412A>G (p.Gly1804=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000761200	12	40716215	12	40322413	761200	769106	rs200951081	NC_000012.12:40322412:A:G
NM_198578.4(LRRK2):c.2517A>G (p.Leu839=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000752449	12	40681169	12	40287367	752449	769104	rs1592226567	NC_000012.12:40287366:A:G
NM_198578.4(LRRK2):c.114C>A (p.Ile38=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Feb 20, 2018)	criteria provided, single submitter	VCV000749146	12	40619047	12	40225245	749146	753349	rs1592124610	NC_000012.12:40225244:C:A
NM_198578.4(LRRK2):c.2778A>G (p.Ser926=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000743537	12	40687435	12	40293633	743537	753353	rs937911118	NC_000012.12:40293632:A:G
NM_198578.4(LRRK2):c.75T>C (p.Asn25=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000738486	12	40619008	12	40225206	738486	753348	rs1592124542	NC_000012.12:40225205:T:C
NM_198578.4(LRRK2):c.4611G>A (p.Glu1537=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000735024	12	40707848	12	40314046	735024	738633	rs575429866	NC_000012.12:40314045:G:A
NM_198578.4(LRRK2):c.1476A>G (p.Lys492=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000722201	12	40653339	12	40259537	722201	738632	rs748115010	NC_000012.12:40259536:A:G
NM_198578.4(LRRK2):c.6900G>A (p.Leu2300=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000716263	12	40753118	12	40359316	716263	725086	rs906855468	NC_000012.12:40359315:G:A
NM_198578.4(LRRK2):c.2322G>A (p.Ala774=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000707538	12	40677757	12	40283955	707538	693198	rs146103273	NC_000012.12:40283954:G:A
NM_198578.4(LRRK2):c.5171-9A>G	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000707077	12	40715828	12	40322026	707077	695567	rs78243554	NC_000012.12:40322025:A:G
NM_198578.4(LRRK2):c.750T>C (p.Tyr250=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Likely benign(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000706954	12	40637395	12	40243593	706954	693197	rs139971538	NC_000012.12:40243592:T:C
NM_198578.4(LRRK2):c.364C>T (p.Leu122=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000706229	12	40629444	12	40235642	706229	693195	rs41286468	NC_000012.12:40235641:C:T
NM_198578.4(LRRK2):c.2594C>T (p.Ser865Phe)	LRRK2	S865F	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000705830	12	40681246	12	40287444	705830	693199	rs142700458	NC_000012.12:40287443:C:T
NM_198578.4(LRRK2):c.4536+3A>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 19, 2021)	criteria provided, conflicting interpretations	VCV000703922	12	40704454	12	40310652	703922	695565	rs41286476	NC_000012.12:40310651:A:G
NM_198578.4(LRRK2):c.699G>A (p.Ala233=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, single submitter	VCV000702314	12	40634412	12	40240610	702314	693196	rs577327683	NC_000012.12:40240609:G:A
NM_198578.4(LRRK2):c.6423G>A (p.Thr2141=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000702228	12	40745382	12	40351580	702228	693203	rs369306296	NC_000012.12:40351579:G:A
NM_198578.4(LRRK2):c.1383T>C (p.Ser461=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695715	12	40651144	12	40257342	695715	684325	rs35847451	NC_000012.12:40257341:T:C
NM_198578.4(LRRK2):c.4881G>A (p.Ser1627=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000695696	12	40713843	12	40320041	695696	684326	rs767307387	NC_000012.12:40320040:G:A
NM_198578.4(LRRK2):c.4318-6C>T	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695341	12	40704227	12	40310425	695341	685380	rs56082834	NC_000012.12:40310424:C:T
NM_198578.4(LRRK2):c.7429C>T (p.Arg2477Trp)	LRRK2	R2477W	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695315	12	40760846	12	40367044	695315	684327	rs138780308	NC_000012.12:40367043:C:T
NM_198578.4(LRRK2):c.1073C>T (p.Thr358Met)	LRRK2	T358M	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2018)	criteria provided, conflicting interpretations	VCV000663402	12	40645148	12	40251346	663402	641104	rs141262110	NC_000012.12:40251345:C:T
NM_198578.4(LRRK2):c.1865G>C (p.Gly622Ala)	LRRK2	G622A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000662235	12	40668719	12	40274917	662235	641106	rs1592203496	NC_000012.12:40274916:G:C
NM_198578.4(LRRK2):c.2357T>C (p.Ile786Thr)	LRRK2	I786T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000661611	12	40677792	12	40283990	661611	641107	rs1592220766	NC_000012.12:40283989:T:C
NM_198578.4(LRRK2):c.4894G>C (p.Glu1632Gln)	LRRK2	E1632Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000652400	12	40713856	12	40320054	652400	641109	rs200580973	NC_000012.12:40320053:G:C
NM_198578.4(LRRK2):c.6347A>G (p.Lys2116Arg)	LRRK2	K2116R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000649401	12	40742277	12	40348475	649401	641111	rs1592321778	NC_000012.12:40348474:A:G
NM_198578.4(LRRK2):c.3184A>G (p.Asn1062Asp)	LRRK2	N1062D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000647579	12	40692132	12	40298330	647579	641108	rs201935017	NC_000012.12:40298329:A:G
NM_198578.4(LRRK2):c.1352A>G (p.Lys451Arg)	LRRK2	K451R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000647525	12	40651113	12	40257311	647525	641105	rs1592172389	NC_000012.12:40257310:A:G
NM_198578.4(LRRK2):c.5363T>C (p.Met1788Thr)	LRRK2	M1788T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000641128	12	40716166	12	40322364	641128	641110	rs376533552	NC_000012.12:40322363:T:C
NM_198578.4(LRRK2):c.2752C>T (p.Arg918Ter)	LRRK2	R918*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000631544	12	40687409	12	40293607	631544	619925	rs957794216	NC_000012.12:40293606:C:T
NM_198578.4(LRRK2):c.736A>C (p.Asn246His)	LRRK2	N246H	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000586130	12	40637381	12	40243579	586130	577259	rs150050676	NC_000012.12:40243578:A:C
NM_198578.4(LRRK2):c.6382-2A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000583272	12	40745339	12	40351537	583272	568030	rs1565772858	NC_000012.12:40351536:A:G
NM_198578.4(LRRK2):c.1093C>A (p.His365Asn)	LRRK2	H365N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000580102	12	40645168	12	40251366	580102	571834	rs765509204	NC_000012.12:40251365:C:A
NM_198578.4(LRRK2):c.1240G>A (p.Val414Ile)	LRRK2	V414I	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000579293	12	40646770	12	40252968	579293	568026	rs1565682626	NC_000012.12:40252967:G:A
NM_198578.4(LRRK2):c.3033G>T (p.Glu1011Asp)	LRRK2	E1011D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000578792	12	40689383	12	40295581	578792	571841	rs141252946	NC_000012.12:40295580:G:T
NM_198578.4(LRRK2):c.2818T>G (p.Phe940Val)	LRRK2	F940V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000577777	12	40688656	12	40294854	577777	566828	rs953836925	NC_000012.12:40294853:T:G
NM_198578.4(LRRK2):c.368C>G (p.Thr123Arg)	LRRK2	T123R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000573487	12	40629448	12	40235646	573487	568025	rs1182341950	NC_000012.12:40235645:C:G
NM_198578.4(LRRK2):c.5594C>G (p.Pro1865Arg)	LRRK2	P1865R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000571682	12	40717046	12	40323244	571682	565444	rs905690564	NC_000012.12:40323243:C:G
NM_198578.4(LRRK2):c.3721G>A (p.Ala1241Thr)	LRRK2	A1241T	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000566690	12	40697880	12	40304078	566690	571842	rs767609721	NC_000012.12:40304077:G:A
NM_198578.4(LRRK2):c.4883G>A (p.Arg1628His)	LRRK2	R1628H	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000546702	12	40713845	12	40320043	546702	537191	rs33949390	NC_000012.12:40320042:G:A
NM_198578.4(LRRK2):c.3960-5A>G	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000533779	12	40702264	12	40308462	533779	527162	rs764870651	NC_000012.12:40308461:A:G
NM_198578.4(LRRK2):c.177T>A (p.Asn59Lys)	LRRK2	N59K	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000533778	12	40619382	12	40225580	533778	527134	rs150422099	NC_000012.12:40225579:T:A
NM_198578.4(LRRK2):c.2915A>G (p.Asp972Gly)	LRRK2	D972G	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533777	12	40689265	12	40295463	533777	527161	rs201718451	NC_000012.12:40295462:A:G
NM_198578.4(LRRK2):c.7384C>T (p.Gln2462Ter)	LRRK2	Q2462*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000533776	12	40758846	12	40365044	533776	527165	rs765894452	NC_000012.12:40365043:C:T
NM_198578.4(LRRK2):c.4608G>A (p.Ser1536=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000533775	12	40707845	12	40314043	533775	527135	rs202073944	NC_000012.12:40314042:G:A
NM_198578.4(LRRK2):c.4417C>T (p.Leu1473Phe)	LRRK2	L1473F	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533774	12	40704332	12	40310530	533774	527626	rs1555187766	NC_000012.12:40310529:C:T
NM_198578.4(LRRK2):c.7296C>G (p.Gly2432=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000465217	12	40758758	12	40364956	465217	463050	rs199964631	NC_000012.12:40364955:C:G
NM_198578.4(LRRK2):c.5870G>T (p.Arg1957Leu)	LRRK2	R1957L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 21, 2017)	criteria provided, single submitter	VCV000465216	12	40728881	12	40335079	465216	462146	rs201012950	NC_000012.12:40335078:G:T
NM_198578.4(LRRK2):c.1201G>A (p.Val401Met)	LRRK2	V401M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000465214	12	40646731	12	40252929	465214	462143	rs1479574336	NC_000012.12:40252928:G:A
NM_198578.4(LRRK2):c.3643G>A (p.Ala1215Thr)	LRRK2	A1215T	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000444287	12	40697802	12	40304000	444287	437927	rs143710836	NC_000012.12:40303999:G:A
NM_198578.4(LRRK2):c.-124G>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369016	12	40618810	12	40225008	369016	353245	rs112643657	NC_000012.12:40225007:G:C
NM_198578.4(LRRK2):c.*1482A>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308680	12	40763049	12	40369247	308680	324765	rs17491835	NC_000012.12:40369246:A:G
NM_198578.4(LRRK2):c.*1464T>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308679	12	40763031	12	40369229	308679	324764	rs17491828	NC_000012.12:40369228:T:G
NM_198578.4(LRRK2):c.*1446T>A	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308678	12	40763013	12	40369211	308678	330898	rs12422278	NC_000012.12:40369210:T:A
NM_198578.4(LRRK2):c.*1388T>C	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308677	12	40762955	12	40369153	308677	324760	rs200410756	NC_000012.12:40369152:T:C
NM_198578.4(LRRK2):c.*1279T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308676	12	40762846	12	40369044	308676	324759	rs886049369	NC_000012.12:40369043:T:C
NM_198578.4(LRRK2):c.*1186C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308675	12	40762753	12	40368951	308675	324757	rs886049368	NC_000012.12:40368950:C:T
NM_198578.4(LRRK2):c.*1182C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308674	12	40762749	12	40368947	308674	330897	rs376228552	NC_000012.12:40368946:C:T
NM_198578.4(LRRK2):c.*1181C>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308673	12	40762748	12	40368946	308673	332404	rs147956597	NC_000012.12:40368945:C:T
NM_198578.4(LRRK2):c.*1140A>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308672	12	40762707	12	40368905	308672	317049	rs886049367	NC_000012.12:40368904:A:T
NM_198578.4(LRRK2):c.*1069A>G	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308671	12	40762636	12	40368834	308671	332397	rs199823070	NC_000012.12:40368833:A:G
NM_198578.4(LRRK2):c.*1035T>C	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308670	12	40762602	12	40368800	308670	332396	rs201488873	NC_000012.12:40368799:T:C
NM_198578.4(LRRK2):c.*1018G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308669	12	40762585	12	40368783	308669	317047	rs200782338	NC_000012.12:40368782:G:T
NM_198578.4(LRRK2):c.*979T>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308668	12	40762546	12	40368744	308668	330896	rs10784548	NC_000012.12:40368743:T:C
NM_198578.4(LRRK2):c.*971C>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000308667	12	40762538	12	40368736	308667	317043	rs200935645	NC_000012.12:40368735:C:A
NM_198578.4(LRRK2):c.*736G>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308662	12	40762303	12	40368501	308662	317036	rs1365770	NC_000012.12:40368500:G:C
NM_198578.4(LRRK2):c.*721G>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308661	12	40762288	12	40368486	308661	332390	rs886049365	NC_000012.12:40368485:G:T
NM_198578.4(LRRK2):c.*615T>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308660	12	40762182	12	40368380	308660	332388	rs201422404	NC_000012.12:40368379:T:A
NM_198578.4(LRRK2):c.*470G>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308659	12	40762037	12	40368235	308659	324746	rs200678400	NC_000012.12:40368234:G:T
NM_198578.4(LRRK2):c.*405C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308658	12	40761972	12	40368170	308658	324745	rs200503610	NC_000012.12:40368169:C:T
NM_198578.4(LRRK2):c.*384C>T	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308657	12	40761951	12	40368149	308657	332384	rs3886747	NC_000012.12:40368148:C:T
NM_198578.4(LRRK2):c.*364A>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308656	12	40761931	12	40368129	308656	317030	rs10878441	NC_000012.12:40368128:A:C
NM_198578.4(LRRK2):c.*346A>G	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308655	12	40761913	12	40368111	308655	324744	rs17520676	NC_000012.12:40368110:A:G
NM_198578.4(LRRK2):c.*223C>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308654	12	40761790	12	40367988	308654	317029	rs886049364	NC_000012.12:40367987:C:T
NM_198578.4(LRRK2):c.*148T>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308653	12	40761715	12	40367913	308653	324729	rs202205832	NC_000012.12:40367912:T:C
NM_198578.4(LRRK2):c.*123A>C	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308651	12	40761690	12	40367888	308651	330873	rs73277568	NC_000012.12:40367887:A:C
NM_198578.4(LRRK2):c.*96T>C	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000308650	12	40761663	12	40367861	308650	330872	rs66737902	NC_000012.12:40367860:T:C
NM_198578.4(LRRK2):c.*84G>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308649	12	40761651	12	40367849	308649	332383	rs201671072	NC_000012.12:40367848:G:A
NM_198578.4(LRRK2):c.7483G>A (p.Val2495Ile)	LRRK2	V2495I	Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308648	12	40761466	12	40367664	308648	324728	rs150062967	NC_000012.12:40367663:G:A
NM_198578.4(LRRK2):c.7190T>C (p.Met2397Thr)	LRRK2	M2397T	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308647	12	40758652	12	40364850	308647	324716	rs3761863	NC_000012.12:40364849:T:C
NM_198578.4(LRRK2):c.7062C>T (p.Ile2354=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308646	12	40757237	12	40363435	308646	324713	rs768811495	NC_000012.12:40363434:C:T
NM_198578.4(LRRK2):c.6801C>T (p.Thr2267=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2019)	criteria provided, conflicting interpretations	VCV000308644	12	40749947	12	40356145	308644	324707	rs148143226	NC_000012.12:40356144:C:T
NM_198578.4(LRRK2):c.6688G>A (p.Glu2230Lys)	LRRK2	E2230K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308643	12	40748212	12	40354410	308643	324706	rs201317931	NC_000012.12:40354409:G:A
NM_198578.4(LRRK2):c.6582T>C (p.Val2194=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308642	12	40748106	12	40354304	308642	332370	rs773085638	NC_000012.12:40354303:T:C
NM_198578.4(LRRK2):c.5713G>C (p.Val1905Leu)	LRRK2	V1905L	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 13, 2018)	criteria provided, conflicting interpretations	VCV000308640	12	40722218	12	40328416	308640	324704	rs754436306	NC_000012.12:40328415:G:C
NM_198578.4(LRRK2):c.5510-9A>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant|not specified|Parkinson Disease, Dominant	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308639	12	40716953	12	40323151	308639	332363	rs41286460	NC_000012.12:40323150:A:G
NM_198578.4(LRRK2):c.5270A>G (p.Asn1757Ser)	LRRK2	N1757S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308638	12	40715936	12	40322134	308638	332354	rs368762897	NC_000012.12:40322133:A:G
NM_198578.4(LRRK2):c.4934A>G (p.Tyr1645Cys)	LRRK2	Y1645C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308637	12	40713896	12	40320094	308637	317022	rs759886320	NC_000012.12:40320093:A:G
NM_198578.4(LRRK2):c.4930A>G (p.Asn1644Asp)	LRRK2	N1644D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308636	12	40713892	12	40320090	308636	332353	rs886049361	NC_000012.12:40320089:A:G
NM_198578.4(LRRK2):c.4828-9A>T	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308635	12	40713781	12	40319979	308635	324698	rs199843206	NC_000012.12:40319978:A:T
NM_198578.4(LRRK2):c.4627A>G (p.Ile1543Val)	LRRK2	I1543V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308634	12	40707864	12	40314062	308634	324697	rs201540075	NC_000012.12:40314061:A:G
NM_198578.4(LRRK2):c.3969A>G (p.Gln1323=)	LRRK2		Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Aug 27, 2019)	criteria provided, conflicting interpretations	VCV000308632	12	40702278	12	40308476	308632	332351	rs372245035	NC_000012.12:40308475:A:G
NM_198578.4(LRRK2):c.3864G>A (p.Met1288Ile)	LRRK2	M1288I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308631	12	40699673	12	40305871	308631	324695	rs747301221	NC_000012.12:40305870:G:A
NM_198578.4(LRRK2):c.3778-9C>T	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308630	12	40699578	12	40305776	308630	332342	rs114948984	NC_000012.12:40305775:C:T
NM_198578.4(LRRK2):c.3777+7C>T	LRRK2		Parkinson disease 8, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2021)	criteria provided, conflicting interpretations	VCV000308629	12	40697943	12	40304141	308629	324694	rs41286480	NC_000012.12:40304140:C:T
NM_198578.4(LRRK2):c.3678A>C (p.Leu1226Phe)	LRRK2	L1226F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308628	12	40697837	12	40304035	308628	330868	rs746701556	NC_000012.12:40304034:A:C
NM_198578.4(LRRK2):c.3595C>A (p.Arg1199=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308627	12	40697754	12	40303952	308627	324690	rs746433333	NC_000012.12:40303951:C:A
NM_198578.4(LRRK2):c.3435A>C (p.Ser1145=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308625	12	40692998	12	40299196	308625	332335	rs886049359	NC_000012.12:40299195:A:C
NM_198578.4(LRRK2):c.3429C>T (p.Ser1143=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308624	12	40692992	12	40299190	308624	330863	rs142989436	NC_000012.12:40299189:C:T
NM_198578.4(LRRK2):c.3026A>C (p.His1009Pro)	LRRK2	H1009P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308623	12	40689376	12	40295574	308623	324688	rs375146075	NC_000012.12:40295573:A:C
NM_198578.4(LRRK2):c.2987A>T (p.Asp996Val)	LRRK2	D996V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308622	12	40689337	12	40295535	308622	332334	rs886049358	NC_000012.12:40295534:A:T
NM_198578.4(LRRK2):c.2900A>G (p.His967Arg)	LRRK2	H967R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000308621	12	40689250	12	40295448	308621	317020	rs533409083	NC_000012.12:40295447:A:G
NM_198578.4(LRRK2):c.2826T>C (p.His942=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308620	12	40688664	12	40294862	308620	330854	rs886049357	NC_000012.12:40294861:T:C
NM_198578.4(LRRK2):c.2588A>G (p.Asn863Ser)	LRRK2	N863S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308618	12	40681240	12	40287438	308618	324686	rs555679009	NC_000012.12:40287437:A:G
NM_198578.4(LRRK2):c.2070+9T>A	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308616	12	40671827	12	40278025	308616	332321	rs201389324	NC_000012.12:40278024:T:A
NM_198578.4(LRRK2):c.1446A>G (p.Ala482=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308615	12	40653309	12	40259507	308615	324685	rs757454147	NC_000012.12:40259506:A:G
NM_198578.4(LRRK2):c.1182-4A>G	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308614	12	40646708	12	40252906	308614	332320	rs7135747	NC_000012.12:40252905:A:G
NM_198578.4(LRRK2):c.1102-10C>A	LRRK2		not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000308613	12	40645257	12	40251455	308613	324683	rs7955902	NC_000012.12:40251454:C:A
NM_198578.4(LRRK2):c.867C>T (p.Asn289=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000308612	12	40643656	12	40249854	308612	332319	rs17490713	NC_000012.12:40249853:C:T
NM_198578.4(LRRK2):c.344A>C (p.His115Pro)	LRRK2	H115P	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Apr 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000308610	12	40626182	12	40232380	308610	317019	rs201439315	NC_000012.12:40232379:A:C
NM_198578.4(LRRK2):c.-44G>A	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000308609	12	40618890	12	40225088	308609	324682	rs765232448	NC_000012.12:40225087:G:A
NM_198578.4(LRRK2):c.7267A>T (p.Thr2423Ser)	LRRK2	T2423S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236298	12	40758729	12	40364927	236298	237853	rs1060499538	NC_000012.12:40364926:A:T
NM_198578.4(LRRK2):c.7006A>G (p.Ile2336Val)	LRRK2	I2336V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236297	12	40753224	12	40359422	236297	237851	rs878853311	NC_000012.12:40359421:A:G
NM_198578.4(LRRK2):c.6929C>T (p.Thr2310Met)	LRRK2	T2310M	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000236296	12	40753147	12	40359345	236296	237850	rs200002022	NC_000012.12:40359344:C:T
NM_198578.4(LRRK2):c.5273A>C (p.His1758Pro)	LRRK2	H1758P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236295	12	40715939	12	40322137	236295	237849	rs878853310	NC_000012.12:40322136:A:C
NM_198578.4(LRRK2):c.4441G>A (p.Ala1481Thr)	LRRK2	A1481T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236294	12	40704356	12	40310554	236294	237848	rs878853309	NC_000012.12:40310553:G:A
NM_198578.4(LRRK2):c.4358A>G (p.His1453Arg)	LRRK2	H1453R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236293	12	40704273	12	40310471	236293	237847	rs878853308	NC_000012.12:40310470:A:G
NM_198578.4(LRRK2):c.4314A>G (p.Ile1438Met)	LRRK2	I1438M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236292	12	40703032	12	40309230	236292	237852	rs878853307	NC_000012.12:40309229:A:G
NM_198578.4(LRRK2):c.3187C>T (p.Leu1063Phe)	LRRK2	L1063F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236291	12	40692135	12	40298333	236291	237846	rs878853306	NC_000012.12:40298332:C:T
NM_198578.4(LRRK2):c.2314C>T (p.Arg772Ter)	LRRK2	R772*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236290	12	40677749	12	40283947	236290	237845	rs376015112	NC_000012.12:40283946:C:T
NM_198578.4(LRRK2):c.1829T>C (p.Ile610Thr)	LRRK2	I610T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236289	12	40668683	12	40274881	236289	237844	rs566811888	NC_000012.12:40274880:T:C
NM_198578.4(LRRK2):c.1288G>A (p.Val430Ile)	LRRK2	V430I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236288	12	40646818	12	40253016	236288	237843	rs878853305	NC_000012.12:40253015:G:A
NM_198578.4(LRRK2):c.1132C>T (p.Leu378Phe)	LRRK2	L378F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236287	12	40645297	12	40251495	236287	237842	rs200870486	NC_000012.12:40251494:C:T
NM_198578.4(LRRK2):c.856C>G (p.Leu286Val)	LRRK2	L286V	Parkinson disease 8, autosomal dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000236286	12	40643645	12	40249843	236286	237841	rs200437744	NC_000012.12:40249842:C:G
NM_198578.4(LRRK2):c.691T>C (p.Ser231Pro)	LRRK2	S231P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Dec 11, 2014)	no assertion criteria provided	VCV000236285	12	40634404	12	40240602	236285	237840	rs201332859	NC_000012.12:40240601:T:C
NM_198578.4(LRRK2):c.4321C>A (p.Arg1441Ser)	LRRK2	R1441S	Parkinson disease 8, autosomal dominant|Parkinson disease, late-onset	Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000225276	12	40704236	12	40310434	225276	227175	rs33939927	NC_000012.12:40310433:C:A
NM_198578.4(LRRK2):c.7300A>G (p.Ile2434Val)	LRRK2	I2434V	Parkinson disease, late-onset|not provided	Uncertain significance(Last reviewed: Jul 21, 2018)	criteria provided, single submitter	VCV000096731	12	40758762	12	40364960	96731	102617	rs398124661	NC_000012.12:40364959:A:G
NM_198578.4(LRRK2):c.2352C>A (p.Ser784Arg)	LRRK2	S784R	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096730	12	40677787	12	40283985	96730	102616	rs398124660	NC_000012.12:40283984:C:A
NM_198578.4(LRRK2):c.6523G>C (p.Asp2175His)	LRRK2	D2175H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039278	12	40745482	12	40351680	39278	47884	rs72547981	NC_000012.12:40351679:G:C
NM_198578.4(LRRK2):c.936G>T (p.Ala312=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039246	12	40643725	12	40249923	39246	47852	rs41286466	NC_000012.12:40249922:G:T
NM_198578.4(LRRK2):c.894T>C (p.Ala298=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039245	12	40643683	12	40249881	39245	47851	rs57355477	NC_000012.12:40249880:T:C
NM_198578.4(LRRK2):c.867= (p.Asn289=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039244	12	40643656	12	40249854	39244	47850	rs17490713	NC_000012.12:40249853:C:C
NM_198578.4(LRRK2):c.825= (p.His275=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039243	12	40637470	12	40243668	39243	47849	rs72546315	NC_000012.12:40243667:T:T
NM_198578.4(LRRK2):c.7435A>G (p.Asn2479Asp)	LRRK2	N2479D	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039241	12	40760852	12	40367050	39241	47847	rs55633591	NC_000012.12:40367049:A:G
NM_198578.4(LRRK2):c.7397T>A (p.Leu2466His)	LRRK2	L2466H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039240	12	40760814	12	40367012	39240	47846	rs281865057	NC_000012.12:40367011:T:A
NM_198578.4(LRRK2):c.7224G>A (p.Met2408Ile)	LRRK2	M2408I	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039239	12	40758686	12	40364884	39239	47845	rs60545352	NC_000012.12:40364883:G:A
NM_198578.4(LRRK2):c.7190= (p.Met2397=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039238	12	40758652	12	40364850	39238	47844	rs3761863	NC_000012.12:40364849:T:T
NM_198578.4(LRRK2):c.7183G>A (p.Glu2395Lys)	LRRK2	E2395K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039236	12	40758645	12	40364843	39236	47842	rs78964014	NC_000012.12:40364842:G:A
NM_198578.4(LRRK2):c.7168G>A (p.Val2390Met)	LRRK2	V2390M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039235	12	40757343	12	40363541	39235	47841	rs79546190	NC_000012.12:40363540:G:A
NM_198578.4(LRRK2):c.7155A>G (p.Gly2385=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039234	12	40757330	12	40363528	39234	47840	rs33962975	NC_000012.12:40363527:A:G
NM_198578.4(LRRK2):c.713A>T (p.Asn238Ile)	LRRK2	N238I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039233	12	40637358	12	40243556	39233	47839	rs28365216	NC_000012.12:40243555:A:T
NM_198578.4(LRRK2):c.7067C>T (p.Thr2356Ile)	LRRK2	T2356I	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000039232	12	40757242	12	40363440	39232	47838	rs113511708	NC_000012.12:40363439:C:T
NM_198578.4(LRRK2):c.683G>C (p.Cys228Ser)	LRRK2	C228S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000039231	12	40634396	12	40240594	39231	47837	rs56108242	NC_000012.12:40240593:G:C
NM_198578.4(LRRK2):c.6782A>T (p.Asn2261Ile)	LRRK2	N2261I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039230	12	40749928	12	40356126	39230	47836	rs12581902	NC_000012.12:40356125:A:T
NM_198578.4(LRRK2):c.6566A>G (p.Tyr2189Cys)	LRRK2	Y2189C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039229	12	40745525	12	40351723	39229	47835	rs35658131	NC_000012.12:40351722:A:G
NM_198578.4(LRRK2):c.6510C>A (p.Gly2170=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039228	12	40745469	12	40351667	39228	47834	rs34869625	NC_000012.12:40351666:C:A
NM_198578.4(LRRK2):c.6428G>A (p.Arg2143His)	LRRK2	R2143H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000039227	12	40745387	12	40351585	39227	47833	rs201271001	NC_000012.12:40351584:G:A
NM_198578.4(LRRK2):c.6422C>T (p.Thr2141Met)	LRRK2	T2141M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039226	12	40745381	12	40351579	39226	47832	rs111691891	NC_000012.12:40351578:C:T
NM_198578.4(LRRK2):c.6415T>A (p.Cys2139Ser)	LRRK2	C2139S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039225	12	40745374	12	40351572	39225	47831	rs112048985	NC_000012.12:40351571:T:A
NM_198578.4(LRRK2):c.6356C>T (p.Pro2119Leu)	LRRK2	P2119L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039224	12	40742286	12	40348484	39224	47830	rs12423862	NC_000012.12:40348483:C:T
NM_198578.4(LRRK2):c.632C>T (p.Ala211Val)	LRRK2	A211V	Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000039223	12	40634345	12	40240543	39223	47829	rs112794616	NC_000012.12:40240542:C:T
NM_198578.4(LRRK2):c.6324G>A (p.Glu2108=)	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039222	12	40742254	12	40348452	39222	47828	rs10878405	NC_000012.12:40348451:G:A
NM_198578.4(LRRK2):c.6241A>G (p.Asn2081Asp)	LRRK2	N2081D	not specified|Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039221	12	40740686	12	40346884	39221	47827	rs33995883	NC_000012.12:40346883:A:G
NM_198578.4(LRRK2):c.6091A>T (p.Thr2031Ser)	LRRK2	T2031S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039219	12	40734238	12	40340436	39219	47825	rs78029637	NC_000012.12:40340435:A:T
NM_198578.4(LRRK2):c.6035T>C (p.Ile2012Thr)	LRRK2	I2012T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039218	12	40734182	12	40340380	39218	47824	rs34015634	NC_000012.12:40340379:T:C
NM_198578.4(LRRK2):c.6016T>C (p.Tyr2006His)	LRRK2	Y2006H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039217	12	40734163	12	40340361	39217	47823	rs281865055	NC_000012.12:40340360:T:C
NM_198578.4(LRRK2):c.5822G>A (p.Arg1941His)	LRRK2	R1941H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039216	12	40728833	12	40335031	39216	47822	rs77428810	NC_000012.12:40335030:G:A
NM_198578.4(LRRK2):c.5620G>T (p.Glu1874Ter)	LRRK2	E1874*	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039215	12	40717072	12	40323270	39215	47821	rs281865054	NC_000012.12:40323269:G:T
NM_198578.4(LRRK2):c.5610G>T (p.Leu1870Phe)	LRRK2	L1870F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039214	12	40717062	12	40323260	39214	47820	rs281865053	NC_000012.12:40323259:G:T
NM_198578.4(LRRK2):c.5606T>C (p.Met1869Thr)	LRRK2	M1869T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039213	12	40717058	12	40323256	39213	47819	rs35602796	NC_000012.12:40323255:T:C
NM_198578.4(LRRK2):c.5605A>G (p.Met1869Val)	LRRK2	M1869V	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039212	12	40717057	12	40323255	39212	47818	rs281865052	NC_000012.12:40323254:A:G
NM_198578.4(LRRK2):c.546A>G (p.Lys182=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039211	12	40631880	12	40238078	39211	47817	rs35517158	NC_000012.12:40238077:A:G
NM_198578.4(LRRK2):c.5467C>A (p.Gln1823Lys)	LRRK2	Q1823K	not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000039210	12	40716270	12	40322468	39210	47816	rs72547980	NC_000012.12:40322467:C:A
NM_198578.4(LRRK2):c.5457T>C (p.Gly1819=)	LRRK2		not specified|not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039209	12	40716260	12	40322458	39209	47815	rs10878371	NC_000012.12:40322457:T:C
NM_198578.4(LRRK2):c.5385G>T (p.Leu1795Phe)	LRRK2	L1795F	Parkinson disease 8, autosomal dominant|not provided	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000039208	12	40716188	12	40322386	39208	47814	rs111910483	NC_000012.12:40322385:G:T
NM_198578.4(LRRK2):c.5183G>T (p.Arg1728Leu)	LRRK2	R1728L	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039207	12	40715849	12	40322047	39207	47813	rs145364431	NC_000012.12:40322046:G:T
NM_198578.4(LRRK2):c.5183G>A (p.Arg1728His)	LRRK2	R1728H	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039206	12	40715849	12	40322047	39206	47812	rs145364431	NC_000012.12:40322046:G:A
NM_198578.4(LRRK2):c.5174G>A (p.Arg1725Gln)	LRRK2	R1725Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039205	12	40715840	12	40322038	39205	47811	rs72547979	NC_000012.12:40322037:G:A
NM_198578.4(LRRK2):c.5173C>T (p.Arg1725Ter)	LRRK2	R1725*	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039204	12	40715839	12	40322037	39204	47810	rs11564176	NC_000012.12:40322036:C:T
NM_198578.4(LRRK2):c.5163A>G (p.Ser1721=)	LRRK2		not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039203	12	40714983	12	40321181	39203	47809	rs79909111	NC_000012.12:40321180:A:G
NM_198578.4(LRRK2):c.4959A>G (p.Leu1653=)	LRRK2		Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000039202	12	40713921	12	40320119	39202	47808	rs111503579	NC_000012.12:40320118:A:G
NM_198578.4(LRRK2):c.4939T>A (p.Ser1647Thr)	LRRK2	S1647T	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Oct 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039201	12	40713901	12	40320099	39201	47807	rs11564148	NC_000012.12:40320098:T:A
NM_198578.4(LRRK2):c.4937T>C (p.Met1646Thr)	LRRK2	M1646T	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039200	12	40713899	12	40320097	39200	47806	rs35303786	NC_000012.12:40320096:T:C
NM_198578.4(LRRK2):c.4911A>G (p.Lys1637=)	LRRK2		not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039199	12	40713873	12	40320071	39199	47805	rs11176013	NC_000012.12:40320070:A:G
NM_198578.4(LRRK2):c.4883G>C (p.Arg1628Pro)	LRRK2	R1628P	Parkinson disease 8, autosomal dominant|Early onset Alzheimer disease with behavioral disturbance|Parkinson disease 8, autosomal dominant|Klippel-Feil syndrome 1, autosomal dominant|Spinocerebellar atrophy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2021)	criteria provided, conflicting interpretations	VCV000039198	12	40713845	12	40320043	39198	47804	rs33949390	NC_000012.12:40320042:G:C
NM_198578.4(LRRK2):c.4872C>A (p.Gly1624=)	LRRK2		not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039197	12	40713834	12	40320032	39197	47803	rs1427263	NC_000012.12:40320031:C:A
NM_198578.4(LRRK2):c.4838T>C (p.Val1613Ala)	LRRK2	V1613A	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039196	12	40713800	12	40319998	39196	47802	rs281865051	NC_000012.12:40319997:T:C
NM_198578.4(LRRK2):c.4793T>A (p.Val1598Glu)	LRRK2	V1598E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039195	12	40709068	12	40315266	39195	47801	rs721710	NC_000012.12:40315265:T:A
NM_198578.4(LRRK2):c.4666C>A (p.Leu1556Ile)	LRRK2	L1556I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039194	12	40707903	12	40314101	39194	47800	rs17491187	NC_000012.12:40314100:C:A
NM_198578.4(LRRK2):c.4624C>T (p.Pro1542Ser)	LRRK2	P1542S	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039193	12	40707861	12	40314059	39193	47799	rs33958906	NC_000012.12:40314058:C:T
NM_198578.4(LRRK2):c.457T>C (p.Leu153=)	LRRK2		not specified|Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039192	12	40631791	12	40237989	39192	47798	rs10878245	NC_000012.12:40237988:T:C
NM_198578.4(LRRK2):c.4541G>A (p.Arg1514Gln)	LRRK2	R1514Q	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039191	12	40707778	12	40313976	39191	47797	rs35507033	NC_000012.12:40313975:G:A
NM_198578.4(LRRK2):c.4448G>A (p.Arg1483Gln)	LRRK2	R1483Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039190	12	40704363	12	40310561	39190	47796	rs113431708	NC_000012.12:40310560:G:A
NM_198578.4(LRRK2):c.4402A>G (p.Lys1468Glu)	LRRK2	K1468E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039189	12	40704317	12	40310515	39189	47795	rs281865050	NC_000012.12:40310514:A:G
NM_198578.4(LRRK2):c.4348G>A (p.Val1450Ile)	LRRK2	V1450I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039187	12	40704263	12	40310461	39187	47793	rs111501952	NC_000012.12:40310460:G:A
NM_198578.4(LRRK2):c.4337C>T (p.Pro1446Leu)	LRRK2	P1446L	not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039186	12	40704252	12	40310450	39186	47792	rs74681492	NC_000012.12:40310449:C:T
NM_198578.4(LRRK2):c.4324G>C (p.Ala1442Pro)	LRRK2	A1442P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039185	12	40704239	12	40310437	39185	47791	rs281865048	NC_000012.12:40310436:G:C
NM_198578.4(LRRK2):c.4323C>T (p.Arg1441=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039184	12	40704238	12	40310436	39184	47790	rs112998035	NC_000012.12:40310435:C:T
NM_198578.4(LRRK2):c.4309A>C (p.Asn1437His)	LRRK2	N1437H	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039183	12	40703027	12	40309225	39183	47789	rs74163686	NC_000012.12:40309224:A:C
NM_198578.4(LRRK2):c.4290C>T (p.Ala1430=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039182	12	40703008	12	40309206	39182	47788	rs111435410	NC_000012.12:40309205:C:T
NM_198578.4(LRRK2):c.4269G>A (p.Lys1423=)	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039181	12	40702987	12	40309185	39181	47787	rs11175964	NC_000012.12:40309184:G:A
NM_198578.4(LRRK2):c.4258G>A (p.Asp1420Asn)	LRRK2	D1420N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039180	12	40702976	12	40309174	39180	47786	rs113589830	NC_000012.12:40309173:G:A
NM_198578.4(LRRK2):c.4229C>T (p.Thr1410Met)	LRRK2	T1410M	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Jun 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039179	12	40702947	12	40309145	39179	47785	rs72546327	NC_000012.12:40309144:C:T
NM_198578.4(LRRK2):c.4193G>A (p.Arg1398His)	LRRK2	R1398H	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039178	12	40702911	12	40309109	39178	47784	rs7133914	NC_000012.12:40309108:G:A
NM_198578.4(LRRK2):c.4125C>A (p.Asp1375Glu)	LRRK2	D1375E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039177	12	40702434	12	40308632	39177	47783	rs28365226	NC_000012.12:40308631:C:A
NM_198578.4(LRRK2):c.4111A>G (p.Ile1371Val)	LRRK2	I1371V	Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039176	12	40702420	12	40308618	39176	47782	rs17466213	NC_000012.12:40308617:A:G
NM_198578.4(LRRK2):c.3974G>A (p.Arg1325Gln)	LRRK2	R1325Q	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Oct 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039175	12	40702283	12	40308481	39175	47781	rs72546338	NC_000012.12:40308480:G:A
NM_198578.4(LRRK2):c.3960G>T (p.Arg1320Ser)	LRRK2	R1320S	not provided|Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Nov 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039174	12	40702269	12	40308467	39174	47780	rs77018758	NC_000012.12:40308466:G:T
NM_198578.4(LRRK2):c.3784C>G (p.Pro1262Ala)	LRRK2	P1262A	Parkinson disease 8, autosomal dominant|not provided	Benign/Likely benign(Last reviewed: Jan 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039173	12	40699593	12	40305791	39173	47779	rs4640000	NC_000012.12:40305790:C:G
NM_198578.4(LRRK2):c.3683G>T (p.Ser1228Ile)	LRRK2	S1228I	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039172	12	40697842	12	40304040	39172	47778	rs60185966	NC_000012.12:40304039:G:T
NM_198578.4(LRRK2):c.3683G>C (p.Ser1228Thr)	LRRK2	S1228T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000039171	12	40697842	12	40304040	39171	47777	rs60185966	NC_000012.12:40304039:G:C
NM_198578.4(LRRK2):c.364= (p.Leu122=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039170	12	40629444	12	40235642	39170	47776	rs41286468	NC_000012.12:40235641:C:C
NM_198578.4(LRRK2):c.3647A>G (p.His1216Arg)	LRRK2	H1216R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039169	12	40697806	12	40304004	39169	47775	rs72546324	NC_000012.12:40304003:A:G
NM_198578.4(LRRK2):c.3574A>G (p.Ile1192Val)	LRRK2	I1192V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000039168	12	40696668	12	40302866	39168	47774	rs281865047	NC_000012.12:40302865:A:G
NM_198578.4(LRRK2):c.356T>C (p.Leu119Pro)	LRRK2	L119P	not provided|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Sep 3, 2021)	criteria provided, conflicting interpretations	VCV000039167	12	40629436	12	40235634	39167	47773	rs33995463	NC_000012.12:40235633:T:C
NM_198578.4(LRRK2):c.3494T>C (p.Leu1165Pro)	LRRK2	L1165P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039166	12	40693057	12	40299255	39166	47772	rs281865046	NC_000012.12:40299254:T:C
NM_198578.4(LRRK2):c.3451G>A (p.Ala1151Thr)	LRRK2	A1151T	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000039165	12	40693014	12	40299212	39165	47771	rs74985840	NC_000012.12:40299211:G:A
NM_198578.4(LRRK2):c.3342A>G (p.Leu1114=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided|not specified	Benign/Likely benign(Last reviewed: May 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039164	12	40692290	12	40298488	39164	47770	rs35808389	NC_000012.12:40298487:A:G
NM_198578.4(LRRK2):c.3333G>T (p.Gln1111His)	LRRK2	Q1111H	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039163	12	40692281	12	40298479	39163	47769	rs78365431	NC_000012.12:40298478:G:T
NM_198578.4(LRRK2):c.3287C>G (p.Ser1096Cys)	LRRK2	S1096C	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039162	12	40692235	12	40298433	39162	47768	rs76535406	NC_000012.12:40298432:C:G
NM_198578.4(LRRK2):c.3200G>A (p.Arg1067Gln)	LRRK2	R1067Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039161	12	40692148	12	40298346	39161	47767	rs111341148	NC_000012.12:40298345:G:A
NM_198578.4(LRRK2):c.3021= (p.Ser1007=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039160	12	40689371	12	40295569	39160	47766	rs55783828	NC_000012.12:40295568:T:T
NM_198578.4(LRRK2):c.3018A>G (p.Ile1006Met)	LRRK2	I1006M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000039159	12	40689368	12	40295566	39159	47765	rs113217062	NC_000012.12:40295565:A:G
NM_198578.4(LRRK2):c.2918G>A (p.Ser973Asn)	LRRK2	S973N	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039158	12	40689268	12	40295466	39158	47764	rs75148313	NC_000012.12:40295465:G:A
NM_198578.4(LRRK2):c.28G>A (p.Glu10Lys)	LRRK2	E10K	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039157	12	40618961	12	40225159	39157	47763	rs281865040	NC_000012.12:40225158:G:A
NM_198578.4(LRRK2):c.2857T>C (p.Leu953=)	LRRK2		Parkinson disease 8, autosomal dominant|not specified|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039156	12	40688695	12	40294893	39156	47762	rs7966550	NC_000012.12:40294892:T:C
NM_198578.4(LRRK2):c.2830G>T (p.Asp944Tyr)	LRRK2	D944Y	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039155	12	40688668	12	40294866	39155	47761	rs17519916	NC_000012.12:40294865:G:T
NM_198578.4(LRRK2):c.2789A>G (p.Gln930Arg)	LRRK2	Q930R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039154	12	40687446	12	40293644	39154	47760	rs281865045	NC_000012.12:40293643:A:G
NM_198578.4(LRRK2):c.2769G>C (p.Gln923His)	LRRK2	Q923H	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 1, 2017)	criteria provided, single submitter	VCV000039153	12	40687426	12	40293624	39153	47759	rs58559150	NC_000012.12:40293623:G:C
NM_198578.4(LRRK2):c.2611A>G (p.Lys871Glu)	LRRK2	K871E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039152	12	40681263	12	40287461	39152	47758	rs281865044	NC_000012.12:40287460:A:G
NM_198578.4(LRRK2):c.2481T>C (p.Ser827=)	LRRK2		Parkinson disease 8, autosomal dominant	Likely benign(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000039151	12	40677916	12	40284114	39151	47757	rs76890302	NC_000012.12:40284113:T:C
NM_198578.4(LRRK2):c.2428A>G (p.Ile810Val)	LRRK2	I810V	not provided|Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000039150	12	40677863	12	40284061	39150	47756	rs72546337	NC_000012.12:40284060:A:G
NM_198578.4(LRRK2):c.2378G>T (p.Arg793Met)	LRRK2	R793M	Parkinson disease 8, autosomal dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 15, 2021)	criteria provided, conflicting interpretations	VCV000039149	12	40677813	12	40284011	39149	47755	rs35173587	NC_000012.12:40284010:G:T
NM_198578.4(LRRK2):c.2264C>T (p.Pro755Leu)	LRRK2	P755L	not provided|Parkinson disease 8, autosomal dominant	Benign/Likely benign(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000039148	12	40677699	12	40283897	39148	47754	rs34410987	NC_000012.12:40283896:C:T
NM_198578.4(LRRK2):c.225G>A (p.Ala75=)	LRRK2		Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039147	12	40619430	12	40225628	39147	47753	rs75054132	NC_000012.12:40225627:G:A
NM_198578.4(LRRK2):c.2167A>G (p.Ile723Val)	LRRK2	I723V	Parkinson disease 8, autosomal dominant|not provided	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039146	12	40671989	12	40278187	39146	47752	rs10878307	NC_000012.12:40278186:A:G
NM_198578.4(LRRK2):c.2147C>T (p.Ala716Val)	LRRK2	A716V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039145	12	40671969	12	40278167	39145	47751	rs281865043	NC_000012.12:40278166:C:T
NM_198578.4(LRRK2):c.2134A>G (p.Met712Val)	LRRK2	M712V	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039144	12	40671956	12	40278154	39144	47750	rs199566791	NC_000012.12:40278153:A:G
NM_198578.4(LRRK2):c.2022A>C (p.Val674=)	LRRK2		not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Aug 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039143	12	40671770	12	40277968	39143	47749	rs72546319	NC_000012.12:40277967:A:C
NM_198578.4(LRRK2):c.1987T>C (p.Ser663Pro)	LRRK2	S663P	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039142	12	40671735	12	40277933	39142	47748	rs78154388	NC_000012.12:40277932:T:C
NM_198578.4(LRRK2):c.1847A>G (p.Lys616Arg)	LRRK2	K616R	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039141	12	40668701	12	40274899	39141	47747	rs281865042	NC_000012.12:40274898:A:G
NM_198578.4(LRRK2):c.1674= (p.Gly558=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039140	12	40668402	12	40274600	39140	47746	rs77424631	NC_000012.12:40274599:G:G
NM_198578.4(LRRK2):c.1653C>G (p.Asn551Lys)	LRRK2	N551K	not provided|not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039139	12	40657700	12	40263898	39139	47745	rs7308720	NC_000012.12:40263897:C:G
NM_198578.4(LRRK2):c.1630A>G (p.Lys544Glu)	LRRK2	K544E	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039138	12	40657677	12	40263875	39138	47744	rs79996249	NC_000012.12:40263874:A:G
NM_198578.4(LRRK2):c.1561A>G (p.Arg521Gly)	LRRK2	R521G	not specified|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2020)	criteria provided, conflicting interpretations	VCV000039137	12	40657608	12	40263806	39137	47743	rs35328937	NC_000012.12:40263805:A:G
NM_198578.4(LRRK2):c.155C>T (p.Ser52Phe)	LRRK2	S52F	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039136	12	40619360	12	40225558	39136	47742	rs72546335	NC_000012.12:40225557:C:T
NM_198578.4(LRRK2):c.1517G>A (p.Arg506Gln)	LRRK2	R506Q	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039135	12	40653380	12	40259578	39135	47741	rs202009639	NC_000012.12:40259577:G:A
NM_198578.3(LRRK2):c.149A>G (p.His50Arg)	LRRK2		not specified|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039134	12	40619082	12	40225280	39134	47740	rs2256408	NC_000012.12:40225279:G:G
NM_198578.4(LRRK2):c.1464A>T (p.Leu488=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039133	12	40653327	12	40259525	39133	47739	rs75711334	NC_000012.12:40259524:A:T
NM_198578.4(LRRK2):c.1383= (p.Ser461=)	LRRK2		Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039132	12	40651144	12	40257342	39132	47738	rs35847451	NC_000012.12:40257341:T:T
NM_198578.4(LRRK2):c.1256C>T (p.Ala419Val)	LRRK2	A419V	not provided|Parkinson disease 8, autosomal dominant	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000039131	12	40646786	12	40252984	39131	47737	rs34594498	NC_000012.12:40252983:C:T
NM_198578.4(LRRK2):c.1096G>A (p.Val366Met)	LRRK2	V366M	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039130	12	40645171	12	40251369	39130	47736	rs113065049	NC_000012.12:40251368:G:A
NM_198578.4(LRRK2):c.1088A>G (p.Asn363Ser)	LRRK2	N363S	Parkinson disease 8, autosomal dominant	Uncertain significance(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000039129	12	40645163	12	40251361	39129	47735	rs72546336	NC_000012.12:40251360:A:G
NM_198578.4(LRRK2):c.1000G>A (p.Glu334Lys)	LRRK2	E334K	not provided|not specified|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000039128	12	40645075	12	40251273	39128	47734	rs78501232	NC_000012.12:40251272:G:A
NM_198578.4(LRRK2):c.7153G>A (p.Gly2385Arg)	LRRK2	G2385R	Parkinson disease|Parkinson disease 8, autosomal dominant	Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000001943	12	40757328	12	40363526	1943	16982	rs34778348	NC_000012.12:40363525:G:A
NM_198578.4(LRRK2):c.4322G>A (p.Arg1441His)	LRRK2	R1441H	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001942	12	40704237	12	40310435	1942	16981	rs34995376	NC_000012.12:40310434:G:A
NM_198578.4(LRRK2):c.6059T>C (p.Ile2020Thr)	LRRK2	I2020T	not provided|Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000001941	12	40734206	12	40340404	1941	16980	rs35870237	NC_000012.12:40340403:T:C
NM_198578.4(LRRK2):c.6055G>A (p.Gly2019Ser)	LRRK2	G2019S	Young-onset Parkinson disease|not provided|Parkinson disease 8, autosomal dominant|Hereditary late onset Parkinson disease|Inborn genetic diseases	Pathogenic, risk factor(Last reviewed: May 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001940	12	40734202	12	40340400	1940	16979	rs34637584	NC_000012.12:40340399:G:A
NM_198578.4(LRRK2):c.3364A>G (p.Ile1122Val)	LRRK2	I1122V	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001939	12	40692927	12	40299125	1939	16978	rs34805604	NC_000012.12:40299124:A:G
NM_198578.4(LRRK2):c.4321C>T (p.Arg1441Cys)	LRRK2	R1441C	Parkinson disease 8, autosomal dominant|Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001938	12	40704236	12	40310434	1938	16977	rs33939927	NC_000012.12:40310433:C:T
NM_198578.4(LRRK2):c.5096A>G (p.Tyr1699Cys)	LRRK2	Y1699C	Parkinson disease 8, autosomal dominant	Pathogenic(Last reviewed: Sep 13, 2012)	no assertion criteria provided	VCV000001937	12	40714916	12	40321114	1937	16976	rs35801418	NC_000012.12:40321113:A:G
NM_198578.4(LRRK2):c.4321C>G (p.Arg1441Gly)	LRRK2	R1441G	Parkinson disease 8, autosomal dominant|not provided	Pathogenic(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001936	12	40704236	12	40310434	1936	16975	rs33939927	NC_000012.12:40310433:C:G
NM_001377265.1(MAPT):c.47G>T (p.Gly16Val)	MAPT	G16V	Frontotemporal dementia|Progressive supranuclear ophthalmoplegia|Pick disease|Parkinson disease, late-onset	Uncertain significance(Last reviewed: Feb 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000548576	17	44039750	17	45962384	548576	539073	rs755131800	NC_000017.11:45962383:G:T
NM_001377265.1(MAPT):c.1115C>T (p.Ala372Val)	MAPT	A297V, A372V	Progressive supranuclear ophthalmoplegia|Frontotemporal dementia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Pick disease|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000429936	17	44061060	17	45983694	429936	422174	rs377402921	NC_000017.11:45983693:C:T
NM_001377265.1(MAPT):c.1630G>A (p.Ala544Thr)	MAPT	A152T, A469T, A123T, A94T, A478T, A544T	Frontotemporal dementia|MAPT-Related Spectrum Disorders|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000323645	17	44068850	17	45991484	323645	338789	rs143624519	NC_000017.11:45991483:G:A
NM_001377265.1(MAPT):c.1891G>A (p.Ala631Thr)	MAPT	A556T, A239T, A574T, A181T, A210T, A565T, A631T	Frontotemporal dementia|MAPT-Related Spectrum Disorders|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000098208	17	44073923	17	45996557	98208	104100	rs63750096	NC_000017.11:45996556:G:A
NM_001377265.1(MAPT):c.2013T>G (p.Asn671Lys)	MAPT	N279K, N221K, N250K, N596K, N614K, N671K	Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Frontotemporal dementia|Pick disease|not provided|Frontotemporal dementia	Pathogenic(Last reviewed: Mar 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000014253	17	44087690	17	46010324	14253	29292	rs63750756	NC_000017.11:46010323:T:G
NM_001377265.1(MAPT):c.2392C>T (p.Arg798Trp)	MAPT	R406W, R723W, R375W, R317W, R346W, R741W, R348W, R377W, R701W, R798W	not provided|Frontotemporal dementia|Pick disease|Parkinson disease, late-onset|Parkinson-dementia syndrome|Progressive supranuclear ophthalmoplegia|Frontotemporal dementia	Pathogenic(Last reviewed: Sep 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014247	17	44101427	17	46024061	14247	29286	rs63750424	NC_000017.11:46024060:C:T
NM_001377265.1(MAPT):c.2078C>T (p.Pro693Leu)	MAPT	P301L, P243L, P272L, P618L, P636L, P693L	Frontotemporal dementia|not provided|Progressive supranuclear ophthalmoplegia|Parkinson disease, late-onset|Parkinson-dementia syndrome|Frontotemporal dementia|Pick disease|Progressive supranuclear ophthalmoplegia	Pathogenic(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014245	17	44087755	17	46010389	14245	29284	rs63751273	NC_000017.11:46010388:C:T
NM_002386.4(MC1R):c.451C>T (p.Arg151Cys)	MC1R	R151C	not specified|not provided|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Cutaneous malignant melanoma 5|Skin/hair/eye pigmentation 2, red hair/fair skin	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014312	16	89986117	16	89919709	14312	29351	rs1805007	NC_000016.10:89919708:C:T
NM_002386.4(MC1R):c.478C>T (p.Arg160Trp)	MC1R	R160W	not specified|Malignant tumor of breast|not provided|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Cutaneous malignant melanoma 5|Skin/hair/eye pigmentation 2, red hair/fair skin	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000014310	16	89986144	16	89919736	14310	29349	rs1805008	NC_000016.10:89919735:C:T
NM_005460.4(SNCAIP):c.*591A>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907914	5	121799782	5	122464087	907914	896019		NC_000005.10:122464086:A:T
NM_005460.4(SNCAIP):c.*498A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907913	5	121799689	5	122463994	907913	892689		NC_000005.10:122463993:A:G
NM_005460.4(SNCAIP):c.*343A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907912	5	121799534	5	122463839	907912	892688		NC_000005.10:122463838:A:G
NM_005460.4(SNCAIP):c.*287G>A	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907911	5	121799478	5	122463783	907911	892687		NC_000005.10:122463782:G:A
NM_005460.4(SNCAIP):c.*253T>A	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907910	5	121799444	5	122463749	907910	892686		NC_000005.10:122463748:T:A
NM_005460.4(SNCAIP):c.1817G>A (p.Arg606Gln)	MGC32805|SNCAIP	R202Q, R606Q, R653Q, R238Q, R240Q, R546Q, R300Q	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907845	5	121786359	5	122450664	907845	892675		NC_000005.10:122450663:G:A
NM_005460.4(SNCAIP):c.1811C>G (p.Ser604Cys)	MGC32805|SNCAIP	S544C, S604C, S651C, S200C, S236C, S238C, S298C	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907844	5	121786353	5	122450658	907844	892674		NC_000005.10:122450657:C:G
NM_005460.4(SNCAIP):c.1496G>A (p.Arg499Gln)	MGC32805|SNCAIP	R131Q, R439Q, R499Q, R95Q, R193Q, R546Q, R133Q	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907843	5	121780331	5	122444636	907843	892673		NC_000005.10:122444635:G:A
NM_005460.4(SNCAIP):c.1448T>C (p.Val483Ala)	MGC32805|SNCAIP	V79A, V115A, V117A, V423A, V530A, V177A, V483A	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907842	5	121780283	5	122444588	907842	892672		NC_000005.10:122444587:T:C
NM_005460.4(SNCAIP):c.1297-3T>C	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907841	5	121776321	5	122440626	907841	896018		NC_000005.10:122440625:T:C
NM_005460.4(SNCAIP):c.*247G>A	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906929	5	121799438	5	122463743	906929	892685		NC_000005.10:122463742:G:A
NM_005460.4(SNCAIP):c.*161A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906928	5	121799352	5	122463657	906928	892684		NC_000005.10:122463656:A:G
NM_005460.4(SNCAIP):c.*103C>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906927	5	121799294	5	122463599	906927	892683		NC_000005.10:122463598:C:T
NM_005460.4(SNCAIP):c.2729C>A (p.Ser910Tyr)	MGC32805|SNCAIP	S506Y, S542Y, S957Y, S850Y, S604Y, S544Y, S910Y	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905322	5	121787271	5	122451576	905322	892682		NC_000005.10:122451575:C:A
NM_005460.4(SNCAIP):c.2685C>T (p.Thr895=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905321	5	121787227	5	122451532	905321	892681		NC_000005.10:122451531:C:T
NM_005460.4(SNCAIP):c.2618G>A (p.Gly873Asp)	MGC32805|SNCAIP	G507D, G873D, G920D, G469D, G813D, G505D, G567D	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905320	5	121787160	5	122451465	905320	892680		NC_000005.10:122451464:G:A
NM_005460.4(SNCAIP):c.2556A>G (p.Glu852=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905319	5	121787098	5	122451403	905319	892679		NC_000005.10:122451402:A:G
NM_005460.4(SNCAIP):c.2291C>T (p.Pro764Leu)	MGC32805|SNCAIP	P396L, P704L, P764L, P811L, P360L, P398L, P458L	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905318	5	121786833	5	122451138	905318	892678		NC_000005.10:122451137:C:T
NM_005460.4(SNCAIP):c.2191C>T (p.Arg731Cys)	MGC32805|SNCAIP	R778C, R363C, R671C, R731C, R327C, R365C, R425C	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905317	5	121786733	5	122451038	905317	892677		NC_000005.10:122451037:C:T
NM_005460.4(SNCAIP):c.1939G>C (p.Ala647Pro)	MGC32805|SNCAIP	A243P, A694P, A281P, A647P, A279P, A341P, A587P	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904533	5	121786481	5	122450786	904533	892676		NC_000005.10:122450785:G:C
NM_005460.4(SNCAIP):c.*314T>C	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350510	5	121799505	5	122463810	350510	300574	rs11326	NC_000005.10:122463809:T:C
NM_005460.4(SNCAIP):c.*202A>T	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350509	5	121799393	5	122463698	350509	296780	rs886059828	NC_000005.10:122463697:A:T
NM_005460.4(SNCAIP):c.*170A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350508	5	121799361	5	122463666	350508	300496	rs886059827	NC_000005.10:122463665:A:G
NM_005460.4(SNCAIP):c.*102A>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350507	5	121799293	5	122463598	350507	300495	rs567026967	NC_000005.10:122463597:A:G
NM_005460.4(SNCAIP):c.*70C>G	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350506	5	121799261	5	122463566	350506	296767	rs149180835	NC_000005.10:122463565:C:G
NM_005460.4(SNCAIP):c.*46T>G	MGC32805|SNCAIP	I593M, I1006M	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350505	5	121799237	5	122463542	350505	295005	rs187197845	NC_000005.10:122463541:T:G
NM_005460.4(SNCAIP):c.2736C>G (p.Ser912Arg)	MGC32805|SNCAIP	S912R, S544R, S606R, S852R, S959R, S508R, S546R	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350504	5	121787278	5	122451583	350504	295003	rs886059826	NC_000005.10:122451582:C:G
NM_005460.4(SNCAIP):c.2710A>G (p.Lys904Glu)	MGC32805|SNCAIP	K904E, K536E, K844E, K951E, K500E, K538E, K598E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350503	5	121787252	5	122451557	350503	300573	rs751412863	NC_000005.10:122451556:A:G
NM_005460.4(SNCAIP):c.2417G>A (p.Arg806His)	MGC32805|SNCAIP	R806H, R440H, R438H, R500H, R746H, R853H, R402H	not provided|Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350502	5	121786959	5	122451264	350502	300484	rs140850272	NC_000005.10:122451263:G:A
NM_005460.4(SNCAIP):c.2148C>T (p.Ser716=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350501	5	121786690	5	122450995	350501	295001	rs536468779	NC_000005.10:122450994:C:T
NM_005460.4(SNCAIP):c.2131A>G (p.Met711Val)	MGC32805|SNCAIP	M711V, M651V, M758V, M343V, M307V, M345V, M405V	not provided|Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350499	5	121786673	5	122450978	350499	296766	rs139256839	NC_000005.10:122450977:A:G
NM_005460.4(SNCAIP):c.2022A>G (p.Ser674=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350497	5	121786564	5	122450869	350497	300543	rs763683428	NC_000005.10:122450868:A:G
NM_005460.4(SNCAIP):c.1969C>T (p.Leu657=)	MGC32805|SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350496	5	121786511	5	122450816	350496	300542	rs376564775	NC_000005.10:122450815:C:T
NM_005460.4(SNCAIP):c.1510C>T (p.Leu504=)	MGC32805|SNCAIP		not provided|Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350495	5	121780345	5	122444650	350495	294999	rs113042472	NC_000005.10:122444649:C:T
NM_005460.4(SNCAIP):c.1861C>T (p.Arg621Cys)	MGC32805|SNCAIP	R621C, R561C, R253C, R255C, R217C, R315C, R668C	Parkinson disease, late-onset|not provided|Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000006078	5	121786403	5	122450708	6078	21117	rs28937592	NC_000005.10:122450707:C:T
NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)	MHRT|MYH7	K1459N	Hypertrophic cardiomyopathy|Myopathy, distal, 1|Cardiovascular phenotype|not provided|Primary familial hypertrophic cardiomyopathy|not specified|Myosin storage myopathy|Familial hypertrophic cardiomyopathy 1|Wolff-Parkinson-White pattern|Congenital myopathy with fiber type disproportion|Cardiomyopathy	Likely benign(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000043012	14	23886504	14	23417295	43012	52182	rs201307101	NC_000014.9:23417294:C:A
NM_032409.3(PINK1):c.189C>T (p.Leu63=)	MIR6084|PINK1		not provided|not specified|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262026	1	20960230	1	20633737	262026	249676	rs45530340	NC_000001.11:20633736:C:T
NC_012920.1:m.8969G>A	MT-ATP6	S148N	Myopathy, lactic acidosis, and sideroblastic anemia 3|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000191364	MT	8969	MT	8969	191364	189167	rs794726857	NC_012920.1:8968:G:A
NC_012920.1:m.3548T>C	MT-ND1	I81T	Leigh syndrome|not specified	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000235006	MT	3548	MT	3548	235006	236826	rs876661353	NC_012920.1:3547:T:C
m.3796A>G	MT-ND1	T164A	Leigh syndrome|Dystonia, adult-onset|not provided	Benign(Last reviewed: Oct 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009730	MT	3796	MT	3796	9730	24769	rs28357970	NC_012920.1:3795:A:G
m.3397A>G	MT-ND1	M31V	Parkinson disease, late-onset|Alzheimer disease|Leigh syndrome	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009726	MT	3397	MT	3397	9726	24765	rs199476120	NC_012920.1:3396:A:G
m.10398A>G	MT-ND3	T114A	Leigh syndrome|Parkinson disease, resistance to	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009713	MT	10398	MT	10398	9713	24752	rs2853826	NC_012920.1:10397:A:G
m.12397A>G	MT-ND5	T21A	Leigh syndrome|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009705	MT	12397	MT	12397	9705	24744	rs1556424100	NC_012920.1:12396:A:G
m.13042G>A	MT-ND5	A236T	Leber hereditary optic neuropathy|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Leigh syndrome due to mitochondrial complex I deficiency	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009703	MT	13042	MT	13042	9703	24742	rs267606898	NC_012920.1:13041:G:A
m.14319T>C	MT-ND6	N119D	Leigh syndrome|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000009695	MT	14319	MT	14319	9695	24734	rs199476110	NC_012920.1:14318:T:C
m.1095T>C	MT-RNR1		Deafness, nonsyndromic sensorineural, mitochondrial|not specified|Aminoglycoside-induced deafness|Auditory neuropathy|neomycin response - Toxicity/ADR|streptomycin response - Toxicity/ADR|tobramycin response - Toxicity/ADR|kanamycin response - Toxicity/ADR|amikacin response - Toxicity/ADR|gentamicin response - Toxicity/ADR|aminoglycoside antibacterials response - Toxicity/ADR	drug response(Last reviewed: May 19, 2017)	reviewed by expert panel	VCV000009631	MT	1095	MT	1095	9631	24670	rs267606618	NC_012920.1:1094:T:C
m.611G>A	MT-TF		MERRF syndrome	Pathogenic(Last reviewed: Jan 29, 2015)	no assertion criteria provided	VCV000009574	MT	611	MT	611	9574	24613	rs118203886	NC_012920.1:610:G:A
m.8361G>A	MT-TK		MERRF syndrome	Pathogenic(Last reviewed: Jan 5, 2021)	no assertion criteria provided	VCV000009585	MT	8361	MT	8361	9585	24624	rs118192104	NC_012920.1:8360:G:A
m.8363G>A	MT-TK		Cardiomyopathy and Deafness|MERRF syndrome|Leigh syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009581	MT	8363	MT	8363	9581	24620	rs118192100	NC_012920.1:8362:G:A
m.8356T>C	MT-TK		MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009580	MT	8356	MT	8356	9580	24619	rs118192099	NC_012920.1:8355:T:C
m.8344A>G	MT-TK		Leigh syndrome|MERRF syndrome|Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not provided|Mitochondrial disease|MT-TK-related mitochondrial disorder	Pathogenic(Last reviewed: Jul 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000009579	MT	8344	MT	8344	9579	24618	rs118192098	NC_012920.1:8343:A:G
m.3256C>T	MT-TL1		Diabetes mellitus, noninsulin-dependent, maternally transmitted|MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009591	MT	3256	MT	3256	9591	24630	rs199474659	NC_012920.1:3255:C:T
m.3271T>C	MT-TL1		MERRF syndrome|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Pathogenic(Last reviewed: Jul 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000009590	MT	3271	MT	3271	9590	24629	rs199474658	NC_012920.1:3270:T:C
NC_012920.1:m.3243A>G	MT-TL1		Stroke|Glucose intolerance|Short stature|Sensorineural hearing loss|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Mitochondrial disease|Cyclical vomiting syndrome|Diabetes-deafness syndrome maternally transmitted|Muscle stiffness, painful|Age-related macular degeneration 2|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|3-Methylglutaconic aciduria type 1|not provided|MERRF/MELAS overlap syndrome|Mitochondrial complex IV deficiency|Leigh syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G
m.15965A>G	MT-TP		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009571	MT	15965	MT	15965	9571	24610	rs199474700	NC_012920.1:15964:A:G
m.4336T>C	MT-TQ		Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|not specified|not provided|Sensorineural deafness and migraine	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000009615	MT	4336	MT	4336	9615	24654	rs41456348	NC_012920.1:4335:T:C
m.15950G>A	MT-TT		Parkinson disease, mitochondrial|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke	Uncertain significance(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000009559	MT	15950	MT	15950	9559	24598	rs118203890	NC_012920.1:15949:G:A
NM_000256.3(MYBPC3):c.1219G>C (p.Gly407Arg)	MYBPC3	G407R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487636	11	47365047	11	47343496	487636	480708	rs727505266	NC_000011.10:47343495:C:G
NM_000256.3(MYBPC3):c.2603G>A (p.Gly868Asp)	MYBPC3	G868D	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487610	11	47357562	11	47336011	487610	480707	rs886048376	NC_000011.10:47336010:C:T
NM_000256.3(MYBPC3):c.1591G>C (p.Gly531Arg)	MYBPC3	G531R	Wolff-Parkinson-White syndrome|Hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Cardiomyopathy|not provided	Likely pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000042550	11	47364162	11	47342611	42550	51720	rs397515912	NC_000011.10:47342610:C:G
NM_000256.3(MYBPC3):c.1321G>A (p.Glu441Lys)	MYBPC3	E441K	Left ventricular noncompaction 10|Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not specified|not provided|Cardiovascular phenotype|Arrhythmogenic right ventricular dysplasia, familial 1|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2021)	criteria provided, conflicting interpretations	VCV000036601	11	47364602	11	47343051	36601	45263	rs193922377	NC_000011.10:47343050:C:T
NM_002471.4(MYH6):c.5653G>A (p.Glu1885Lys)	MYH6	E1885K	not specified|not provided|Familial hypertrophic cardiomyopathy 14	Uncertain significance(Last reviewed: Dec 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000537966	14	23852442	14	23383233	537966	528044	rs760353963	NC_000014.9:23383232:C:T
NM_002471.4(MYH6):c.635C>T (p.Ala212Val)	MYH6|LOC114827851	A212V	Familial hypertrophic cardiomyopathy 14|not specified|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Aug 2, 2019)	criteria provided, conflicting interpretations	VCV000519020	14	23873927	14	23404718	519020	510455	rs780456381	NC_000014.9:23404717:G:A
NM_002471.4(MYH6):c.4430G>T (p.Arg1477Leu)	MYH6	R1477L	Familial hypertrophic cardiomyopathy 14|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000487615	14	23857062	14	23387853	487615	480712	rs147586142	NC_000014.9:23387852:C:A
NM_002471.4(MYH6):c.3010G>T (p.Ala1004Ser)	MYH6	A1004S	Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy|none provided|Familial hypertrophic cardiomyopathy 14|Dilated cardiomyopathy 1EE|Ventricular tachycardia|Primary dilated cardiomyopathy|Cardiovascular phenotype|Sudden cardiac death|Familial hypertrophic cardiomyopathy 14|not provided|Wolff-Parkinson-White pattern|not specified|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000014151	14	23862646	14	23393437	14151	29190	rs143978652	NC_000014.9:23393436:C:A
NM_000257.4(MYH7):c.5779A>T (p.Ile1927Phe)	MYH7	I1927F	Cardiomyopathy|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Hypertrophic cardiomyopathy|not provided	Uncertain significance(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487639	14	23882979	14	23413770	487639	480713	rs767300277	NC_000014.9:23413769:T:A
NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)	MYH7	A797T	Cardiovascular phenotype|Cardiomyopathy|Primary familial dilated cardiomyopathy|Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|Immunodeficiency|Lymphopenia|Abnormality of cellular immune system|Abnormality of T cell physiology|Combined T and B cell immunodeficiency|Severe combined immunodeficiency disease|Familial hypertrophic cardiomyopathy 1|not provided|Hypertrophic cardiomyopathy|Congenital myopathy with fiber type disproportion|Myopathy, distal, 1|MYH7-related late-onset scapuloperoneal muscular dystrophy|Familial hypertrophic cardiomyopathy 1|Myopathy, myosin storage, autosomal recessive|Myosin storage myopathy|Dilated cardiomyopathy 1S	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042901	14	23894525	14	23425316	42901	52071	rs3218716	NC_000014.9:23425315:C:T
NM_000257.4(MYH7):c.728G>A (p.Arg243His)	MYH7	R243H	Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|not provided|Left ventricular noncompaction 5|Wolff-Parkinson-White pattern|Cardiomyopathy	Uncertain significance(Last reviewed: Jun 16, 2021)	reviewed by expert panel	VCV000014126	14	23900798	14	23431589	14126	29165	rs267606910	NC_000014.9:23431588:C:T
NM_002474.3(MYH11):c.5897A>G (p.Asn1966Ser)	NDE1|MYH11	N1973S, N1966S	Wolff-Parkinson-White pattern|Familial thoracic aortic aneurysm and aortic dissection	Uncertain significance(Last reviewed: Nov 24, 2018)	criteria provided, single submitter	VCV000487586	16	15797870	16	15704013	487586	480716	rs1317809527	NC_000016.10:15704012:T:C
NM_016013.4(NDUFAF1):c.619A>C (p.Thr207Pro)	NDUFAF1	T207P	Mitochondrial complex 1 deficiency, nuclear type 11	Pathogenic(Last reviewed: Jul 11, 2007)	no assertion criteria provided	VCV000030622	15	41687197	15	41394999	30622	39579	rs387906956	NC_000015.10:41394998:T:G
NM_021074.5(NDUFV2):c.86T>C (p.Val29Ala)	NDUFV2	V29A	Parkinson disease, mitochondrial|Mitochondrial complex I deficiency, nuclear type 1|Mitochondrial complex 1 deficiency, nuclear type 7|not specified|not provided	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009054	18	9117867	18	9117869	9054	24093	rs906807	NC_000018.10:9117868:T:C
NM_006393.3(NEBL):c.2473C>T (p.His825Tyr)	NEBL	H162Y, H825Y, H126Y, H140Y, H143Y, H146Y	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487585	10	21101743	10	20812814	487585	480703	rs1554774990	NC_000010.11:20812813:G:A
NM_018055.5(NODAL):c.778G>A (p.Gly260Arg)	NODAL	G260R, G127R	not provided|heterotaxia syndrome|Inborn genetic diseases|Visceral heterotaxy 5, autosomal|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Jan 7, 2021)	criteria provided, conflicting interpretations	VCV000008269	10	72195155	10	70435399	8269	23308	rs121909283	NC_000010.11:70435398:C:T
NM_000271.5(NPC1):c.2974G>C (p.Gly992Arg)	NPC1	G992R	Niemann-Pick disease type C1|not provided|Niemann-Pick disease, type C	Pathogenic/Likely pathogenic(Last reviewed: Sep 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002969	18	21118573	18	23538609	2969	18008	rs80358254	NC_000018.10:23538608:C:G
NM_006432.5(NPC2):c.292A>C (p.Asn98His)	NPC2	N98H	Niemann-Pick disease, type C2|not provided	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377030	14	74951189	14	74484486	377030	363908	rs142858704	NC_000014.9:74484485:T:G
NM_006186.4(NR4A2):c.325C>A (p.Gln109Lys)	NR4A2	Q109K, Q46K	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894762	2	157186374	2	156329862	894762	881259		NC_000002.12:156329861:G:T
NM_006186.4(NR4A2):c.325C>G (p.Gln109Glu)	NR4A2	Q109E, Q46E	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000894761	2	157186374	2	156329862	894761	881258		NC_000002.12:156329861:G:C
NM_006186.4(NR4A2):c.360T>G (p.Val120=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000894760	2	157186339	2	156329827	894760	881257		NC_000002.12:156329826:A:C
NM_006186.4(NR4A2):c.372C>T (p.Pro124=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894759	2	157186327	2	156329815	894759	881256		NC_000002.12:156329814:G:A
NM_006186.4(NR4A2):c.591C>A (p.Pro197=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000894758	2	157186108	2	156329596	894758	881255		NC_000002.12:156329595:G:T
NM_006186.4(NR4A2):c.1163A>T (p.Gln388Leu)	NR4A2	Q325L, Q388L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893841	2	157183428	2	156326916	893841	881254		NC_000002.12:156326915:T:A
NM_006186.4(NR4A2):c.1170C>A (p.Asn390Lys)	NR4A2	N390K, N327K	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893840	2	157183421	2	156326909	893840	881253		NC_000002.12:156326908:G:T
NM_006186.4(NR4A2):c.1230G>A (p.Leu410=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893839	2	157183361	2	156326849	893839	881252		NC_000002.12:156326848:C:T
NM_006186.4(NR4A2):c.1273C>T (p.Pro425Ser)	NR4A2	P362S, P425S	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893838	2	157183318	2	156326806	893838	881251		NC_000002.12:156326805:G:A
NM_006186.4(NR4A2):c.1548C>T (p.His516=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893837	2	157182505	2	156325993	893837	881250		NC_000002.12:156325992:G:A
NC_000002.12:g.156332790T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893588	2	157189302	2	156332790	893588	882817		NC_000002.12:156332789:T:C
NM_006186.4(NR4A2):c.1588A>C (p.Lys530Gln)	NR4A2	K467Q, K530Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893544	2	157182465	2	156325953	893544	881249		NC_000002.12:156325952:T:G
NM_006186.4(NR4A2):c.1638G>A (p.Leu546=)	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000893543	2	157182415	2	156325903	893543	881248		NC_000002.12:156325902:C:T
NM_006186.4(NR4A2):c.-339C>A	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892777	2	157189204	2	156332692	892777	881262		NC_000002.12:156332691:G:T
NM_006186.4(NR4A2):c.-304C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892776	2	157189169	2	156332657	892776	881261		NC_000002.12:156332656:G:A
NM_006186.4(NR4A2):c.-253C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000892775	2	157189118	2	156332606	892775	881260		NC_000002.12:156332605:G:A
NM_006186.4(NR4A2):c.*599T>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892747	2	157181657	2	156325145	892747	881247		NC_000002.12:156325144:A:C
NM_006186.4(NR4A2):c.*1017T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892746	2	157181239	2	156324727	892746	881246		NC_000002.12:156324726:A:G
NM_006186.4(NR4A2):c.*1249A>G	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892745	2	157181007	2	156324495	892745	881245		NC_000002.12:156324494:T:C
NM_006186.3(NR4A2):c.-387A>T	NR4A2		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331671	2	157189252	2	156332740	331671	284978	rs886054983	NC_000002.12:156332739:T:A
NM_006186.3(NR4A2):c.-384T>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331670	2	157189249	2	156332737	331670	284576	rs886054982	NC_000002.12:156332736:A:G
NM_006186.4(NR4A2):c.-325C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331669	2	157189190	2	156332678	331669	282322	rs886054981	NC_000002.12:156332677:G:C
NM_006186.4(NR4A2):c.-241C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331668	2	157189106	2	156332594	331668	284969	rs536532102	NC_000002.12:156332593:G:C
NM_006186.4(NR4A2):c.-227C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331667	2	157189092	2	156332580	331667	284959	rs886054980	NC_000002.12:156332579:G:C
NM_006186.4(NR4A2):c.-223C>T	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000331666	2	157189088	2	156332576	331666	283008	rs114461423	NC_000002.12:156332575:G:A
NM_006186.4(NR4A2):c.-166C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331665	2	157189031	2	156332519	331665	282318	rs755057457	NC_000002.12:156332518:G:C
NM_006186.4(NR4A2):c.-144G>A	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331664	2	157189009	2	156332497	331664	283007	rs886054979	NC_000002.12:156332496:C:T
NM_006186.4(NR4A2):c.585C>T (p.Asp195=)	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331663	2	157186114	2	156329602	331663	282317	rs143064317	NC_000002.12:156329601:G:A
NM_006186.4(NR4A2):c.657T>C (p.Ala219=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331662	2	157186042	2	156329530	331662	284563	rs769677341	NC_000002.12:156329529:A:G
NM_006186.4(NR4A2):c.732C>A (p.Leu244=)	NR4A2		Parkinson disease, late-onset|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000331661	2	157185967	2	156329455	331661	284553	rs16840266	NC_000002.12:156329454:G:T
NM_006186.4(NR4A2):c.1158+13C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331660	2	157184350	2	156327838	331660	284958	rs372468197	NC_000002.12:156327837:G:A
NM_006186.4(NR4A2):c.1635G>T (p.Gly545=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331659	2	157182418	2	156325906	331659	282316	rs886054978	NC_000002.12:156325905:C:A
NM_006186.4(NR4A2):c.1659C>G (p.Ser553=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331658	2	157182394	2	156325882	331658	284957	rs886054977	NC_000002.12:156325881:G:C
NM_006186.4(NR4A2):c.1746G>A (p.Val582=)	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331657	2	157182307	2	156325795	331657	282315	rs886054976	NC_000002.12:156325794:C:T
NM_006186.4(NR4A2):c.*192C>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331656	2	157182064	2	156325552	331656	284551	rs747113198	NC_000002.12:156325551:G:C
NM_006186.4(NR4A2):c.*331T>G	NR4A2		Parkinson disease, late-onset	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331655	2	157181925	2	156325413	331655	283004	rs12803	NC_000002.12:156325412:A:C
NM_006186.4(NR4A2):c.*352C>A	NR4A2		Parkinson disease, late-onset	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331654	2	157181904	2	156325392	331654	282313	rs115393922	NC_000002.12:156325391:G:T
NM_006186.4(NR4A2):c.*822A>C	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331651	2	157181434	2	156324922	331651	282301	rs886054975	NC_000002.12:156324921:T:G
NM_006186.4(NR4A2):c.*933G>A	NR4A2		Parkinson disease, late-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331650	2	157181323	2	156324811	331650	284548	rs563505935	NC_000002.12:156324810:C:T
NM_006186.4(NR4A2):c.*1198C>T	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000331649	2	157181058	2	156324546	331649	284952	rs577905348	NC_000002.12:156324545:G:A
NM_006186.3(NR4A2):c.*1311A>G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000331648	2	157180945	2	156324433	331648	282298	rs886054974	NC_000002.12:156324432:T:C
NR4A2, -245T-G	NR4A2		Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jun 8, 2004)	no assertion criteria provided	VCV000007680					7680	22719		
NM_014321.4(ORC6):c.-20T>C	ORC6|VPS35		Parkinson Disease, Dominant|Meier-Gorlin syndrome 3|Meier-Gorlin syndrome|not specified	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000260386	16	46723598	16	46689686	260386	255745	rs33994299	NC_000016.10:46689685:T:C
NM_004562.3(PRKN):c.-85G>A	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906286	6	163148785	6	162727753	906286	895664		NC_000006.12:162727752:C:T
NM_004562.3(PRKN):c.-78C>A	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906285	6	163148778	6	162727746	906285	895663		NC_000006.12:162727745:G:T
NM_004562.3(PRKN):c.-57G>C	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906284	6	163148757	6	162727725	906284	895662		NC_000006.12:162727724:C:G
NM_004562.3(PRKN):c.4A>G (p.Ile2Val)	PACRG|PRKN	I2V	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000579609	6	163148697	6	162727665	579609	563481	rs747682986	NC_000006.12:162727664:T:C
NM_004562.3(PRKN):c.7+5G>T	PACRG|PRKN		not provided|Parkinson disease 2	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000573661	6	163148689	6	162727657	573661	560660	rs1204087943	NC_000006.12:162727656:C:A
NM_004562.3(PRKN):c.1A>G (p.Met1Val)	PACRG|PRKN	M1V	not provided|Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493448	6	163148700	6	162727668	493448	486411	rs772786691	NC_000006.12:162727667:T:C
NM_004562.3(PRKN):c.-46C>T	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356024	6	163148746	6	162727714	356024	306812	rs369389244	NC_000006.12:162727713:G:A
NM_004562.3(PRKN):c.-42T>C	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356023	6	163148742	6	162727710	356023	302129	rs112850281	NC_000006.12:162727709:A:G
NM_004562.3(PRKN):c.-30T>C	PACRG|PRKN		not provided|Parkinson disease 2	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356022	6	163148730	6	162727698	356022	306811	rs200065081	NC_000006.12:162727697:A:G
NM_004562.3(PRKN):c.7+4C>T	PACRG|PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356021	6	163148690	6	162727658	356021	306546	rs749081702	NC_000006.12:162727657:G:A
NM_004562.3(PRKN):c.7+1G>T	PACRG|PRKN		Parkinson disease 2	Pathogenic(Last reviewed: Mar 1, 2006)	no assertion criteria provided	VCV000007053	6	163148693	6	162727661	7053	22092	rs397518439	NC_000006.12:162727660:C:A
NM_007262.5(PARK7):c.83G>A (p.Arg28Gln)	PARK7	R28Q	Parkinson disease 7	Likely pathogenic(Last reviewed: Sep 21, 2021)	no assertion criteria provided	VCV001319906	1	8022928	1	7962868	1319906	1310154		NC_000001.11:7962867:G:A
NM_007262.5(PARK7):c.429G>A (p.Glu143=)	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001144766	1	8044973	1	7984913	1144766	1131726		NC_000001.11:7984912:G:A
NM_007262.5(PARK7):c.460A>G (p.Thr154Ala)	PARK7	T154A	Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001119998	1	8045004	1	7984944	1119998	1108786		NC_000001.11:7984943:A:G
NM_007262.5(PARK7):c.91-5C>T	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV001078275	1	8025379	1	7965319	1078275	1067599		NC_000001.11:7965318:C:T
NM_007262.5(PARK7):c.16G>T (p.Ala6Ser)	PARK7	A6S	Parkinson disease 7	Uncertain significance(Last reviewed: May 19, 2018)	criteria provided, single submitter	VCV001015099	1	8022861	1	7962801	1015099	1003014		NC_000001.11:7962800:G:T
NM_007262.5(PARK7):c.56C>T (p.Thr19Met)	PARK7	T19M	Parkinson disease 7	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000963192	1	8022901	1	7962841	963192	942104		NC_000001.11:7962840:C:T
NM_007262.5(PARK7):c.*185T>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875477	1	8045299	1	7985239	875477	864823		NC_000001.11:7985238:T:A
NM_007262.5(PARK7):c.*124C>T	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875476	1	8045238	1	7985178	875476	864822		NC_000001.11:7985177:C:T
NM_007262.5(PARK7):c.*49A>G	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875475	1	8045163	1	7985103	875475	864821		NC_000001.11:7985102:A:G
NM_007262.5(PARK7):c.502A>G (p.Ile168Val)	PARK7	I168V	Parkinson disease 7	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000875474	1	8045046	1	7984986	875474	864820		NC_000001.11:7984985:A:G
NM_007262.5(PARK7):c.425C>T (p.Ser142Phe)	PARK7	S142F	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874552	1	8044969	1	7984909	874552	864819		NC_000001.11:7984908:C:T
NM_007262.5(PARK7):c.91A>G (p.Ile31Val)	PARK7	I31V	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874551	1	8025384	1	7965324	874551	864818		NC_000001.11:7965323:A:G
NM_007262.5(PARK7):c.91-11C>T	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874550	1	8025373	1	7965313	874550	865210		NC_000001.11:7965312:C:T
NM_007262.5(PARK7):c.535G>A (p.Ala179Thr)	PARK7	A179T	Parkinson disease 7|not provided	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000854701	1	8045079	1	7985019	854701	824426		NC_000001.11:7985018:G:A
NM_007262.5(PARK7):c.101C>T (p.Thr34Ile)	PARK7	T34I	Parkinson disease 7|not provided	Uncertain significance(Last reviewed: Jun 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000806045	1	8025394	1	7965334	806045	794726	rs772272696	NC_000001.11:7965333:C:T
NM_007262.5(PARK7):c.501A>G (p.Ala167=)	PARK7		Parkinson disease 7	Conflicting interpretations of pathogenicity(Last reviewed: Oct 30, 2020)	criteria provided, conflicting interpretations	VCV000707607	1	8045045	1	7984985	707607	690677	rs71653621	NC_000001.11:7984984:A:G
NM_007262.5(PARK7):c.28C>G (p.Leu10Val)	PARK7	L10V	Parkinson disease 7	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000643343	1	8022873	1	7962813	643343	628270	rs1309873819	NC_000001.11:7962812:C:G
NM_007262.5(PARK7):c.310G>A (p.Ala104Thr)	PARK7	A104T	Parkinson disease 7	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000642328	1	8031011	1	7970951	642328	628271	rs774005786	NC_000001.11:7970950:G:A
NM_007262.5(PARK7):c.511G>T (p.Ala171Ser)	PARK7	A171S	Parkinson disease 7	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000582678	1	8045055	1	7984995	582678	558597	rs777026628	NC_000001.11:7984994:G:T
NM_007262.5(PARK7):c.448G>A (p.Gly150Ser)	PARK7	G150S	Parkinson disease 7	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000577231	1	8044992	1	7984932	577231	557378	rs368420490	NC_000001.11:7984931:G:A
NM_007262.5(PARK7):c.91-4G>A	PARK7		Parkinson disease 7	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000534230	1	8025380	1	7965320	534230	516087	rs756040385	NC_000001.11:7965319:G:A
NM_007262.5(PARK7):c.293G>A (p.Arg98Gln)	PARK7	R98Q	Parkinson disease 7|not specified|Renal cysts and diabetes syndrome|not provided	Benign/Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465831	1	8030994	1	7970934	465831	448380	rs71653619	NC_000001.11:7970933:G:A
NM_007262.4(PARK7):c.[-24+75_-24+92dup;487G>A]	PARK7	E163K	Parkinson disease 7	Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000446717	1|1	8021910 - 8021911	1|1	7961850 - 7961851	446717	75266|22107	rs200968609|rs74315354	NC_000001.11:7961850:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC:GTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCCTGTGCTGGACGGTGTCCC|NC_000001.11:7984970:G:A
NM_007262.5(PARK7):c.*125G>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298124	1	8045239	1	7985179	298124	283319	rs779587926	NC_000001.11:7985178:G:A
NM_007262.5(PARK7):c.500C>G (p.Ala167Gly)	PARK7	A167G	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298123	1	8045044	1	7984984	298123	283318	rs886046546	NC_000001.11:7984983:C:G
NM_007262.5(PARK7):c.323-14A>G	PARK7		Parkinson disease 7|not provided	Benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000298122	1	8037698	1	7977638	298122	281870	rs72854882	NC_000001.11:7977637:A:G
NM_007262.5(PARK7):c.234C>T (p.Gly78=)	PARK7		not provided|Parkinson disease 7|Parkinson Disease, Recessive|not specified	Benign/Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000298121	1	8029446	1	7969386	298121	283121	rs11548937	NC_000001.11:7969385:C:T
NM_007262.5(PARK7):c.223G>A (p.Gly75Ser)	PARK7	G75S	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298120	1	8029435	1	7969375	298120	283317	rs886046545	NC_000001.11:7969374:G:A
NM_007262.5(PARK7):c.73G>A (p.Val25Ile)	PARK7	V25I	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298119	1	8022918	1	7962858	298119	283116	rs781346135	NC_000001.11:7962857:G:A
NM_007262.5(PARK7):c.59T>C (p.Val20Ala)	PARK7	V20A	Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298118	1	8022904	1	7962844	298118	281253	rs370430693	NC_000001.11:7962843:T:C
NM_007262.5(PARK7):c.-22C>T	PARK7		not specified|Parkinson disease 7|not provided	Benign(Last reviewed: Jan 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000298117	1	8022824	1	7962764	298117	283115	rs11548933	NC_000001.11:7962763:C:T
NM_007262.5(PARK7):c.-30G>C	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000298116	1	8021847	1	7961787	298116	281251	rs886046544	NC_000001.11:7961786:G:C
NM_007262.5(PARK7):c.-70C>T	PARK7		Parkinson disease 7|not provided	Benign(Last reviewed: Aug 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000298115	1	8021807	1	7961747	298115	283316	rs11121064	NC_000001.11:7961746:C:T
NM_007262.5(PARK7):c.-80T>A	PARK7		Parkinson disease 7	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298114	1	8021797	1	7961737	298114	281869	rs140230911	NC_000001.11:7961736:T:A
NM_007262.5(PARK7):c.-99T>C	PARK7		Parkinson disease 7	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000298113	1	8021778	1	7961718	298113	283315	rs226249	NC_000001.11:7961717:T:C
NM_001123377.1(PARK7):c.-69G>C	PARK7		Parkinson Disease, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000298112	1	8021750	1	7961690	298112	283113	rs557801400	NC_000001.11:7961689:G:C
NM_001123377.1(PARK7):c.-79G>A	PARK7		Parkinson Disease, Recessive|not provided	Benign/Likely benign(Last reviewed: Aug 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000298111	1	8021740	1	7961680	298111	283314	rs17523802	NC_000001.11:7961679:G:A
NM_007262.5(PARK7):c.399G>C (p.Met133Ile)	PARK7	M133I	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096726	1	8037788	1	7977728	96726	102612	rs398124657	NC_000001.11:7977727:G:C
NM_007262.5(PARK7):c.115G>T (p.Ala39Ser)	PARK7	A39S	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000007069	1	8025408	1	7965348	7069	22108	rs137853051	NC_000001.11:7965347:G:T
NM_007262.5(PARK7):c.192G>C (p.Glu64Asp)	PARK7	E64D	Parkinson disease 7	Pathogenic(Last reviewed: Oct 1, 2004)	no assertion criteria provided	VCV000007067	1	8025485	1	7965425	7067	22106	rs74315353	NC_000001.11:7965424:G:C
NM_007262.5(PARK7):c.446A>C (p.Asp149Ala)	PARK7	D149A	Parkinson disease 7	Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	VCV000007066	1	8044990	1	7984930	7066	22105	rs74315352	NC_000001.11:7984929:A:C
NM_007262.5(PARK7):c.78G>A (p.Met26Ile)	PARK7	M26I	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007065	1	8022923	1	7962863	7065	22104	rs74315351	NC_000001.11:7962862:G:A
NM_007262.5(PARK7):c.497T>C (p.Leu166Pro)	PARK7	L166P	Parkinson disease 7	Pathogenic(Last reviewed: Jul 1, 2012)	no assertion criteria provided	VCV000007064	1	8045041	1	7984981	7064	22103	rs28938172	NC_000001.11:7984980:T:C
NM_018622.7(PARL):c.230G>A (p.Ser77Asn)	PARL	S77N	not provided	Uncertain significance(Last reviewed: Nov 1, 2011)	no assertion criteria provided	VCV000218097	3	183585744	3	183867956	218097	214751	rs571537271	NC_000003.12:183867955:C:T
NM_032409.3(PINK1):c.1024A>C (p.Met342Leu)	PINK1|PINK1-AS	M342L	not provided	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV001310405	1	20972117	1	20645624	1310405	1302255		NC_000001.11:20645623:A:C
NM_032409.3(PINK1):c.558G>C (p.Lys186Asn)	PINK1	K186N	Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001169544	1	20964505	1	20638012	1169544	1153429		NC_000001.11:20638011:G:C
NM_032409.3(PINK1):c.624T>C (p.Ala208=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001154692	1	20964571	1	20638078	1154692	1130817		NC_000001.11:20638077:T:C
NM_032409.3(PINK1):c.942G>A (p.Leu314=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001150377	1	20971148	1	20644655	1150377	1130818		NC_000001.11:20644654:G:A
NM_032409.3(PINK1):c.1530C>T (p.Ser510=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001149020	1	20976968	1	20650475	1149020	1130819		NC_000001.11:20650474:C:T
NM_032409.3(PINK1):c.1023G>A (p.Met341Ile)	PINK1|PINK1-AS	M341I	Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Apr 29, 2019)	criteria provided, single submitter	VCV001139313	1	20972116	1	20645623	1139313	1109921		NC_000001.11:20645622:G:A
NM_032409.3(PINK1):c.435G>A (p.Thr145=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV001130785	1	20964382	1	20637889	1130785	1109919		NC_000001.11:20637888:G:A
NM_032409.3(PINK1):c.690C>T (p.Ser230=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Sep 7, 2019)	criteria provided, single submitter	VCV001130158	1	20966399	1	20639906	1130158	1109920		NC_000001.11:20639905:C:T
NM_032409.3(PINK1):c.426G>A (p.Pro142=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001110165	1	20964373	1	20637880	1110165	1088405		NC_000001.11:20637879:G:A
NM_032409.3(PINK1):c.488G>A (p.Gly163Asp)	PINK1	G163D	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001040371	1	20964435	1	20637942	1040371	1022886		NC_000001.11:20637941:G:A
NM_032409.3(PINK1):c.161C>A (p.Ala54Glu)	PINK1|MIR6084	A54E	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001030969	1	20960202	1	20633709	1030969	1015627		NC_000001.11:20633708:C:A
NM_032409.3(PINK1):c.1123+19A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001030968	1	20972235	1	20645742	1030968	1015628		NC_000001.11:20645741:A:G
NM_032409.3(PINK1):c.388-3C>T	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001021120	1	20964332	1	20637839	1021120	1002435		NC_000001.11:20637838:C:T
NM_032409.3(PINK1):c.838G>A (p.Ala280Thr)	PINK1|PINK1-AS	A280T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001017772	1	20971044	1	20644551	1017772	1002436		NC_000001.11:20644550:G:A
NM_032409.3(PINK1):c.76G>C (p.Gly26Arg)	PINK1	G26R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001016581	1	20960117	1	20633624	1016581	1002434		NC_000001.11:20633623:G:C
NM_032409.3(PINK1):c.1573G>A (p.Asp525Asn)	PINK1|PINK1-AS	D525N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001011956	1	20977011	1	20650518	1011956	987171		NC_000001.11:20650517:G:A
NM_032409.3(PINK1):c.1580T>C (p.Met527Thr)	PINK1|PINK1-AS	M527T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001009480	1	20977018	1	20650525	1009480	987172		NC_000001.11:20650524:T:C
NM_032409.3(PINK1):c.1220G>A (p.Arg407Gln)	PINK1|PINK1-AS	R407Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000967822	1	20975094	1	20648601	967822	952221		NC_000001.11:20648600:G:A
NM_032409.3(PINK1):c.124C>T (p.Arg42Cys)	PINK1	R42C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000939290	1	20960165	1	20633672	939290	930252		NC_000001.11:20633671:C:T
NM_032409.3(PINK1):c.454C>T (p.Arg152Trp)	PINK1	R152W	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000931833	1	20964401	1	20637908	931833	918593		NC_000001.11:20637907:C:T
NM_032409.3(PINK1):c.*817C>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876908	1	20978001	1	20651508	876908	863366		NC_000001.11:20651507:C:A
NM_032409.3(PINK1):c.*702G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876907	1	20977886	1	20651393	876907	863365		NC_000001.11:20651392:G:A
NM_032409.3(PINK1):c.*586T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876906	1	20977770	1	20651277	876906	863364		NC_000001.11:20651276:T:C
NM_032409.3(PINK1):c.*579C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876905	1	20977763	1	20651270	876905	863363		NC_000001.11:20651269:C:T
NM_032409.3(PINK1):c.1729T>C (p.Trp577Arg)	PINK1|PINK1-AS	W577R	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000876859	1	20977167	1	20650674	876859	863353		NC_000001.11:20650673:T:C
NM_032409.3(PINK1):c.1728A>G (p.Ser576=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000876858	1	20977166	1	20650673	876858	863352		NC_000001.11:20650672:A:G
NM_032409.3(PINK1):c.813C>T (p.His271=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000876799	1	20971019	1	20644526	876799	863345		NC_000001.11:20644525:C:T
NM_032409.3(PINK1):c.620G>A (p.Arg207Gln)	PINK1	R207Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000876798	1	20964567	1	20638074	876798	863344		NC_000001.11:20638073:G:A
NM_032409.3(PINK1):c.*571C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875913	1	20977755	1	20651262	875913	863362		NC_000001.11:20651261:C:T
NM_032409.3(PINK1):c.*542G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000875912	1	20977726	1	20651233	875912	863361		NC_000001.11:20651232:G:A
NM_032409.3(PINK1):c.*519G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875911	1	20977703	1	20651210	875911	863360		NC_000001.11:20651209:G:A
NM_032409.3(PINK1):c.1194G>A (p.Leu398=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000875861	1	20975068	1	20648575	875861	863351		NC_000001.11:20648574:G:A
NM_032409.3(PINK1):c.414G>A (p.Pro138=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000875808	1	20964361	1	20637868	875808	863343		NC_000001.11:20637867:G:A
NM_032409.3(PINK1):c.387+14G>A	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875807	1	20960442	1	20633949	875807	865097		NC_000001.11:20633948:G:A
NM_032409.3(PINK1):c.279G>C (p.Ala93=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000875806	1	20960320	1	20633827	875806	863342		NC_000001.11:20633826:G:C
NM_032409.3(PINK1):c.*352G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874986	1	20977536	1	20651043	874986	863359		NC_000001.11:20651042:G:A
NM_032409.3(PINK1):c.*340C>T	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874985	1	20977524	1	20651031	874985	863358		NC_000001.11:20651030:C:T
NM_032409.3(PINK1):c.*263C>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874984	1	20977447	1	20650954	874984	863357		NC_000001.11:20650953:C:A
NM_032409.3(PINK1):c.1095C>T (p.Ser365=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)	criteria provided, conflicting interpretations	VCV000874928	1	20972188	1	20645695	874928	863350		NC_000001.11:20645694:C:T
NM_032409.3(PINK1):c.1075G>A (p.Ala359Thr)	PINK1|PINK1-AS	A359T	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874927	1	20972168	1	20645675	874927	863349		NC_000001.11:20645674:G:A
NM_032409.3(PINK1):c.1003A>G (p.Ser335Gly)	PINK1|PINK1-AS	S335G	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000874926	1	20972096	1	20645603	874926	863348		NC_000001.11:20645602:A:G
NM_032409.3(PINK1):c.218C>T (p.Ser73Leu)	PINK1|MIR6084	S73L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874873	1	20960259	1	20633766	874873	863341		NC_000001.11:20633765:C:T
NM_032409.3(PINK1):c.*113G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874058	1	20977297	1	20650804	874058	863356		NC_000001.11:20650803:G:A
NM_032409.3(PINK1):c.*64G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874057	1	20977248	1	20650755	874057	863355		NC_000001.11:20650754:G:A
NM_032409.3(PINK1):c.960-11C>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000873991	1	20972042	1	20645549	873991	865098		NC_000001.11:20645548:C:G
NM_032409.3(PINK1):c.887C>T (p.Pro296Leu)	PINK1|PINK1-AS	P296L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000873990	1	20971093	1	20644600	873990	863347		NC_000001.11:20644599:C:T
NM_032409.3(PINK1):c.835C>T (p.Arg279Cys)	PINK1|PINK1-AS	R279C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2017)	criteria provided, single submitter	VCV000873989	1	20971041	1	20644548	873989	863346		NC_000001.11:20644547:C:T
NM_032409.3(PINK1):c.1065A>G (p.Gln355=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000859181	1	20972158	1	20645665	859181	823273		NC_000001.11:20645664:A:G
NM_032409.3(PINK1):c.449G>A (p.Gly150Asp)	PINK1	G150D	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000846127	1	20964396	1	20637903	846127	823272		NC_000001.11:20637902:G:A
NM_032409.3(PINK1):c.745T>G (p.Leu249Val)	PINK1	L249V	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000806077	1	20966454	1	20639961	806077	794551	rs145650643	NC_000001.11:20639960:T:G
NM_032409.3(PINK1):c.827G>A (p.Arg276Gln)	PINK1|PINK1-AS	R276Q	Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 7, 2020)	criteria provided, conflicting interpretations	VCV000787365	1	20971033	1	20644540	787365	707026	rs548506734	NC_000001.11:20644539:G:A
NM_032409.3(PINK1):c.1549C>T (p.Leu517=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Likely benign(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000772756	1	20976987	1	20650494	772756	696419	rs149466252	NC_000001.11:20650493:C:T
NM_032409.3(PINK1):c.537C>T (p.Pro179=)	PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000719562	1	20964484	1	20637991	719562	718571	rs773064713	NC_000001.11:20637990:C:T
NM_032409.3(PINK1):c.852C>T (p.Ser284=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Apr 30, 2020)	criteria provided, single submitter	VCV000712196	1	20971058	1	20644565	712196	718573	rs368453193	NC_000001.11:20644564:C:T
NM_032409.3(PINK1):c.564C>T (p.Thr188=)	PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000709154	1	20964511	1	20638018	709154	718572	rs754328101	NC_000001.11:20638017:C:T
NM_032409.3(PINK1):c.267C>T (p.Ala89=)	PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2018)	criteria provided, conflicting interpretations	VCV000707527	1	20960308	1	20633815	707527	690471	rs770933972	NC_000001.11:20633814:C:T
NM_032409.3(PINK1):c.1481C>T (p.Ala494Val)	PINK1|PINK1-AS	A494V	not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000706953	1	20975717	1	20649224	706953	690475	rs542258150	NC_000001.11:20649223:C:T
NM_032409.3(PINK1):c.1077G>A (p.Ala359=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000704989	1	20972170	1	20645677	704989	690473	rs144550985	NC_000001.11:20645676:G:A
NM_032409.3(PINK1):c.948C>T (p.Leu316=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703838	1	20971154	1	20644661	703838	690472	rs142183624	NC_000001.11:20644660:C:T
NM_032409.3(PINK1):c.1502G>A (p.Arg501Gln)	PINK1|PINK1-AS	R501Q	not provided|Parkinson disease 6, autosomal recessive early-onset	Benign/Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000703805	1	20976940	1	20650447	703805	690476	rs61744200	NC_000001.11:20650446:G:A
NM_032409.3(PINK1):c.1231G>A (p.Gly411Ser)	PINK1|PINK1-AS	G411S	Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000703421	1	20975105	1	20648612	703421	690474	rs45478900	NC_000001.11:20648611:G:A
NM_032409.3(PINK1):c.1096G>A (p.Asp366Asn)	PINK1|PINK1-AS	D366N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000662914	1	20972189	1	20645696	662914	627317	rs200729715	NC_000001.11:20645695:G:A
NM_032409.3(PINK1):c.13C>T (p.Gln5Ter)	PINK1	Q5*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000661098	1	20960054	1	20633561	661098	627313	rs1005937012	NC_000001.11:20633560:C:T
NM_032409.3(PINK1):c.962A>G (p.Tyr321Cys)	PINK1|PINK1-AS	Y321C	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000652873	1	20972055	1	20645562	652873	627316	rs755060576	NC_000001.11:20645561:A:G
NM_032409.3(PINK1):c.626C>T (p.Pro209Leu)	PINK1	P209L	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000647795	1	20964573	1	20638080	647795	627315	rs34677717	NC_000001.11:20638079:C:T
NM_032409.3(PINK1):c.1212C>G (p.Tyr404Ter)	PINK1|PINK1-AS	Y404*	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000631592	1	20975086	1	20648593	631592	619988	rs747239996	NC_000001.11:20648592:C:G
NM_032409.3(PINK1):c.774C>A (p.Tyr258Ter)	PINK1	Y258*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000631591	1	20966483	1	20639990	631591	619987	rs756783990	NC_000001.11:20639989:C:A
NM_032409.3(PINK1):c.665G>A (p.Trp222Ter)	PINK1	W222*	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000631590	1	20964612	1	20638119	631590	619986	rs777160388	NC_000001.11:20638118:G:A
NM_032409.3(PINK1):c.1147G>A (p.Ala383Thr)	PINK1|PINK1-AS	A383T	not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2019)	criteria provided, conflicting interpretations	VCV000618283	1	20975021	1	20648528	618283	609368	rs45515602	NC_000001.11:20648527:G:A
NM_032409.3(PINK1):c.1173T>C (p.Asp391=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000534248	1	20975047	1	20648554	534248	515409	rs45499398	NC_000001.11:20648553:T:C
NM_032409.3(PINK1):c.1488G>A (p.Lys496=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000534247	1	20975724	1	20649231	534247	515514	rs56217826	NC_000001.11:20649230:G:A
NM_032409.3(PINK1):c.1015G>A (p.Ala339Thr)	PINK1|PINK1-AS	A339T	not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2021)	criteria provided, conflicting interpretations	VCV000500148	1	20972108	1	20645615	500148	491572	rs55831733	NC_000001.11:20645614:G:A
NM_032409.3(PINK1):c.565G>A (p.Gly189Arg)	PINK1	G189R	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000493026	1	20964512	1	20638019	493026	485989	rs757581951	NC_000001.11:20638018:G:A
NM_032409.3(PINK1):c.935G>A (p.Arg312Gln)	PINK1|PINK1-AS	R312Q	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 19, 2017)	criteria provided, single submitter	VCV000465847	1	20971141	1	20644648	465847	447474	rs202128685	NC_000001.11:20644647:G:A
NM_032409.3(PINK1):c.804A>G (p.Leu268=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000465846	1	20971010	1	20644517	465846	447721	rs200708848	NC_000001.11:20644516:A:G
NM_032409.3(PINK1):c.952A>T (p.Met318Leu)	PINK1|PINK1-AS	M318L	Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447942	1	20971158	1	20644665	447942	440434	rs139226733	NC_000001.11:20644664:A:T
NM_032409.3(PINK1):c.67G>A (p.Gly23Ser)	PINK1	G23S	not specified|not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jun 26, 2018)	criteria provided, conflicting interpretations	VCV000447940	1	20960108	1	20633615	447940	440432	rs551542832	NC_000001.11:20633614:G:A
NM_032409.3(PINK1):c.587C>T (p.Pro196Leu)	PINK1	P196L	not provided|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000445908	1	20964534	1	20638041	445908	439180	rs138302371	NC_000001.11:20638040:C:T
NM_032409.3(PINK1):c.1474C>T (p.Arg492Ter)	PINK1|PINK1-AS	R492*	not provided|Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000431963	1	20975710	1	20649217	431963	425331	rs34208370	NC_000001.11:20649216:C:T
NM_032409.3(PINK1):c.802C>G (p.Leu268Val)	PINK1|PINK1-AS	L268V	Parkinson disease 6, autosomal recessive early-onset|not provided	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374600	1	20971008	1	20644515	374600	361486	rs372280083	NC_000001.11:20644514:C:G
NM_032409.3(PINK1):c.770C>T (p.Thr257Ile)	PINK1	T257I	Parkinson disease 6, autosomal recessive early-onset|not provided	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000374599	1	20966479	1	20639986	374599	361485	rs370906995	NC_000001.11:20639985:C:T
NM_032409.3(PINK1):c.*807T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295032	1	20977991	1	20651498	295032	278559	rs78349864	NC_000001.11:20651497:T:C
NM_032409.3(PINK1):c.*672T>C	PINK1|PINK1-AS|DDOST		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295030	1	20977856	1	20651363	295030	279967	rs2078073	NC_000001.11:20651362:T:C
NM_032409.3(PINK1):c.*655T>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295028	1	20977839	1	20651346	295028	278551	rs141140099	NC_000001.11:20651345:T:C
NM_032409.3(PINK1):c.*613A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295027	1	20977797	1	20651304	295027	278550	rs886045852	NC_000001.11:20651303:A:G
NM_032409.3(PINK1):c.*534A>G	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295023	1	20977718	1	20651225	295023	278678	rs553977557	NC_000001.11:20651224:A:G
NM_032409.3(PINK1):c.*532G>A	PINK1|PINK1-AS		Parkinson Disease, Recessive|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000295022	1	20977716	1	20651223	295022	278676	rs190393061	NC_000001.11:20651222:G:A
NM_032409.3(PINK1):c.*510G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295020	1	20977694	1	20651201	295020	278543	rs886045850	NC_000001.11:20651200:G:A
NM_032409.3(PINK1):c.*490A>C	PINK1|PINK1-AS|DDOST		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: May 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000295019	1	20977674	1	20651181	295019	278672	rs16824318	NC_000001.11:20651180:A:C
NM_032409.3(PINK1):c.*349G>C	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295016	1	20977533	1	20651040	295016	278657	rs114112086	NC_000001.11:20651039:G:C
NM_032409.3(PINK1):c.*265G>T	PINK1|PINK1-AS|DDOST		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295015	1	20977449	1	20650956	295015	279965	rs512550	NC_000001.11:20650955:G:T
NM_032409.3(PINK1):c.*121G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295012	1	20977305	1	20650812	295012	279962	rs570308715	NC_000001.11:20650811:G:A
NM_032409.3(PINK1):c.*37A>T	PINK1|PINK1-AS|DDOST		not provided|Parkinson disease 6, autosomal recessive early-onset|Congenital disorder of glycosylation|Parkinson Disease, Recessive	Benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000295011	1	20977221	1	20650728	295011	278644	rs686658	NC_000001.11:20650727:A:T
NM_032409.3(PINK1):c.*18G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295010	1	20977202	1	20650709	295010	278542	rs369117599	NC_000001.11:20650708:G:A
NM_032409.3(PINK1):c.1719C>G (p.Leu573=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295009	1	20977157	1	20650664	295009	279812	rs201936304	NC_000001.11:20650663:C:G
NM_032409.3(PINK1):c.1698G>A (p.Thr566=)	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 27, 2018)	criteria provided, conflicting interpretations	VCV000295008	1	20977136	1	20650643	295008	278541	rs777232150	NC_000001.11:20650642:G:A
NM_032409.3(PINK1):c.1578G>C (p.Lys526Asn)	PINK1|PINK1-AS	K526N	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295007	1	20977016	1	20650523	295007	279953	rs886045848	NC_000001.11:20650522:G:C
NM_032409.3(PINK1):c.1251+5G>A	PINK1|PINK1-AS		Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000295005	1	20975130	1	20648637	295005	279803	rs756873744	NC_000001.11:20648636:G:A
NM_032409.3(PINK1):c.1018G>A (p.Ala340Thr)	PINK1|PINK1-AS	A340T	not provided|Parkinson disease 6, autosomal recessive early-onset|not specified	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000295004	1	20972111	1	20645618	295004	278643	rs3738136	NC_000001.11:20645617:G:A
NM_032409.3(PINK1):c.960-11C>T	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Nov 29, 2018)	criteria provided, conflicting interpretations	VCV000295003	1	20972042	1	20645549	295003	279798	rs371943401	NC_000001.11:20645548:C:T
NM_032409.3(PINK1):c.936G>A (p.Arg312=)	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000295002	1	20971142	1	20644649	295002	278534	rs56200357	NC_000001.11:20644648:G:A
NM_032409.3(PINK1):c.826C>T (p.Arg276Trp)	PINK1|PINK1-AS	R276W	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295001	1	20971032	1	20644539	295001	278532	rs778009684	NC_000001.11:20644538:C:T
NM_032409.3(PINK1):c.695C>T (p.Ala232Val)	PINK1	A232V	Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000295000	1	20966404	1	20639911	295000	279797	rs144071530	NC_000001.11:20639910:C:T
NM_032409.3(PINK1):c.344A>T (p.Gln115Leu)	PINK1	Q115L	not specified|Parkinson disease 6, autosomal recessive early-onset|not provided	Benign(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000294999	1	20960385	1	20633892	294999	279796	rs148871409	NC_000001.11:20633891:A:T
NM_032409.3(PINK1):c.165G>A (p.Glu55=)	PINK1|MIR6084		Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000294998	1	20960206	1	20633713	294998	278531	rs537679886	NC_000001.11:20633712:G:A
NM_032409.3(PINK1):c.88G>C (p.Gly30Arg)	PINK1	G30R	Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000294997	1	20960129	1	20633636	294997	278529	rs569753606	NC_000001.11:20633635:G:C
NM_032409.3(PINK1):c.858G>A (p.Pro286=)	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2019)	criteria provided, conflicting interpretations	VCV000289332	1	20971064	1	20644571	289332	273569	rs148144773	NC_000001.11:20644570:G:A
NM_032409.3(PINK1):c.1251+10G>A	PINK1|PINK1-AS		not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jul 6, 2019)	criteria provided, conflicting interpretations	VCV000288962	1	20975135	1	20648642	288962	273199	rs192131551	NC_000001.11:20648641:G:A
NM_032409.3(PINK1):c.434C>T (p.Thr145Met)	PINK1	T145M	not specified|not provided|Parkinson disease 6, autosomal recessive early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2019)	criteria provided, conflicting interpretations	VCV000286781	1	20964381	1	20637888	286781	271018	rs45604240	NC_000001.11:20637887:C:T
NM_032409.3(PINK1):c.1426G>A (p.Glu476Lys)	PINK1|PINK1-AS	E476K	not specified|not provided|Parkinson disease 6, autosomal recessive early-onset	Benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000286390	1	20975662	1	20649169	286390	270627	rs115477764	NC_000001.11:20649168:G:A
NM_032409.3(PINK1):c.388-7A>G	PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262027	1	20964328	1	20637835	262027	249677	rs2298298	NC_000001.11:20637834:A:G
NM_032409.3(PINK1):c.799C>T (p.Gln267Ter)	PINK1|PINK1-AS	Q267*	Parkinson disease 6, autosomal recessive early-onset	not provided	no assertion provided	VCV000183259	1	20971005	1	20644512	183259	181392	rs730882053	NC_000001.11:20644511:C:T
NM_032409.3(PINK1):c.644C>T (p.Pro215Leu)	PINK1	P215L	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096728	1	20964591	1	20638098	96728	102614	rs371854396	NC_000001.11:20638097:C:T
NM_032409.3(PINK1):c.1196C>T (p.Pro399Leu)	PINK1|PINK1-AS	P399L	Parkinson disease, autosomal recessive early-onset, digenic, PINK1/DJ1|Parkinson disease 6, autosomal recessive early-onset	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000002417	1	20975070	1	20648577	2417	17456	rs119451946	NC_000001.11:20648576:C:T
NM_032409.3(PINK1):c.1291T>C (p.Tyr431His)	PINK1|PINK1-AS	Y431H	Parkinson disease 6	risk factor(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000002416	1	20975527	1	20649034	2416	17455	rs74315361	NC_000001.11:20649033:T:C
NM_032409.3(PINK1):c.1366C>T (p.Gln456Ter)	PINK1|PINK1-AS	Q456*	Parkinson disease 6, autosomal recessive early-onset|not provided	Pathogenic(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000002415	1	20975602	1	20649109	2415	17454	rs45539432	NC_000001.11:20649108:C:T
NM_032409.3(PINK1):c.650C>A (p.Ala217Asp)	PINK1	A217D	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2006)	no assertion criteria provided	VCV000002414	1	20964597	1	20638104	2414	17453	rs74315360	NC_000001.11:20638103:C:A
NM_032409.3(PINK1):c.938C>T (p.Thr313Met)	PINK1|PINK1-AS	T313M	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2006)	no assertion criteria provided	VCV000002413	1	20971144	1	20644651	2413	17452	rs74315359	NC_000001.11:20644650:C:T
NM_032409.3(PINK1):c.836G>A (p.Arg279His)	PINK1|PINK1-AS	R279H	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Oct 1, 2008)	no assertion criteria provided	VCV000002411	1	20971042	1	20644549	2411	17450	rs74315358	NC_000001.11:20644548:G:A
NM_032409.3(PINK1):c.1040T>C (p.Leu347Pro)	PINK1|PINK1-AS	L347P	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002408	1	20972133	1	20645640	2408	17447	rs28940285	NC_000001.11:20645639:T:C
NM_032409.3(PINK1):c.736C>T (p.Arg246Ter)	PINK1	R246*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000002407	1	20966445	1	20639952	2407	17446	rs74315357	NC_000001.11:20639951:C:T
NM_032409.3(PINK1):c.1311G>A (p.Trp437Ter)	PINK1|PINK1-AS	W437*	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2008)	no assertion criteria provided	VCV000002406	1	20975547	1	20649054	2406	17445	rs74315356	NC_000001.11:20649053:G:A
NM_032409.3(PINK1):c.813C>A (p.His271Gln)	PINK1|PINK1-AS	H271Q	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Sep 1, 2004)	no assertion criteria provided	VCV000002405	1	20971019	1	20644526	2405	17444	rs28940284	NC_000001.11:20644525:C:A
NM_032409.3(PINK1):c.926G>A (p.Gly309Asp)	PINK1|PINK1-AS	G309D	Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Feb 15, 2008)	no assertion criteria provided	VCV000002404	1	20971132	1	20644639	2404	17443	rs74315355	NC_000001.11:20644638:G:A
NM_032409.3(PINK1):c.1488+1G>A	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset	Pathogenic(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000961640	1	20975725	1	20649232	961640	959540		NC_000001.11:20649231:G:A
NM_032409.3(PINK1):c.1252-1G>A	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000934238	1	20975487	1	20648994	934238	939792		NC_000001.11:20648993:G:A
NM_032409.3(PINK1):c.*40G>A	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided	Benign/Likely benign(Last reviewed: Jul 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000874056	1	20977224	1	20650731	874056	863354		NC_000001.11:20650730:G:A
NM_032409.3(PINK1):c.960-5G>A	PINK1-AS|PINK1		Parkinson disease 6, autosomal recessive early-onset|not provided|not specified	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000262028	1	20972048	1	20645555	262028	249678	rs3131713	NC_000001.11:20645554:G:A
NM_032409.3(PINK1):c.923T>A (p.Leu308Gln)	PINK1-AS|PINK1	L308Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096729	1	20971129	1	20644636	96729	102615	rs398124659	NC_000001.11:20644635:T:A
NM_000325.6(PITX2):c.194C>T (p.Pro65Leu)	PITX2	P65L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487594	4	111543423	4	110622267	487594	480684	rs1320287028	NC_000004.12:110622266:G:A
NM_003560.4(PLA2G6):c.1786C>T (p.Leu596Phe)	PLA2G6	L364F, L370F, L418F, L542F, L596F	Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000962233	22	38512175	22	38116168	962233	951474		NC_000022.11:38116167:G:A
NM_003560.4(PLA2G6):c.547G>A (p.Asp183Asn)	PLA2G6	D183N, D5N	not provided|Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000854667	22	38539174	22	38143167	854667	849346		NC_000022.11:38143166:C:T
NM_003560.4(PLA2G6):c.2240G>A (p.Arg747Gln)	PLA2G6	R515Q, R521Q, R569Q, R693Q, R747Q	not provided|Infantile neuroaxonal dystrophy	Uncertain significance(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000851527	22	38508547	22	38112540	851527	849341		NC_000022.11:38112539:C:T
NM_003560.4(PLA2G6):c.956C>T (p.Thr319Met)	PLA2G6	T141M, T93M, T319M	Infantile neuroaxonal dystrophy|Parkinson disease 14|not provided|PLA2G6-associated neurodegeneration	Uncertain significance(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000847008	22	38528959	22	38132952	847008	849345		NC_000022.11:38132951:G:A
NM_003560.4(PLA2G6):c.1061T>C (p.Leu354Pro)	PLA2G6	L128P, L176P, L354P	Infantile neuroaxonal dystrophy|Parkinson disease 14	Pathogenic(Last reviewed: May 6, 2019)	criteria provided, single submitter	VCV000846843	22	38528854	22	38132847	846843	849344		NC_000022.11:38132846:A:G
NM_003560.4(PLA2G6):c.991G>A (p.Asp331Asn)	PLA2G6	D331N, D105N, D153N	not provided|Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration	Conflicting interpretations of pathogenicity(Last reviewed: May 7, 2018)	criteria provided, conflicting interpretations	VCV000522939	22	38528924	22	38132917	522939	513670	rs199935023	NC_000022.11:38132916:C:T
NM_003560.4(PLA2G6):c.16C>T (p.Arg6Cys)	PLA2G6	R6C	Infantile neuroaxonal dystrophy|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided|PLA2G6-associated neurodegeneration	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000493345	22	38565418	22	38169411	493345	486308	rs143250889	NC_000022.11:38169410:G:A
NM_003560.4(PLA2G6):c.1427+1G>A	PLA2G6		Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437465	22	38522377	22	38126370	437465	431023	rs750939090	NC_000022.11:38126369:C:T
NM_003560.4(PLA2G6):c.416G>A (p.Arg139His)	PLA2G6	R139H	Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Parkinson disease 14|Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000426191	22	38541454	22	38145447	426191	415714	rs141825182	NC_000022.11:38145446:C:T
NM_003560.4(PLA2G6):c.91G>A (p.Asp31Asn)	PLA2G6	D31N	Parkinson disease 14|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|Infantile neuroaxonal dystrophy|PLA2G6-associated neurodegeneration|not provided	Uncertain significance(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341650	22	38565343	22	38169336	341650	352560	rs150024227	NC_000022.11:38169335:C:T
NM_003560.4(PLA2G6):c.101C>T (p.Ser34Leu)	PLA2G6	S34L	PLA2G6-associated neurodegeneration|not provided|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy|not specified	Uncertain significance(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000341649	22	38565333	22	38169326	341649	347766	rs147948449	NC_000022.11:38169325:G:A
NM_003560.4(PLA2G6):c.1077G>A (p.Ser359=)	PLA2G6		Infantile neuroaxonal dystrophy|not provided	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000279875	22	38528838	22	38132831	279875	264928	rs368497893	NC_000022.11:38132830:C:T
NM_003560.4(PLA2G6):c.898G>A (p.Ala300Thr)	PLA2G6	A300T, A74T, A122T	PLA2G6-associated neurodegeneration|Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 30, 2021)	criteria provided, conflicting interpretations	VCV000235257	22	38529017	22	38133010	235257	236944	rs528966598	NC_000022.11:38133009:C:T
NM_003560.4(PLA2G6):c.1615G>A (p.Gly539Ser)	PLA2G6	G539S, G307S, G361S, G313S, G485S	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|PLA2G6-associated neurodegeneration|not provided|Iron accumulation in brain|Infantile neuroaxonal dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2021)	criteria provided, conflicting interpretations	VCV000159740	22	38516893	22	38120886	159740	169787	rs143826762	NC_000022.11:38120885:C:T
NM_003560.4(PLA2G6):c.991G>T (p.Asp331Tyr)	PLA2G6	D331Y, D105Y, D153Y	Parkinson disease 14|not provided	Pathogenic(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000030371	22	38528924	22	38132917	30371	39328	rs199935023	NC_000022.11:38132916:C:A
NM_003560.4(PLA2G6):c.216C>A (p.Phe72Leu)	PLA2G6	F72L	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030368	22	38541654	22	38145647	30368	39325	rs774631197	NC_000022.11:38145646:G:T
NM_003560.4(PLA2G6):c.1354C>T (p.Gln452Ter)	PLA2G6	Q452*, Q220*, Q226*, Q274*, Q398*	Parkinson disease 14	Pathogenic(Last reviewed: Oct 12, 2010)	no assertion criteria provided	VCV000030367	22	38522451	22	38126444	30367	39324	rs387906864	NC_000022.11:38126443:G:A
NM_003560.4(PLA2G6):c.1904G>A (p.Arg635Gln)	PLA2G6	R635Q, R403Q, R581Q, R457Q, R409Q	Parkinson disease 14|PLA2G6-associated neurodegeneration	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000030366	22	38511664	22	38115657	30366	39323	rs387906863	NC_000022.11:38115656:C:T
NM_003560.4(PLA2G6):c.2239C>T (p.Arg747Trp)	PLA2G6	R747W, R521W, R515W, R569W, R693W	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|not provided|Parkinson disease 14	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006204	22	38508548	22	38112541	6204	21243	rs121908687	NC_000022.11:38112540:G:A
NM_003560.4(PLA2G6):c.2222G>A (p.Arg741Gln)	PLA2G6	R741Q, R515Q, R687Q, R509Q, R563Q	Parkinson disease 14|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006203	22	38508565	22	38112558	6203	21242	rs121908686	NC_000022.11:38112557:C:T
NM_003560.4(PLA2G6):c.238G>A (p.Ala80Thr)	PLA2G6	A80T	Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|not provided|Neurodegeneration with brain iron accumulation 2b|Infantile neuroaxonal dystrophy	Conflicting interpretations of pathogenicity(Last reviewed: Oct 5, 2020)	criteria provided, conflicting interpretations	VCV000006202	22	38541632	22	38145625	6202	21241	rs121908685	NC_000022.11:38145624:C:T
NM_003560.4(PLA2G6):c.1634A>C (p.Lys545Thr)	PLA2G6	K545T, K491T, K313T, K319T, K367T	Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14|Developmental regression|Microcephaly|Global developmental delay|Cerebellar ataxia|Congenital cerebellar hypoplasia	Pathogenic	criteria provided, single submitter	VCV000006196	22	38516874	22	38120867	6196	21235	rs121908681	NC_000022.11:38120866:T:G
NM_003560.4(PLA2G6):c.2370T>G (p.Tyr790Ter)	PLA2G6	Y790*, Y558*, Y564*, Y612*, Y736*	Iron accumulation in brain|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Inborn genetic diseases|Autistic disorder of childhood onset|Seizures|not provided|PLA2G6-associated neurodegeneration|Infantile neuroaxonal dystrophy|Neurodegeneration with brain iron accumulation 2b|Parkinson disease 14	Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2021)	criteria provided, conflicting interpretations	VCV000006195	22	38508219	22	38112212	6195	21234	rs121908680	NC_000022.11:38112211:A:C
NM_001018111.3(PODXL):c.977G>A (p.Arg326Gln)	PODXL	R326Q, R294Q	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218945	7	131194170	7	131509411	218945	215778	rs869312172	NC_000007.14:131509410:C:T
NM_001018111.3(PODXL):c.1214G>A (p.Ser405Asn)	PODXL	S405N, S373N	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218944	7	131191373	7	131506614	218944	215777	rs869312171	NC_000007.14:131506613:C:T
NM_001018111.3(PODXL):c.1381C>A (p.Pro461Thr)	PODXL	P461T, P429T	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Dec 12, 2015)	criteria provided, single submitter	VCV000218943	7	131190725	7	131505966	218943	215776	rs869312170	NC_000007.14:131505965:G:T
NM_002693.3(POLG):c.2977C>T (p.Arg993Cys)	POLG	R993C	not provided|Progressive sclerosing poliodystrophy	Uncertain significance(Last reviewed: Mar 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000405570	15	89864001	15	89320770	405570	400549	rs551811489	NC_000015.10:89320769:G:A
NM_002693.3(POLG):c.752C>T (p.Thr251Ile)	POLG	T251I	Progressive sclerosing poliodystrophy|Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1|Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1|Toe walking|Progressive sclerosing poliodystrophy|Mitochondrial DNA depletion syndrome 4B, MNGIE type|Seizures|Global developmental delay|Mitochondrial DNA depletion syndrome 1 (MNGIE type)|Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis|POLG-Related Spectrum Disorders|not provided|not specified|Mitochondrial DNA depletion syndrome 4B, MNGIE type	Conflicting interpretations of pathogenicity(Last reviewed: Nov 3, 2021)	criteria provided, conflicting interpretations	VCV000013503	15	89873415	15	89330184	13503	28542	rs11394094|rs113994094	NC_000015.10:89330183:G:A
NM_022114.4(PRDM16):c.1642C>A (p.Pro548Thr)	PRDM16	P548T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487633	1	3328403	1	3411839	487633	480676	rs866090726	NC_000001.11:3411838:C:A
NM_022114.4(PRDM16):c.2666C>T (p.Pro889Leu)	PRDM16	P889L	Left ventricular noncompaction 8|not provided|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487607	1	3331186	1	3414622	487607	480677	rs201814961	NC_000001.11:3414621:C:T
NM_022114.4(PRDM16):c.2855C>T (p.Thr952Met)	PRDM16	T952M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487592	1	3334555	1	3417991	487592	480678	rs749180764	NC_000001.11:3417990:C:T
NM_022114.4(PRDM16):c.706G>A (p.Asp236Asn)	PRDM16	D236N	Left ventricular noncompaction 8|not provided|Wolff-Parkinson-White pattern	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487582	1	3319384	1	3402820	487582	480675	rs185041492	NC_000001.11:3402819:G:A
NM_016203.4(PRKAG2):c.1024G>A (p.Glu342Lys)	PRKAG2	E101K, E217K, E218K, E298K, E342K	not specified	Uncertain significance(Last reviewed: Apr 15, 2021)	criteria provided, single submitter	VCV001065164	7	151269777	7	151572691	1065164	1053465		NC_000007.14:151572690:C:T
NM_016203.4(PRKAG2):c.869A>T (p.Lys290Ile)	PRKAG2	K290I, K166I, K165I, K246I, K49I	Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000943169	7	151273534	7	151576448	943169	933790		NC_000007.14:151576447:T:A
NM_016203.4(PRKAG2):c.413C>G (p.Ser138Cys)	PRKAG2	S138C, S94C	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 2, 2019)	criteria provided, single submitter	VCV000931949	7	151478291	7	151781205	931949	919090		NC_000007.14:151781204:G:C
NM_016203.4(PRKAG2):c.90G>T (p.Arg30Ser)	PRKAG2	R30S	Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000912206	7	151573616	7	151876531	912206	897699		NC_000007.14:151876530:C:A
NM_016203.4(PRKAG2):c.341C>T (p.Pro114Leu)	PRKAG2	P114L, P70L	Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: May 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000912141	7	151478363	7	151781277	912141	897696		NC_000007.14:151781276:G:A
NM_016203.4(PRKAG2):c.1324G>A (p.Asp442Asn)	PRKAG2	D201N, D317N, D318N, D442N, D398N	Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000912070	7	151262881	7	151565795	912070	897695		NC_000007.14:151565794:C:T
NM_016203.4(PRKAG2):c.*256T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000912012	7	151254031	7	151556945	912012	897692		NC_000007.14:151556944:A:C
NM_016203.4(PRKAG2):c.*953T>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV000911968	7	151253334	7	151556248	911968	897685		NC_000007.14:151556247:A:T
NM_016203.4(PRKAG2):c.119T>A (p.Leu40Gln)	PRKAG2	L40Q	Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000910975	7	151483623	7	151786537	910975	897698		NC_000007.14:151786536:A:T
NM_016203.4(PRKAG2):c.*398C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910804	7	151253889	7	151556803	910804	897691		NC_000007.14:151556802:G:A
NM_016203.4(PRKAG2):c.*399G>A	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000910803	7	151253888	7	151556802	910803	897690		NC_000007.14:151556801:C:T
NM_016203.4(PRKAG2):c.*419C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000910802	7	151253868	7	151556782	910802	897689		NC_000007.14:151556781:G:A
NM_016203.4(PRKAG2):c.*450T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910801	7	151253837	7	151556751	910801	897688		NC_000007.14:151556750:A:G
NM_016203.4(PRKAG2):c.*1021T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000910747	7	151253266	7	151556180	910747	897684		NC_000007.14:151556179:A:C
NM_016203.4(PRKAG2):c.*1030T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910746	7	151253257	7	151556171	910746	897683		NC_000007.14:151556170:A:C
NM_016203.4(PRKAG2):c.*1043G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910745	7	151253244	7	151556158	910745	897682		NC_000007.14:151556157:C:T
NM_016203.4(PRKAG2):c.-481G>A	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000910143	7	151574186	7	151877101	910143	897700		NC_000007.14:151877100:C:T
NM_016203.4(PRKAG2):c.*56G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000909955	7	151254231	7	151557145	909955	897694		NC_000007.14:151557144:C:T
NM_016203.4(PRKAG2):c.*471T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909898	7	151253816	7	151556730	909898	897687		NC_000007.14:151556729:A:G
NM_016203.4(PRKAG2):c.*156A>G	PRKAG2		Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909098	7	151254131	7	151557045	909098	897693		NC_000007.14:151557044:T:C
NM_016203.4(PRKAG2):c.*771C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909038	7	151253516	7	151556430	909038	897686		NC_000007.14:151556429:G:A
NM_016203.4(PRKAG2):c.278T>C (p.Val93Ala)	PRKAG2	V93A, V49A	Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000908128	7	151478426	7	151781340	908128	897697		NC_000007.14:151781339:A:G
NM_016203.4(PRKAG2):c.31A>G (p.Lys11Glu)	PRKAG2	K11E	Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000520489	7	151573675	7	151876590	520489	511090	rs1041124171	NC_000007.14:151876589:T:C
NM_016203.4(PRKAG2):c.432C>T (p.Pro144=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Cardiovascular phenotype|not provided|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000520278	7	151478272	7	151781186	520278	509882	rs764742900	NC_000007.14:151781185:G:A
NM_016203.4(PRKAG2):c.1679-19A>T	PRKAG2		not specified	Benign/Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000517071	7	151254337	7	151557251	517071	501991	rs200262620	NC_000007.14:151557250:T:A
NM_016203.4(PRKAG2):c.359G>A (p.Arg120His)	PRKAG2	R120H, R76H	Cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Dec 2, 2018)	criteria provided, single submitter	VCV000487637	7	151478345	7	151781259	487637	480696	rs775756069	NC_000007.14:151781258:C:T
NM_016203.4(PRKAG2):c.947-7G>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2019)	criteria provided, conflicting interpretations	VCV000465344	7	151272042	7	151574956	465344	456900	rs1554464198	NC_000007.14:151574955:C:T
NM_016203.4(PRKAG2):c.88A>C (p.Arg30=)	PRKAG2		Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2019)	criteria provided, conflicting interpretations	VCV000465343	7	151573618	7	151876533	465343	457592	rs756923555	NC_000007.14:151876532:T:G
NM_016203.4(PRKAG2):c.1584+8G>A	PRKAG2		not specified|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Nov 2, 2020)	criteria provided, conflicting interpretations	VCV000465341	7	151261156	7	151564070	465341	456500	rs762649633	NC_000007.14:151564069:C:T
NM_016203.4(PRKAG2):c.1114G>A (p.Asp372Asn)	PRKAG2	D372N, D247N, D328N, D131N, D248N	not provided|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Cardiovascular phenotype|Cardiomyopathy	Uncertain significance(Last reviewed: Feb 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000465337	7	151265921	7	151568835	465337	456504	rs760826751	NC_000007.14:151568834:C:T
NM_016203.4(PRKAG2):c.547G>A (p.Glu183Lys)	PRKAG2	E183K, E59K, E139K	Cardiomyopathy|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2020)	criteria provided, conflicting interpretations	VCV000430968	7	151372643	7	151675557	430968	424509	rs1131692281	NC_000007.14:151675556:C:T
NM_016203.4(PRKAG2):c.750C>T (p.Asp250=)	PRKAG2		not specified|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000378428	7	151329159	7	151632073	378428	369358	rs201735117	NC_000007.14:151632072:G:A
NM_016203.4(PRKAG2):c.590C>G (p.Pro197Arg)	PRKAG2	P197R, P153R, P73R	not provided|Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Ventricular tachycardia|Left ventricular hypertrophy|Webbed neck|Coronary artery disease|Hypertensive disorder|Stroke	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000374128	7	151372600	7	151675514	374128	360891	rs368637364	NC_000007.14:151675513:G:C
NM_016203.3(PRKAG2):c.-575C>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359366	7	151574280	7	151877195	359366	310359	rs886062108	NC_000007.14:151877194:G:A
NM_016203.3(PRKAG2):c.-560C>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000359365	7	151574265	7	151877180	359365	305450	rs117728810	NC_000007.14:151877179:G:A
NM_016203.3(PRKAG2):c.-520C>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000359364	7	151574225	7	151877140	359364	310235	rs73160072	NC_000007.14:151877139:G:A
NM_016203.3(PRKAG2):c.-517G>T	PRKAG2|PRKAG2-AS1		Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359363	7	151574222	7	151877137	359363	305449	rs886062107	NC_000007.14:151877136:C:A
NM_016203.4(PRKAG2):c.-397G>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359362	7	151574102	7	151877017	359362	310234	rs886062106	NC_000007.14:151877016:C:G
NM_016203.4(PRKAG2):c.-351G>A	PRKAG2		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Wolff-Parkinson-White syndrome|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359361	7	151574056	7	151876971	359361	310230	rs886062105	NC_000007.14:151876970:C:T
NM_016203.4(PRKAG2):c.-322T>C	PRKAG2		Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000359360	7	151574027	7	151876942	359360	302225	rs142348760	NC_000007.14:151876941:A:G
NM_016203.4(PRKAG2):c.-287C>G	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Likely benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359359	7	151573992	7	151876907	359359	310357	rs75059373	NC_000007.14:151876906:G:C
NM_016203.4(PRKAG2):c.-274C>A	PRKAG2		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359358	7	151573979	7	151876894	359358	305448	rs886062104	NC_000007.14:151876893:G:T
NM_016203.4(PRKAG2):c.-262C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359357	7	151573967	7	151876882	359357	310347	rs886062103	NC_000007.14:151876881:G:A
NM_016203.4(PRKAG2):c.-252C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359356	7	151573957	7	151876872	359356	302224	rs546312513	NC_000007.14:151876871:G:A
NM_016203.4(PRKAG2):c.-249G>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359355	7	151573954	7	151876869	359355	310346	rs534059998	NC_000007.14:151876868:C:G
NM_016203.4(PRKAG2):c.-90G>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359354	7	151573795	7	151876710	359354	305447	rs76351165	NC_000007.14:151876709:C:A
NM_016203.4(PRKAG2):c.-40C>T	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000359353	7	151573745	7	151876660	359353	305446	rs148715621	NC_000007.14:151876659:G:A
NM_016203.4(PRKAG2):c.-16A>G	PRKAG2		not provided|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: May 24, 2018)	criteria provided, conflicting interpretations	VCV000359352	7	151573721	7	151876636	359352	310329	rs200468798	NC_000007.14:151876635:T:C
NM_016203.4(PRKAG2):c.138G>A (p.Pro46=)	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not specified|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2018)	criteria provided, conflicting interpretations	VCV000359351	7	151483604	7	151786518	359351	305445	rs767613486	NC_000007.14:151786517:C:T
NM_016203.4(PRKAG2):c.186+7C>T	PRKAG2		Wolff-Parkinson-White syndrome|Glycogen storage disease of heart, lethal congenital|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000359350	7	151483549	7	151786463	359350	302218	rs886062102	NC_000007.14:151786462:G:A
NM_016203.4(PRKAG2):c.224G>C (p.Gly75Ala)	PRKAG2	G75A, G31A	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000359349	7	151478480	7	151781394	359349	310328	rs199963585	NC_000007.14:151781393:C:G
NM_016203.4(PRKAG2):c.248C>T (p.Pro83Leu)	PRKAG2	P83L, P39L	Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000359348	7	151478456	7	151781370	359348	305444	rs757900380	NC_000007.14:151781369:G:A
NM_016203.4(PRKAG2):c.395A>G (p.Lys132Arg)	PRKAG2	K132R, K88R	Wolff-Parkinson-White syndrome|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000359347	7	151478309	7	151781223	359347	302217	rs779753891	NC_000007.14:151781222:T:C
NM_016203.4(PRKAG2):c.429G>A (p.Ser143=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 23, 2021)	criteria provided, conflicting interpretations	VCV000359346	7	151478275	7	151781189	359346	305443	rs757727533	NC_000007.14:151781188:C:T
NM_016203.4(PRKAG2):c.433G>A (p.Gly145Arg)	PRKAG2	G145R, G101R	Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359345	7	151478271	7	151781185	359345	310229	rs886062101	NC_000007.14:151781184:C:T
NM_016203.4(PRKAG2):c.787C>A (p.Arg263=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359344	7	151292508	7	151595422	359344	305441	rs886062100	NC_000007.14:151595421:G:T
NM_016203.4(PRKAG2):c.*55C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359343	7	151254232	7	151557146	359343	305440	rs371637024	NC_000007.14:151557145:G:A
NM_016203.4(PRKAG2):c.*112A>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359342	7	151254175	7	151557089	359342	302216	rs8961	NC_000007.14:151557088:T:C
NM_016203.4(PRKAG2):c.*127C>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359341	7	151254160	7	151557074	359341	302215	rs189787963	NC_000007.14:151557073:G:C
NM_016203.4(PRKAG2):c.*135T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359340	7	151254152	7	151557066	359340	305434	rs184932311	NC_000007.14:151557065:A:G
NM_016203.4(PRKAG2):c.*350C>A	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359339	7	151253937	7	151556851	359339	302214	rs886062099	NC_000007.14:151556850:G:T
NM_016203.4(PRKAG2):c.*365G>A	PRKAG2		Wolff-Parkinson-White pattern|not provided|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000359338	7	151253922	7	151556836	359338	310228	rs886062098	NC_000007.14:151556835:C:T
NM_016203.4(PRKAG2):c.*384C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not provided	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000359337	7	151253903	7	151556817	359337	310327	rs75418446	NC_000007.14:151556816:G:A
NM_016203.4(PRKAG2):c.*452C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359336	7	151253835	7	151556749	359336	310227	rs17714947	NC_000007.14:151556748:G:A
NM_016203.4(PRKAG2):c.*522G>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359335	7	151253765	7	151556679	359335	305426	rs1051956	NC_000007.14:151556678:C:A
NM_016203.4(PRKAG2):c.*572G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359334	7	151253715	7	151556629	359334	310221	rs78192883	NC_000007.14:151556628:C:T
NM_016203.4(PRKAG2):c.*612G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359333	7	151253675	7	151556589	359333	302212	rs371404960	NC_000007.14:151556588:C:T
NM_016203.4(PRKAG2):c.*614A>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359332	7	151253673	7	151556587	359332	305406	rs567058170	NC_000007.14:151556586:T:A
NM_016203.4(PRKAG2):c.*835T>C	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359331	7	151253452	7	151556366	359331	310325	rs886062097	NC_000007.14:151556365:A:G
NM_016203.4(PRKAG2):c.*887G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359330	7	151253400	7	151556314	359330	305405	rs886062096	NC_000007.14:151556313:C:T
NM_016203.4(PRKAG2):c.*964G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359328	7	151253323	7	151556237	359328	305396	rs75512992	NC_000007.14:151556236:C:T
NM_016203.4(PRKAG2):c.*1012T>G	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000359327	7	151253275	7	151556189	359327	310323	rs886062095	NC_000007.14:151556188:A:C
NM_016203.4(PRKAG2):c.*1061G>A	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000359320	7	151253226	7	151556140	359320	302196	rs7429	NC_000007.14:151556139:C:T
NM_016203.4(PRKAG2):c.-26C>T	PRKAG2		not specified|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|not provided	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260692	7	151573731	7	151876646	260692	252655	rs66628686	NC_000007.14:151876645:G:A
NM_016203.4(PRKAG2):c.137C>T (p.Pro46Leu)	PRKAG2	P46L, P2L	not specified	Uncertain significance(Last reviewed: Mar 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000229171	7	151483605	7	151786519	229171	229568	rs373477232	NC_000007.14:151786518:G:A
NM_016203.4(PRKAG2):c.981A>G (p.Leu327=)	PRKAG2		Wolff-Parkinson-White pattern|Cardiomyopathy|not specified|not provided|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2020)	criteria provided, conflicting interpretations	VCV000227880	7	151272001	7	151574915	227880	229564	rs764162597	NC_000007.14:151574914:T:C
NM_016203.4(PRKAG2):c.1310C>G (p.Ala437Gly)	PRKAG2	A437G, A312G, A393G, A196G, A313G	Wolff-Parkinson-White pattern|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000222770	7	151262895	7	151565809	222770	224349	rs762111172	NC_000007.14:151565808:G:C
NM_016203.4(PRKAG2):c.431C>T (p.Pro144Leu)	PRKAG2	P144L, P100L	not provided|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Congestive heart failure|not specified	Uncertain significance(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181485	7	151478273	7	151781187	181485	179133	rs150140412	NC_000007.14:151781186:G:A
NM_016203.4(PRKAG2):c.1646A>C (p.Asp549Ala)	PRKAG2	D549A, D505A, D308A, D424A, D425A	not provided	Likely pathogenic(Last reviewed: Apr 13, 2015)	criteria provided, single submitter	VCV000181481	7	151257642	7	151560556	181481	179112	rs730880982	NC_000007.14:151560555:T:G
NM_016203.4(PRKAG2):c.946+3A>G	PRKAG2		not specified|Glycogen storage disease of heart, lethal congenital|not provided|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2020)	criteria provided, conflicting interpretations	VCV000181475	7	151273454	7	151576368	181475	179120	rs376173303	NC_000007.14:151576367:T:C
NM_016203.4(PRKAG2):c.866T>C (p.Val289Ala)	PRKAG2	V289A, V165A, V164A, V48A, V245A	not provided|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Sep 26, 2020)	criteria provided, conflicting interpretations	VCV000181473	7	151273537	7	151576451	181473	179122	rs730880975	NC_000007.14:151576450:A:G
NM_016203.4(PRKAG2):c.202G>A (p.Gly68Ser)	PRKAG2	G68S, G24S	not specified|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Wolff-Parkinson-White syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 22, 2019)	criteria provided, conflicting interpretations	VCV000181465	7	151478502	7	151781416	181465	179136	rs730880970	NC_000007.14:151781415:C:T
NM_016203.4(PRKAG2):c.1006G>A (p.Val336Ile)	PRKAG2	V336I, V292I, V211I, V212I, V95I	not specified|Glycogen storage disease of heart, lethal congenital|not provided|Cardiovascular phenotype	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179205	7	151269795	7	151572709	179205	174049	rs727504707	NC_000007.14:151572708:C:T
NM_016203.4(PRKAG2):c.*2C>T	PRKAG2		not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 15, 2021)	criteria provided, conflicting interpretations	VCV000177987	7	151254285	7	151557199	177987	174047	rs199559205	NC_000007.14:151557198:G:A
NM_016203.4(PRKAG2):c.1304A>G (p.Asn435Ser)	PRKAG2	N435S, N310S, N311S, N391S, N194S	Wolff-Parkinson-White pattern|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|not provided	Uncertain significance(Last reviewed: Dec 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000167533	7	151262901	7	151565815	167533	177380	rs200589374	NC_000007.14:151565814:T:C
NM_016203.4(PRKAG2):c.912G>A (p.Ala304=)	PRKAG2		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Cardiovascular phenotype|Wolff-Parkinson-White syndrome|not specified|not provided|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000045738	7	151273491	7	151576405	45738	54903	rs145029525	NC_000007.14:151576404:C:T
NM_016203.4(PRKAG2):c.698C>G (p.Ala233Gly)	PRKAG2	A233G, A189G, A109G	Wolff-Parkinson-White pattern|not specified|Familial hypertrophic cardiomyopathy 6|Familial hypertrophic cardiomyopathy 1|not provided|Glycogen storage disease of heart, lethal congenital|See cases|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)	criteria provided, conflicting interpretations	VCV000045733	7	151329211	7	151632125	45733	54898	rs201240745	NC_000007.14:151632124:G:C
NM_016203.4(PRKAG2):c.620C>G (p.Ser207Cys)	PRKAG2	S207C, S163C, S83C	not specified|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Wolff-Parkinson-White syndrome|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045729	7	151372570	7	151675484	45729	54894	rs397517277	NC_000007.14:151675483:G:C
NM_016203.4(PRKAG2):c.59G>T (p.Ser20Ile)	PRKAG2	S20I	not specified|Familial hypertrophic cardiomyopathy 6|none provided|Wolff-Parkinson-White pattern|Cardiomyopathy|not provided|Glycogen storage disease of heart, lethal congenital|Cardiovascular phenotype	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045727	7	151573647	7	151876562	45727	54892	rs116605521	NC_000007.14:151876561:C:A
NM_016203.4(PRKAG2):c.532G>A (p.Glu178Lys)	PRKAG2	E178K, E134K, E54K	not specified|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045723	7	151372658	7	151675572	45723	54888	rs397517273	NC_000007.14:151675571:C:T
NM_016203.4(PRKAG2):c.471C>T (p.Ser157=)	PRKAG2		Cardiovascular phenotype|Cardiomyopathy|Wolff-Parkinson-White pattern|not specified|Familial hypertrophic cardiomyopathy 6|not provided|Glycogen storage disease of heart, lethal congenital	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000045721	7	151372719	7	151675633	45721	54886	rs141804012	NC_000007.14:151675632:G:A
NM_016203.4(PRKAG2):c.425C>T (p.Thr142Ile)	PRKAG2	T142I, T98I	not specified|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Cardiomyopathy|Wolff-Parkinson-White pattern|not provided|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Arrhythmogenic right ventricular dysplasia 9|Hypertrophic cardiomyopathy	Uncertain significance(Last reviewed: Dec 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045717	7	151478279	7	151781193	45717	54882	rs397517270	NC_000007.14:151781192:G:A
NM_016203.4(PRKAG2):c.312C>T (p.Thr104=)	PRKAG2		Wolff-Parkinson-White pattern|not provided|Cardiomyopathy|not specified|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000045713	7	151478392	7	151781306	45713	54878	rs397517268	NC_000007.14:151781305:G:A
NM_016203.4(PRKAG2):c.247C>T (p.Pro83Ser)	PRKAG2	P83S, P39S	not specified|Wolff-Parkinson-White pattern|not provided|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|Heart failure|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000045711	7	151478457	7	151781371	45711	54876	rs148791216	NC_000007.14:151781370:G:A
NM_016203.4(PRKAG2):c.240C>A (p.Gly80=)	PRKAG2		not specified|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000045710	7	151478464	7	151781378	45710	54875	rs142482217	NC_000007.14:151781377:G:T
NM_016203.4(PRKAG2):c.207G>A (p.Pro69=)	PRKAG2		Cardiovascular phenotype|not specified|not provided|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|none provided	Benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045709	7	151478497	7	151781411	45709	54874	rs144384573	NC_000007.14:151781410:C:T
NM_016203.4(PRKAG2):c.1704G>A (p.Thr568=)	PRKAG2		Cardiovascular phenotype|not provided|Cardiomyopathy|Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045706	7	151254293	7	151557207	45706	54871	rs138167675	NC_000007.14:151557206:C:T
NM_016203.4(PRKAG2):c.1623T>C (p.Ile541=)	PRKAG2		Cardiovascular phenotype|Cardiomyopathy|Wolff-Parkinson-White pattern|not specified|not provided|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045702	7	151257665	7	151560579	45702	54867	rs28763998	NC_000007.14:151560578:A:G
NM_016203.4(PRKAG2):c.1584+7C>T	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|not specified|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000045699	7	151261157	7	151564071	45699	54864	rs111627309	NC_000007.14:151564070:G:A
NM_016203.4(PRKAG2):c.1390G>A (p.Asp464Asn)	PRKAG2	D464N, D340N, D339N, D420N, D223N	Cardiomyopathy|Wolff-Parkinson-White pattern|not provided|Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 6|not specified|Glycogen storage disease of heart, lethal congenital	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045697	7	151262815	7	151565729	45697	54862	rs397517264	NC_000007.14:151565728:C:T
NM_016203.4(PRKAG2):c.123C>T (p.Ser41=)	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not specified|not provided|Cardiomyopathy|Familial hypertrophic cardiomyopathy 6|Cardiovascular phenotype	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2021)	criteria provided, conflicting interpretations	VCV000045692	7	151483619	7	151786533	45692	54857	rs397517263	NC_000007.14:151786532:G:A
NM_016203.4(PRKAG2):c.114+12C>T	PRKAG2		Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|not specified|not provided	Benign(Last reviewed: Jan 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000045689	7	151573580	7	151876495	45689	54854	rs77902041	NC_000007.14:151876494:G:A
NM_016203.4(PRKAG2):c.111T>A (p.Ile37=)	PRKAG2		Cardiomyopathy|not provided|Familial hypertrophic cardiomyopathy 6|Cardiovascular phenotype|Glycogen storage disease of heart, lethal congenital|not specified|Wolff-Parkinson-White pattern	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2021)	criteria provided, conflicting interpretations	VCV000045688	7	151573595	7	151876510	45688	54853	rs144426409	NC_000007.14:151876509:A:T
NM_016203.4(PRKAG2):c.1106+9G>C	PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White pattern|not provided|not specified|Familial hypertrophic cardiomyopathy 6|Cardiomyopathy|none provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000045687	7	151267248	7	151570162	45687	54852	rs200429988	NC_000007.14:151570161:C:G
NM_016203.4(PRKAG2):c.1098A>G (p.Pro366=)	PRKAG2		Cardiovascular phenotype|not specified|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|not provided|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000045686	7	151267265	7	151570179	45686	54851	rs116541276	NC_000007.14:151570178:T:C
NM_016203.4(PRKAG2):c.*3G>A	PRKAG2		none provided|not provided|not specified|Familial hypertrophic cardiomyopathy 6|Wolff-Parkinson-White pattern|Cardiovascular phenotype|Cardiomyopathy	Benign/Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000045684	7	151254284	7	151557198	45684	54849	rs113234987	NC_000007.14:151557197:C:T
NM_016203.4(PRKAG2):c.298G>A (p.Gly100Ser)	PRKAG2	G100S, G56S	not specified|not provided|Cardiovascular phenotype|Glycogen storage disease of heart, lethal congenital|none provided|Cardiomyopathy|Renal cysts and diabetes syndrome|PRKAG2 cardiac syndrome|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000036697	7	151478406	7	151781320	36697	45358	rs79474211	NC_000007.14:151781319:C:T
NM_016203.4(PRKAG2):c.1593G>A (p.Arg531=)	PRKAG2		not specified|not provided|Cardiovascular phenotype|Glycogen storage disease of heart, lethal congenital|Cardiomyopathy|none provided|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000036696	7	151257695	7	151560609	36696	45357	rs148197254	NC_000007.14:151560608:C:T
NM_016203.4(PRKAG2):c.1589A>G (p.His530Arg)	PRKAG2	H530R, H406R, H289R, H486R, H405R	not provided|Glycogen storage disease of heart, lethal congenital|Familial hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Sep 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006854	7	151257699	7	151560613	6854	21893	rs267606977	NC_000007.14:151560612:T:C
NM_016203.4(PRKAG2):c.1591C>G (p.Arg531Gly)	PRKAG2	R531G, R290G, R407G, R406G, R487G	Wolff-Parkinson-White syndrome, childhood-onset	Pathogenic(Last reviewed: Dec 18, 2001)	no assertion criteria provided	VCV000006851	7	151257697	7	151560611	6851	21890	rs121908990	NC_000007.14:151560610:G:C
NM_016203.4(PRKAG2):c.1463A>T (p.Asn488Ile)	PRKAG2	N488I, N247I, N363I, N364I, N444I	Familial hypertrophic cardiomyopathy 6	Pathogenic(Last reviewed: Feb 1, 2002)	no assertion criteria provided	VCV000006850	7	151261285	7	151564199	6850	21889	rs121908989	NC_000007.14:151564198:T:A
NM_016203.4(PRKAG2):c.1199C>A (p.Thr400Asn)	PRKAG2	T400N, T275N, T276N, T159N, T356N	Familial hypertrophic cardiomyopathy 6|Hypertrophic cardiomyopathy	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000006849	7	151265836	7	151568750	6849	21888	rs28938173	NC_000007.14:151568749:G:T
NM_016203.4(PRKAG2):c.1148A>G (p.His383Arg)	PRKAG2	H142R, H383R, H259R, H339R, H258R	not specified|not provided|Familial hypertrophic cardiomyopathy 6	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006847	7	151265887	7	151568801	6847	21886	rs121908988	NC_000007.14:151568800:T:C
NM_016203.4(PRKAG2):c.905G>A (p.Arg302Gln)	PRKAG2	R302Q, R61Q, R178Q, R177Q, R258Q	Cardiomyopathy|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not provided|Primary familial hypertrophic cardiomyopathy|Wolff-Parkinson-White pattern|Familial hypertrophic cardiomyopathy 6|Glycogen storage disease of heart, lethal congenital	Pathogenic(Last reviewed: Sep 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000006846	7	151273498	7	151576412	6846	21885	rs121908987	NC_000007.14:151576411:C:T
NM_016203.3(PRKAG2):c.-580C>T	PRKAG2-AS1|PRKAG2		Glycogen storage disease of heart, lethal congenital|Wolff-Parkinson-White syndrome|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000359367	7	151574285	7	151877200	359367	305452	rs886062109	NC_000007.14:151877199:G:A
NM_001164760.2(PRKAR1B):c.149T>G (p.Leu50Arg)	PRKAR1B	L50R	not provided	Uncertain significance(Last reviewed: Aug 28, 2017)	no assertion criteria provided	VCV000375411	7	750994	7	711357	375411	362178	rs1057519490	NC_000007.14:711356:A:C
NM_004562.3(PRKN):c.1288G>A (p.Gly430Ser)	PRKN	G281S, G402S, G430S	Young-onset Parkinson disease	Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, single submitter	VCV001120007	6	161771241	6	161350209	1120007	1108787		NC_000006.12:161350208:C:T
NM_004562.3(PRKN):c.1302G>A (p.Met434Ile)	PRKN	M406I, M434I, M285I	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001030818	6	161771227	6	161350195	1030818	1016688		NC_000006.12:161350194:C:T
NM_004562.3(PRKN):c.848T>C (p.Leu283Pro)	PRKN	L134P, L255P, L283P	not provided	Uncertain significance(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001025727	6	162206827	6	161785795	1025727	1006542		NC_000006.12:161785794:A:G
NM_004562.3(PRKN):c.594C>T (p.Ser198=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907231	6	162475147	6	162054115	907231	895659		NC_000006.12:162054114:G:A
NM_004562.3(PRKN):c.600C>T (p.His200=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907230	6	162475141	6	162054109	907230	895658		NC_000006.12:162054108:G:A
NM_004562.3(PRKN):c.614G>A (p.Ser205Asn)	PRKN	S205N	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907229	6	162475127	6	162054095	907229	895657		NC_000006.12:162054094:C:T
NM_004562.3(PRKN):c.735-14C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907228	6	162206954	6	161785922	907228	896213		NC_000006.12:161785921:G:C
NM_004562.3(PRKN):c.*106G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907166	6	161771025	6	161349993	907166	895646		NC_000006.12:161349992:C:T
NM_004562.3(PRKN):c.*121A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907165	6	161771010	6	161349978	907165	895645		NC_000006.12:161349977:T:G
NM_004562.3(PRKN):c.*140A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000907164	6	161770991	6	161349959	907164	895644		NC_000006.12:161349958:T:C
NM_004562.3(PRKN):c.*320C>A	PRKN		not provided|Parkinson disease 2	Benign(Last reviewed: Oct 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000907163	6	161770811	6	161349779	907163	895643		NC_000006.12:161349778:G:T
NM_004562.3(PRKN):c.*1909G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907101	6	161769222	6	161348190	907101	895631		NC_000006.12:161348189:C:T
NM_004562.3(PRKN):c.*1997G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907100	6	161769134	6	161348102	907100	895630		NC_000006.12:161348101:C:T
NM_004562.3(PRKN):c.*2187C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907099	6	161768944	6	161347912	907099	895629		NC_000006.12:161347911:G:A
NM_004562.3(PRKN):c.*2192G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907098	6	161768939	6	161347907	907098	895628		NC_000006.12:161347906:C:T
NM_004562.3(PRKN):c.814C>A (p.Leu272Ile)	PRKN	L244I, L123I, L272I	Parkinson disease 2	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000906230	6	162206861	6	161785829	906230	895656		NC_000006.12:161785828:G:T
NM_004562.3(PRKN):c.892A>T (p.Ile298Phe)	PRKN	I149F, I270F, I298F	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000906229	6	161990428	6	161569396	906229	895655		NC_000006.12:161569395:T:A
NM_004562.3(PRKN):c.987C>T (p.Gly329=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000906228	6	161969982	6	161548950	906228	895654		NC_000006.12:161548949:G:A
NM_004562.3(PRKN):c.*433C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906165	6	161770698	6	161349666	906165	895642		NC_000006.12:161349665:G:C
NM_004562.3(PRKN):c.*623T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906164	6	161770508	6	161349476	906164	895641		NC_000006.12:161349475:A:G
NM_004562.3(PRKN):c.*722G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906163	6	161770409	6	161349377	906163	895640		NC_000006.12:161349376:C:T
NM_004562.3(PRKN):c.*1102C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906162	6	161770029	6	161348997	906162	895639		NC_000006.12:161348996:G:C
NM_004562.3(PRKN):c.*2214C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906096	6	161768917	6	161347885	906096	895627		NC_000006.12:161347884:G:A
NM_004562.3(PRKN):c.*2232G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906095	6	161768899	6	161347867	906095	895626		NC_000006.12:161347866:C:T
NM_004562.3(PRKN):c.*2259T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906094	6	161768872	6	161347840	906094	895625		NC_000006.12:161347839:A:G
NM_004562.3(PRKN):c.*2451G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906093	6	161768680	6	161347648	906093	895624		NC_000006.12:161347647:C:T
NM_004562.3(PRKN):c.1041G>A (p.Gln347=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905718	6	161969928	6	161548896	905718	895653		NC_000006.12:161548895:C:T
NM_004562.3(PRKN):c.1056C>T (p.Cys352=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000905717	6	161969913	6	161548881	905717	895652		NC_000006.12:161548880:G:A
NM_004562.3(PRKN):c.1193C>T (p.Ala398Val)	PRKN	A249V, A370V, A398V	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905716	6	161781212	6	161360180	905716	895651		NC_000006.12:161360179:G:A
NM_004562.3(PRKN):c.*1158T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000905653	6	161769973	6	161348941	905653	895638		NC_000006.12:161348940:A:G
NM_004562.3(PRKN):c.*1243C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905652	6	161769888	6	161348856	905652	895637		NC_000006.12:161348855:G:T
NM_004562.3(PRKN):c.*1383T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000905651	6	161769748	6	161348716	905651	895636		NC_000006.12:161348715:A:G
NM_004562.3(PRKN):c.*2486C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905587	6	161768645	6	161347613	905587	895623		NC_000006.12:161347612:G:T
NM_004562.3(PRKN):c.*2488A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000905586	6	161768643	6	161347611	905586	895622		NC_000006.12:161347610:T:C
NM_004562.3(PRKN):c.*2518A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000905585	6	161768613	6	161347581	905585	895621		NC_000006.12:161347580:T:C
NM_004562.3(PRKN):c.247A>G (p.Thr83Ala)	PRKN	T83A	Parkinson disease 2|Neoplasm of ovary	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000903886	6	162683722	6	162262690	903886	895661		NC_000006.12:162262689:T:C
NM_004562.3(PRKN):c.255C>T (p.Gly85=)	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000903885	6	162683714	6	162262682	903885	895660		NC_000006.12:162262681:G:A
NM_004562.3(PRKN):c.1205G>A (p.Arg402His)	PRKN	R253H, R374H, R402H	Parkinson disease 2	Uncertain significance(Last reviewed: Nov 20, 2017)	criteria provided, single submitter	VCV000903817	6	161781200	6	161360168	903817	895650		NC_000006.12:161360167:C:T
NM_004562.3(PRKN):c.1366G>A (p.Val456Ile)	PRKN	V456I, V307I, V428I	Parkinson disease 2	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000903816	6	161771163	6	161350131	903816	895649		NC_000006.12:161350130:C:T
NM_004562.3(PRKN):c.*60C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903815	6	161771071	6	161350039	903815	895648		NC_000006.12:161350038:G:T
NM_004562.3(PRKN):c.*94A>G	PRKN		not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000903814	6	161771037	6	161350005	903814	895647		NC_000006.12:161350004:T:C
NM_004562.3(PRKN):c.*1407C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903737	6	161769724	6	161348692	903737	895635		NC_000006.12:161348691:G:A
NM_004562.3(PRKN):c.*1500C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903736	6	161769631	6	161348599	903736	895634		NC_000006.12:161348598:G:A
NM_004562.3(PRKN):c.*1550A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903735	6	161769581	6	161348549	903735	895633		NC_000006.12:161348548:T:C
NM_004562.3(PRKN):c.*1576C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903734	6	161769555	6	161348523	903734	895632		NC_000006.12:161348522:G:A
NM_004562.3(PRKN):c.110C>T (p.Pro37Leu)	PRKN	P37L	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2020)	criteria provided, conflicting interpretations	VCV000871036	6	162864403	6	162443371	871036	859497		NC_000006.12:162443370:G:A
NM_004562.3(PRKN):c.701G>A (p.Arg234Gln)	PRKN	R234Q, R85Q, R206Q	not provided	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV000835347	6	162394367	6	161973335	835347	831744		NC_000006.12:161973334:C:T
NM_004562.3(PRKN):c.1301T>C (p.Met434Thr)	PRKN	M285T, M406T, M434T	Parkinson disease 2	Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000810783	6	161771228	6	161350196	810783	799032	rs1582953433	NC_000006.12:161350195:A:G
NM_004562.3(PRKN):c.174T>C (p.Asn58=)	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2018)	criteria provided, conflicting interpretations	VCV000701646	6	162683795	6	162262763	701646	686815	rs536687809	NC_000006.12:162262762:A:G
NM_004562.3(PRKN):c.531C>A (p.Thr177=)	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 23, 2020)	criteria provided, conflicting interpretations	VCV000696404	6	162622166	6	162201134	696404	683771	rs140590552	NC_000006.12:162201133:G:T
NM_004562.3(PRKN):c.517A>G (p.Thr173Ala)	PRKN	T173A	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000659916	6	162622180	6	162201148	659916	634771	rs749094429	NC_000006.12:162201147:T:C
NM_004562.3(PRKN):c.1019G>A (p.Gly340Glu)	PRKN	G312E, G191E, G340E	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000655063	6	161969950	6	161548918	655063	634764	rs1318163167	NC_000006.12:161548917:C:T
NM_004562.3(PRKN):c.799T>C (p.Tyr267His)	PRKN	Y239H, Y118H, Y267H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000649511	6	162206876	6	161785844	649511	634766	rs114696251	NC_000006.12:161785843:A:G
NM_004562.3(PRKN):c.300G>C (p.Gln100His)	PRKN	Q100H	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000648034	6	162683669	6	162262637	648034	634773	rs1256316516	NC_000006.12:162262636:C:G
NM_004562.3(PRKN):c.758G>A (p.Cys253Tyr)	PRKN	C253Y, C104Y, C225Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000645725	6	162206917	6	161785885	645725	634768	rs747427602	NC_000006.12:161785884:C:T
NM_004562.3(PRKN):c.686T>C (p.Ile229Thr)	PRKN	I229T, I80T, I201T	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000579186	6	162394382	6	161973350	579186	563480	rs1562430302	NC_000006.12:161973349:A:G
NM_004562.3(PRKN):c.838G>A (p.Asp280Asn)	PRKN	D280N, D252N, D131N	Parkinson disease 2	Uncertain significance(Last reviewed: Dec 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000579080	6	162206837	6	161785805	579080	565509	rs72480422	NC_000006.12:161785804:C:T
NM_004562.3(PRKN):c.98G>A (p.Arg33Gln)	PRKN	R33Q	not provided|Young-onset Parkinson disease|Parkinson disease 2	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578186	6	162864415	6	162443383	578186	560658	rs147757966	NC_000006.12:162443382:C:T
NM_004562.3(PRKN):c.930G>C (p.Glu310Asp)	PRKN	E310D, E161D, E282D	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000577057	6	161990390	6	161569358	577057	565508	rs72480423	NC_000006.12:161569357:C:G
NM_004562.3(PRKN):c.766C>T (p.Arg256Cys)	PRKN	R256C, R107C, R228C	not provided|Neoplasm of ovary|Parkinson disease 2	Uncertain significance(Last reviewed: Nov 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000574874	6	162206909	6	161785877	574874	560656	rs150562946	NC_000006.12:161785876:G:A
NM_004562.3(PRKN):c.988G>A (p.Val330Met)	PRKN	V330M, V302M, V181M	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000574344	6	161969981	6	161548949	574344	560501	rs749768565	NC_000006.12:161548948:C:T
NM_004562.3(PRKN):c.734+1G>A	PRKN		not provided|Parkinson disease 2	Likely pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000571536	6	162394333	6	161973301	571536	565522	rs1562430103	NC_000006.12:161973300:C:T
NM_004562.3(PRKN):c.1117C>A (p.His373Asn)	PRKN	H373N, H224N, H345N	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000567796	6	161807876	6	161386844	567796	560654	rs1240306663	NC_000006.12:161386843:G:T
NM_004562.3(PRKN):c.8-14A>G	PRKN		Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Sep 4, 2018)	criteria provided, single submitter	VCV000468589	6	162864519	6	162443487	468589	456276	rs769722629	NC_000006.12:162443486:T:C
NM_004562.3(PRKN):c.730G>A (p.Val244Ile)	PRKN	V244I, V216I, V95I	Parkinson disease 2	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000468588	6	162394338	6	161973306	468588	455450	rs771259513	NC_000006.12:161973305:C:T
NM_004562.3(PRKN):c.458C>G (p.Pro153Arg)	PRKN	P153R	not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000468587	6	162622239	6	162201207	468587	455455	rs55654276	NC_000006.12:162201206:G:C
NM_004562.3(PRKN):c.136G>A (p.Ala46Thr)	PRKN	A46T	Parkinson disease 2|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468586	6	162864377	6	162443345	468586	456269	rs75860381	NC_000006.12:162443344:C:T
NM_004562.3(PRKN):c.1330G>C (p.Glu444Gln)	PRKN	E444Q, E416Q, E295Q	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Jan 23, 2017)	criteria provided, single submitter	VCV000468585	6	161771199	6	161350167	468585	455430	rs772592654	NC_000006.12:161350166:C:G
NM_004562.3(PRKN):c.101A>G (p.Gln34Arg)	PRKN	Q34R	Parkinson disease 2|not provided|not specified	Benign/Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000468584	6	162864412	6	162443380	468584	455534	rs148851677	NC_000006.12:162443379:T:C
NM_004562.3(PRKN):c.1001G>A (p.Arg334His)	PRKN	R334H, R185H, R306H	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Jun 22, 2017)	criteria provided, single submitter	VCV000468583	6	161969968	6	161548936	468583	456260	rs746215864	NC_000006.12:161548935:C:T
NM_004562.3(PRKN):c.919C>T (p.Leu307=)	PRKN		Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000444707	6	161990401	6	161569369	444707	438347	rs138920699	NC_000006.12:161569368:G:A
NM_004562.3(PRKN):c.1204C>T (p.Arg402Cys)	PRKN	R402C, R253C, R374C	not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Oct 27, 2020)	criteria provided, conflicting interpretations	VCV000425402	6	161781201	6	161360169	425402	413736	rs55830907	NC_000006.12:161360168:G:A
NM_004562.3(PRKN):c.535-9T>A	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000420046	6	162475215	6	162054183	420046	406849	rs201039350	NC_000006.12:162054182:A:T
NM_004562.3(PRKN):c.957T>C (p.Gly319=)	PRKN		Parkinson disease 2|not provided	Benign/Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415532	6	161970012	6	161548980	415532	395226	rs144340740	NC_000006.12:161548979:A:G
NM_004562.3(PRKN):c.574A>C (p.Met192Leu)	PRKN	M192L	not specified|Parkinson disease 2|not provided	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000415531	6	162475167	6	162054135	415531	395426	rs9456735	NC_000006.12:162054134:T:G
NM_004562.3(PRKN):c.172-9C>G	PRKN		Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Sep 26, 2016)	criteria provided, single submitter	VCV000409271	6	162683806	6	162262774	409271	395080	rs758769558	NC_000006.12:162262773:G:C
NM_004562.3(PRKN):c.689C>T (p.Ala230Val)	PRKN	A230V, A202V, A81V	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jul 29, 2016)	criteria provided, single submitter	VCV000409270	6	162394379	6	161973347	409270	395227	rs571490973	NC_000006.12:161973346:G:A
NM_004562.3(PRKN):c.443T>A (p.Val148Glu)	PRKN	V148E	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000409269	6	162622254	6	162201222	409269	395079	rs1060502319	NC_000006.12:162201221:A:T
NM_004562.3(PRKN):c.125G>A (p.Arg42His)	PRKN	R42H	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Feb 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000409268	6	162864388	6	162443356	409268	395228	rs368134308	NC_000006.12:162443355:C:T
NM_004562.3(PRKN):c.761A>G (p.Asn254Ser)	PRKN	N254S, N226S, N105S	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000409267	6	162206914	6	161785882	409267	395420	rs139600787	NC_000006.12:161785881:T:C
NM_152410.3(PACRG):c.-76-385C>T	PRKN|PACRG		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000356025	6	163148807	6	162727775	356025	306813	rs886061239	NC_000006.12:162727774:C:T
NM_004562.3(PRKN):c.111G>A (p.Pro37=)	PRKN		not provided|not specified|Parkinson disease 2	Benign(Last reviewed: Apr 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000356020	6	162864402	6	162443370	356020	306809	rs77795533	NC_000006.12:162443369:C:T
NM_004562.3(PRKN):c.522C>T (p.Leu174=)	PRKN		not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)	criteria provided, conflicting interpretations	VCV000356019	6	162622175	6	162201143	356019	302128	rs147121590	NC_000006.12:162201142:G:A
NM_004562.3(PRKN):c.706A>G (p.Ile236Val)	PRKN	I236V, I87V, I208V	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356018	6	162394362	6	161973330	356018	302116	rs886061238	NC_000006.12:161973329:T:C
NM_004562.3(PRKN):c.783A>G (p.Leu261=)	PRKN		not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356017	6	162206892	6	161785860	356017	299590	rs9456711	NC_000006.12:161785859:T:C
NM_004562.3(PRKN):c.1289G>A (p.Gly430Asp)	PRKN	G430D, G281D, G402D	Parkinson disease 2|Young-onset Parkinson disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000356016	6	161771240	6	161350208	356016	306532	rs191486604	NC_000006.12:161350207:C:T
NM_004562.3(PRKN):c.1213G>A (p.Ala405Thr)	PRKN	A405T, A256T, A377T	Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356015	6	161781192	6	161360160	356015	299589	rs886061237	NC_000006.12:161360159:C:T
NM_004562.3(PRKN):c.1364G>A (p.Arg455His)	PRKN	R455H, R306H, R427H	Parkinson disease 2|not provided	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000356014	6	161771165	6	161350133	356014	302111	rs748955949	NC_000006.12:161350132:C:T
NM_004562.3(PRKN):c.*15C>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356013	6	161771116	6	161350084	356013	299583	rs35125035	NC_000006.12:161350083:G:T
NM_004562.3(PRKN):c.*98G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356012	6	161771033	6	161350001	356012	306808	rs771094906	NC_000006.12:161350000:C:T
NM_004562.3(PRKN):c.*301G>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356010	6	161770830	6	161349798	356010	306531	rs576586040	NC_000006.12:161349797:C:G
NM_004562.3(PRKN):c.*314C>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356009	6	161770817	6	161349785	356009	299582	rs886061236	NC_000006.12:161349784:G:T
NM_004562.3(PRKN):c.*372C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356008	6	161770759	6	161349727	356008	302107	rs764753874	NC_000006.12:161349726:G:C
NM_004562.3(PRKN):c.*472T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356007	6	161770659	6	161349627	356007	302104	rs886061235	NC_000006.12:161349626:A:G
NM_004562.3(PRKN):c.*652C>T	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356006	6	161770479	6	161349447	356006	299579	rs71653629	NC_000006.12:161349446:G:A
NM_004562.3(PRKN):c.*820A>T	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356005	6	161770311	6	161349279	356005	302102	rs74701717	NC_000006.12:161349278:T:A
NM_004562.3(PRKN):c.*1016C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356003	6	161770115	6	161349083	356003	302101	rs886061234	NC_000006.12:161349082:G:A
NM_004562.3(PRKN):c.*1156C>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000356001	6	161769975	6	161348943	356001	306528	rs886061232	NC_000006.12:161348942:G:C
NM_004562.3(PRKN):c.*1252C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000356000	6	161769879	6	161348847	356000	299576	rs77926621	NC_000006.12:161348846:G:A
NM_004562.3(PRKN):c.*1281C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355999	6	161769850	6	161348818	355999	306524	rs571904443	NC_000006.12:161348817:G:A
NM_004562.3(PRKN):c.*1296A>G	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355998	6	161769835	6	161348803	355998	302100	rs3734464	NC_000006.12:161348802:T:C
NM_004562.3(PRKN):c.*1386A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355997	6	161769745	6	161348713	355997	306792	rs140107485	NC_000006.12:161348712:T:C
NM_004562.3(PRKN):c.*1462C>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355996	6	161769669	6	161348637	355996	302095	rs11961229	NC_000006.12:161348636:G:T
NM_004562.3(PRKN):c.*1470G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355995	6	161769661	6	161348629	355995	306785	rs886061231	NC_000006.12:161348628:C:T
NM_004562.3(PRKN):c.*1601G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355994	6	161769530	6	161348498	355994	306523	rs779851186	NC_000006.12:161348497:C:T
NM_004562.3(PRKN):c.*1685A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355993	6	161769446	6	161348414	355993	302094	rs187134044	NC_000006.12:161348413:T:C
NM_004562.3(PRKN):c.*1694C>T	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355992	6	161769437	6	161348405	355992	306784	rs16892481	NC_000006.12:161348404:G:A
NM_004562.3(PRKN):c.*1695G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355991	6	161769436	6	161348404	355991	302087	rs77283740	NC_000006.12:161348403:C:T
NM_004562.3(PRKN):c.*2021G>A	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355990	6	161769110	6	161348078	355990	299575	rs1122470	NC_000006.12:161348077:C:T
NM_004562.3(PRKN):c.*2022T>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355989	6	161769109	6	161348077	355989	299567	rs886061230	NC_000006.12:161348076:A:G
NM_004562.3(PRKN):c.*2194G>A	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355988	6	161768937	6	161347905	355988	306783	rs149239597	NC_000006.12:161347904:C:T
NM_004562.3(PRKN):c.*2217G>A	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355987	6	161768914	6	161347882	355987	299566	rs138660139	NC_000006.12:161347881:C:T
NM_004562.3(PRKN):c.*2354C>T	PRKN		Parkinson disease 2	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000355986	6	161768777	6	161347745	355986	299558	rs191130749	NC_000006.12:161347744:G:A
NM_004562.3(PRKN):c.*2363C>A	PRKN		Parkinson Disease, Juvenile	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355985	6	161768768	6	161347736	355985	302086	rs12215447	NC_000006.12:161347735:G:T
NM_004562.3(PRKN):c.*2443A>G	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355984	6	161768688	6	161347656	355984	299552	rs886061229	NC_000006.12:161347655:T:C
NM_004562.3(PRKN):c.*2474A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355983	6	161768657	6	161347625	355983	306775	rs886061228	NC_000006.12:161347624:T:G
NM_004562.3(PRKN):c.*2475A>C	PRKN		Parkinson disease 2	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355982	6	161768656	6	161347624	355982	306507	rs868117815	NC_000006.12:161347623:T:G
NM_004562.3(PRKN):c.*2480C>A	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355981	6	161768651	6	161347619	355981	306772	rs68121389	NC_000006.12:161347618:G:T
NM_004562.3(PRKN):c.*2492A>G	PRKN		Parkinson disease 2	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000355980	6	161768639	6	161347607	355980	306771	rs117341007	NC_000006.12:161347606:T:C
NM_004562.3(PRKN):c.48G>A (p.Glu16=)	PRKN		not specified|not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2019)	criteria provided, conflicting interpretations	VCV000289182	6	162864465	6	162443433	289182	273419	rs143477190	NC_000006.12:162443432:C:T
NM_004562.3(PRKN):c.1310C>T (p.Pro437Leu)	PRKN	P437L, P409L, P288L	Parkinson disease 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 30, 2021)	criteria provided, conflicting interpretations	VCV000283504	6	161771219	6	161350187	283504	267741	rs149953814	NC_000006.12:161350186:G:A
NM_004562.3(PRKN):c.1000C>T (p.Arg334Cys)	PRKN	R334C, R306C, R185C	not specified|not provided|Parkinson disease 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2019)	criteria provided, conflicting interpretations	VCV000281504	6	161969969	6	161548937	281504	265741	rs199657839	NC_000006.12:161548936:G:A
NM_004562.3(PRKN):c.1292G>T (p.Cys431Phe)	PRKN	C431F, C403F, C282F	Parkinson disease 2	Pathogenic(Last reviewed: Aug 1, 2000)	no assertion criteria provided	VCV000050354	6	161771237	6	161350205	50354	59479	rs397514694	NC_000006.12:161350204:C:A
NM_004562.3(PRKN):c.500G>A (p.Ser167Asn)	PRKN	S167N	Parkinson disease 2|not specified|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041223	6	162622197	6	162201165	41223	49647	rs1801474	NC_000006.12:162201164:C:T
NM_004562.3(PRKN):c.1180G>A (p.Asp394Asn)	PRKN	D394N, D245N, D366N	not provided|Parkinson disease 2|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041222	6	161781225	6	161360193	41222	49646	rs1801334	NC_000006.12:161360192:C:T
NM_004562.3(PRKN):c.1138G>C (p.Val380Leu)	PRKN	V380L, V352L, V231L	Parkinson disease 2|not specified|not provided	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041221	6	161807855	6	161386823	41221	49645	rs1801582	NC_000006.12:161386822:C:G
NM_004562.3(PRKN):c.1096C>T (p.Arg366Trp)	PRKN	R366W, R217W, R338W	not provided|Parkinson disease 2	Benign/Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000041220	6	161807897	6	161386865	41220	49644	rs56092260	NC_000006.12:161386864:G:A
NM_004562.3(PRKN):c.719C>T (p.Thr240Met)	PRKN	T240M, T212M, T91M	Parkinson disease 2|Neoplasm of ovary|Young-onset Parkinson disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 3, 2021)	criteria provided, conflicting interpretations	VCV000007054	6	162394349	6	161973317	7054	22093	rs137853054	NC_000006.12:161973316:G:A
NM_004562.3(PRKN):c.633A>T (p.Lys211Asn)	PRKN	K211N, K62N, K183N	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007051	6	162394435	6	161973403	7051	22090	rs137853060	NC_000006.12:161973402:T:A
NM_004562.3(PRKN):c.823C>T (p.Arg275Trp)	PRKN	R275W, R126W, R247W	Young-onset Parkinson disease|Parkinson disease 2|Lung carcinoma|Neoplasm of ovary|Leprosy 2|See cases|not provided|Parkinson disease 2	Pathogenic(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007050	6	162206852	6	161785820	7050	22089	rs34424986	NC_000006.12:161785819:G:A
NM_004562.3(PRKN):c.167T>A (p.Val56Glu)	PRKN	V56E	not provided|Parkinson disease 2	Uncertain significance(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000007047	6	162864346	6	162443314	7047	22086	rs137853059	NC_000006.12:162443313:A:T
NM_004562.3(PRKN):c.635G>A (p.Cys212Tyr)	PRKN	C212Y, C184Y, C63Y	Parkinson disease 2|not provided	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000007046	6	162394433	6	161973401	7046	22085	rs137853058	NC_000006.12:161973400:C:T
NM_004562.3(PRKN):c.483A>T (p.Lys161Asn)	PRKN	K161N	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007043	6	162622214	6	162201182	7043	22082	rs137853057	NC_000006.12:162201181:T:A
NM_004562.3(PRKN):c.1358G>A (p.Trp453Ter)	PRKN	W453*, W304*, W425*	Parkinson disease 2|not provided	Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, single submitter	VCV000007042	6	161771171	6	161350139	7042	22081	rs137853056	NC_000006.12:161350138:C:T
NM_004562.3(PRKN):c.245C>A (p.Ala82Glu)	PRKN	A82E	not provided|Parkinson disease 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000007038	6	162683724	6	162262692	7038	22077	rs55774500	NC_000006.12:162262691:G:T
NM_004562.3(PRKN):c.931C>T (p.Gln311Ter)	PRKN	Q311*, Q162*, Q283*	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007037	6	161990389	6	161569357	7037	22076	rs137853055	NC_000006.12:161569356:G:A
NM_004562.3(PRKN):c.719C>G (p.Thr240Arg)	PRKN	T240R, T212R, T91R	Parkinson disease 2	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000007036	6	162394349	6	161973317	7036	22075	rs137853054	NC_000006.12:161973316:G:C
NM_002778.4(PSAP):c.1235G>A (p.Cys412Tyr)	PSAP	C412Y, C414Y, C415Y	PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210323	10	73579337	10	71819580	1210323	1200323		NC_000010.11:71819579:C:T
NM_002778.4(PSAP):c.1431G>A (p.Leu477=)	PSAP		PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210322	10	73578788	10	71819031	1210322	1200322		NC_000010.11:71819030:C:T
NM_002778.4(PSAP):c.1358A>C (p.Gln453Pro)	PSAP	Q453P, Q455P, Q456P	PARKINSON DISEASE 24, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO	risk factor(Last reviewed: Aug 26, 2021)	no assertion criteria provided	VCV001210321	10	73578861	10	71819104	1210321	1200321		NC_000010.11:71819103:T:G
NM_002778.4(PSAP):c.470A>G (p.Asn157Ser)	PSAP	N157S	Hereditary late onset Parkinson disease	Pathogenic(Last reviewed: Apr 22, 2020)	no assertion criteria provided	VCV000870633	10	73588740	10	71828983	870633	858795		NC_000010.11:71828982:T:C
NM_000021.4(PSEN1):c.1307C>A (p.Pro436Gln)	PSEN1	P436Q, P432Q	not provided|Alzheimer disease, type 3	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000018150	14	73685900	14	73219192	18150	33189	rs121917808	NC_000014.9:73219191:C:A
NM_171998.4(RAB39B):c.428C>G (p.Ala143Gly)	RAB39B	A143G	Parkinson disease, X-linked dominant	Uncertain significance(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218363	X	154490302	X	155261017	218363	215091	rs864309528	NC_000023.11:155261016:G:C
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)	RAB39B	G192R	Early-onset parkinsonism-intellectual disability syndrome|Parkinson disease, X-linked dominant	Pathogenic(Last reviewed: Sep 14, 2015)	criteria provided, single submitter	VCV000218362	X	154490156	X	155260871	218362	215090	rs864309527	NC_000023.11:155260870:C:T
NM_001134363.3(RBM20):c.934C>A (p.Leu312Met)	RBM20	L312M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487629	10	112541301	10	110781543	487629	480702	rs1164333931	NC_000010.11:110781542:C:A
NM_020975.6(RET):c.431G>A (p.Arg144His)	RET	R144H	Multiple endocrine neoplasia, type 2a|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma	Uncertain significance(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216729	10	43597883	10	43102435	216729	212769	rs551142665	NC_000010.11:43102434:G:A
NM_022450.5(RHBDF1):c.47A>C (p.Lys16Thr)	RHBDF1	K16T	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487618	16	114967	16	64969	487618	480720	rs999812302	NC_000016.10:64968:T:G
NM_022450.5(RHBDF1):c.1613C>T (p.Ala538Val)	RHBDF1	A538V	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487611	16	110482	16	60484	487611	480717	rs201706583	NC_000016.10:60483:G:A
NM_022450.5(RHBDF1):c.200G>A (p.Arg67Gln)	RHBDF1	R67Q	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487605	16	114745	16	64747	487605	480719	rs757169652	NC_000016.10:64746:C:T
NM_022450.5(RHBDF1):c.14G>A (p.Arg5His)	RHBDF1	R5H	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487604	16	115000	16	65002	487604	480721	rs376110986	NC_000016.10:65001:C:T
NM_022450.5(RHBDF1):c.1384G>A (p.Gly462Arg)	RHBDF1	G462R	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487583	16	111394	16	61396	487583	480718	rs760441920	NC_000016.10:61395:C:T
NM_001206671.4(RIC3):c.169C>A (p.Pro57Thr)	RIC3	P57T, P8T	not provided	Uncertain significance(Last reviewed: Sep 26, 2016)	no assertion criteria provided	VCV000254687	11	8161696	11	8140149	254687	249263	rs778138358	NC_000011.10:8140148:G:T
NM_001143854.2(RPH3A):c.1349C>G (p.Thr450Ser)	RPH3A	T446S, T450S, T383S	not specified	Uncertain significance(Last reviewed: Jan 14, 2016)	criteria provided, single submitter	VCV000224156	12	113321120	12	112883315	224156	225884	rs869312710	NC_000012.12:112883314:C:G
NM_001035.3(RYR2):c.3767C>T (p.Pro1256Leu)	RYR2	P1256L	Catecholaminergic polymorphic ventricular tachycardia|not provided|Cardiomyopathy|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000487620	1	237753261	1	237589961	487620	480674	rs773915323	NC_000001.11:237589960:C:T
NM_001035.3(RYR2):c.2984T>C (p.Met995Thr)	RYR2	M995T	Catecholaminergic polymorphic ventricular tachycardia|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000487602	1	237711808	1	237548508	487602	480673	rs1009381849	NC_000001.11:237548507:T:C
NM_001035.3(RYR2):c.4747C>T (p.Pro1583Ser)	RYR2	P1583S	not specified|Catecholaminergic polymorphic ventricular tachycardia|not provided|Wolff-Parkinson-White pattern|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2021)	criteria provided, conflicting interpretations	VCV000419965	1	237774125	1	237610825	419965	405107	rs200070226	NC_000001.11:237610824:C:T
NM_001035.3(RYR2):c.3181G>A (p.Gly1061Ser)	RYR2	G1061S	not provided|Wolff-Parkinson-White pattern|Catecholaminergic polymorphic ventricular tachycardia type 1|Arrhythmogenic right ventricular dysplasia, familial, 2	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000296718	1	237713958	1	237550658	296718	281616	rs747447414	NC_000001.11:237550657:G:A
NM_001035.3(RYR2):c.11919T>G (p.Asp3973Glu)	RYR2	D3973E	Catecholaminergic polymorphic ventricular tachycardia|Wolff-Parkinson-White pattern|not specified|Cardiomyopathy	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000201316	1	237944903	1	237781603	201316	196689	rs370103782	NC_000001.11:237781602:T:G
NM_001035.3(RYR2):c.982G>A (p.Ala328Thr)	RYR2	A328T	Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia|Cardiomyopathy|not provided|Catecholaminergic polymorphic ventricular tachycardia type 1|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000093480	1	237586525	1	237423225	93480	99385	rs201669522	NC_000001.11:237423224:G:A
NM_001035.3(RYR2):c.8162T>C (p.Ile2721Thr)	RYR2	I2721T	Arrhythmogenic right ventricular cardiomyopathy|Cardiomyopathy|Arrhythmogenic right ventricular dysplasia, familial, 2|Catecholaminergic polymorphic ventricular tachycardia|Cardiovascular phenotype|Wolff-Parkinson-White pattern|not specified|not provided|Catecholaminergic polymorphic ventricular tachycardia type 1	Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2020)	criteria provided, conflicting interpretations	VCV000043828	1	237821276	1	237657976	43828	52997	rs201500134	NC_000001.11:237657975:T:C
NM_138967.4(SCAMP5):c.271C>T (p.Arg91Trp)	SCAMP5	R91W	not provided	Uncertain significance(Last reviewed: Nov 10, 2020)	no assertion criteria provided	VCV000983558	15	75309068	15	75016727	983558	971626		NC_000015.10:75016726:C:T
NM_000335.5(SCN5A):c.1705C>G (p.Arg569Gly)	SCN5A	R569G	not provided|Wolff-Parkinson-White pattern|Arrhythmia	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000201576	3	38645388	3	38603897	201576	196972	rs199473576	NC_000003.12:38603896:G:C
NM_000335.5(SCN5A):c.1567C>T (p.Arg523Cys)	SCN5A	R523C	Congenital long QT syndrome|Arrhythmia|Brugada syndrome|not provided|Wolff-Parkinson-White pattern|Brugada syndrome 1|Dilated cardiomyopathy 1E|Long QT syndrome 3|Paroxysmal familial ventricular fibrillation 1|Progressive familial heart block, type 1A|Atrial fibrillation, familial, 10	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2021)	criteria provided, conflicting interpretations	VCV000067667	3	38645526	3	38604035	67667	78562	rs199473119	NC_000003.12:38604034:G:A
NM_012434.5(SLC17A5):c.1177G>A (p.Val393Ile)	SLC17A5	V393I	Salla disease|Sialic acid storage disease, severe infantile type|not provided|Focal segmental glomerulosclerosis	Uncertain significance(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000558967	6	74320205	6	73610482	558967	549612	rs140060360	NC_000006.12:73610481:C:T
NM_012434.5(SLC17A5):c.899C>T (p.Ser300Phe)	SLC17A5	S300F	not provided|Salla disease|Sialic acid storage disease, severe infantile type|Salla disease|Sialic acid storage disease, severe infantile type	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000191213	6	74331606	6	73621883	191213	189016	rs142553916	NC_000006.12:73621882:G:A
NM_000441.2(SLC26A4):c.85G>C (p.Glu29Gln)	SLC26A4|SLC26A4-AS1	E29Q	Rare genetic deafness|not provided|SLC26A4-Related Disorders|Wolff-Parkinson-White pattern|Deafness, autosomal recessive 4, with enlarged vestibular aqueduct|Pendred syndrome	Pathogenic(Last reviewed: Mar 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000004839	7	107302171	7	107661726	4839	19878	rs111033205	NC_000007.14:107661725:G:C
NM_018713.3(SLC30A10):c.284C>T (p.Thr95Ile)	SLC30A10	T95I	Hypermanganesemia with dystonia, polycythemia, and cirrhosis|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 15, 2021)	criteria provided, conflicting interpretations	VCV000295593	1	220101499	1	219928157	295593	279268	rs188273166	NC_000001.11:219928156:G:A
NM_017986.4(SLC52A1):c.1240G>A (p.Ala414Thr)	SLC52A1	A414T	Maternal riboflavin deficiency	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000583054	17	4936359	17	5033064	583054	571709	rs142353672	NC_000017.11:5033063:C:T
NM_001044.5(SLC6A3):c.70G>A (p.Val24Met)	SLC6A3	V24M	Tobacco addiction, susceptibility to|Parkinsonism-dystonia, infantile, 1|Parkinsonism-dystonia, infantile	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000538067	5	1443243	5	1443128	538067	521089	rs201800694	NC_000005.10:1443127:C:T
NM_003073.5(SMARCB1):c.34C>T (p.Gln12Ter)	SMARCB1	Q12*	Schwannomatosis 1	Pathogenic(Last reviewed: Apr 1, 2007)	no assertion criteria provided	VCV000008026	22	24129390	22	23787203	8026	23065	rs74315513	NC_000022.11:23787202:C:T
NM_000543.5(SMPD1):c.1133G>A (p.Arg378His)	SMPD1	R378H, R377H, R71H	Niemann-Pick disease, type B|Niemann-Pick disease, type A|Niemann-Pick disease, type A|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 26, 2021)	criteria provided, conflicting interpretations	VCV000554977	11	6414487	11	6393257	554977	546349	rs559088058	NC_000011.10:6393256:G:A
NM_000543.5(SMPD1):c.1474G>A (p.Gly492Ser)	SMPD1	G492S, G448S, G185S, G491S	not provided|Niemann-Pick disease, type B|Niemann-Pick disease, type A|not specified|Sphingomyelin/cholesterol lipidosis|Niemann-Pick disease, type A|Niemann-Pick disease, type B	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2021)	criteria provided, conflicting interpretations	VCV000445832	11	6415259	11	6394029	445832	439104	rs144873307	NC_000011.10:6394028:G:A
NM_000543.5(SMPD1):c.733T>C (p.Tyr245His)	SMPD1	Y245H, Y244H	not provided|Sphingomyelin/cholesterol lipidosis	Uncertain significance(Last reviewed: Feb 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV000291201	11	6413028	11	6391798	291201	275438	rs370178721	NC_000011.10:6391797:T:C
NM_000345.4(SNCA):c.306+7C>T	SNCA		Lewy body dementia|Parkinson disease 1	Likely benign(Last reviewed: Jun 18, 2020)	criteria provided, single submitter	VCV001147109	4	90743390	4	89822239	1147109	1136038		NC_000004.12:89822238:G:A
NM_000345.4(SNCA):c.71A>G (p.Gln24Arg)	SNCA	Q24R	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001051847	4	90756748	4	89835597	1051847	1042983		NC_000004.12:89835596:T:C
NM_000345.4(SNCA):c.*464C>A	SNCA		Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001020728	4	90647315	4	89726164	1020728	1005504		NC_000004.12:89726163:G:T
NM_000345.4(SNCA):c.47T>C (p.Val16Ala)	SNCA	V16A	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001009952	4	90756772	4	89835621	1009952	990319		NC_000004.12:89835620:A:G
NM_000345.4(SNCA):c.100A>G (p.Lys34Glu)	SNCA	K34E	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001003636	4	90756719	4	89835568	1003636	990318		NC_000004.12:89835567:T:C
NM_000345.4(SNCA):c.249G>A (p.Glu83=)	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907548	4	90743454	4	89822303	907548	892534		NC_000004.12:89822302:C:T
NM_000345.4(SNCA):c.382C>A (p.Pro128Thr)	SNCA	P80T, P128T	Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907547	4	90650353	4	89729202	907547	892533		NC_000004.12:89729201:G:T
NM_000345.4(SNCA):c.*56C>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907546	4	90647723	4	89726572	907546	892532		NC_000004.12:89726571:G:C
NM_000345.4(SNCA):c.*77C>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907545	4	90647702	4	89726551	907545	892531		NC_000004.12:89726550:G:T
NM_000345.4(SNCA):c.*112A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907544	4	90647667	4	89726516	907544	892530		NC_000004.12:89726515:T:C
NM_000345.4(SNCA):c.*114C>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907543	4	90647665	4	89726514	907543	892529		NC_000004.12:89726513:G:C
NM_000345.4(SNCA):c.*1292C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907477	4	90646487	4	89725336	907477	892518		NC_000004.12:89725335:G:A
NM_000345.4(SNCA):c.*1311C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907476	4	90646468	4	89725317	907476	892517		NC_000004.12:89725316:G:A
NM_000345.4(SNCA):c.*1518T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907475	4	90646261	4	89725110	907475	892516		NC_000004.12:89725109:A:G
NM_000345.4(SNCA):c.*1678G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907474	4	90646101	4	89724950	907474	892515		NC_000004.12:89724949:C:T
NM_000345.4(SNCA):c.*116C>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906531	4	90647663	4	89726512	906531	892528		NC_000004.12:89726511:G:A
NM_000345.4(SNCA):c.*249G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906530	4	90647530	4	89726379	906530	892527		NC_000004.12:89726378:C:T
NM_000345.4(SNCA):c.*504T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906529	4	90647275	4	89726124	906529	892526		NC_000004.12:89726123:A:G
NM_000345.4(SNCA):c.*1716A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906480	4	90646063	4	89724912	906480	892514		NC_000004.12:89724911:T:A
NM_000345.4(SNCA):c.*1893T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906479	4	90645886	4	89724735	906479	892513		NC_000004.12:89724734:A:G
NM_000345.4(SNCA):c.*1983A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906478	4	90645796	4	89724645	906478	892512		NC_000004.12:89724644:T:C
NM_000345.4(SNCA):c.*2047G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906477	4	90645732	4	89724581	906477	892511		NC_000004.12:89724580:C:T
NM_000345.4(SNCA):c.-127C>T	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904994	4	90758214	4	89837063	904994	892536		NC_000004.12:89837062:G:A
NM_000345.4(SNCA):c.*852G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904938	4	90646927	4	89725776	904938	892525		NC_000004.12:89725775:C:T
NM_000345.4(SNCA):c.*894G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904937	4	90646885	4	89725734	904937	892524		NC_000004.12:89725733:C:T
NM_000345.4(SNCA):c.*923A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904936	4	90646856	4	89725705	904936	892523		NC_000004.12:89725704:T:C
NM_000345.4(SNCA):c.*2106G>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904878	4	90645673	4	89724522	904878	892510		NC_000004.12:89724521:C:T
NM_000345.4(SNCA):c.*2230G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904877	4	90645549	4	89724398	904877	892509		NC_000004.12:89724397:C:T
NM_000345.4(SNCA):c.*2320A>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904876	4	90645459	4	89724308	904876	892508		NC_000004.12:89724307:T:A
NM_000345.4(SNCA):c.-115C>G	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904212	4	90758202	4	89837051	904212	892535		NC_000004.12:89837050:G:C
NM_000345.4(SNCA):c.-26+7G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904211	4	90758106	4	89836955	904211	896007		NC_000004.12:89836954:C:T
NM_000345.4(SNCA):c.121+11C>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Oct 18, 2017)	criteria provided, single submitter	VCV000904210	4	90756687	4	89835536	904210	896006		NC_000004.12:89835535:G:A
NM_000345.4(SNCA):c.*1276C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904158	4	90646503	4	89725352	904158	892522		NC_000004.12:89725351:G:A
NM_000345.4(SNCA):c.*1280T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904157	4	90646499	4	89725348	904157	892521		NC_000004.12:89725347:A:G
NM_000345.4(SNCA):c.*1285T>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000904156	4	90646494	4	89725343	904156	892520		NC_000004.12:89725342:A:T
NM_000345.4(SNCA):c.*1287G>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000904155	4	90646492	4	89725341	904155	892519		NC_000004.12:89725340:C:A
NM_000345.4(SNCA):c.*2396G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000904097	4	90645383	4	89724232	904097	892507		NC_000004.12:89724231:C:T
NM_000345.4(SNCA):c.225A>T (p.Thr75=)	SNCA		not provided|Lewy body dementia|Parkinson disease 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 9, 2020)	criteria provided, conflicting interpretations	VCV000872747	4	90743478	4	89822327	872747	859358		NC_000004.12:89822326:T:A
NM_000345.4(SNCA):c.156G>T (p.Val52=)	SNCA		Lewy body dementia|Parkinson disease 1	Likely benign(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000772345	4	90749301	4	89828150	772345	698680	rs148108612	NC_000004.12:89828149:C:A
NM_000345.4(SNCA):c.147G>A (p.Val49=)	SNCA		Lewy body dementia|Parkinson disease 1	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000767542	4	90749310	4	89828159	767542	698681	rs141859659	NC_000004.12:89828158:C:T
NM_000345.4(SNCA):c.163+7T>G	SNCA		not provided|Parkinson disease 1|Lewy body dementia	Likely benign(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000763646	4	90749287	4	89828136	763646	774989	rs1578405610	NC_000004.12:89828135:A:C
NM_000345.4(SNCA):c.216G>A (p.Thr72=)	SNCA		Parkinson Disease, Dominant|Lewy body dementia|Parkinson disease 1|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000705925	4	90743487	4	89822336	705925	691638	rs144758871	NC_000004.12:89822335:C:T
NM_000345.4(SNCA):c.287A>G (p.Lys96Arg)	SNCA	K96R	Parkinson Disease, Dominant|not provided	Benign(Last reviewed: May 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000704527	4	90743416	4	89822265	704527	691637	rs548523899	NC_000004.12:89822264:T:C
NM_000345.4(SNCA):c.349C>A (p.Pro117Thr)	SNCA	P117T, P69T	Lewy body dementia|Parkinson disease 1	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000652694	4	90650386	4	89729235	652694	632527	rs145138372	NC_000004.12:89729234:G:T
NM_000345.4(SNCA):c.-26+1G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000631952	4	90758112	4	89836961	631952	620776	rs1560562993	NC_000004.12:89836960:C:T
NM_001146055.2(SNCA):c.-26+1042G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000369445	4	90758361	4	89837210	369445	353674	rs372025454	NC_000004.12:89837209:C:T
NM_001146055.2(SNCA):c.-26+1065A>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350112	4	90758338	4	89837187	350112	299966	rs767878442	NC_000004.12:89837186:T:G
NM_000345.4(SNCA):c.-219G>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350111	4	90758306	4	89837155	350111	299952	rs757451373	NC_000004.12:89837154:C:G
NM_000345.4(SNCA):c.-129G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350110	4	90758216	4	89837065	350110	296211	rs367902113	NC_000004.12:89837064:C:T
NM_000345.4(SNCA):c.-42T>C	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350109	4	90758129	4	89836978	350109	294667	rs886059730	NC_000004.12:89836977:A:G
NM_000345.4(SNCA):c.-40G>A	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350108	4	90758127	4	89836976	350108	294666	rs886059729	NC_000004.12:89836975:C:T
NM_000345.4(SNCA):c.-26+15C>T	SNCA|SNCA-AS1		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350107	4	90758098	4	89836947	350107	299943	rs545809130	NC_000004.12:89836946:G:A
NM_000345.4(SNCA):c.243A>G (p.Thr81=)	SNCA		Parkinson Disease, Dominant|Lewy body dementia|Parkinson disease 1|not provided	Benign(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350106	4	90743460	4	89822309	350106	299978	rs568436589	NC_000004.12:89822308:T:C
NM_000345.4(SNCA):c.298T>C (p.Leu100=)	SNCA		Parkinson Disease, Dominant|Lewy body dementia|Parkinson disease 1	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2020)	criteria provided, conflicting interpretations	VCV000350105	4	90743405	4	89822254	350105	299977	rs138969470	NC_000004.12:89822253:A:G
NM_000345.4(SNCA):c.408C>T (p.Tyr136=)	SNCA		Parkinson Disease, Dominant|Lewy body dementia|Parkinson disease 1|not provided	Benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000350104	4	90647794	4	89726643	350104	294660	rs76642636	NC_000004.12:89726642:G:A
NM_000345.4(SNCA):c.*139T>G	SNCA		not provided|Parkinson Disease, Dominant	Benign/Likely benign(Last reviewed: Jul 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350103	4	90647640	4	89726489	350103	294658	rs10024743	NC_000004.12:89726488:A:C
NM_000345.4(SNCA):c.*173G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350102	4	90647606	4	89726455	350102	299932	rs79726680	NC_000004.12:89726454:C:T
NM_000345.4(SNCA):c.*211G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350101	4	90647568	4	89726417	350101	299924	rs886059728	NC_000004.12:89726416:C:T
NM_000345.4(SNCA):c.*277G>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000350100	4	90647502	4	89726351	350100	296195	rs886059727	NC_000004.12:89726350:C:A
NM_000345.4(SNCA):c.*465A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350099	4	90647314	4	89726163	350099	299976	rs886059726	NC_000004.12:89726162:T:A
NM_000345.4(SNCA):c.*501C>T	SNCA		Parkinson Disease, Dominant|Lewy body dementia|Parkinson disease 1	Benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000350098	4	90647278	4	89726127	350098	299975	rs17016074	NC_000004.12:89726126:G:A
NM_000345.4(SNCA):c.*593C>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350096	4	90647186	4	89726035	350096	294651	rs35101723	NC_000004.12:89726034:G:T
NM_000345.4(SNCA):c.*630T>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350095	4	90647149	4	89725998	350095	299973	rs886059725	NC_000004.12:89725997:A:C
NM_000345.4(SNCA):c.*860T>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350094	4	90646919	4	89725768	350094	299923	rs577490090	NC_000004.12:89725767:A:T
NM_000345.4(SNCA):c.*893C>T	SNCA		not provided|Parkinson Disease, Dominant	Benign(Last reviewed: Feb 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000350093	4	90646886	4	89725735	350093	299919	rs356165	NC_000004.12:89725734:G:A
NM_000345.4(SNCA):c.*1002T>G	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350092	4	90646777	4	89725626	350092	299964	rs182722435	NC_000004.12:89725625:A:C
NM_000345.4(SNCA):c.*1033T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350091	4	90646746	4	89725595	350091	299913	rs550521282	NC_000004.12:89725594:A:G
NM_000345.4(SNCA):c.*1047T>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350090	4	90646732	4	89725581	350090	294649	rs532025477	NC_000004.12:89725580:A:C
NM_000345.4(SNCA):c.*1078A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350088	4	90646701	4	89725550	350088	299912	rs886059723	NC_000004.12:89725549:T:A
NM_000345.4(SNCA):c.*1287G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350085	4	90646492	4	89725341	350085	299958	rs377356638	NC_000004.12:89725340:C:T
NM_000345.4(SNCA):c.*1289T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350084	4	90646490	4	89725339	350084	294641	rs527798413	NC_000004.12:89725338:A:G
NM_000345.4(SNCA):c.*1310A>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350076	4	90646469	4	89725318	350076	299944	rs886059719	NC_000004.12:89725317:T:A
NM_000345.4(SNCA):c.*1325A>G	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350069	4	90646454	4	89725303	350069	294630	rs886059715	NC_000004.12:89725302:T:C
NM_000345.4(SNCA):c.*1677C>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350068	4	90646102	4	89724951	350068	296145	rs17016072	NC_000004.12:89724950:G:A
NM_000345.4(SNCA):c.*1702G>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350067	4	90646077	4	89724926	350067	299935	rs886059714	NC_000004.12:89724925:C:T
NM_000345.4(SNCA):c.*1896C>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350066	4	90645883	4	89724732	350066	299878	rs186189862	NC_000004.12:89724731:G:A
NM_000345.4(SNCA):c.*2037T>C	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350065	4	90645742	4	89724591	350065	299930	rs553070344	NC_000004.12:89724590:A:G
NM_000345.4(SNCA):c.*2105G>A	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350064	4	90645674	4	89724523	350064	299868	rs3857053	NC_000004.12:89724522:C:T
NM_000345.4(SNCA):c.*2108A>T	SNCA		Parkinson Disease, Dominant	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350063	4	90645671	4	89724520	350063	294628	rs1045722	NC_000004.12:89724519:T:A
NM_000345.4(SNCA):c.*2227C>A	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350062	4	90645552	4	89724401	350062	296144	rs551886776	NC_000004.12:89724400:G:T
NM_000345.4(SNCA):c.*2269C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350061	4	90645510	4	89724359	350061	299859	rs886059713	NC_000004.12:89724358:G:A
NM_000345.4(SNCA):c.*2277A>C	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350060	4	90645502	4	89724351	350060	299856	rs375815714	NC_000004.12:89724350:T:G
NM_000345.4(SNCA):c.*2291C>T	SNCA		Parkinson Disease, Dominant	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350059	4	90645488	4	89724337	350059	296136	rs550895688	NC_000004.12:89724336:G:A
NM_000345.4(SNCA):c.*2330C>T	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350058	4	90645449	4	89724298	350058	299848	rs886059712	NC_000004.12:89724297:G:A
NM_000345.4(SNCA):c.*2501C>A	SNCA		Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350057	4	90645278	4	89724127	350057	299916	rs886059711	NC_000004.12:89724126:G:T
NM_000345.4(SNCA):c.150T>G (p.His50Gln)	SNCA	H50Q	Parkinson disease 1|Lewy body dementia|Parkinson disease 1|Parkinson Disease, Dominant	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000162095	4	90749307	4	89828156	162095	171811	rs201106962	NC_000004.12:89828155:A:C
NM_000345.4(SNCA):c.152G>A (p.Gly51Asp)	SNCA	G51D	Parkinson disease 1	Pathogenic(Last reviewed: Apr 1, 2013)	no assertion criteria provided	VCV000097000	4	90749305	4	89828154	97000	102896	rs431905511	NC_000004.12:89828153:C:T
NM_000345.4(SNCA):c.88G>C (p.Ala30Pro)	SNCA	A30P	Parkinson disease 1	Pathogenic(Last reviewed: Nov 22, 2013)	no assertion criteria provided	VCV000014008	4	90756731	4	89835580	14008	29047	rs104893878	NC_000004.12:89835579:C:G
NM_000345.4(SNCA):c.157G>A (p.Ala53Thr)	SNCA	A53T	Parkinson disease 1|Lewy body dementia|Parkinson disease 1	Pathogenic(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000014007	4	90749300	4	89828149	14007	29046	rs104893877	NC_000004.12:89828148:C:T
NM_005460.4(SNCAIP):c.1206C>T (p.Arg402=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000907840	5	121767687	5	122431992	907840	892671		NC_000005.10:122431991:C:T
NM_005460.4(SNCAIP):c.-26G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907795	5	121726804	5	122391109	907795	892661		NC_000005.10:122391108:G:A
NM_005460.4(SNCAIP):c.-46-6G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000907794	5	121726778	5	122391083	907794	896015		NC_000005.10:122391082:G:A
NM_005460.4(SNCAIP):c.-48G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907793	5	121647978	5	122312283	907793	892660		NC_000005.10:122312282:G:A
NM_005460.4(SNCAIP):c.-54C>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000907792	5	121647972	5	122312277	907792	892659		NC_000005.10:122312276:C:A
NM_005460.4(SNCAIP):c.1087G>A (p.Ala363Thr)	SNCAIP	A410T, A363T, A57T	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906851	5	121761131	5	122425436	906851	892670		NC_000005.10:122425435:G:A
NM_005460.4(SNCAIP):c.1002+7A>G	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906850	5	121759441	5	122423746	906850	896017		NC_000005.10:122423745:A:G
NM_005460.4(SNCAIP):c.1002+2T>C	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000906849	5	121759436	5	122423741	906849	896016		NC_000005.10:122423740:T:C
NM_005460.4(SNCAIP):c.806G>A (p.Arg269Gln)	SNCAIP	R269Q, R316Q	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000906848	5	121759238	5	122423543	906848	892669		NC_000005.10:122423542:G:A
NM_005460.4(SNCAIP):c.709G>A (p.Glu237Lys)	SNCAIP	E237K, E284K	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000906847	5	121759141	5	122423446	906847	892668		NC_000005.10:122423445:G:A
NM_005460.4(SNCAIP):c.417G>A (p.Ser139=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000905253	5	121758849	5	122423154	905253	892667		NC_000005.10:122423153:G:A
NM_005460.4(SNCAIP):c.388C>T (p.Pro130Ser)	SNCAIP	P130S, P177S	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904473	5	121758820	5	122423125	904473	892666		NC_000005.10:122423124:C:T
NM_005460.4(SNCAIP):c.292A>G (p.Lys98Glu)	SNCAIP	K98E, K145E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904472	5	121758724	5	122423029	904472	892665		NC_000005.10:122423028:A:G
NM_005460.4(SNCAIP):c.258A>G (p.Pro86=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904471	5	121758690	5	122422995	904471	892664		NC_000005.10:122422994:A:G
NM_005460.4(SNCAIP):c.198C>T (p.Ile66=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904470	5	121758630	5	122422935	904470	892663		NC_000005.10:122422934:C:T
NM_005460.4(SNCAIP):c.137G>A (p.Ser46Asn)	SNCAIP	S46N, S93N	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000904469	5	121758569	5	122422874	904469	892662		NC_000005.10:122422873:G:A
NM_005460.4(SNCAIP):c.111G>A (p.Thr37=)	SNCAIP	R22H, R20H	Parkinson Disease, Dominant/Recessive|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000784627	5	121739541	5	122403846	784627	709594	rs10070158	NC_000005.10:122403845:G:A
NM_005460.4(SNCAIP):c.2140G>A (p.Ala714Thr)	SNCAIP|MGC32805	A714T, A310T, A348T, A654T, A346T, A408T, A761T	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350500	5	121786682	5	122450987	350500	300483	rs143468222	NC_000005.10:122450986:G:A
NM_005460.4(SNCAIP):c.2125G>C (p.Glu709Gln)	SNCAIP|MGC32805	E709Q, E649Q, E343Q, E305Q, E341Q, E403Q, E756Q	Parkinson Disease, Dominant/Recessive|not provided|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350498	5	121786667	5	122450972	350498	300482	rs55712196	NC_000005.10:122450971:G:C
NM_005460.4(SNCAIP):c.1218C>T (p.Ser406=)	SNCAIP		not provided|Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000350494	5	121767699	5	122432004	350494	300472	rs148152880	NC_000005.10:122432003:C:T
NM_005460.4(SNCAIP):c.1134C>T (p.Leu378=)	SNCAIP		not provided|Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350493	5	121761178	5	122425483	350493	294994	rs55770446	NC_000005.10:122425482:C:T
NM_005460.4(SNCAIP):c.786A>C (p.Thr262=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350492	5	121759218	5	122423523	350492	300471	rs147831994	NC_000005.10:122423522:A:C
NM_005460.4(SNCAIP):c.708C>T (p.Thr236=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350491	5	121759140	5	122423445	350491	296761	rs377374083	NC_000005.10:122423444:C:T
NM_005460.4(SNCAIP):c.688A>G (p.Lys230Glu)	SNCAIP	K230E, K277E	Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350490	5	121759120	5	122423425	350490	300469	rs374522874	NC_000005.10:122423424:A:G
NM_005460.4(SNCAIP):c.672C>T (p.Val224=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350489	5	121759104	5	122423409	350489	300540	rs376151621	NC_000005.10:122423408:C:T
NM_005460.4(SNCAIP):c.665C>T (p.Ser222Leu)	SNCAIP	S222L, S269L	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350488	5	121759097	5	122423402	350488	294993	rs147594642	NC_000005.10:122423401:C:T
NM_005460.4(SNCAIP):c.636C>T (p.Pro212=)	SNCAIP		not provided|Parkinson Disease, Dominant/Recessive	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350487	5	121759068	5	122423373	350487	300451	rs56331004	NC_000005.10:122423372:C:T
NM_005460.4(SNCAIP):c.608A>G (p.Asn203Ser)	SNCAIP	N203S, N250S	Parkinson Disease, Dominant/Recessive	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350486	5	121759040	5	122423345	350486	296739	rs144384727	NC_000005.10:122423344:A:G
NM_005460.4(SNCAIP):c.444C>T (p.Leu148=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350485	5	121758876	5	122423181	350485	300525	rs762767013	NC_000005.10:122423180:C:T
NM_005460.4(SNCAIP):c.429G>A (p.Leu143=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350484	5	121758861	5	122423166	350484	296738	rs886059825	NC_000005.10:122423165:G:A
NM_005460.4(SNCAIP):c.204T>C (p.Asp68=)	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350483	5	121758636	5	122422941	350483	300518	rs770583296	NC_000005.10:122422940:T:C
NM_005460.4(SNCAIP):c.81G>A (p.Thr27=)	SNCAIP	R12Q, R10Q	Parkinson Disease, Dominant/Recessive|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000350482	5	121739511	5	122403816	350482	300450	rs149915358	NC_000005.10:122403815:G:A
NM_005460.4(SNCAIP):c.-13G>T	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350481	5	121726817	5	122391122	350481	300509	rs762576870	NC_000005.10:122391121:G:T
NM_005460.4(SNCAIP):c.-47+3G>A	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350480	5	121647982	5	122312287	350480	300501	rs886059824	NC_000005.10:122312286:G:A
NM_005460.4(SNCAIP):c.-49C>G	SNCAIP		Parkinson Disease, Dominant/Recessive	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000350479	5	121647977	5	122312282	350479	296735	rs192969505	NC_000005.10:122312281:C:G
NM_005460.4(SNCAIP):c.-66C>T	SNCAIP		Parkinson Disease, Dominant/Recessive	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000350478	5	121647960	5	122312265	350478	294991	rs886059823	NC_000005.10:122312264:C:T
NM_003098.3(SNTA1):c.1088A>C (p.Glu363Ala)	SNTA1	E363A	not provided|Wolff-Parkinson-White pattern|Cardiovascular phenotype|Long QT syndrome|Long QT syndrome 12	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2019)	criteria provided, conflicting interpretations	VCV000190918	20	31998090	20	33410284	190918	188722	rs147964932	NC_000020.11:33410283:T:G
NM_025137.4(SPG11):c.5121G>T (p.Glu1707Asp)	SPG11	E1707D	Intellectual disability|Spastic paraplegia 11, autosomal recessive|not provided	Uncertain significance(Last reviewed: Jun 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000406519	15	44877834	15	44585636	406519	400100	rs145643238	NC_000015.10:44585635:C:A
NM_203446.3(SYNJ1):c.*690G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001169968	21	34003425	21	32631115	1169968	1158955		NC_000021.9:32631114:C:T
NM_203446.3(SYNJ1):c.1182G>A (p.Gln394=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001169220	21	34056366	21	32684056	1169220	1158959		NC_000021.9:32684055:C:T
NM_203446.3(SYNJ1):c.1971T>C (p.Thr657=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001168786	21	34038427	21	32666117	1168786	1158957		NC_000021.9:32666116:A:G
NM_203446.3(SYNJ1):c.1201-3A>T	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV001168202	21	34053961	21	32681651	1168202	1158958		NC_000021.9:32681650:T:A
NM_203446.3(SYNJ1):c.3697+10C>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001167619	21	34011971	21	32639661	1167619	1158956		NC_000021.9:32639660:G:C
NM_203446.3(SYNJ1):c.462T>A (p.Thr154=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001160938	21	34072165	21	32699855	1160938	1149710		NC_000021.9:32699854:A:T
NM_203446.3(SYNJ1):c.705+9A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 27, 2019)	criteria provided, single submitter	VCV001160911	21	34067358	21	32695048	1160911	1149708		NC_000021.9:32695047:T:C
NM_203446.3(SYNJ1):c.1017T>C (p.Val339=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001160684	21	34058159	21	32685849	1160684	1149705		NC_000021.9:32685848:A:G
NM_203446.3(SYNJ1):c.*753T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001160648	21	34003362	21	32631052	1160648	1149686		NC_000021.9:32631051:A:G
NM_203446.3(SYNJ1):c.2217C>T (p.Asn739=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001158092	21	34037310	21	32665000	1158092	1149699		NC_000021.9:32664999:G:A
NM_203446.3(SYNJ1):c.711G>A (p.Val237=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001157232	21	34066616	21	32694306	1157232	1149707		NC_000021.9:32694305:C:T
NM_203446.3(SYNJ1):c.597G>A (p.Ala199=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001156550	21	34067475	21	32695165	1156550	1149709		NC_000021.9:32695164:C:T
NM_203446.3(SYNJ1):c.1719G>A (p.Glu573=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001156418	21	34045657	21	32673347	1156418	1149701		NC_000021.9:32673346:C:T
NM_203446.3(SYNJ1):c.1257T>G (p.Thr419=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001156265	21	34053902	21	32681592	1156265	1149704		NC_000021.9:32681591:A:C
NM_203446.3(SYNJ1):c.3879C>G (p.Ser1293=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001156013	21	34011254	21	32638944	1156013	1149691		NC_000021.9:32638943:G:C
NM_203446.3(SYNJ1):c.2685A>T (p.Thr895=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 3, 2019)	criteria provided, single submitter	VCV001155432	21	34029107	21	32656797	1155432	1149698		NC_000021.9:32656796:T:A
NM_203446.3(SYNJ1):c.2202A>C (p.Arg734=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV001153296	21	34037325	21	32665015	1153296	1149700		NC_000021.9:32665014:T:G
NM_203446.3(SYNJ1):c.3589-8A>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV001152452	21	34012097	21	32639787	1152452	1149693		NC_000021.9:32639786:T:A
NM_203446.3(SYNJ1):c.3327G>A (p.Pro1109=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001152089	21	34018020	21	32645710	1152089	1149696		NC_000021.9:32645709:C:T
NM_203446.3(SYNJ1):c.873C>T (p.Asn291=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV001151977	21	34059363	21	32687053	1151977	1149706		NC_000021.9:32687052:G:A
NM_203446.3(SYNJ1):c.1611C>G (p.Val537=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001151828	21	34045765	21	32673455	1151828	1149702		NC_000021.9:32673454:G:C
NM_203446.3(SYNJ1):c.150G>A (p.Lys50=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001150726	21	34074332	21	32702022	1150726	1149712		NC_000021.9:32702021:C:T
NM_203446.3(SYNJ1):c.*665C>G	SYNJ1	T1479R, T1565R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV001149531	21	34003450	21	32631140	1149531	1149687		NC_000021.9:32631139:G:C
NM_203446.3(SYNJ1):c.2802A>G (p.Val934=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV001149203	21	34025670	21	32653360	1149203	1149697		NC_000021.9:32653359:T:C
NM_203446.3(SYNJ1):c.*443G>A	SYNJ1	S1405N, S1491N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001147907	21	34003672	21	32631362	1147907	1149688		NC_000021.9:32631361:C:T
NM_203446.3(SYNJ1):c.3588+7A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 4, 2020)	criteria provided, single submitter	VCV001147806	21	34014199	21	32641889	1147806	1149694		NC_000021.9:32641888:T:C
NM_203446.3(SYNJ1):c.3714T>G (p.Pro1238=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001147414	21	34011419	21	32639109	1147414	1149692		NC_000021.9:32639108:A:C
NM_203446.3(SYNJ1):c.*75A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001144796	21	34004040	21	32631730	1144796	1149689		NC_000021.9:32631729:T:C
NM_203446.3(SYNJ1):c.3378T>A (p.Pro1126=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 27, 2019)	criteria provided, single submitter	VCV001144320	21	34017969	21	32645659	1144320	1149695		NC_000021.9:32645658:A:T
NM_203446.3(SYNJ1):c.435G>A (p.Ala145=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001143311	21	34072192	21	32699882	1143311	1149711		NC_000021.9:32699881:C:T
NM_203446.3(SYNJ1):c.1311T>C (p.Ser437=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001141863	21	34053848	21	32681538	1141863	1149703		NC_000021.9:32681537:A:G
NM_203446.3(SYNJ1):c.*60A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 16, 2020)	criteria provided, single submitter	VCV001141633	21	34004055	21	32631745	1141633	1149690		NC_000021.9:32631744:T:C
NM_203446.3(SYNJ1):c.3261C>T (p.Asp1087=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV001138103	21	34018086	21	32645776	1138103	1128755		NC_000021.9:32645775:G:A
NM_203446.3(SYNJ1):c.3489C>T (p.Ser1163=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001137259	21	34014433	21	32642123	1137259	1128752		NC_000021.9:32642122:G:A
NM_203446.3(SYNJ1):c.1179G>T (p.Val393=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001136800	21	34056369	21	32684059	1136800	1128766		NC_000021.9:32684058:C:A
NM_203446.3(SYNJ1):c.3807A>C (p.Ala1269=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001136484	21	34011326	21	32639016	1136484	1128747		NC_000021.9:32639015:T:G
NM_203446.3(SYNJ1):c.2994G>A (p.Leu998=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001136379	21	34022537	21	32650227	1136379	1128757		NC_000021.9:32650226:C:T
NM_203446.3(SYNJ1):c.2587G>A (p.Val863Ile)	SYNJ1	V858I, V863I, V902I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001136325	21	34029205	21	32656895	1136325	1128761		NC_000021.9:32656894:C:T
NM_203446.3(SYNJ1):c.-64C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001135357	21	34100298	21	32727987	1135357	1128768		NC_000021.9:32727986:G:A
NM_003895.3(SYNJ1):c.9G>A (p.Lys3=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001134388	21	34100343	21	32728032	1134388	1128769		NC_000021.9:32728031:C:T
NM_203446.3(SYNJ1):c.2860C>T (p.Leu954=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001132567	21	34025612	21	32653302	1132567	1128758		NC_000021.9:32653301:G:A
NM_203446.3(SYNJ1):c.2607T>C (p.Asp869=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001131326	21	34029185	21	32656875	1131326	1128760		NC_000021.9:32656874:A:G
NM_203446.3(SYNJ1):c.3697+8C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV001131278	21	34011973	21	32639663	1131278	1128751		NC_000021.9:32639662:G:A
NM_203446.3(SYNJ1):c.3431-10C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001130551	21	34015777	21	32643467	1130551	1128754		NC_000021.9:32643466:G:A
NM_203446.3(SYNJ1):c.*9A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001129811	21	34004106	21	32631796	1129811	1128745		NC_000021.9:32631795:T:C
NM_203446.3(SYNJ1):c.3195C>T (p.Pro1065=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001129554	21	34018755	21	32646445	1129554	1128756		NC_000021.9:32646444:G:A
NM_203446.3(SYNJ1):c.*303T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001129034	21	34003812	21	32631502	1129034	1128744		NC_000021.9:32631501:A:C
NM_203446.3(SYNJ1):c.2295T>C (p.Asn765=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001128623	21	34037232	21	32664922	1128623	1128762		NC_000021.9:32664921:A:G
NM_203446.3(SYNJ1):c.3915+7C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001128183	21	34011211	21	32638901	1128183	1128746		NC_000021.9:32638900:G:C
NM_203446.3(SYNJ1):c.3786G>A (p.Glu1262=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001127875	21	34011347	21	32639037	1127875	1128748		NC_000021.9:32639036:C:T
NM_203446.3(SYNJ1):c.-22-10G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001127579	21	34099238	21	32726927	1127579	1128767		NC_000021.9:32726926:C:T
NM_203446.3(SYNJ1):c.*411C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: May 10, 2019)	criteria provided, single submitter	VCV001127312	21	34003704	21	32631394	1127312	1128743		NC_000021.9:32631393:G:A
NM_203446.3(SYNJ1):c.3783A>G (p.Gln1261=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001127292	21	34011350	21	32639040	1127292	1128749		NC_000021.9:32639039:T:C
NM_203446.3(SYNJ1):c.3431-6A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001126754	21	34015773	21	32643463	1126754	1128753		NC_000021.9:32643462:T:C
NM_203446.3(SYNJ1):c.1728T>C (p.Asp576=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001123709	21	34042681	21	32670371	1123709	1128765		NC_000021.9:32670370:A:G
NM_203446.3(SYNJ1):c.3732G>A (p.Gln1244=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001123555	21	34011401	21	32639091	1123555	1128750		NC_000021.9:32639090:C:T
NM_203446.3(SYNJ1):c.2079G>A (p.Gly693=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001123411	21	34038319	21	32666009	1123411	1128763		NC_000021.9:32666008:C:T
NM_203446.3(SYNJ1):c.2795+7T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV001122116	21	34028990	21	32656680	1122116	1128759		NC_000021.9:32656679:A:G
NM_203446.3(SYNJ1):c.2076A>T (p.Ala692=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001121508	21	34038322	21	32666012	1121508	1128764		NC_000021.9:32666011:T:A
NM_203446.3(SYNJ1):c.*132C>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001119715	21	34003983	21	32631673	1119715	1107334		NC_000021.9:32631672:G:T
NM_203446.3(SYNJ1):c.38T>C (p.Leu13Ser)	SYNJ1	L13S, L52S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2021)	criteria provided, conflicting interpretations	VCV001119322	21	34099169	21	32726858	1119322	1107355		NC_000021.9:32726857:A:G
NM_203446.3(SYNJ1):c.*187T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001118406	21	34003928	21	32631618	1118406	1107333		NC_000021.9:32631617:A:G
NM_203446.3(SYNJ1):c.*396T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV001117002	21	34003719	21	32631409	1117002	1107330		NC_000021.9:32631408:A:G
NM_203446.3(SYNJ1):c.*393C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001116849	21	34003722	21	32631412	1116849	1107331		NC_000021.9:32631411:G:A
NM_203446.3(SYNJ1):c.2766T>C (p.Phe922=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV001115577	21	34029026	21	32656716	1115577	1107340		NC_000021.9:32656715:A:G
NM_203446.3(SYNJ1):c.*540C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 30, 2019)	criteria provided, single submitter	VCV001114590	21	34003575	21	32631265	1114590	1107329		NC_000021.9:32631264:G:A
NM_203446.3(SYNJ1):c.*270C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 11, 2020)	criteria provided, single submitter	VCV001114327	21	34003845	21	32631535	1114327	1107332		NC_000021.9:32631534:G:A
NM_203446.3(SYNJ1):c.-22-4G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV001114235	21	34099232	21	32726921	1114235	1107356		NC_000021.9:32726920:C:T
NM_203446.3(SYNJ1):c.1045A>G (p.Ser349Gly)	SYNJ1	S349G, S388G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001113763	21	34058131	21	32685821	1113763	1107350		NC_000021.9:32685820:T:C
NM_203446.3(SYNJ1):c.303T>C (p.Thr101=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 19, 2019)	criteria provided, single submitter	VCV001112820	21	34072324	21	32700014	1112820	1107354		NC_000021.9:32700013:A:G
NM_203446.3(SYNJ1):c.3517+7A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001111106	21	34014398	21	32642088	1111106	1107336		NC_000021.9:32642087:T:C
NM_203446.3(SYNJ1):c.2304+9A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001110400	21	34037214	21	32664904	1110400	1107344		NC_000021.9:32664903:T:C
NM_203446.3(SYNJ1):c.-25G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001109613	21	34100259	21	32727948	1109613	1107357		NC_000021.9:32727947:C:T
NM_203446.3(SYNJ1):c.747C>T (p.Ile249=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001108337	21	34066580	21	32694270	1108337	1107353		NC_000021.9:32694269:G:A
NM_203446.3(SYNJ1):c.1800T>C (p.Ile600=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001107637	21	34042609	21	32670299	1107637	1107347		NC_000021.9:32670298:A:G
NM_203446.3(SYNJ1):c.2325A>G (p.Glu775=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001107342	21	34030162	21	32657852	1107342	1107343		NC_000021.9:32657851:T:C
NM_203446.3(SYNJ1):c.2025A>G (p.Arg675=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV001106986	21	34038373	21	32666063	1106986	1107346		NC_000021.9:32666062:T:C
NM_203446.3(SYNJ1):c.-34C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001106933	21	34100268	21	32727957	1106933	1107358		NC_000021.9:32727956:G:A
NM_203446.3(SYNJ1):c.762A>G (p.Pro254=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001106824	21	34066565	21	32694255	1106824	1107352		NC_000021.9:32694254:T:C
NM_203446.3(SYNJ1):c.2223A>G (p.Glu741=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001105035	21	34037304	21	32664994	1105035	1107345		NC_000021.9:32664993:T:C
NM_203446.3(SYNJ1):c.851+10T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001104014	21	34060606	21	32688296	1104014	1107351		NC_000021.9:32688295:A:G
NM_203446.3(SYNJ1):c.1118+9G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 28, 2019)	criteria provided, single submitter	VCV001103736	21	34058049	21	32685739	1103736	1107349		NC_000021.9:32685738:C:T
NM_203446.3(SYNJ1):c.2955A>G (p.Lys985=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001102559	21	34022576	21	32650266	1102559	1107337		NC_000021.9:32650265:T:C
NM_203446.3(SYNJ1):c.2909G>C (p.Ser970Thr)	SYNJ1	S1009T, S965T, S970T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001102053	21	34022622	21	32650312	1102053	1107339		NC_000021.9:32650311:C:G
NM_203446.3(SYNJ1):c.2403C>T (p.Thr801=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV001102039	21	34030084	21	32657774	1102039	1107341		NC_000021.9:32657773:G:A
NM_203446.3(SYNJ1):c.*21C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2019)	criteria provided, single submitter	VCV001101028	21	34004094	21	32631784	1101028	1107335		NC_000021.9:32631783:G:T
NM_203446.3(SYNJ1):c.2373C>T (p.Asp791=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV001100687	21	34030114	21	32657804	1100687	1107342		NC_000021.9:32657803:G:A
NM_203446.3(SYNJ1):c.2937A>G (p.Glu979=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV001100339	21	34022594	21	32650284	1100339	1107338		NC_000021.9:32650283:T:C
NM_203446.3(SYNJ1):c.1176T>C (p.Ser392=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001099008	21	34056372	21	32684062	1099008	1107348		NC_000021.9:32684061:A:G
NM_203446.3(SYNJ1):c.*729G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 15, 2019)	criteria provided, single submitter	VCV001097087	21	34003386	21	32631076	1097087	1085613		NC_000021.9:32631075:C:T
NM_203446.3(SYNJ1):c.3392-10G>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001097058	21	34017326	21	32645016	1097058	1085621		NC_000021.9:32645015:C:G
NM_203446.3(SYNJ1):c.*741C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001094900	21	34003374	21	32631064	1094900	1085612		NC_000021.9:32631063:G:A
NM_203446.3(SYNJ1):c.*633C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001093632	21	34003482	21	32631172	1093632	1085614		NC_000021.9:32631171:G:A
NM_203446.3(SYNJ1):c.2352T>C (p.Tyr784=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV001093571	21	34030135	21	32657825	1093571	1085626		NC_000021.9:32657824:A:G
NM_203446.3(SYNJ1):c.1953-10T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV001092383	21	34038455	21	32666145	1092383	1085627		NC_000021.9:32666144:A:G
NM_203446.3(SYNJ1):c.3270A>G (p.Pro1090=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001091449	21	34018077	21	32645767	1091449	1085622		NC_000021.9:32645766:T:C
NM_203446.3(SYNJ1):c.981T>C (p.Asp327=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV001089846	21	34058195	21	32685885	1089846	1085631		NC_000021.9:32685884:A:G
NM_203446.3(SYNJ1):c.162C>T (p.Ser54=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001089580	21	34074320	21	32702010	1089580	1085633		NC_000021.9:32702009:G:A
NM_203446.3(SYNJ1):c.2757G>T (p.Leu919=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV001088259	21	34029035	21	32656725	1088259	1085623		NC_000021.9:32656724:C:A
NM_203446.3(SYNJ1):c.2580-7C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, single submitter	VCV001085170	21	34029219	21	32656909	1085170	1085624		NC_000021.9:32656908:G:A
NM_203446.3(SYNJ1):c.1671A>G (p.Thr557=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV001084481	21	34045705	21	32673395	1084481	1085628		NC_000021.9:32673394:T:C
NM_203446.3(SYNJ1):c.3915+10A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001084001	21	34011208	21	32638898	1084001	1085616		NC_000021.9:32638897:T:C
NM_203446.3(SYNJ1):c.3517+10C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 28, 2020)	criteria provided, single submitter	VCV001083529	21	34014395	21	32642085	1083529	1085620		NC_000021.9:32642084:G:A
NM_203446.3(SYNJ1):c.1659T>C (p.Phe553=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 16, 2019)	criteria provided, single submitter	VCV001083263	21	34045717	21	32673407	1083263	1085629		NC_000021.9:32673406:A:G
NM_203446.3(SYNJ1):c.3635C>T (p.Ala1212Val)	SYNJ1	A1165V, A1196V, A1212V, A1251V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001082568	21	34012043	21	32639733	1082568	1085619		NC_000021.9:32639732:G:A
NM_203446.3(SYNJ1):c.-61C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV001081943	21	34100295	21	32727984	1081943	1085634		NC_000021.9:32727983:G:A
NM_203446.3(SYNJ1):c.1150T>C (p.Leu384=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV001081409	21	34056398	21	32684088	1081409	1085630		NC_000021.9:32684087:A:G
NM_203446.3(SYNJ1):c.3912G>T (p.Pro1304=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001081128	21	34011221	21	32638911	1081128	1085617		NC_000021.9:32638910:C:A
NM_203446.3(SYNJ1):c.3753T>G (p.Ser1251=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001079551	21	34011380	21	32639070	1079551	1085618		NC_000021.9:32639069:A:C
NM_203446.3(SYNJ1):c.*459A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV001078685	21	34003656	21	32631346	1078685	1085615		NC_000021.9:32631345:T:C
NM_203446.3(SYNJ1):c.2439G>A (p.Arg813=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV001077637	21	34030048	21	32657738	1077637	1085625		NC_000021.9:32657737:C:T
NM_203446.3(SYNJ1):c.948+7A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001077636	21	34059281	21	32686971	1077636	1085632		NC_000021.9:32686970:T:C
NM_203446.3(SYNJ1):c.3865C>T (p.Arg1289Ter)	SYNJ1	R1242*, R1273*, R1289*, R1328*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001076901	21	34011268	21	32638958	1076901	1064882		NC_000021.9:32638957:G:A
NM_203446.3(SYNJ1):c.2603T>C (p.Ile868Thr)	SYNJ1	I863T, I868T, I907T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001063784	21	34029189	21	32656879	1063784	1051848		NC_000021.9:32656878:A:G
NM_203446.3(SYNJ1):c.121C>T (p.Leu41Phe)	SYNJ1	L41F, L80F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001062858	21	34099086	21	32726775	1062858	1051859		NC_000021.9:32726774:G:A
NM_203446.3(SYNJ1):c.455A>G (p.Gln152Arg)	SYNJ1	Q152R, Q191R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV001060872	21	34072172	21	32699862	1060872	1051857		NC_000021.9:32699861:T:C
NM_203446.3(SYNJ1):c.*89C>T	SYNJ1	A1287V, A1373V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001059946	21	34004026	21	32631716	1059946	1051841		NC_000021.9:32631715:G:A
NM_203446.3(SYNJ1):c.-23+3G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001059706	21	34100254	21	32727943	1059706	1051860		NC_000021.9:32727942:C:T
NM_203446.3(SYNJ1):c.*598C>A	SYNJ1	L1457M, L1543M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV001059323	21	34003517	21	32631207	1059323	1051839		NC_000021.9:32631206:G:T
NM_203446.3(SYNJ1):c.3598C>T (p.Pro1200Ser)	SYNJ1	P1153S, P1184S, P1200S, P1239S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001058703	21	34012080	21	32639770	1058703	1051845		NC_000021.9:32639769:G:A
NM_203446.3(SYNJ1):c.741A>G (p.Ile247Met)	SYNJ1	I247M, I286M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV001057776	21	34066586	21	32694276	1057776	1051855		NC_000021.9:32694275:T:C
NM_203446.3(SYNJ1):c.2201G>A (p.Arg734Gln)	SYNJ1	R729Q, R734Q, R773Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001057755	21	34037326	21	32665016	1057755	1051850		NC_000021.9:32665015:C:T
NM_203446.3(SYNJ1):c.2525C>A (p.Thr842Asn)	SYNJ1	T837N, T842N, T881N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001057509	21	34029367	21	32657057	1057509	1051849		NC_000021.9:32657056:G:T
NM_203446.3(SYNJ1):c.988A>T (p.Met330Leu)	SYNJ1	M330L, M369L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001056959	21	34058188	21	32685878	1056959	1051853		NC_000021.9:32685877:T:A
NM_203446.3(SYNJ1):c.2113A>T (p.Ile705Leu)	SYNJ1	I700L, I705L, I744L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001056898	21	34038285	21	32665975	1056898	1051851		NC_000021.9:32665974:T:A
NM_203446.3(SYNJ1):c.3832C>A (p.Pro1278Thr)	SYNJ1	P1231T, P1262T, P1278T, P1317T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001056884	21	34011301	21	32638991	1056884	1051843		NC_000021.9:32638990:G:T
NM_203446.3(SYNJ1):c.3604G>T (p.Ala1202Ser)	SYNJ1	A1155S, A1186S, A1202S, A1241S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001055785	21	34012074	21	32639764	1055785	1051844		NC_000021.9:32639763:C:A
NM_203446.3(SYNJ1):c.193G>A (p.Val65Ile)	SYNJ1	V104I, V65I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001055087	21	34074289	21	32701979	1055087	1051858		NC_000021.9:32701978:C:T
NM_203446.3(SYNJ1):c.2786T>G (p.Ile929Arg)	SYNJ1	I924R, I929R, I968R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001054047	21	34029006	21	32656696	1054047	1051847		NC_000021.9:32656695:A:C
NM_203446.3(SYNJ1):c.*119C>T	SYNJ1	T1297M, T1383M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001053673	21	34003996	21	32631686	1053673	1051840		NC_000021.9:32631685:G:A
NM_203446.3(SYNJ1):c.856T>C (p.Phe286Leu)	SYNJ1	F286L, F325L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001053057	21	34059380	21	32687070	1053057	1051854		NC_000021.9:32687069:A:G
NM_203446.3(SYNJ1):c.1370G>A (p.Arg457His)	SYNJ1	R457H, R460H, R496H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001052149	21	34051095	21	32678785	1052149	1051852		NC_000021.9:32678784:C:T
NM_203446.3(SYNJ1):c.559G>A (p.Val187Ile)	SYNJ1	V187I, V226I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001052026	21	34067513	21	32695203	1052026	1051856		NC_000021.9:32695202:C:T
NM_203446.3(SYNJ1):c.*88G>C	SYNJ1	A1287P, A1373P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001051293	21	34004027	21	32631717	1051293	1051842		NC_000021.9:32631716:C:G
NM_203446.3(SYNJ1):c.952C>A (p.His318Asn)	SYNJ1	H357N, H318N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001046811	21	34058224	21	32685914	1046811	1034876		NC_000021.9:32685913:G:T
NM_203446.3(SYNJ1):c.3475G>A (p.Glu1159Lys)	SYNJ1	E1198K, E1159K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001044826	21	34015723	21	32643413	1044826	1034868		NC_000021.9:32643412:C:T
NM_203446.3(SYNJ1):c.*265C>A	SYNJ1	P1346T, P1432T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001044768	21	34003850	21	32631540	1044768	1034864		NC_000021.9:32631539:G:T
NM_203446.3(SYNJ1):c.*195T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001044445	21	34003920	21	32631610	1044445	1034865		NC_000021.9:32631609:A:C
NM_203446.3(SYNJ1):c.3806C>G (p.Ala1269Gly)	SYNJ1	A1222G, A1253G, A1269G, A1308G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001044285	21	34011327	21	32639017	1044285	1034866		NC_000021.9:32639016:G:C
NM_203446.3(SYNJ1):c.2608A>G (p.Ile870Val)	SYNJ1	I909V, I865V, I870V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001044033	21	34029184	21	32656874	1044033	1034871		NC_000021.9:32656873:T:C
NM_203446.3(SYNJ1):c.2372A>G (p.Asp791Gly)	SYNJ1	D786G, D830G, D791G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001043701	21	34030115	21	32657805	1043701	1034872		NC_000021.9:32657804:T:C
NM_203446.3(SYNJ1):c.*295A>G	SYNJ1	T1356A, T1442A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001042375	21	34003820	21	32631510	1042375	1034863		NC_000021.9:32631509:T:C
NM_203446.3(SYNJ1):c.1868A>G (p.Asn623Ser)	SYNJ1	N623S, N662S, N618S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001042251	21	34038827	21	32666517	1042251	1034873		NC_000021.9:32666516:T:C
NM_203446.3(SYNJ1):c.-83A>G	SYNJ1	D12G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001041856	21	34100317	21	32728006	1041856	1034881		NC_000021.9:32728005:T:C
NM_203446.3(SYNJ1):c.3688A>C (p.Thr1230Pro)	SYNJ1	T1214P, T1230P, T1183P, T1269P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV001040229	21	34011990	21	32639680	1040229	1034867		NC_000021.9:32639679:T:G
NM_203446.3(SYNJ1):c.3266A>G (p.Gln1089Arg)	SYNJ1	Q1089R, Q1128R, Q1084R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001039933	21	34018081	21	32645771	1039933	1034869		NC_000021.9:32645770:T:C
NM_203446.3(SYNJ1):c.1825A>C (p.Lys609Gln)	SYNJ1	K604Q, K648Q, K609Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001038345	21	34038870	21	32666560	1038345	1034874		NC_000021.9:32666559:T:G
NM_203446.3(SYNJ1):c.*755C>T	SYNJ1	P1509L, P1595L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001038118	21	34003360	21	32631050	1038118	1034862		NC_000021.9:32631049:G:A
NM_203446.3(SYNJ1):c.887A>G (p.Gln296Arg)	SYNJ1	Q296R, Q335R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001037836	21	34059349	21	32687039	1037836	1034877		NC_000021.9:32687038:T:C
NM_203446.3(SYNJ1):c.-23G>C	SYNJ1	R32T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001037566	21	34100257	21	32727946	1037566	1034880		NC_000021.9:32727945:C:G
NM_203446.3(SYNJ1):c.161C>T (p.Ser54Phe)	SYNJ1	S54F, S93F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001037081	21	34074321	21	32702011	1037081	1034878		NC_000021.9:32702010:G:A
NM_203446.3(SYNJ1):c.96G>A (p.Met32Ile)	SYNJ1	M71I, M32I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001035303	21	34099111	21	32726800	1035303	1034879		NC_000021.9:32726799:C:T
NM_203446.3(SYNJ1):c.1265A>C (p.Gln422Pro)	SYNJ1	Q461P, Q422P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001035021	21	34053894	21	32681584	1035021	1034875		NC_000021.9:32681583:T:G
NM_203446.3(SYNJ1):c.3007G>A (p.Ala1003Thr)	SYNJ1	A998T, A1042T, A1003T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 19, 2020)	criteria provided, single submitter	VCV001034741	21	34022524	21	32650214	1034741	1034870		NC_000021.9:32650213:C:T
NM_203446.3(SYNJ1):c.359G>A (p.Arg120Gln)	SYNJ1	R120Q, R159Q	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV001026655	21	34072268	21	32699958	1026655	1014308		NC_000021.9:32699957:C:T
NM_203446.3(SYNJ1):c.2446C>T (p.Pro816Ser)	SYNJ1	P811S, P816S, P855S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001026478	21	34030041	21	32657731	1026478	1014296		NC_000021.9:32657730:G:A
NM_203446.3(SYNJ1):c.3355C>A (p.Arg1119Ser)	SYNJ1	R1114S, R1119S, R1158S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001026362	21	34017992	21	32645682	1026362	1014292		NC_000021.9:32645681:G:T
NM_203446.3(SYNJ1):c.3680C>G (p.Thr1227Arg)	SYNJ1	T1180R, T1211R, T1227R, T1266R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001025770	21	34011998	21	32639688	1025770	1014289		NC_000021.9:32639687:G:C
NM_203446.3(SYNJ1):c.*668A>C	SYNJ1	N1480T, N1566T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001025546	21	34003447	21	32631137	1025546	1014280		NC_000021.9:32631136:T:G
NM_203446.3(SYNJ1):c.*319G>C	SYNJ1	A1364P, A1450P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001024664	21	34003796	21	32631486	1024664	1014281		NC_000021.9:32631485:C:G
NM_203446.3(SYNJ1):c.-23G>A	SYNJ1	R32K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001024247	21	34100257	21	32727946	1024247	1014310		NC_000021.9:32727945:C:T
NM_203446.3(SYNJ1):c.1427T>C (p.Ile476Thr)	SYNJ1	I476T, I479T, I515T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001023898	21	34051038	21	32678728	1023898	1014299		NC_000021.9:32678727:A:G
NM_203446.3(SYNJ1):c.*257G>A	SYNJ1	R1343Q, R1429Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001023642	21	34003858	21	32631548	1023642	1014283		NC_000021.9:32631547:C:T
NM_203446.3(SYNJ1):c.*309T>G	SYNJ1	S1360R, S1446R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001023572	21	34003806	21	32631496	1023572	1014282		NC_000021.9:32631495:A:C
NM_203446.3(SYNJ1):c.3873G>T (p.Arg1291Ser)	SYNJ1	R1244S, R1275S, R1291S, R1330S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001023024	21	34011260	21	32638950	1023024	1014286		NC_000021.9:32638949:C:A
NM_203446.3(SYNJ1):c.*110C>T	SYNJ1	S1294F, S1380F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001022955	21	34004005	21	32631695	1022955	1014285		NC_000021.9:32631694:G:A
NM_203446.3(SYNJ1):c.601G>T (p.Ala201Ser)	SYNJ1	A201S, A240S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001022534	21	34067471	21	32695161	1022534	1014302		NC_000021.9:32695160:C:A
NM_203446.3(SYNJ1):c.2125C>G (p.Arg709Gly)	SYNJ1	R704G, R709G, R748G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV001022461	21	34038273	21	32665963	1022461	1014297		NC_000021.9:32665962:G:C
NM_203446.3(SYNJ1):c.3637C>T (p.Arg1213Trp)	SYNJ1	R1166W, R1197W, R1213W, R1252W	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001020401	21	34012041	21	32639731	1020401	1014290		NC_000021.9:32639730:G:A
NM_203446.3(SYNJ1):c.437A>G (p.His146Arg)	SYNJ1	H146R, H185R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001020033	21	34072190	21	32699880	1020033	1014307		NC_000021.9:32699879:T:C
NM_203446.3(SYNJ1):c.-30A>G	SYNJ1	R30G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001019696	21	34100264	21	32727953	1019696	1014311		NC_000021.9:32727952:T:C
NM_203446.3(SYNJ1):c.1701G>C (p.Lys567Asn)	SYNJ1	K562N, K567N, K606N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001019669	21	34045675	21	32673365	1019669	1014298		NC_000021.9:32673364:C:G
NM_203446.3(SYNJ1):c.3296C>T (p.Pro1099Leu)	SYNJ1	P1094L, P1099L, P1138L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001019084	21	34018051	21	32645741	1019084	1014293		NC_000021.9:32645740:G:A
NM_203446.3(SYNJ1):c.574A>G (p.Ile192Val)	SYNJ1	I192V, I231V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV001018958	21	34067498	21	32695188	1018958	1014303		NC_000021.9:32695187:T:C
NM_203446.3(SYNJ1):c.3249T>G (p.Ser1083Arg)	SYNJ1	S1078R, S1083R, S1122R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001017909	21	34018098	21	32645788	1017909	1014294		NC_000021.9:32645787:A:C
NM_203446.3(SYNJ1):c.549G>A (p.Met183Ile)	SYNJ1	M183I, M222I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001016682	21	34067523	21	32695213	1016682	1014304		NC_000021.9:32695212:C:T
NM_203446.3(SYNJ1):c.3409C>T (p.Pro1137Ser)	SYNJ1	P1137S, P1176S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001016679	21	34017299	21	32644989	1016679	1014291		NC_000021.9:32644988:G:A
NM_203446.3(SYNJ1):c.528T>A (p.Asp176Glu)	SYNJ1	D176E, D215E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 3, 2020)	criteria provided, single submitter	VCV001016420	21	34067544	21	32695234	1016420	1014305		NC_000021.9:32695233:A:T
NM_203446.3(SYNJ1):c.3866G>C (p.Arg1289Pro)	SYNJ1	R1242P, R1273P, R1289P, R1328P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001016371	21	34011267	21	32638957	1016371	1014287		NC_000021.9:32638956:C:G
NM_203446.3(SYNJ1):c.3796C>T (p.Pro1266Ser)	SYNJ1	P1219S, P1250S, P1266S, P1305S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001016247	21	34011337	21	32639027	1016247	1014288		NC_000021.9:32639026:G:A
NM_203446.3(SYNJ1):c.1315A>G (p.Ile439Val)	SYNJ1	I439V, I478V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV001016131	21	34053844	21	32681534	1016131	1014301		NC_000021.9:32681533:T:C
NM_203446.3(SYNJ1):c.2861T>G (p.Leu954Arg)	SYNJ1	L949R, L954R, L993R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001016093	21	34025611	21	32653301	1016093	1014295		NC_000021.9:32653300:A:C
NM_203446.3(SYNJ1):c.1400T>A (p.Phe467Tyr)	SYNJ1	F467Y, F470Y, F506Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV001015083	21	34051065	21	32678755	1015083	1014300		NC_000021.9:32678754:A:T
NM_203446.3(SYNJ1):c.-43G>C	SYNJ1	R25S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001014911	21	34100277	21	32727966	1014911	1014312		NC_000021.9:32727965:C:G
NM_203446.3(SYNJ1):c.440G>A (p.Arg147His)	SYNJ1	R147H, R186H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001014566	21	34072187	21	32699877	1014566	1014306		NC_000021.9:32699876:C:T
NM_203446.3(SYNJ1):c.4G>A (p.Ala2Thr)	SYNJ1	A2T, A41T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001014043	21	34099203	21	32726892	1014043	1014309		NC_000021.9:32726891:C:T
NM_203446.3(SYNJ1):c.1399T>C (p.Phe467Leu)	SYNJ1	F467L, F470L, F506L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001011703	21	34051066	21	32678756	1011703	999149		NC_000021.9:32678755:A:G
NM_003895.3(SYNJ1):c.13T>C (p.Trp5Arg)	SYNJ1	W5R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001010675	21	34100339	21	32728028	1010675	999160		NC_000021.9:32728027:A:G
NM_203446.3(SYNJ1):c.225A>C (p.Leu75Phe)	SYNJ1	L114F, L75F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001010606	21	34072402	21	32700092	1010606	999156		NC_000021.9:32700091:T:G
NM_203446.3(SYNJ1):c.2332G>A (p.Val778Ile)	SYNJ1	V773I, V778I, V817I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001010158	21	34030155	21	32657845	1010158	999146		NC_000021.9:32657844:C:T
NM_203446.3(SYNJ1):c.948G>C (p.Gln316His)	SYNJ1	Q316H, Q355H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001009571	21	34059288	21	32686978	1009571	999150		NC_000021.9:32686977:C:G
NM_203446.3(SYNJ1):c.156A>G (p.Thr52=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001009506	21	34074326	21	32702016	1009506	999157		NC_000021.9:32702015:T:C
NM_203446.3(SYNJ1):c.517G>A (p.Val173Met)	SYNJ1	V173M, V212M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV001005847	21	34067555	21	32695245	1005847	999154		NC_000021.9:32695244:C:T
NM_203446.3(SYNJ1):c.3749A>T (p.Gln1250Leu)	SYNJ1	Q1203L, Q1234L, Q1250L, Q1289L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV001005510	21	34011384	21	32639074	1005510	999143		NC_000021.9:32639073:T:A
NM_203446.3(SYNJ1):c.*526G>A	SYNJ1	G1433R, G1519R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001005279	21	34003589	21	32631279	1005279	999140		NC_000021.9:32631278:C:T
NM_203446.3(SYNJ1):c.1601G>A (p.Arg534Gln)	SYNJ1	R529Q, R534Q, R573Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001004293	21	34045775	21	32673465	1004293	999148		NC_000021.9:32673464:C:T
NM_203446.3(SYNJ1):c.344G>A (p.Arg115His)	SYNJ1	R115H, R154H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001003992	21	34072283	21	32699973	1003992	999155		NC_000021.9:32699972:C:T
NM_203446.3(SYNJ1):c.842C>T (p.Ala281Val)	SYNJ1	A281V, A320V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001002258	21	34060625	21	32688315	1002258	999151		NC_000021.9:32688314:G:A
NM_203446.3(SYNJ1):c.3560G>A (p.Gly1187Glu)	SYNJ1	G1140E, G1171E, G1187E, G1226E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001002142	21	34014234	21	32641924	1002142	999144		NC_000021.9:32641923:C:T
NM_203446.3(SYNJ1):c.809G>T (p.Arg270Leu)	SYNJ1	R270L, R309L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001000830	21	34060658	21	32688348	1000830	999152		NC_000021.9:32688347:C:A
NM_203446.3(SYNJ1):c.2050T>G (p.Cys684Gly)	SYNJ1	C679G, C684G, C723G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001000814	21	34038348	21	32666038	1000814	999147		NC_000021.9:32666037:A:C
NM_203446.3(SYNJ1):c.3391+6A>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001000406	21	34017950	21	32645640	1000406	999145		NC_000021.9:32645639:T:G
NM_203446.3(SYNJ1):c.46C>T (p.Pro16Ser)	SYNJ1	P16S, P55S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV000999277	21	34099161	21	32726850	999277	999158		NC_000021.9:32726849:G:A
NM_203446.3(SYNJ1):c.549G>T (p.Met183Ile)	SYNJ1	M183I, M222I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV000999098	21	34067523	21	32695213	999098	999153		NC_000021.9:32695212:C:A
NM_203446.3(SYNJ1):c.-57T>G	SYNJ1	C21G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000998439	21	34100291	21	32727980	998439	999159		NC_000021.9:32727979:A:C
NM_203446.3(SYNJ1):c.577T>C (p.Tyr193His)	SYNJ1	Y193H, Y232H	Parkinson disease 20, early-onset	Uncertain significance	criteria provided, single submitter	VCV000992918	21	34067495	21	32695185	992918	980856		NC_000021.9:32695184:A:G
NM_203446.3(SYNJ1):c.3359C>T (p.Pro1120Leu)	SYNJ1	P1120L, P1115L, P1159L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000978523	21	34017988	21	32645678	978523	575149	rs773242399	NC_000021.9:32645677:G:A
NM_203446.3(SYNJ1):c.1367C>A (p.Ala456Asp)	SYNJ1	A456D, A459D, A495D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000972193	21	34051098	21	32678788	972193	958939		NC_000021.9:32678787:G:T
NM_203446.3(SYNJ1):c.3602G>A (p.Arg1201His)	SYNJ1	R1154H, R1240H, R1185H, R1201H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000970653	21	34012076	21	32639766	970653	958934		NC_000021.9:32639765:C:T
NM_203446.3(SYNJ1):c.2744T>G (p.Ile915Ser)	SYNJ1	I910S, I954S, I915S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV000970332	21	34029048	21	32656738	970332	958937		NC_000021.9:32656737:A:C
NM_203446.3(SYNJ1):c.1886C>T (p.Ala629Val)	SYNJ1	A629V, A624V, A668V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000970028	21	34038809	21	32666499	970028	958938		NC_000021.9:32666498:G:A
NM_203446.3(SYNJ1):c.3340G>A (p.Val1114Ile)	SYNJ1	V1109I, V1114I, V1153I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV000969879	21	34018007	21	32645697	969879	958935		NC_000021.9:32645696:C:T
NM_203446.3(SYNJ1):c.542G>A (p.Arg181His)	SYNJ1	R181H, R220H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV000969151	21	34067530	21	32695220	969151	958941		NC_000021.9:32695219:C:T
NM_203446.3(SYNJ1):c.2760G>C (p.Gln920His)	SYNJ1	Q920H, Q915H, Q959H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000968963	21	34029032	21	32656722	968963	958936		NC_000021.9:32656721:C:G
NM_203446.3(SYNJ1):c.889A>G (p.Ile297Val)	SYNJ1	I297V, I336V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV000967394	21	34059347	21	32687037	967394	958940		NC_000021.9:32687036:T:C
NM_203446.3(SYNJ1):c.*485A>T	SYNJ1	D1505V, D1419V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000966535	21	34003630	21	32631320	966535	958933		NC_000021.9:32631319:T:A
NM_203446.3(SYNJ1):c.1812-10T>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV000965674	21	34038893	21	32666583	965674	960950		NC_000021.9:32666582:A:T
NM_203446.3(SYNJ1):c.*763A>G	SYNJ1	T1512A, T1598A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000965663	21	34003352	21	32631042	965663	958932		NC_000021.9:32631041:T:C
NM_203446.3(SYNJ1):c.*806G>C	SYNJ1	R1612T, R1526T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000964521	21	34003309	21	32630999	964521	951192		NC_000021.9:32630998:C:G
NM_203446.3(SYNJ1):c.2524A>G (p.Thr842Ala)	SYNJ1	T842A, T837A, T881A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV000963122	21	34029368	21	32657058	963122	951201		NC_000021.9:32657057:T:C
NM_203446.3(SYNJ1):c.3476A>T (p.Glu1159Val)	SYNJ1	E1198V, E1159V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV000962874	21	34015722	21	32643412	962874	951199		NC_000021.9:32643411:T:A
NM_203446.3(SYNJ1):c.789+1G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely pathogenic(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV000962464	21	34066537	21	32694227	962464	960325		NC_000021.9:32694226:C:T
NM_203446.3(SYNJ1):c.*541G>A	SYNJ1	E1438K, E1524K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000961882	21	34003574	21	32631264	961882	951196		NC_000021.9:32631263:C:T
NM_203446.3(SYNJ1):c.*412C>G	SYNJ1	P1481A, P1395A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000961830	21	34003703	21	32631393	961830	951197		NC_000021.9:32631392:G:C
NM_203446.3(SYNJ1):c.-56G>T	SYNJ1	C21F	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000961827	21	34100290	21	32727979	961827	951207		NC_000021.9:32727978:C:A
NM_203446.3(SYNJ1):c.841G>C (p.Ala281Pro)	SYNJ1	A281P, A320P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV000961375	21	34060626	21	32688316	961375	951204		NC_000021.9:32688315:C:G
NM_203446.3(SYNJ1):c.2902T>G (p.Leu968Val)	SYNJ1	L1007V, L968V, L963V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV000959786	21	34022629	21	32650319	959786	951200		NC_000021.9:32650318:A:C
NM_203446.3(SYNJ1):c.35A>G (p.Lys12Arg)	SYNJ1	K12R, K51R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV000959287	21	34099172	21	32726861	959287	951206		NC_000021.9:32726860:T:C
NM_203446.3(SYNJ1):c.-75G>A	SYNJ1	G15S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 17, 2019)	criteria provided, single submitter	VCV000958535	21	34100309	21	32727998	958535	951209		NC_000021.9:32727997:C:T
NM_203446.3(SYNJ1):c.550T>A (p.Cys184Ser)	SYNJ1	C223S, C184S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000956704	21	34067522	21	32695212	956704	951205		NC_000021.9:32695211:A:T
NM_203446.3(SYNJ1):c.1042C>A (p.His348Asn)	SYNJ1	H348N, H387N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000956460	21	34058134	21	32685824	956460	951203		NC_000021.9:32685823:G:T
NM_203446.3(SYNJ1):c.*613A>C	SYNJ1	S1462R, S1548R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000956367	21	34003502	21	32631192	956367	951195		NC_000021.9:32631191:T:G
NM_203446.3(SYNJ1):c.*100G>T	SYNJ1	A1291S, A1377S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000954583	21	34004015	21	32631705	954583	951198		NC_000021.9:32631704:C:A
NM_203446.3(SYNJ1):c.1046G>T (p.Ser349Ile)	SYNJ1	S349I, S388I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000954122	21	34058130	21	32685820	954122	951202		NC_000021.9:32685819:C:A
NM_203446.3(SYNJ1):c.-63G>A	SYNJ1	G19S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000954119	21	34100297	21	32727986	954119	951208		NC_000021.9:32727985:C:T
NM_203446.3(SYNJ1):c.*704C>G	SYNJ1	P1492R, P1578R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000953612	21	34003411	21	32631101	953612	951194		NC_000021.9:32631100:G:C
NM_203446.3(SYNJ1):c.1846C>A (p.Gln616Lys)	SYNJ1	Q616K, Q655K, Q611K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 5, 2019)	criteria provided, single submitter	VCV000952808	21	34038849	21	32666539	952808	929298		NC_000021.9:32666538:G:T
NM_203446.3(SYNJ1):c.*806G>A	SYNJ1	R1526K, R1612K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 19, 2019)	criteria provided, single submitter	VCV000952732	21	34003309	21	32630999	952732	929282		NC_000021.9:32630998:C:T
NM_203446.3(SYNJ1):c.-89G>T	SYNJ1	G10V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000952376	21	34100323	21	32728012	952376	929303		NC_000021.9:32728011:C:A
NM_203446.3(SYNJ1):c.*709C>T	SYNJ1	P1494S, P1580S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000951974	21	34003406	21	32631096	951974	929285		NC_000021.9:32631095:G:A
NM_203446.3(SYNJ1):c.*602G>A	SYNJ1	G1544D, G1458D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2020)	criteria provided, single submitter	VCV000951973	21	34003513	21	32631203	951973	929287		NC_000021.9:32631202:C:T
NM_203446.3(SYNJ1):c.-29G>A	SYNJ1	R30K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000951416	21	34100263	21	32727952	951416	929301		NC_000021.9:32727951:C:T
NM_203446.3(SYNJ1):c.443G>A (p.Ser148Asn)	SYNJ1	S148N, S187N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000951273	21	34072184	21	32699874	951273	929299		NC_000021.9:32699873:C:T
NM_203446.3(SYNJ1):c.2609T>C (p.Ile870Thr)	SYNJ1	I870T, I909T, I865T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV000950655	21	34029183	21	32656873	950655	929296		NC_000021.9:32656872:A:G
NM_203446.3(SYNJ1):c.3481C>G (p.Pro1161Ala)	SYNJ1	P1161A, P1145A, P1200A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000950300	21	34014441	21	32642131	950300	929291		NC_000021.9:32642130:G:C
NM_203446.3(SYNJ1):c.*158A>G	SYNJ1	Q1310R, Q1396R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000949578	21	34003957	21	32631647	949578	929289		NC_000021.9:32631646:T:C
NM_203446.3(SYNJ1):c.3673A>T (p.Ser1225Cys)	SYNJ1	S1178C, S1209C, S1264C, S1225C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000949440	21	34012005	21	32639695	949440	929290		NC_000021.9:32639694:T:A
NM_203446.3(SYNJ1):c.*737C>G	SYNJ1	T1503S, T1589S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000948839	21	34003378	21	32631068	948839	929283		NC_000021.9:32631067:G:C
NM_203446.3(SYNJ1):c.3181G>C (p.Val1061Leu)	SYNJ1	V1100L, V1056L, V1061L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV000948127	21	34018769	21	32646459	948127	929293		NC_000021.9:32646458:C:G
NM_203446.3(SYNJ1):c.*469T>C	SYNJ1	F1414L, F1500L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000947823	21	34003646	21	32631336	947823	929288		NC_000021.9:32631335:A:G
NM_203446.3(SYNJ1):c.*733G>A	SYNJ1	G1502S, G1588S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV000946789	21	34003382	21	32631072	946789	929284		NC_000021.9:32631071:C:T
NM_203446.3(SYNJ1):c.1353+5A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000946737	21	34053801	21	32681491	946737	941257		NC_000021.9:32681490:T:C
NM_203446.3(SYNJ1):c.2708C>G (p.Ser903Cys)	SYNJ1	S942C, S898C, S903C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000945946	21	34029084	21	32656774	945946	929295		NC_000021.9:32656773:G:C
NM_203446.3(SYNJ1):c.-60G>T	SYNJ1	G20C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000945173	21	34100294	21	32727983	945173	929302		NC_000021.9:32727982:C:A
NM_203446.3(SYNJ1):c.1961C>T (p.Ala654Val)	SYNJ1	A693V, A654V, A649V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000945015	21	34038437	21	32666127	945015	929297		NC_000021.9:32666126:G:A
NM_203446.3(SYNJ1):c.*689C>T	SYNJ1	P1487L, P1573L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000944936	21	34003426	21	32631116	944936	929286		NC_000021.9:32631115:G:A
NM_203446.3(SYNJ1):c.434C>T (p.Ala145Val)	SYNJ1	A184V, A145V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000944403	21	34072193	21	32699883	944403	929300		NC_000021.9:32699882:G:A
NM_203446.3(SYNJ1):c.790-6T>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 6, 2019)	criteria provided, single submitter	VCV000944369	21	34060683	21	32688373	944369	941258		NC_000021.9:32688372:A:C
NM_203446.3(SYNJ1):c.53T>A (p.Phe18Tyr)	SYNJ1	F57Y, F18Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 6, 2019)	criteria provided, single submitter	VCV000943891	21	34099154	21	32726843	943891	939081		NC_000021.9:32726842:A:T
NM_203446.3(SYNJ1):c.*676T>C	SYNJ1	F1569L, F1483L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000943773	21	34003439	21	32631129	943773	939069		NC_000021.9:32631128:A:G
NM_203446.3(SYNJ1):c.3764C>T (p.Pro1255Leu)	SYNJ1	P1294L, P1208L, P1255L, P1239L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 20, 2019)	criteria provided, single submitter	VCV000941115	21	34011369	21	32639059	941115	939072		NC_000021.9:32639058:G:A
NM_203446.3(SYNJ1):c.1867A>G (p.Asn623Asp)	SYNJ1	N618D, N623D, N662D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000940831	21	34038828	21	32666518	940831	939074		NC_000021.9:32666517:T:C
NM_203446.3(SYNJ1):c.33C>G (p.His11Gln)	SYNJ1	H50Q, H11Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000940698	21	34099174	21	32726863	940698	939082		NC_000021.9:32726862:G:C
NM_203446.3(SYNJ1):c.592C>A (p.Gln198Lys)	SYNJ1	Q237K, Q198K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, single submitter	VCV000940408	21	34067480	21	32695170	940408	939079		NC_000021.9:32695169:G:T
NM_203446.3(SYNJ1):c.1717G>C (p.Glu573Gln)	SYNJ1	E568Q, E573Q, E612Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000939879	21	34045659	21	32673349	939879	939075		NC_000021.9:32673348:C:G
NM_203446.3(SYNJ1):c.*124C>T	SYNJ1	P1385S, P1299S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV000939861	21	34003991	21	32631681	939861	939070		NC_000021.9:32631680:G:A
NM_203446.3(SYNJ1):c.1465T>G (p.Leu489Val)	SYNJ1	L528V, L492V, L489V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 17, 2019)	criteria provided, single submitter	VCV000939253	21	34051000	21	32678690	939253	939076		NC_000021.9:32678689:A:C
NM_203446.3(SYNJ1):c.749G>A (p.Arg250Gln)	SYNJ1	R250Q, R289Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000938727	21	34066578	21	32694268	938727	939078		NC_000021.9:32694267:C:T
NM_203446.3(SYNJ1):c.862A>C (p.Thr288Pro)	SYNJ1	T288P, T327P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000936901	21	34059374	21	32687064	936901	939077		NC_000021.9:32687063:T:G
NM_203446.3(SYNJ1):c.344G>T (p.Arg115Leu)	SYNJ1	R154L, R115L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 23, 2020)	criteria provided, single submitter	VCV000936877	21	34072283	21	32699973	936877	939080		NC_000021.9:32699972:C:A
NM_203446.3(SYNJ1):c.3364C>T (p.Pro1122Ser)	SYNJ1	P1122S, P1117S, P1161S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000936291	21	34017983	21	32645673	936291	939073		NC_000021.9:32645672:G:A
NM_203446.3(SYNJ1):c.3780G>T (p.Leu1260Phe)	SYNJ1	L1213F, L1260F, L1244F, L1299F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000935179	21	34011353	21	32639043	935179	939071		NC_000021.9:32639042:C:A
NM_203446.3(SYNJ1):c.2668G>C (p.Gly890Arg)	SYNJ1	G885R, G890R, G929R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000864653	21	34029124	21	32656814	864653	848696		NC_000021.9:32656813:C:G
NM_203446.3(SYNJ1):c.2282T>C (p.Ile761Thr)	SYNJ1	I756T, I800T, I761T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000863393	21	34037245	21	32664935	863393	848699		NC_000021.9:32664934:A:G
NM_203446.3(SYNJ1):c.*770C>T	SYNJ1	A1514V, A1600V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000863244	21	34003345	21	32631035	863244	848671		NC_000021.9:32631034:G:A
NM_203446.3(SYNJ1):c.*442A>G	SYNJ1	S1491G, S1405G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000863007	21	34003673	21	32631363	863007	848675		NC_000021.9:32631362:T:C
NM_203446.3(SYNJ1):c.244A>T (p.Thr82Ser)	SYNJ1	T82S, T121S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000862638	21	34072383	21	32700073	862638	848712		NC_000021.9:32700072:T:A
NM_203446.3(SYNJ1):c.3202C>G (p.Pro1068Ala)	SYNJ1	P1068A, P1063A, P1107A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 23, 2019)	criteria provided, single submitter	VCV000862404	21	34018748	21	32646438	862404	848687		NC_000021.9:32646437:G:C
NM_203446.3(SYNJ1):c.407G>A (p.Gly136Asp)	SYNJ1	G136D, G175D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000862230	21	34072220	21	32699910	862230	848709		NC_000021.9:32699909:C:T
NM_203446.3(SYNJ1):c.83A>C (p.Glu28Ala)	SYNJ1	E28A, E67A	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV000861393	21	34099124	21	32726813	861393	848716		NC_000021.9:32726812:T:G
NM_203446.3(SYNJ1):c.*235A>C	SYNJ1	S1336R, S1422R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000861168	21	34003880	21	32631570	861168	848677		NC_000021.9:32631569:T:G
NM_203446.3(SYNJ1):c.3036A>C (p.Glu1012Asp)	SYNJ1	E1051D, E1007D, E1012D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000860291	21	34022495	21	32650185	860291	848691		NC_000021.9:32650184:T:G
NM_203446.3(SYNJ1):c.2782G>A (p.Val928Ile)	SYNJ1	V923I, V928I, V967I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000859863	21	34029010	21	32656700	859863	848694		NC_000021.9:32656699:C:T
NM_203446.3(SYNJ1):c.356T>C (p.Val119Ala)	SYNJ1	V119A, V158A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000859361	21	34072271	21	32699961	859361	848710		NC_000021.9:32699960:A:G
NM_203446.3(SYNJ1):c.2525C>T (p.Thr842Ile)	SYNJ1	T837I, T842I, T881I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000859350	21	34029367	21	32657057	859350	848697		NC_000021.9:32657056:G:A
NM_203446.3(SYNJ1):c.*807A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000858730	21	34003308	21	32630998	858730	848670		NC_000021.9:32630997:T:C
NM_203446.3(SYNJ1):c.3175G>A (p.Gly1059Ser)	SYNJ1	G1098S, G1054S, G1059S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 6, 2019)	criteria provided, single submitter	VCV000858529	21	34018775	21	32646465	858529	848688		NC_000021.9:32646464:C:T
NM_203446.3(SYNJ1):c.2236A>C (p.Ile746Leu)	SYNJ1	I746L, I741L, I785L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV000858033	21	34037291	21	32664981	858033	848700		NC_000021.9:32664980:T:G
NM_203446.3(SYNJ1):c.3352A>G (p.Thr1118Ala)	SYNJ1	T1157A, T1118A, T1113A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV000857362	21	34017995	21	32645685	857362	848685		NC_000021.9:32645684:T:C
NM_203446.3(SYNJ1):c.2814G>A (p.Met938Ile)	SYNJ1	M938I, M933I, M977I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000856645	21	34025658	21	32653348	856645	848693		NC_000021.9:32653347:C:T
NM_203446.3(SYNJ1):c.1534+5A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000856584	21	34048637	21	32676327	856584	852914		NC_000021.9:32676326:T:C
NM_203446.3(SYNJ1):c.3368C>A (p.Pro1123Gln)	SYNJ1	P1123Q, P1118Q, P1162Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV000856384	21	34017979	21	32645669	856384	848684		NC_000021.9:32645668:G:T
NM_203446.3(SYNJ1):c.3248-6T>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000855423	21	34018105	21	32645795	855423	851857		NC_000021.9:32645794:A:C
NM_203446.3(SYNJ1):c.3042T>A (p.Asp1014Glu)	SYNJ1	D1053E, D1009E, D1014E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000855210	21	34018908	21	32646598	855210	848690		NC_000021.9:32646597:A:T
NM_203446.3(SYNJ1):c.*712C>T	SYNJ1	P1495S, P1581S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000854482	21	34003403	21	32631093	854482	848672		NC_000021.9:32631092:G:A
NM_203446.3(SYNJ1):c.3915+5G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000854383	21	34011213	21	32638903	854383	852396		NC_000021.9:32638902:C:T
NM_203446.3(SYNJ1):c.1349C>A (p.Ala450Glu)	SYNJ1	A450E, A489E	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 4, 2019)	criteria provided, single submitter	VCV000854207	21	34053810	21	32681500	854207	848705		NC_000021.9:32681499:G:T
NM_203446.3(SYNJ1):c.1835C>A (p.Ala612Asp)	SYNJ1	A612D, A607D, A651D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000854051	21	34038860	21	32666550	854051	848704		NC_000021.9:32666549:G:T
NM_203446.3(SYNJ1):c.-81G>T	SYNJ1	A13S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000852777	21	34100315	21	32728004	852777	848720		NC_000021.9:32728003:C:A
NM_203446.3(SYNJ1):c.212G>A (p.Gly71Asp)	SYNJ1	G110D, G71D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 24, 2020)	criteria provided, single submitter	VCV000852235	21	34072415	21	32700105	852235	848714		NC_000021.9:32700104:C:T
NM_203446.3(SYNJ1):c.*638C>T	SYNJ1	T1556I, T1470I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000852145	21	34003477	21	32631167	852145	848673		NC_000021.9:32631166:G:A
NM_203446.3(SYNJ1):c.220A>G (p.Met74Val)	SYNJ1	M74V, M113V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000852144	21	34072407	21	32700097	852144	848713		NC_000021.9:32700096:T:C
NM_203446.3(SYNJ1):c.3584G>C (p.Arg1195Thr)	SYNJ1	R1179T, R1148T, R1195T, R1234T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV000850502	21	34014210	21	32641900	850502	848680		NC_000021.9:32641899:C:G
NM_203446.3(SYNJ1):c.133G>A (p.Glu45Lys)	SYNJ1	E45K, E84K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 12, 2020)	criteria provided, single submitter	VCV000850483	21	34074349	21	32702039	850483	848715		NC_000021.9:32702038:C:T
NM_203446.3(SYNJ1):c.3547C>G (p.Leu1183Val)	SYNJ1	L1136V, L1222V, L1167V, L1183V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000849387	21	34014247	21	32641937	849387	848681		NC_000021.9:32641936:G:C
NM_203446.3(SYNJ1):c.1157G>A (p.Cys386Tyr)	SYNJ1	C386Y, C425Y	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000849125	21	34056391	21	32684081	849125	848706		NC_000021.9:32684080:C:T
NM_203446.3(SYNJ1):c.*256C>T	SYNJ1	R1343*, R1429*	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000848334	21	34003859	21	32631549	848334	848676		NC_000021.9:32631548:G:A
NM_203446.3(SYNJ1):c.29A>G (p.Tyr10Cys)	SYNJ1	Y10C, Y49C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000848124	21	34099178	21	32726867	848124	848717		NC_000021.9:32726866:T:C
NM_203446.3(SYNJ1):c.1957G>A (p.Val653Ile)	SYNJ1	V653I, V692I, V648I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000847083	21	34038441	21	32666131	847083	573749		NC_000021.9:32666130:C:T
NM_203446.3(SYNJ1):c.564A>C (p.Glu188Asp)	SYNJ1	E227D, E188D	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000846518	21	34067508	21	32695198	846518	848708		NC_000021.9:32695197:T:G
NM_203446.3(SYNJ1):c.3347C>T (p.Pro1116Leu)	SYNJ1	P1111L, P1155L, P1116L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000846437	21	34018000	21	32645690	846437	848686		NC_000021.9:32645689:G:A
NM_203446.3(SYNJ1):c.1126A>G (p.Ser376Gly)	SYNJ1	S376G, S415G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 8, 2019)	criteria provided, single submitter	VCV000844134	21	34056422	21	32684112	844134	848707		NC_000021.9:32684111:T:C
NM_203446.3(SYNJ1):c.2885G>A (p.Arg962Gln)	SYNJ1	R1001Q, R957Q, R962Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV000844027	21	34022646	21	32650336	844027	848692		NC_000021.9:32650335:C:T
NM_203446.3(SYNJ1):c.3403C>T (p.Pro1135Ser)	SYNJ1	P1174S, P1135S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Dec 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000843708	21	34017305	21	32644995	843708	848683		NC_000021.9:32644994:G:A
NM_203446.3(SYNJ1):c.3520C>T (p.Arg1174Cys)	SYNJ1	R1158C, R1213C, R1127C, R1174C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000843574	21	34014274	21	32641964	843574	848682		NC_000021.9:32641963:G:A
NM_203446.3(SYNJ1):c.2113A>G (p.Ile705Val)	SYNJ1	I700V, I744V, I705V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000840666	21	34038285	21	32665975	840666	848701		NC_000021.9:32665974:T:C
NM_203446.3(SYNJ1):c.2047C>T (p.Leu683Phe)	SYNJ1	L683F, L678F, L722F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000839942	21	34038351	21	32666041	839942	848702		NC_000021.9:32666040:G:A
NM_203446.3(SYNJ1):c.254T>A (p.Met85Lys)	SYNJ1	M124K, M85K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000839553	21	34072373	21	32700063	839553	848711		NC_000021.9:32700062:A:T
NM_203446.3(SYNJ1):c.2364G>C (p.Leu788Phe)	SYNJ1	L783F, L788F, L827F	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000838918	21	34030123	21	32657813	838918	848698		NC_000021.9:32657812:C:G
NM_203446.3(SYNJ1):c.2720A>G (p.Asn907Ser)	SYNJ1	N902S, N907S, N946S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000838036	21	34029072	21	32656762	838036	848695		NC_000021.9:32656761:T:C
NM_203446.3(SYNJ1):c.1876G>A (p.Val626Met)	SYNJ1	V665M, V621M, V626M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000837638	21	34038819	21	32666509	837638	848703		NC_000021.9:32666508:C:T
NM_203446.3(SYNJ1):c.-47G>C	SYNJ1	R24T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000837456	21	34100281	21	32727970	837456	848718		NC_000021.9:32727969:C:G
NM_203446.3(SYNJ1):c.3601C>G (p.Arg1201Gly)	SYNJ1	R1154G, R1201G, R1185G, R1240G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000837455	21	34012077	21	32639767	837455	848679		NC_000021.9:32639766:G:C
NM_203446.3(SYNJ1):c.-68G>A	SYNJ1	C17Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000835467	21	34100302	21	32727991	835467	848719		NC_000021.9:32727990:C:T
NM_203446.3(SYNJ1):c.1277G>A (p.Arg426Gln)	SYNJ1	R426Q, R465Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000809285	21	34053882	21	32681572	809285	798022	rs1601403500	NC_000021.9:32681571:C:T
NM_203446.3(SYNJ1):c.2505C>A (p.Ser835Arg)	SYNJ1	S830R, S835R, S874R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000809282	21	34029387	21	32657077	809282	798019	rs748032685	NC_000021.9:32657076:G:T
NM_203446.3(SYNJ1):c.*108A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000799758	21	34004007	21	32631697	799758	786481	rs371381727	NC_000021.9:32631696:T:C
NM_203446.3(SYNJ1):c.1878G>A (p.Val626=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000798065	21	34038817	21	32666507	798065	786483	rs1601348321	NC_000021.9:32666506:C:T
NM_203446.3(SYNJ1):c.1611C>T (p.Val537=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000794335	21	34045765	21	32673455	794335	786484	rs150180190	NC_000021.9:32673454:G:A
NM_203446.3(SYNJ1):c.3392-5A>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV000794326	21	34017321	21	32645011	794326	788353	rs776721216	NC_000021.9:32645010:T:A
NM_203446.3(SYNJ1):c.1323A>G (p.Ala441=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Oct 20, 2018)	criteria provided, single submitter	VCV000793246	21	34053836	21	32681526	793246	786485	rs1468223961	NC_000021.9:32681525:T:C
NM_203446.3(SYNJ1):c.2875-6C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000790290	21	34022662	21	32650352	790290	780000	rs183558612	NC_000021.9:32650351:G:A
NM_203446.3(SYNJ1):c.*732C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000783108	21	34003383	21	32631073	783108	717181	rs148676465	NC_000021.9:32631072:G:A
NM_203446.3(SYNJ1):c.2547T>C (p.Tyr849=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000773999	21	34029345	21	32657035	773999	705657	rs61756207	NC_000021.9:32657034:A:G
NM_203446.3(SYNJ1):c.3591G>A (p.Thr1197=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000772993	21	34012087	21	32639777	772993	705656	rs764207431	NC_000021.9:32639776:C:T
NM_203446.3(SYNJ1):c.*618A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000767326	21	34003497	21	32631187	767326	705654	rs139212871	NC_000021.9:32631186:T:C
NM_203446.3(SYNJ1):c.-31G>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000766465	21	34100265	21	32727954	766465	773293	rs751083536	NC_000021.9:32727953:C:G
NM_203446.3(SYNJ1):c.969A>G (p.Glu323=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000765753	21	34058207	21	32685897	765753	773291	rs1601418926	NC_000021.9:32685896:T:C
NM_203446.3(SYNJ1):c.-49A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000765717	21	34100283	21	32727972	765717	773294	rs780877494	NC_000021.9:32727971:T:C
NM_203446.3(SYNJ1):c.706-8T>C	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000765259	21	34066629	21	32694319	765259	776697	rs752261171	NC_000021.9:32694318:A:G
NM_203446.3(SYNJ1):c.1511-4A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000763054	21	34048669	21	32676359	763054	776946	rs533995497	NC_000021.9:32676358:T:C
NM_203446.3(SYNJ1):c.3285G>T (p.Pro1095=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000763053	21	34018062	21	32645752	763053	773284	rs376395608	NC_000021.9:32645751:C:A
NM_203446.3(SYNJ1):c.2976A>G (p.Ser992=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000761985	21	34022555	21	32650245	761985	773285	rs115204185	NC_000021.9:32650244:T:C
NM_203446.3(SYNJ1):c.2580-9T>C	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000760946	21	34029221	21	32656911	760946	776708	rs1601308461	NC_000021.9:32656910:A:G
NM_203446.3(SYNJ1):c.1167A>G (p.Arg389=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000757163	21	34056381	21	32684071	757163	773290	rs747274485	NC_000021.9:32684070:T:C
NM_203446.3(SYNJ1):c.2795+10T>C	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000755071	21	34028987	21	32656677	755071	776945	rs756959605	NC_000021.9:32656676:A:G
NM_203446.3(SYNJ1):c.1641A>G (p.Gln547=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000754998	21	34045735	21	32673425	754998	773289	rs753893833	NC_000021.9:32673424:T:C
NM_203446.3(SYNJ1):c.3392-8A>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV000752644	21	34017324	21	32645014	752644	776944	rs533064963	NC_000021.9:32645013:T:A
NM_203446.3(SYNJ1):c.1968T>C (p.Asp656=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 10, 2020)	criteria provided, single submitter	VCV000748526	21	34038430	21	32666120	748526	757746	rs140112176	NC_000021.9:32666119:A:G
NM_203446.3(SYNJ1):c.2691G>A (p.Leu897=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV000746655	21	34029101	21	32656791	746655	757741	rs115263361	NC_000021.9:32656790:C:T
NM_203446.3(SYNJ1):c.3357C>T (p.Arg1119=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000745451	21	34017990	21	32645680	745451	757740	rs1601259728	NC_000021.9:32645679:G:A
NM_203446.3(SYNJ1):c.3585A>G (p.Arg1195=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000744345	21	34014209	21	32641899	744345	757739	rs1404447301	NC_000021.9:32641898:T:C
NM_203446.3(SYNJ1):c.126A>T (p.Ser42=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000743558	21	34074356	21	32702046	743558	757748	rs1286622528	NC_000021.9:32702045:T:A
NM_203446.3(SYNJ1):c.789+10T>C	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 29, 2018)	criteria provided, single submitter	VCV000743543	21	34066528	21	32694218	743543	760715	rs1601446146	NC_000021.9:32694217:A:G
NM_203446.3(SYNJ1):c.3633C>T (p.His1211=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000742958	21	34012045	21	32639735	742958	757738	rs771394723	NC_000021.9:32639734:G:A
NM_203446.3(SYNJ1):c.2205C>T (p.Ile735=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000742896	21	34037322	21	32665012	742896	757743	rs149236383	NC_000021.9:32665011:G:A
NM_203446.3(SYNJ1):c.3690G>A (p.Thr1230=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, single submitter	VCV000742419	21	34011988	21	32639678	742419	757737	rs1446522492	NC_000021.9:32639677:C:T
NM_203446.3(SYNJ1):c.3747G>A (p.Pro1249=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000741641	21	34011386	21	32639076	741641	757736	rs138579227	NC_000021.9:32639075:C:T
NM_203446.3(SYNJ1):c.2472A>C (p.Leu824=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000739738	21	34029420	21	32657110	739738	757742	rs1601309726	NC_000021.9:32657109:T:G
NM_203446.3(SYNJ1):c.1245T>C (p.Pro415=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV000739404	21	34053914	21	32681604	739404	757747	rs111655347	NC_000021.9:32681603:A:G
NM_203446.3(SYNJ1):c.2157A>G (p.Leu719=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV000739403	21	34037370	21	32665060	739403	757744	rs112875942	NC_000021.9:32665059:T:C
NM_203446.3(SYNJ1):c.1119-7G>C	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000739137	21	34056436	21	32684126	739137	760792	rs562245468	NC_000021.9:32684125:C:G
NM_203446.3(SYNJ1):c.1081T>A (p.Tyr361Asn)	SYNJ1	Y361N, Y400N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000733580	21	34058095	21	32685785	733580	742588	rs533216340	NC_000021.9:32685784:A:T
NM_203446.3(SYNJ1):c.324C>T (p.Ile108=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000729814	21	34072303	21	32699993	729814	742591	rs551070196	NC_000021.9:32699992:G:A
NM_203446.3(SYNJ1):c.831C>T (p.Ala277=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV000729536	21	34060636	21	32688326	729536	742589	rs148732160	NC_000021.9:32688325:G:A
NM_203446.3(SYNJ1):c.*333C>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV000727422	21	34003782	21	32631472	727422	742586	rs548047319	NC_000021.9:32631471:G:A
NM_203446.3(SYNJ1):c.2958T>C (p.Ile986=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000723019	21	34022573	21	32650263	723019	742587	rs879835661	NC_000021.9:32650262:A:G
NM_203446.3(SYNJ1):c.1707T>G (p.Ala569=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV000718212	21	34045669	21	32673359	718212	728860	rs1384171922	NC_000021.9:32673358:A:C
NM_203446.3(SYNJ1):c.2172T>C (p.Tyr724=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000708833	21	34037355	21	32665045	708833	728859	rs144454116	NC_000021.9:32665044:A:G
NM_203446.3(SYNJ1):c.883A>C (p.Lys295Gln)	SYNJ1	K334Q, K295Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000707464	21	34059353	21	32687043	707464	694623	rs554456240	NC_000021.9:32687042:T:G
NM_203446.3(SYNJ1):c.*120G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not provided	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV000707260	21	34003995	21	32631685	707260	694622	rs377721268	NC_000021.9:32631684:C:T
NM_203446.3(SYNJ1):c.2954A>G (p.Lys985Arg)	SYNJ1	K985R, K1024R, K980R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000665872	21	34022577	21	32650267	665872	648905	rs1325187801	NC_000021.9:32650266:T:C
NM_203446.3(SYNJ1):c.1004A>C (p.Tyr335Ser)	SYNJ1	Y374S, Y335S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000665285	21	34058172	21	32685862	665285	648918	rs1469620917	NC_000021.9:32685861:T:G
NM_203446.3(SYNJ1):c.177A>G (p.Ala59=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000664700	21	34074305	21	32701995	664700	648924	rs749212329	NC_000021.9:32701994:T:C
NM_203446.3(SYNJ1):c.1554G>C (p.Lys518Asn)	SYNJ1	K557N, K513N, K518N	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000664236	21	34045822	21	32673512	664236	648914	rs371301276	NC_000021.9:32673511:C:G
NM_203446.3(SYNJ1):c.768C>G (p.Phe256Leu)	SYNJ1	F256L, F295L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000664226	21	34066559	21	32694249	664226	648919	rs1456955061	NC_000021.9:32694248:G:C
NM_203446.3(SYNJ1):c.2996T>A (p.Leu999His)	SYNJ1	L1038H, L994H, L999H	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 10, 2018)	criteria provided, single submitter	VCV000663525	21	34022535	21	32650225	663525	648903	rs1601283152	NC_000021.9:32650224:A:T
NM_203446.3(SYNJ1):c.3652A>G (p.Arg1218Gly)	SYNJ1	R1171G, R1202G, R1257G, R1218G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV000663463	21	34012026	21	32639716	663463	648899	rs139146760	NC_000021.9:32639715:T:C
NM_203446.3(SYNJ1):c.*678C>G	SYNJ1	F1569L, F1483L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000662893	21	34003437	21	32631127	662893	648890	rs760299495	NC_000021.9:32631126:G:C
NM_203446.3(SYNJ1):c.*127G>C	SYNJ1	V1300L, V1386L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jan 24, 2020)	criteria provided, single submitter	VCV000662385	21	34003988	21	32631678	662385	648896	rs1342453394	NC_000021.9:32631677:C:G
NM_203446.3(SYNJ1):c.2981C>A (p.Thr994Lys)	SYNJ1	T1033K, T989K, T994K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000662045	21	34022550	21	32650240	662045	648904	rs776726487	NC_000021.9:32650239:G:T
NM_203446.3(SYNJ1):c.*233G>A	SYNJ1	R1421Q, R1335Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000661401	21	34003882	21	32631572	661401	648895	rs765410501	NC_000021.9:32631571:C:T
NM_203446.3(SYNJ1):c.1449T>G (p.Asn483Lys)	SYNJ1	N486K, N483K, N522K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000659932	21	34051016	21	32678706	659932	648916	rs1490214505	NC_000021.9:32678705:A:C
NM_203446.3(SYNJ1):c.3823G>A (p.Gly1275Ser)	SYNJ1	G1314S, G1259S, G1228S, G1275S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 29, 2019)	criteria provided, single submitter	VCV000658700	21	34011310	21	32639000	658700	648897	rs1601231173	NC_000021.9:32638999:C:T
NM_203446.3(SYNJ1):c.2884C>T (p.Arg962Trp)	SYNJ1	R957W, R962W, R1001W	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000658652	21	34022647	21	32650337	658652	648907	rs149147152	NC_000021.9:32650336:G:A
NM_203446.3(SYNJ1):c.2462-6C>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000658593	21	34029436	21	32657126	658593	653575	rs1601309850	NC_000021.9:32657125:G:T
NM_203446.3(SYNJ1):c.3376C>A (p.Pro1126Thr)	SYNJ1	P1121T, P1165T, P1126T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000658281	21	34017971	21	32645661	658281	648902	rs1485482944	NC_000021.9:32645660:G:T
NM_203446.3(SYNJ1):c.*666A>G	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000657310	21	34003449	21	32631139	657310	648891	rs763776246	NC_000021.9:32631138:T:C
NM_203446.3(SYNJ1):c.3803C>T (p.Ala1268Val)	SYNJ1	A1221V, A1252V, A1307V, A1268V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000656584	21	34011330	21	32639020	656584	648898	rs1601231363	NC_000021.9:32639019:G:A
NM_203446.3(SYNJ1):c.*257G>T	SYNJ1	R1343L, R1429L	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000655746	21	34003858	21	32631548	655746	648893	rs112469776	NC_000021.9:32631547:C:A
NM_203446.3(SYNJ1):c.2250T>A (p.Asn750Lys)	SYNJ1	N745K, N750K, N789K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000653769	21	34037277	21	32664967	653769	648911	rs570501803	NC_000021.9:32664966:A:T
NM_203446.3(SYNJ1):c.583G>A (p.Ala195Thr)	SYNJ1	A195T, A234T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 25, 2020)	criteria provided, single submitter	VCV000653212	21	34067489	21	32695179	653212	648921	rs774367309	NC_000021.9:32695178:C:T
NM_003895.3(SYNJ1):c.7A>C (p.Lys3Gln)	SYNJ1	K3Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000652266	21	34100345	21	32728034	652266	648926	rs1037328706	NC_000021.9:32728033:T:G
NM_203446.3(SYNJ1):c.2685A>G (p.Thr895=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000651107	21	34029107	21	32656797	651107	648908	rs939655575	NC_000021.9:32656796:T:C
NM_203446.3(SYNJ1):c.2090T>C (p.Val697Ala)	SYNJ1	V692A, V697A, V736A	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000649325	21	34038308	21	32665998	649325	648912	rs764946363	NC_000021.9:32665997:A:G
NM_203446.3(SYNJ1):c.200G>A (p.Arg67Gln)	SYNJ1	R106Q, R67Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000648787	21	34074282	21	32701972	648787	648923	rs969446324	NC_000021.9:32701971:C:T
NM_203446.3(SYNJ1):c.*491A>C	SYNJ1	Q1507P, Q1421P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 11, 2018)	criteria provided, single submitter	VCV000647401	21	34003624	21	32631314	647401	648892	rs776115769	NC_000021.9:32631313:T:G
NM_203446.3(SYNJ1):c.622A>G (p.Ser208Gly)	SYNJ1	S208G, S247G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000646785	21	34067450	21	32695140	646785	648920	rs1601449471	NC_000021.9:32695139:T:C
NM_203446.3(SYNJ1):c.-86G>A	SYNJ1	S11N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV000646660	21	34100320	21	32728009	646660	648925	rs768854034	NC_000021.9:32728008:C:T
NM_203446.3(SYNJ1):c.1291G>A (p.Val431Met)	SYNJ1	V431M, V470M	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000646642	21	34053868	21	32681558	646642	648917	rs749980859	NC_000021.9:32681557:C:T
NM_203446.3(SYNJ1):c.3634G>A (p.Ala1212Thr)	SYNJ1	A1196T, A1251T, A1165T, A1212T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000646428	21	34012044	21	32639734	646428	648900	rs769125182	NC_000021.9:32639733:C:T
NM_203446.3(SYNJ1):c.1507C>T (p.Arg503Cys)	SYNJ1	R506C, R503C, R542C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV000645824	21	34050958	21	32678648	645824	648915	rs115061921	NC_000021.9:32678647:G:A
NM_203446.3(SYNJ1):c.2567C>A (p.Thr856Asn)	SYNJ1	T851N, T856N, T895N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000644595	21	34029325	21	32657015	644595	648909	rs1191504880	NC_000021.9:32657014:G:T
NM_203446.3(SYNJ1):c.3431-8C>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000644375	21	34015775	21	32643465	644375	653662	rs369584002	NC_000021.9:32643464:G:T
NM_203446.3(SYNJ1):c.3392-5A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000644039	21	34017321	21	32645011	644039	653666	rs776721216	NC_000021.9:32645010:T:C
NM_203446.3(SYNJ1):c.326A>T (p.Asp109Val)	SYNJ1	D109V, D148V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000642833	21	34072301	21	32699991	642833	648922	rs764528223	NC_000021.9:32699990:T:A
NM_203446.3(SYNJ1):c.3581C>G (p.Ala1194Gly)	SYNJ1	A1178G, A1233G, A1147G, A1194G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000642561	21	34014213	21	32641903	642561	648901	rs779766895	NC_000021.9:32641902:G:C
NM_203446.3(SYNJ1):c.1789G>A (p.Ala597Thr)	SYNJ1	A592T, A597T, A636T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000642097	21	34042620	21	32670310	642097	648913	rs1601363222	NC_000021.9:32670309:C:T
NM_203446.3(SYNJ1):c.2896A>G (p.Ile966Val)	SYNJ1	I1005V, I961V, I966V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000641996	21	34022635	21	32650325	641996	648906	rs1601283648	NC_000021.9:32650324:T:C
NM_203446.3(SYNJ1):c.2519C>T (p.Thr840Met)	SYNJ1	T840M, T835M, T879M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000640780	21	34029373	21	32657063	640780	648910	rs560413403	NC_000021.9:32657062:G:A
NM_203446.3(SYNJ1):c.*767T>G	SYNJ1	L1599W, L1513W	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000639005	21	34003348	21	32631038	639005	648889	rs764949465	NC_000021.9:32631037:A:C
NM_203446.3(SYNJ1):c.*253A>G	SYNJ1	M1428V, M1342V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jul 15, 2018)	criteria provided, single submitter	VCV000638900	21	34003862	21	32631552	638900	648894	rs1398328287	NC_000021.9:32631551:T:C
NM_203446.3(SYNJ1):c.3601C>T (p.Arg1201Cys)	SYNJ1	R1240C, R1185C, R1154C, R1201C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000634476	21	34012077	21	32639767	634476	622474	rs114994257	NC_000021.9:32639766:G:A
NM_203446.3(SYNJ1):c.3721C>T (p.Leu1241=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586761	21	34011412	21	32639102	586761	577889	rs2230766	NC_000021.9:32639101:G:A
NM_203446.3(SYNJ1):c.3518-7G>T	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586760	21	34014283	21	32641973	586760	577890	rs2833929	NC_000021.9:32641972:C:A
NM_203446.3(SYNJ1):c.884A>G (p.Lys295Arg)	SYNJ1	K334R, K295R	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000586758	21	34059352	21	32687042	586758	577892	rs2254562	NC_000021.9:32687041:T:C
NM_203446.3(SYNJ1):c.2874+6G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000583130	21	34025592	21	32653282	583130	573055	rs368204504	NC_000021.9:32653281:C:T
NM_203446.3(SYNJ1):c.470G>C (p.Arg157Thr)	SYNJ1	R196T, R157T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000582994	21	34072157	21	32699847	582994	573063	rs375831365	NC_000021.9:32699846:C:G
NM_203446.3(SYNJ1):c.1106G>A (p.Ser369Asn)	SYNJ1	S408N, S369N	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Apr 5, 2020)	criteria provided, single submitter	VCV000582650	21	34058070	21	32685760	582650	573754	rs147544792	NC_000021.9:32685759:C:T
NM_203446.3(SYNJ1):c.2653G>A (p.Val885Ile)	SYNJ1	V924I, V880I, V885I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000581736	21	34029139	21	32656829	581736	573746	rs763757097	NC_000021.9:32656828:C:T
NM_203446.3(SYNJ1):c.3097T>C (p.Ser1033Pro)	SYNJ1	S1072P, S1028P, S1033P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580644	21	34018853	21	32646543	580644	573738	rs61752559	NC_000021.9:32646542:A:G
NM_203446.3(SYNJ1):c.2378A>G (p.Tyr793Cys)	SYNJ1	Y832C, Y793C, Y788C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000579673	21	34030109	21	32657799	579673	573058	rs1283151166	NC_000021.9:32657798:T:C
NM_203446.3(SYNJ1):c.2744T>C (p.Ile915Thr)	SYNJ1	I954T, I910T, I915T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000578766	21	34029048	21	32656738	578766	573740	rs867564053	NC_000021.9:32656737:A:G
NM_203446.3(SYNJ1):c.3797C>G (p.Pro1266Arg)	SYNJ1	P1305R, P1219R, P1250R, P1266R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000577253	21	34011336	21	32639026	577253	573731	rs767170641	NC_000021.9:32639025:G:C
NM_203446.3(SYNJ1):c.803G>A (p.Arg268His)	SYNJ1	R307H, R268H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000576906	21	34060664	21	32688354	576906	571498	rs201796096	NC_000021.9:32688353:C:T
NM_203446.3(SYNJ1):c.3882T>G (p.His1294Gln)	SYNJ1	H1333Q, H1247Q, H1278Q, H1294Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000576646	21	34011251	21	32638941	576646	573729	rs1569025711	NC_000021.9:32638940:A:C
NM_203446.3(SYNJ1):c.3139C>G (p.Arg1047Gly)	SYNJ1	R1086G, R1042G, R1047G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000576516	21	34018811	21	32646501	576516	573050	rs147931121	NC_000021.9:32646500:G:C
NM_203446.3(SYNJ1):c.3587C>A (p.Pro1196Gln)	SYNJ1	P1235Q, P1180Q, P1149Q, P1196Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000576177	21	34014207	21	32641897	576177	575148	rs61752550	NC_000021.9:32641896:G:T
NM_203446.3(SYNJ1):c.1603G>A (p.Val535Ile)	SYNJ1	V574I, V530I, V535I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000575982	21	34045773	21	32673463	575982	573750	rs145712835	NC_000021.9:32673462:C:T
NM_203446.3(SYNJ1):c.930G>A (p.Met310Ile)	SYNJ1	M349I, M310I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 11, 2020)	criteria provided, single submitter	VCV000575493	21	34059306	21	32686996	575493	573756	rs749045961	NC_000021.9:32686995:C:T
NM_203446.3(SYNJ1):c.3587C>T (p.Pro1196Leu)	SYNJ1	P1235L, P1149L, P1180L, P1196L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 17, 2018)	criteria provided, single submitter	VCV000575346	21	34014207	21	32641897	575346	571479	rs61752550	NC_000021.9:32641896:G:A
NM_003895.3(SYNJ1):c.24G>A (p.Trp8Ter)	SYNJ1	W8*	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Jun 7, 2018)	criteria provided, single submitter	VCV000575322	21	34100328	21	32728017	575322	571505	rs1569147057	NC_000021.9:32728016:C:T
NM_203446.3(SYNJ1):c.1508G>A (p.Arg503His)	SYNJ1	R542H, R503H, R506H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000574661	21	34050957	21	32678647	574661	571492	rs756697570	NC_000021.9:32678646:C:T
NM_203446.3(SYNJ1):c.2254G>T (p.Asp752Tyr)	SYNJ1	D791Y, D752Y, D747Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000573462	21	34037273	21	32664963	573462	573060	rs145978776	NC_000021.9:32664962:C:A
NM_203446.3(SYNJ1):c.*613A>G	SYNJ1	S1548G, S1462G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000573244	21	34003502	21	32631192	573244	573029	rs769954720	NC_000021.9:32631191:T:C
NM_203446.3(SYNJ1):c.2781A>G (p.Glu927=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 2, 2018)	criteria provided, single submitter	VCV000572728	21	34029011	21	32656701	572728	573739	rs1350091132	NC_000021.9:32656700:T:C
NM_203446.3(SYNJ1):c.3610G>A (p.Val1204Ile)	SYNJ1	V1243I, V1157I, V1188I, V1204I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 10, 2018)	criteria provided, single submitter	VCV000572373	21	34012068	21	32639758	572373	573036	rs1569027714	NC_000021.9:32639757:C:T
NM_203446.3(SYNJ1):c.25A>G (p.Ile9Val)	SYNJ1	I48V, I9V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000572043	21	34099182	21	32726871	572043	571503	rs757895747	NC_000021.9:32726870:T:C
NM_203446.3(SYNJ1):c.3767C>T (p.Pro1256Leu)	SYNJ1	P1295L, P1209L, P1240L, P1256L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000571046	21	34011366	21	32639056	571046	571476	rs147025577	NC_000021.9:32639055:G:A
NM_203446.3(SYNJ1):c.1201-2A>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely pathogenic(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV000570738	21	34053960	21	32681650	570738	573062	rs1569086116	NC_000021.9:32681649:T:C
NM_203446.3(SYNJ1):c.41A>G (p.Asp14Gly)	SYNJ1	D53G, D14G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000570473	21	34099166	21	32726855	570473	575151	rs565807712	NC_000021.9:32726854:T:C
NM_203446.3(SYNJ1):c.20T>A (p.Phe7Tyr)	SYNJ1	F46Y, F7Y	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Uncertain significance(Last reviewed: Sep 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000570462	21	34099187	21	32726876	570462	573759	rs748690832	NC_000021.9:32726875:A:T
NM_203446.3(SYNJ1):c.630A>T (p.Glu210Asp)	SYNJ1	E249D, E210D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000570013	21	34067442	21	32695132	570013	571499	rs1377390036	NC_000021.9:32695131:T:A
NM_203446.3(SYNJ1):c.3320G>A (p.Arg1107Gln)	SYNJ1	R1146Q, R1102Q, R1107Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000569857	21	34018027	21	32645717	569857	573736	rs917502531	NC_000021.9:32645716:C:T
NM_203446.3(SYNJ1):c.*212C>T	SYNJ1	T1414I, T1328I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jun 25, 2018)	criteria provided, single submitter	VCV000569496	21	34003903	21	32631593	569496	575147	rs754791304	NC_000021.9:32631592:G:A
NM_203446.3(SYNJ1):c.2171A>G (p.Tyr724Cys)	SYNJ1	Y763C, Y724C, Y719C	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000569415	21	34037356	21	32665046	569415	575150	rs201485861	NC_000021.9:32665045:T:C
NM_203446.3(SYNJ1):c.3554G>A (p.Gly1185Asp)	SYNJ1	G1224D, G1138D, G1169D, G1185D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV000568134	21	34014240	21	32641930	568134	571485	rs1569030684	NC_000021.9:32641929:C:T
NM_203446.3(SYNJ1):c.3746C>T (p.Pro1249Leu)	SYNJ1	P1288L, P1202L, P1233L, P1249L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000567214	21	34011387	21	32639077	567214	573034	rs149288077	NC_000021.9:32639076:G:A
NM_203446.3(SYNJ1):c.3057T>G (p.Ser1019Arg)	SYNJ1	S1058R, S1014R, S1019R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000566546	21	34018893	21	32646583	566546	571486	rs767760891	NC_000021.9:32646582:A:C
NM_203446.3(SYNJ1):c.211G>C (p.Gly71Arg)	SYNJ1	G110R, G71R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000565896	21	34074271	21	32701961	565896	573757	rs1569113660	NC_000021.9:32701960:C:G
NM_203446.3(SYNJ1):c.3215C>A (p.Pro1072Gln)	SYNJ1	P1111Q, P1067Q, P1072Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000565611	21	34018735	21	32646425	565611	573042	rs771524798	NC_000021.9:32646424:G:T
NM_203446.3(SYNJ1):c.395G>A (p.Trp132Ter)	SYNJ1	W171*, W132*	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000549503	21	34072232	21	32699922	549503	539985	rs1555907463	NC_000021.9:32699921:C:T
NM_203446.3(SYNJ1):c.3747G>T (p.Pro1249=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV000544589	21	34011386	21	32639076	544589	533759	rs138579227	NC_000021.9:32639075:C:A
NM_203446.3(SYNJ1):c.*738C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000544588	21	34003377	21	32631067	544588	533778	rs747245690	NC_000021.9:32631066:G:A
NM_203446.3(SYNJ1):c.3912G>A (p.Pro1304=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV000544587	21	34011221	21	32638911	544587	533788	rs372695378	NC_000021.9:32638910:C:T
NM_203446.3(SYNJ1):c.*315G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Benign/Likely benign(Last reviewed: Mar 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000544586	21	34003800	21	32631490	544586	534349	rs145347648	NC_000021.9:32631489:C:T
NM_203446.3(SYNJ1):c.3285G>A (p.Pro1095=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV000544585	21	34018062	21	32645752	544585	533768	rs376395608	NC_000021.9:32645751:C:T
NM_203446.3(SYNJ1):c.2146-8G>A	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000544584	21	34037389	21	32665079	544584	533789	rs759701632	NC_000021.9:32665078:C:T
NM_203446.3(SYNJ1):c.93C>G (p.Leu31=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV000544583	21	34099114	21	32726803	544583	533825	rs201322530	NC_000021.9:32726802:G:C
NM_203446.3(SYNJ1):c.165A>G (p.Lys55=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000544581	21	34074317	21	32702007	544581	533792	rs141138675	NC_000021.9:32702006:T:C
NM_203446.3(SYNJ1):c.2997T>C (p.Leu999=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000544580	21	34022534	21	32650224	544580	533775	rs111774827	NC_000021.9:32650223:A:G
NM_203446.3(SYNJ1):c.1535C>T (p.Ala512Val)	SYNJ1	A551V, A507V, A512V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000544579	21	34045841	21	32673531	544579	533814	rs115989459	NC_000021.9:32673530:G:A
NM_203446.3(SYNJ1):c.*312C>T	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV000544578	21	34003803	21	32631493	544578	534351	rs149199429	NC_000021.9:32631492:G:A
NM_203446.3(SYNJ1):c.2943G>T (p.Met981Ile)	SYNJ1	M1020I, M981I, M976I	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Feb 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000544577	21	34022588	21	32650278	544577	533777	rs115683257	NC_000021.9:32650277:C:A
NM_203446.3(SYNJ1):c.2844C>T (p.Ala948=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Likely benign(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000544575	21	34025628	21	32653318	544575	534360	rs1432339434	NC_000021.9:32653317:G:A
NM_203446.3(SYNJ1):c.1914G>A (p.Leu638=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000544574	21	34038781	21	32666471	544574	534367	rs534908601	NC_000021.9:32666470:C:T
NM_203446.3(SYNJ1):c.2226T>A (p.Val742=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Benign(Last reviewed: Oct 5, 2020)	criteria provided, single submitter	VCV000544573	21	34037301	21	32664991	544573	533794	rs566533509	NC_000021.9:32664990:A:T
NM_203446.3(SYNJ1):c.*521C>G	SYNJ1	P1517R, P1431R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV000544572	21	34003594	21	32631284	544572	534347	rs749527882	NC_000021.9:32631283:G:C
NM_203446.3(SYNJ1):c.3410C>T (p.Pro1137Leu)	SYNJ1	P1176L, P1137L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000544570	21	34017298	21	32644988	544570	533786	rs569046864	NC_000021.9:32644987:G:A
NM_203446.3(SYNJ1):c.3580G>C (p.Ala1194Pro)	SYNJ1	A1233P, A1178P, A1147P, A1194P	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV000544569	21	34014214	21	32641904	544569	534356	rs77164494	NC_000021.9:32641903:C:G
NM_203446.3(SYNJ1):c.1832G>T (p.Trp611Leu)	SYNJ1	W650L, W606L, W611L	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000544568	21	34038863	21	32666553	544568	533800	rs1481650772	NC_000021.9:32666552:C:A
NM_203446.3(SYNJ1):c.3837T>A (p.Asn1279Lys)	SYNJ1	N1318K, N1232K, N1263K, N1279K	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV000544567	21	34011296	21	32638986	544567	533751	rs1555888329	NC_000021.9:32638985:A:T
NM_203446.3(SYNJ1):c.2462-10C>G	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000544566	21	34029440	21	32657130	544566	533784	rs775703634	NC_000021.9:32657129:G:C
NM_203446.3(SYNJ1):c.3179C>G (p.Pro1060Arg)	SYNJ1	P1099R, P1060R, P1055R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	VCV000544565	21	34018771	21	32646461	544565	533809	rs1430500307	NC_000021.9:32646460:G:C
NM_203446.3(SYNJ1):c.1466T>C (p.Leu489Ser)	SYNJ1	L528S, L489S, L492S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000544564	21	34050999	21	32678689	544564	533802	rs1238065971	NC_000021.9:32678688:A:G
NM_203446.3(SYNJ1):c.3908A>G (p.Gln1303Arg)	SYNJ1	Q1342R, Q1256R, Q1287R, Q1303R	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV000544562	21	34011225	21	32638915	544562	533779	rs546986773	NC_000021.9:32638914:T:C
NM_203446.3(SYNJ1):c.3811A>G (p.Met1271Val)	SYNJ1	M1310V, M1224V, M1255V, M1271V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000544561	21	34011322	21	32639012	544561	533758	rs751069566	NC_000021.9:32639011:T:C
NM_203446.3(SYNJ1):c.2120T>C (p.Ile707Thr)	SYNJ1	I746T, I707T, I702T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 18, 2021)	criteria provided, conflicting interpretations	VCV000544560	21	34038278	21	32665968	544560	533799	rs147929290	NC_000021.9:32665967:A:G
NM_203446.3(SYNJ1):c.2786T>C (p.Ile929Thr)	SYNJ1	I968T, I929T, I924T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000544559	21	34029006	21	32656696	544559	533782	rs755258923	NC_000021.9:32656695:A:G
NM_203446.3(SYNJ1):c.3304C>T (p.Pro1102Ser)	SYNJ1	P1141S, P1102S, P1097S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000544558	21	34018043	21	32645733	544558	533801	rs1368672974	NC_000021.9:32645732:G:A
NM_203446.3(SYNJ1):c.1306A>G (p.Ile436Val)	SYNJ1	I475V, I436V	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000544557	21	34053853	21	32681543	544557	533804	rs763870801	NC_000021.9:32681542:T:C
NM_203446.3(SYNJ1):c.1609G>A (p.Val537Ile)	SYNJ1	V576I, V537I, V532I	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 18, 2017)	criteria provided, single submitter	VCV000544556	21	34045767	21	32673457	544556	534368	rs1555898799	NC_000021.9:32673456:C:T
NM_203446.3(SYNJ1):c.2792T>C (p.Ile931Thr)	SYNJ1	I970T, I931T, I926T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000544555	21	34029000	21	32656690	544555	533781	rs932390799	NC_000021.9:32656689:A:G
NM_203446.3(SYNJ1):c.2597T>C (p.Ile866Thr)	SYNJ1	I905T, I861T, I866T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000544554	21	34029195	21	32656885	544554	533811	rs114053718	NC_000021.9:32656884:A:G
NM_203446.3(SYNJ1):c.809G>A (p.Arg270His)	SYNJ1	R309H, R270H	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000544553	21	34060658	21	32688348	544553	533815	rs532075408	NC_000021.9:32688347:C:T
NM_203446.3(SYNJ1):c.*188T>C	SYNJ1	L1406S, L1320S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000544552	21	34003927	21	32631617	544552	533780	rs866258846	NC_000021.9:32631616:A:G
NM_203446.3(SYNJ1):c.311T>C (p.Ile104Thr)	SYNJ1	I143T, I104T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000544551	21	34072316	21	32700006	544551	533818	rs779426150	NC_000021.9:32700005:A:G
NM_203446.3(SYNJ1):c.2631G>C (p.Glu877Asp)	SYNJ1	E916D, E872D, E877D	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Sep 14, 2017)	criteria provided, single submitter	VCV000544550	21	34029161	21	32656851	544550	534364	rs375526059	NC_000021.9:32656850:C:G
NM_203446.3(SYNJ1):c.3209G>A (p.Arg1070Gln)	SYNJ1	R1109Q, R1070Q, R1065Q	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV000544549	21	34018741	21	32646431	544549	533805	rs141107054	NC_000021.9:32646430:C:T
NM_203446.3(SYNJ1):c.199C>T (p.Arg67Trp)	SYNJ1	R106W, R67W	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000544548	21	34074283	21	32701973	544548	533816	rs372488661	NC_000021.9:32701972:G:A
NM_203446.3(SYNJ1):c.3524G>C (p.Ser1175Thr)	SYNJ1	S1214T, S1128T, S1159T, S1175T	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, single submitter	VCV000544547	21	34014270	21	32641960	544547	533798	rs994115947	NC_000021.9:32641959:C:G
NM_203446.3(SYNJ1):c.-42A>G	SYNJ1	R26G	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000544546	21	34100276	21	32727965	544546	534372	rs988950141	NC_000021.9:32727964:T:C
NM_203446.3(SYNJ1):c.851G>A (p.Arg284Lys)	SYNJ1	R323K, R284K	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Inborn genetic diseases|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 6, 2020)	criteria provided, conflicting interpretations	VCV000521749	21	34060616	21	32688306	521749	512478	rs565013600	NC_000021.9:32688305:C:T
NM_203446.3(SYNJ1):c.843T>C (p.Ala281=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000478369	21	34060624	21	32688314	478369	469576	rs372016074	NC_000021.9:32688313:A:G
NM_203446.3(SYNJ1):c.842C>G (p.Ala281Gly)	SYNJ1	A320G, A281G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000478368	21	34060625	21	32688315	478368	471589	rs1046699971	NC_000021.9:32688314:G:C
NM_203446.3(SYNJ1):c.808C>T (p.Arg270Cys)	SYNJ1	R309C, R270C	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV000478367	21	34060659	21	32688349	478367	471591	rs547450707	NC_000021.9:32688348:G:A
NM_203446.3(SYNJ1):c.705+7A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000478366	21	34067360	21	32695050	478366	471594	rs187016397	NC_000021.9:32695049:T:C
NM_203446.3(SYNJ1):c.573A>G (p.Thr191=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478365	21	34067499	21	32695189	478365	471129	rs61756694	NC_000021.9:32695188:T:C
NM_203446.3(SYNJ1):c.479+9A>G	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478364	21	34072139	21	32699829	478364	471133	rs76502784	NC_000021.9:32699828:T:C
NM_203446.3(SYNJ1):c.421T>C (p.Leu141=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV000478363	21	34072206	21	32699896	478363	471599	rs140461566	NC_000021.9:32699895:A:G
NM_203446.3(SYNJ1):c.*761C>T	SYNJ1	T1597M, T1511M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000478362	21	34003354	21	32631044	478362	469550	rs111516740	NC_000021.9:32631043:G:A
NM_203446.3(SYNJ1):c.*728C>T	SYNJ1	P1586L, P1500L	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478361	21	34003387	21	32631077	478361	471083	rs2230767	NC_000021.9:32631076:G:A
NM_203446.3(SYNJ1):c.*611C>T	SYNJ1	P1547L, P1461L	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478360	21	34003504	21	32631194	478360	471567	rs76056543	NC_000021.9:32631193:G:A
NM_203446.3(SYNJ1):c.*574T>A	SYNJ1	S1535T, S1449T	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000478359	21	34003541	21	32631231	478359	471088	rs138122167	NC_000021.9:32631230:A:T
NM_203446.3(SYNJ1):c.*552G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478358	21	34003563	21	32631253	478358	469552	rs146425050	NC_000021.9:32631252:C:T
NM_203446.3(SYNJ1):c.*522G>A	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000478357	21	34003593	21	32631283	478357	471092	rs777945782	NC_000021.9:32631282:C:T
NM_203446.3(SYNJ1):c.*329G>A	SYNJ1	G1453E, G1367E	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478356	21	34003786	21	32631476	478356	471569	rs61750217	NC_000021.9:32631475:C:T
NM_203446.3(SYNJ1):c.*234G>T	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV000478355	21	34003881	21	32631571	478355	470593	rs777299829	NC_000021.9:32631570:C:A
NM_203446.3(SYNJ1):c.*223A>G	SYNJ1	I1418V, I1332V	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000478354	21	34003892	21	32631582	478354	471571	rs113978322	NC_000021.9:32631581:T:C
NM_203446.3(SYNJ1):c.*173C>T	SYNJ1	T1401M, T1315M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000478353	21	34003942	21	32631632	478353	470595	rs1341548536	NC_000021.9:32631631:G:A
NM_203446.3(SYNJ1):c.*4G>A	SYNJ1	V1345I, V1259I	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Mar 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478352	21	34004111	21	32631801	478352	471096	rs115648918	NC_000021.9:32631800:C:T
NM_203446.3(SYNJ1):c.3762C>T (p.Pro1254=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000478351	21	34011371	21	32639061	478351	469557	rs201117151	NC_000021.9:32639060:G:A
NM_203446.3(SYNJ1):c.3722T>C (p.Leu1241Pro)	SYNJ1	L1280P, L1194P, L1225P, L1241P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV000478350	21	34011411	21	32639101	478350	470597	rs548516848	NC_000021.9:32639100:A:G
NM_203446.3(SYNJ1):c.3691T>C (p.Ser1231Pro)	SYNJ1	S1270P, S1184P, S1215P, S1231P	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000478349	21	34011987	21	32639677	478349	471573	rs767695759	NC_000021.9:32639676:A:G
NM_203446.3(SYNJ1):c.3689C>T (p.Thr1230Met)	SYNJ1	T1269M, T1183M, T1214M, T1230M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000478348	21	34011989	21	32639679	478348	471102	rs752805765	NC_000021.9:32639678:G:A
NM_203446.3(SYNJ1):c.3638G>A (p.Arg1213Gln)	SYNJ1	R1252Q, R1197Q, R1166Q, R1213Q	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478347	21	34012040	21	32639730	478347	471106	rs144048853	NC_000021.9:32639729:C:T
NM_203446.3(SYNJ1):c.3636G>A (p.Ala1212=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000478346	21	34012042	21	32639732	478346	470598	rs576444776	NC_000021.9:32639731:C:T
NM_203446.3(SYNJ1):c.3590C>T (p.Thr1197Met)	SYNJ1	T1236M, T1181M, T1150M, T1197M	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478345	21	34012088	21	32639778	478345	469561	rs145937537	NC_000021.9:32639777:G:A
NM_203446.3(SYNJ1):c.3588G>A (p.Pro1196=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000478344	21	34014206	21	32641896	478344	470600	rs1160685381	NC_000021.9:32641895:C:T
NM_203446.3(SYNJ1):c.3431G>A (p.Gly1144Asp)	SYNJ1	G1183D, G1144D	not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Uncertain significance(Last reviewed: Oct 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478343	21	34015767	21	32643457	478343	469562	rs142964720	NC_000021.9:32643456:C:T
NM_203446.3(SYNJ1):c.3915+5G>T	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478342	21	34011213	21	32638903	478342	471100	rs61750220	NC_000021.9:32638902:C:A
NM_203446.3(SYNJ1):c.3369A>G (p.Pro1123=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|not specified	Benign/Likely benign(Last reviewed: Jan 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478341	21	34017978	21	32645668	478341	471107	rs368850131	NC_000021.9:32645667:T:C
NM_203446.3(SYNJ1):c.3290A>G (p.Lys1097Arg)	SYNJ1	K1136R, K1092R, K1097R	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Jun 24, 2017)	criteria provided, single submitter	VCV000478340	21	34018057	21	32645747	478340	471114	rs946267411	NC_000021.9:32645746:T:C
NM_203446.3(SYNJ1):c.3205A>G (p.Ser1069Gly)	SYNJ1	S1108G, S1064G, S1069G	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000478339	21	34018745	21	32646435	478339	470606	rs149817769	NC_000021.9:32646434:T:C
NM_203446.3(SYNJ1):c.2882A>G (p.Asn961Ser)	SYNJ1	N1000S, N956S, N961S	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000478338	21	34022649	21	32650339	478338	470608	rs754401787	NC_000021.9:32650338:T:C
NM_203446.3(SYNJ1):c.2875-5G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV000478337	21	34022661	21	32650351	478337	471575	rs376206541	NC_000021.9:32650350:C:T
NM_203446.3(SYNJ1):c.2874+5G>A	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Apr 8, 2021)	criteria provided, conflicting interpretations	VCV000478336	21	34025593	21	32653283	478336	471577	rs371765751	NC_000021.9:32653282:C:T
NM_203446.3(SYNJ1):c.2604A>G (p.Ile868Met)	SYNJ1	I907M, I863M, I868M	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000478335	21	34029188	21	32656878	478335	471579	rs377165480	NC_000021.9:32656877:T:C
NM_203446.3(SYNJ1):c.2586C>T (p.Val862=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV000478334	21	34029206	21	32656896	478334	469563	rs771973400	NC_000021.9:32656895:G:A
NM_203446.3(SYNJ1):c.2346G>A (p.Pro782=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478333	21	34030141	21	32657831	478333	469565	rs61753644	NC_000021.9:32657830:C:T
NM_203446.3(SYNJ1):c.1906G>A (p.Val636Ile)	SYNJ1	V675I, V631I, V636I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 1|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2020)	criteria provided, conflicting interpretations	VCV000478331	21	34038789	21	32666479	478331	471582	rs373820739	NC_000021.9:32666478:C:T
NM_203446.3(SYNJ1):c.1830C>G (p.Leu610=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Nov 6, 2020)	criteria provided, single submitter	VCV000478330	21	34038865	21	32666555	478330	471125	rs115658799	NC_000021.9:32666554:G:C
NM_203446.3(SYNJ1):c.1555A>G (p.Ser519Gly)	SYNJ1	S558G, S514G, S519G	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000478329	21	34045821	21	32673511	478329	470609	rs148901211	NC_000021.9:32673510:T:C
NM_203446.3(SYNJ1):c.1546G>A (p.Val516Ile)	SYNJ1	V555I, V511I, V516I	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000478328	21	34045830	21	32673520	478328	470612	rs113708828	NC_000021.9:32673519:C:T
NM_203446.3(SYNJ1):c.1481G>A (p.Arg494Gln)	SYNJ1	R533Q, R497Q, R494Q	Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Uncertain significance(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000478327	21	34050984	21	32678674	478327	471585	rs781599934	NC_000021.9:32678673:C:T
NM_203446.3(SYNJ1):c.6G>A (p.Ala2=)	SYNJ1		not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Benign/Likely benign(Last reviewed: Aug 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478326	21	34099201	21	32726890	478326	471135	rs61750221	NC_000021.9:32726889:C:T
NM_203446.3(SYNJ1):c.1119-8G>T	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not specified	Benign(Last reviewed: Sep 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478325	21	34056437	21	32684127	478325	469567	rs138882423	NC_000021.9:32684126:C:A
NM_203446.3(SYNJ1):c.1030G>A (p.Ala344Thr)	SYNJ1	A383T, A344T	not provided|Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478324	21	34058146	21	32685836	478324	471126	rs114942253	NC_000021.9:32685835:C:T
NM_203446.3(SYNJ1):c.1002C>T (p.Asp334=)	SYNJ1		Epileptic encephalopathy, early infantile, 53|Parkinson disease 20, early-onset	Likely benign(Last reviewed: Sep 14, 2019)	criteria provided, single submitter	VCV000478323	21	34058174	21	32685864	478323	469569	rs763601982	NC_000021.9:32685863:G:A
NM_203446.3(SYNJ1):c.909A>G (p.Gly303=)	SYNJ1		not provided|Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000478316	21	34059327	21	32687017	478316	470613	rs145522240	NC_000021.9:32687016:T:C
NM_203446.3(SYNJ1):c.43C>T (p.Pro15Ser)	SYNJ1	P54S, P15S	Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53|not provided	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000445927	21	34099164	21	32726853	445927	439199	rs61755328	NC_000021.9:32726852:G:A
NM_203446.3(SYNJ1):c.1259G>C (p.Arg420Pro)	SYNJ1	R459P, R420P	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Mar 8, 2017)	no assertion criteria provided	VCV000393356	21	34053900	21	32681590	393356	380176	rs1060499619	NC_000021.9:32681589:C:G
NM_203446.3(SYNJ1):c.656G>A (p.Arg219Gln)	SYNJ1	R258Q, R219Q	Parkinson disease 20, early-onset	Pathogenic(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000088844	21	34067416	21	32695106	88844	94413	rs398122403	NC_000021.9:32695105:C:T
NM_203446.3(SYNJ1):c.2739C>T (p.Ala913=)	SYNJ1		Parkinson disease 20, early-onset|Epileptic encephalopathy, early infantile, 53	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000081827	21	34029053	21	32656743	81827	92718	rs267606107	NC_000021.9:32656742:G:A
NM_007375.4(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP		not provided|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED|Amyotrophic lateral sclerosis type 10	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000021474	1	11082610	1	11022553	21474	34326	rs367543041	NC_000001.11:11022552:G:A
NM_005996.4(TBX3):c.991C>T (p.Gln331Ter)	TBX3	Q331*, Q351*	Ulnar-mammary syndrome	Pathogenic(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000031909	12	115114166	12	114676361	31909	40565	rs397514484	NC_000012.12:114676360:G:A
NM_181486.4(TBX5):c.618T>G (p.Phe206Leu)	TBX5	F206L, F156L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487603	12	114832591	12	114394786	487603	480709	rs533581420	NC_000012.12:114394785:A:C
NM_003673.4(TCAP):c.97C>T (p.Arg33Trp)	TCAP	R33W	Hypertrophic cardiomyopathy 25|Primary familial hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Dec 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000282451	17	37821709	17	39665456	282451	266688	rs145524909	NC_000017.11:39665455:C:T
NM_003242.6(TGFBR2):c.1563G>A (p.Trp521Ter)	TGFBR2	W521*, W546*	Familial thoracic aortic aneurysm and aortic dissection|Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 16, 2018)	criteria provided, single submitter	VCV000487632	3	30732950	3	30691458	487632	480682	rs1553631968	NC_000003.12:30691457:G:A
NM_000360.4(TH):c.406G>A (p.Val136Met)	TH	V136M, V167M, V163M	Autosomal recessive DOPA responsive dystonia|Dystonia|not provided	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000304078	11	2189802	11	2168572	304078	326007	rs142046543	NC_000011.10:2168571:C:T
NM_000360.4(TH):c.1400A>G (p.Asp467Gly)	TH	D467G, D498G, D494G	Autosomal recessive DOPA responsive dystonia	Conflicting interpretations of pathogenicity(Last reviewed: Jul 23, 2020)	criteria provided, conflicting interpretations	VCV000304067	11	2185557	11	2164327	304067	313638	rs771351747	NC_000011.10:2164326:T:C
NM_001009923.2(TMEM230):c.422G>T (p.Arg141Leu)	TMEM230	R141L, R78L	not provided	Uncertain significance(Last reviewed: Apr 1, 2014)	no assertion criteria provided	VCV000243014	20	5081567	20	5100921	243014	244095	rs764786986	NC_000020.11:5100920:C:A
NM_001382273.1(TNK2):c.1088T>C (p.Val363Ala)	TNK2	V363A, V387A, V395A	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224860	3	195605390	3	195878519	224860	226710	rs370013968	NC_000003.12:195878518:A:G
NM_001382273.1(TNK2):c.2675G>A (p.Arg892His)	TNK2	R877H, R916H, R909H, R892H, R901H, R924H	Parkinson disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	VCV000224859	3	195594494	3	195867623	224859	226709	rs112384084	NC_000003.12:195867622:C:T
NM_001382273.1(TNK2):c.2981C>T (p.Ala994Val)	TNK2	A977V, A1003V, A1011V, A1018V, A1026V, A979V, A994V	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224858	3	195594092	3	195867221	224858	226708	rs571171423	NC_000003.12:195867220:G:A
NM_001382273.1(TNK2):c.1957G>A (p.Val653Met)	TNK2	V638M, V677M, V670M, V653M, V662M, V685M	Autosomal recessive infantile epilepsy|Infantile epilepsy|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2016)	criteria provided, conflicting interpretations	VCV000088849	3	195595212	3	195868341	88849	94418	rs201407161	NC_000003.12:195868340:C:T
NM_000363.5(TNNI3):c.466C>G (p.Gln156Glu)	TNNI3	Q156E	Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000894379	19	55665481	19	55154113	894379	882546		NC_000019.10:55154112:G:C
NM_000363.5(TNNI3):c.104C>A (p.Ala35Asp)	TNNI3	A35D	Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894052	19	55668422	19	55157054	894052	882547		NC_000019.10:55157053:G:T
NM_000363.5(TNNI3):c.*44A>G	TNNI3		Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000893714	19	55663158	19	55151790	893714	882545		NC_000019.10:55151789:T:C
NM_000363.5(TNNI3):c.-45C>T	TNNI3		Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893021	19	55669002	19	55157634	893021	882548		NC_000019.10:55157633:G:A
NM_000363.4(TNNI3):c.-148A>G	TNNI3		not provided|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy	Likely benign(Last reviewed: Jul 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000369294	19	55669105	19	55157737	369294	353523	rs73935313	NC_000019.10:55157736:T:C
NM_000363.5(TNNI3):c.-133G>T	TNNI3		Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000330203	19	55669090	19	55157722	330203	350409	rs886054636	NC_000019.10:55157721:C:A
NM_000363.5(TNNI3):c.-103C>T	TNNI3		Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000330202	19	55669060	19	55157692	330202	334391	rs557391836	NC_000019.10:55157691:G:A
NM_000363.5(TNNI3):c.-85A>C	TNNI3		not provided|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 14, 2016)	criteria provided, conflicting interpretations	VCV000330201	19	55669042	19	55157674	330201	350406	rs186540595	NC_000019.10:55157673:T:G
NM_000363.5(TNNI3):c.157C>T (p.Leu53=)	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|Hypertrophic cardiomyopathy|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2018)	criteria provided, conflicting interpretations	VCV000330200	19	55667694	19	55156326	330200	344273	rs763981651	NC_000019.10:55156325:G:A
NM_000363.5(TNNI3):c.283-9C>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Hypertrophic cardiomyopathy|Cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2019)	criteria provided, conflicting interpretations	VCV000330199	19	55666207	19	55154839	330199	349397	rs759922995	NC_000019.10:55154838:G:A
NM_000363.5(TNNI3):c.550-11C>T	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000330198	19	55663296	19	55151928	330198	344272	rs886054635	NC_000019.10:55151927:G:A
NM_000363.5(TNNI3):c.109-15A>G	TNNI3		Cardiomyopathy|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 8, 2019)	criteria provided, conflicting interpretations	VCV000229330	19	55668027	19	55156659	229330	231083	rs779144176	NC_000019.10:55156658:T:C
NM_000363.5(TNNI3):c.*35C>T	TNNI3		not provided|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000188677	19	55663167	19	55151799	188677	186575	rs375447438	NC_000019.10:55151798:G:A
NM_000363.5(TNNI3):c.-47C>T	TNNI3		not provided|Cardiomyopathy|none provided|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 17, 2020)	criteria provided, conflicting interpretations	VCV000188667	19	55669004	19	55157636	188667	186585	rs202159627	NC_000019.10:55157635:G:A
NM_000363.5(TNNI3):c.-98C>A	TNNI3		not provided|Dilated cardiomyopathy 2A|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000188666	19	55669055	19	55157687	188666	186586		NC_000019.10:55157686:G:T
NM_000363.5(TNNI3):c.372+7C>T	TNNI3		Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|not provided|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2020)	criteria provided, conflicting interpretations	VCV000165519	19	55666102	19	55154734	165519	176339	rs367809676	NC_000019.10:55154733:G:A
NM_000363.5(TNNI3):c.139T>C (p.Leu47=)	TNNI3		not specified|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Cardiomyopathy|Hypertrophic cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2020)	criteria provided, conflicting interpretations	VCV000137685	19	55667982	19	55156614	137685	141388	rs587780967	NC_000019.10:55156613:A:G
NM_003283.6(TNNT1):c.33-8G>A	TNNI3|TNNT1		Nemaline Myopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Familial restrictive cardiomyopathy|not specified|Hypertrophic cardiomyopathy|Nemaline myopathy 5	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000130603	19	55658397	19	55147029	130603	136049	rs76630067	NC_000019.10:55147028:C:T
NM_000363.5(TNNI3):c.373-4C>G	TNNI3		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|not specified|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Dilated cardiomyopathy 2A	Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)	criteria provided, conflicting interpretations	VCV000043378	19	55665578	19	55154210	43378	52548	rs2288530	NC_000019.10:55154209:G:C
NM_000363.5(TNNI3):c.373-15C>G	TNNI3		Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not provided|not specified|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2018)	criteria provided, conflicting interpretations	VCV000043377	19	55665589	19	55154221	43377	52547	rs192630178	NC_000019.10:55154220:G:C
NM_000363.5(TNNI3):c.273G>A (p.Ala91=)	TNNI3		Cardiomyopathy|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|not specified|Hypertrophic cardiomyopathy|not provided|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000043372	19	55667578	19	55156210	43372	52542	rs75491697	NC_000019.10:55156209:C:T
NM_000363.5(TNNI3):c.235C>T (p.Arg79Cys)	TNNI3	R79C	not provided|Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|not specified|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)	criteria provided, conflicting interpretations	VCV000043367	19	55667616	19	55156248	43367	52537	rs3729712	NC_000019.10:55156247:G:A
NM_000363.5(TNNI3):c.198G>A (p.Glu66=)	TNNI3		Cardiovascular phenotype|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|not specified|not provided|Cardiomyopathy|Familial restrictive cardiomyopathy|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043364	19	55667653	19	55156285	43364	52534	rs3729710	NC_000019.10:55156284:C:T
NM_000363.5(TNNI3):c.151-6C>G	TNNI3		Dilated cardiomyopathy 2A|Familial restrictive cardiomyopathy 1|Familial hypertrophic cardiomyopathy 7|Cardiomyopathy|not specified|Hypertrophic cardiomyopathy|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2019)	criteria provided, conflicting interpretations	VCV000043363	19	55667706	19	55156338	43363	52533	rs377258542	NC_000019.10:55156337:G:C
NM_000363.5(TNNI3):c.373-10=	TNNI3|TNNT1|DNAAF3		Familial hypertrophic cardiomyopathy 7|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|not specified|not provided|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Nemaline Myopathy, Recessive|Primary familial hypertrophic cardiomyopathy|Cardiomyopathy|Primary ciliary dyskinesia|Hypertrophic cardiomyopathy	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000036881	19	55665584	19	55154216	36881	45542	rs7252610	NC_000019.10:55154215:C:C
NM_003283.6(TNNT1):c.35A>G (p.Glu12Gly)	TNNI3|TNNT1	E12G	Nemaline myopathy 5|not provided|not specified|Dilated Cardiomyopathy, Recessive|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy	Benign/Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031865	19	55658387	19	55147019	31865	40525	rs112562759	NC_000019.10:55147018:T:C
NM_003283.6(TNNT1):c.-20A>G	TNNI3|TNNT1		Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Nemaline Myopathy, Recessive|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|Nemaline myopathy 5|not specified|not provided	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000031855	19	55660537	19	55149169	31855	40515	rs9636153	NC_000019.10:55149168:T:C
NM_000363.5(TNNI3):c.607G>A (p.Gly203Ser)	TNNI3	G203S	Familial hypertrophic cardiomyopathy 7	Pathogenic(Last reviewed: Aug 1, 1997)	no assertion criteria provided	VCV000012432	19	55663228	19	55151860	12432	27471	rs267607127	NC_000019.10:55151859:C:T
NM_000363.5(TNNI3):c.244C>T (p.Pro82Ser)	TNNI3	P82S	none provided|not provided|Cardiomyopathy|Familial restrictive cardiomyopathy 1|Dilated cardiomyopathy 2A|Familial hypertrophic cardiomyopathy 7|Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome|Dilated Cardiomyopathy, Recessive|Cardiovascular phenotype|Cardiomyopathy|Amyloidogenic transthyretin amyloidosis|Hypertrophic cardiomyopathy|Familial restrictive cardiomyopathy|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012421	19	55667607	19	55156239	12421	27460	rs77615401	NC_000019.10:55156238:G:A
NM_001276345.2(TNNT2):c.3G>A (p.Met1Ile)	TNNT2	M1I	Wolff-Parkinson-White pattern|not provided	Uncertain significance(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV000487631	1	201342380	1	201373252	487631	480671	rs1289914935	NC_000001.11:201373251:C:T
NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu)	TNNT2	F110L, F120L, F105L	Primary familial hypertrophic cardiomyopathy|Hypertrophic cardiomyopathy|not provided|Hypertrophic cardiomyopathy|Wolff-Parkinson-White syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000177807	1	201334370	1	201365242	177807	172501	rs727504331	NC_000001.11:201365241:A:C
NM_001276345.2(TNNT2):c.281G>C (p.Arg94Thr)	TNNT2	R84T, R94T, R93T, R79T	not provided|Familial restrictive cardiomyopathy 3|Familial hypertrophic cardiomyopathy 2|Left ventricular noncompaction 6|Hypertrophic cardiomyopathy|Cardiovascular phenotype|not specified	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043623	1	201334751	1	201365623	43623	52792	rs397516452	NC_000001.11:201365622:C:G
NM_003285.3(TNR):c.463T>A (p.Cys155Ser)	TNR	C155S	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224865	1	175375388	1	175406252	224865	226707	rs150331590	NC_000001.11:175406251:A:T
NM_003285.3(TNR):c.496A>G (p.Thr166Ala)	TNR	T166A	not provided|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000224864	1	175375355	1	175406219	224864	226706	rs147204644	NC_000001.11:175406218:T:C
NM_003285.3(TNR):c.538A>C (p.Asn180His)	TNR	N180H	not provided|Parkinson disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000224863	1	175372714	1	175403578	224863	226705	rs61731112	NC_000001.11:175403577:T:G
NM_003285.3(TNR):c.1732C>T (p.Arg578Ter)	TNR	R578*, R245*	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224862	1	175355213	1	175386077	224862	226704	rs869312899	NC_000001.11:175386076:G:A
NM_003285.3(TNR):c.1774A>G (p.Thr592Ala)	TNR	T592A, T259A	Parkinson disease	Uncertain significance(Last reviewed: Jan 1, 2016)	criteria provided, single submitter	VCV000224861	1	175355171	1	175386035	224861	226703	rs140481433	NC_000001.11:175386034:T:C
NM_017636.4(TRPM4):c.2732C>T (p.Thr911Met)	TRPM4	T911M, T557M, T766M, T796M, T737M, T375M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487616	19	49703643	19	49200386	487616	480724	rs148006852	NC_000019.10:49200385:C:T
NM_001297663.2(TTC39A):c.1322C>T (p.Thr441Met)	TTC39A	T445M, T414M, T18M, T85M, T441M, T442M, T477M	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487628	1	51756242	1	51290570	487628	480680	rs756251338	NC_000001.11:51290569:G:A
NM_001297663.2(TTC39A):c.1490C>G (p.Ala497Gly)	TTC39A	A501G, A141G, A470G, A533G, A497G, A498G, A74G	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487623	1	51755680	1	51290008	487623	480679	rs1553171591	NC_000001.11:51290007:G:C
NM_001267550.2(TTN):c.66904C>T (p.Leu22302=)	TTN|TTN-AS1		Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487595	2	179445202	2	178580475	487595	480681	rs1553624186	NC_000002.12:178580474:G:A
NM_001267550.2(TTN):c.46065G>C (p.Lys15355Asn)	TTN	K15355N, K12787N, K13714N, K6290N, K6415N, K6482N	Cardiomyopathy|Myopathy, myofibrillar, 9, with early respiratory failure|Dilated Cardiomyopathy, Dominant|Tibial muscular dystrophy|Hypertrophic cardiomyopathy|Limb-Girdle Muscular Dystrophy, Recessive|Limb-girdle muscular dystrophy, type 2J|Dilated cardiomyopathy 1G|Myopathy, early-onset, with fatal cardiomyopathy|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2021)	criteria provided, conflicting interpretations	VCV000046995	2	179485183	2	178620456	46995	56160	rs397517583	NC_000002.12:178620455:C:G
NM_001267550.2(TTN):c.92683C>T (p.Arg30895Ter)	TTN-AS1|TTN	R30895*, R21955*, R22022*, R21830*, R28327*, R29254*	Dilated cardiomyopathy 1G|Primary dilated cardiomyopathy|Wolff-Parkinson-White pattern	Likely pathogenic(Last reviewed: Oct 8, 2014)	criteria provided, single submitter	VCV000223300	2	179413670	2	178548943	223300	225032	rs869312065	NC_000002.12:178548942:G:A
NM_021830.5(TWNK):c.1001G>A (p.Arg334Gln)	TWNK	R334Q	Infantile onset spinocerebellar ataxia|Progressive external ophthalmoplegia with mitochondrial DNA deletions, digenic|Mitochondrial disease|not provided	Pathogenic(Last reviewed: Aug 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000004623	10	102748968	10	100989211	4623	19662	rs28937887	NC_000010.11:100989210:G:A
NM_004181.5(UCHL1):c.-17C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903526	4	41258977	4	41256960	903526	890659		NC_000004.12:41256959:C:T
NM_004181.5(UCHL1):c.-25T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903525	4	41258969	4	41256952	903525	890658		NC_000004.12:41256951:T:C
NM_004181.5(UCHL1):c.-26C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000903524	4	41258968	4	41256951	903524	890657		NC_000004.12:41256950:C:T
NM_004181.5(UCHL1):c.-46T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000903523	4	41258948	4	41256931	903523	890656		NC_000004.12:41256930:T:C
NM_004181.5(UCHL1):c.*276T>A	UCHL1		Parkinson disease 5	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901643	4	41270366	4	41268349	901643	890664		NC_000004.12:41268348:T:A
NM_004181.5(UCHL1):c.*250T>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901642	4	41270340	4	41268323	901642	890663		NC_000004.12:41268322:T:C
NC_000004.12:g.41256926C>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901592	4	41258943	4	41256926	901592	890655		NC_000004.12:41256925:C:A
NC_000004.12:g.41256918C>G	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000901591	4	41258935	4	41256918	901591	890654		NC_000004.12:41256917:C:G
NM_004181.5(UCHL1):c.*84C>G	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901096	4	41270174	4	41268157	901096	890662		NC_000004.12:41268156:C:G
NM_004181.5(UCHL1):c.586-4C>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000901095	4	41270000	4	41267983	901095	891794		NC_000004.12:41267982:C:A
NM_004181.5(UCHL1):c.457C>T (p.Arg153Trp)	UCHL1	R153W	Parkinson disease 5	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000901094	4	41263938	4	41261921	901094	890661		NC_000004.12:41261920:C:T
NM_004181.5(UCHL1):c.223G>A (p.Val75Ile)	UCHL1	V75I	Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899925	4	41262712	4	41260695	899925	890660		NC_000004.12:41260694:G:A
NM_004181.5(UCHL1):c.174+6G>A	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000899924	4	41259760	4	41257743	899924	891793		NC_000004.12:41257742:G:A
NM_004181.5(UCHL1):c.69C>T (p.Ala23=)	UCHL1		Parkinson disease 5|not provided	Likely benign(Last reviewed: Sep 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000771361	4	41259649	4	41257632	771361	698518	rs753720793	NC_000004.12:41257631:C:T
NM_004181.5(UCHL1):c.412-4G>A	UCHL1		Parkinson disease 5|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000731878	4	41263889	4	41261872	731878	744105	rs765745344	NC_000004.12:41261871:G:A
NM_004181.5(UCHL1):c.533G>A (p.Arg178Gln)	UCHL1	R178Q	Parkinson disease 5|Spastic paraplegia 79, autosomal recessive	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000375649	4	41266126	4	41264109	375649	362490	rs768996179	NC_000004.12:41264108:G:A
NM_004181.5(UCHL1):c.*309T>C	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000348778	4	41270399	4	41268382	348778	294817	rs78683791	NC_000004.12:41268381:T:C
NM_004181.5(UCHL1):c.*294G>A	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000348777	4	41270384	4	41268367	348777	298513	rs116700032	NC_000004.12:41268366:G:A
NM_004181.5(UCHL1):c.*125C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348776	4	41270215	4	41268198	348776	293418	rs886059408	NC_000004.12:41268197:C:T
NM_004181.5(UCHL1):c.609A>G (p.Glu203=)	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348775	4	41270027	4	41268010	348775	298451	rs147661219	NC_000004.12:41268009:A:G
NM_004181.5(UCHL1):c.558C>T (p.Gly186=)	UCHL1		Parkinson disease 5|not provided	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348774	4	41266151	4	41264134	348774	298512	rs116680633	NC_000004.12:41264133:C:T
NM_004181.5(UCHL1):c.527-3C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348773	4	41266117	4	41264100	348773	298447	rs749663332	NC_000004.12:41264099:C:T
NM_004181.5(UCHL1):c.513C>T (p.His171=)	UCHL1		Parkinson disease 5|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348772	4	41265295	4	41263278	348772	298446	rs145093131	NC_000004.12:41263277:C:T
NM_004181.5(UCHL1):c.175-5C>T	UCHL1		Parkinson disease 5|not provided	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000348770	4	41262659	4	41260642	348770	298445	rs373327947	NC_000004.12:41260641:C:T
NM_004181.5(UCHL1):c.45+6T>C	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Mar 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348769	4	41259149	4	41257132	348769	293414	rs11556273	NC_000004.12:41257131:T:C
NM_004181.5(UCHL1):c.33+5G>C	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348768	4	41259031	4	41257014	348768	294808	rs886059407	NC_000004.12:41257013:G:C
NM_004181.5(UCHL1):c.-16C>T	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348767	4	41258978	4	41256961	348767	294806	rs9321	NC_000004.12:41256960:C:T
NM_004181.5(UCHL1):c.-24A>G	UCHL1		not provided|Parkinson disease 5	Benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000348766	4	41258970	4	41256953	348766	298506	rs11556271	NC_000004.12:41256952:A:G
NM_004181.5(UCHL1):c.-47C>T	UCHL1		Parkinson disease 5	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348765	4	41258947	4	41256930	348765	298505	rs752001613	NC_000004.12:41256929:C:T
NM_004181.4(UCHL1):c.-71C>G	UCHL1		Parkinson disease 5	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000348764	4	41258923	4	41256906	348764	298441	rs201100258	NC_000004.12:41256905:C:G
NM_004181.5(UCHL1):c.370A>C (p.Met124Leu)	UCHL1	M124L	Parkinson disease 5|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)	criteria provided, conflicting interpretations	VCV000252624	4	41263776	4	41261759	252624	246966	rs150601238	NC_000004.12:41261758:A:C
NM_004181.5(UCHL1):c.20A>C (p.Glu7Ala)	UCHL1	E7A	Spastic paraplegia 79, autosomal recessive	Pathogenic(Last reviewed: Feb 26, 2013)	no assertion criteria provided	VCV000088635	4	41259013	4	41256996	88635	94224	rs397515634	NC_000004.12:41256995:A:C
NM_004181.5(UCHL1):c.53C>A (p.Ser18Tyr)	UCHL1	S18Y	Parkinson disease 5|not provided	Benign(Last reviewed: Apr 20, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012298	4	41259633	4	41257616	12298	27337	rs5030732	NC_000004.12:41257615:C:A
NM_004181.5(UCHL1):c.279C>G (p.Ile93Met)	UCHL1	I93M	Parkinson disease 5	risk factor(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000012297	4	41262768	4	41260751	12297	27336	rs121917767	NC_000004.12:41260750:C:G
NM_014000.3(VCL):c.3379G>A (p.Val1127Ile)	VCL	V1127I, V1059I	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487634	10	75877901	10	74118143	487634	480706	rs1312868617	NC_000010.11:74118142:G:A
NM_014000.3(VCL):c.550C>T (p.His184Tyr)	VCL	H184Y	Wolff-Parkinson-White pattern|none provided	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000487630	10	75832538	10	74072780	487630	480704	rs1321660809	NC_000010.11:74072779:C:T
NM_014000.3(VCL):c.1928C>T (p.Thr643Met)	VCL	T643M	Wolff-Parkinson-White pattern|not provided|Dilated cardiomyopathy 1W	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000487627	10	75860761	10	74101003	487627	480705	rs150643310	NC_000010.11:74101002:C:T
NM_007126.5(VCP):c.2193C>T (p.Ile731=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001169485	9	35057495	9	35057498	1169485	1156213		NC_000009.12:35057497:G:A
NM_007126.5(VCP):c.465T>G (p.Arg155=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Oct 7, 2019)	criteria provided, single submitter	VCV001167708	9	35065359	9	35065362	1167708	1156215		NC_000009.12:35065361:A:C
NM_007126.5(VCP):c.2229G>A (p.Ala743=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001167285	9	35057459	9	35057462	1167285	1156212		NC_000009.12:35057461:C:T
NM_007126.5(VCP):c.1407A>G (p.Val469=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Nov 19, 2020)	criteria provided, single submitter	VCV001167035	9	35060873	9	35060876	1167035	1156214		NC_000009.12:35060875:T:C
NM_007126.5(VCP):c.54A>G (p.Lys18=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001164584	9	35068323	9	35068326	1164584	1156216		NC_000009.12:35068325:T:C
NM_007126.5(VCP):c.804G>A (p.Leu268=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001162132	9	35062982	9	35062985	1162132	1140515		NC_000009.12:35062984:C:T
NM_007126.5(VCP):c.2197C>A (p.Arg733=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001160158	9	35057491	9	35057494	1160158	1140511		NC_000009.12:35057493:G:T
NM_007126.5(VCP):c.1437C>T (p.Ile479=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV001153191	9	35060843	9	35060846	1153191	1140513		NC_000009.12:35060845:G:A
NM_007126.5(VCP):c.147G>A (p.Leu49=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV001149179	9	35068043	9	35068046	1149179	1140516		NC_000009.12:35068045:C:T
NM_007126.5(VCP):c.897C>G (p.Ala299=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001145804	9	35062262	9	35062265	1145804	1140514		NC_000009.12:35062264:G:C
NM_007126.5(VCP):c.1360-9C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001141057	9	35060929	9	35060932	1141057	1119689		NC_000009.12:35060931:G:A
NM_007126.5(VCP):c.975A>G (p.Val325=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001133903	9	35062106	9	35062109	1133903	1119691		NC_000009.12:35062108:T:C
NM_007126.5(VCP):c.1081+8C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV001131632	9	35061992	9	35061995	1131632	1119690		NC_000009.12:35061994:G:A
NM_007126.5(VCP):c.349C>T (p.Leu117=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001126709	9	35066768	9	35066771	1126709	1119693		NC_000009.12:35066770:G:A
NM_007126.5(VCP):c.2223C>T (p.Arg741=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV001124905	9	35057465	9	35057468	1124905	1119687		NC_000009.12:35057467:G:A
NM_007126.5(VCP):c.711T>G (p.Pro237=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001123267	9	35063075	9	35063078	1123267	1119692		NC_000009.12:35063077:A:C
NM_007126.5(VCP):c.2161-5T>C	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV001121489	9	35057532	9	35057535	1121489	1119688		NC_000009.12:35057534:A:G
NM_007126.5(VCP):c.675A>G (p.Arg225=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, single submitter	VCV001109941	9	35064184	9	35064187	1109941	1098114		NC_000009.12:35064186:T:C
NM_007126.5(VCP):c.351G>T (p.Leu117=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 27, 2019)	criteria provided, single submitter	VCV001109164	9	35066766	9	35066769	1109164	1098116		NC_000009.12:35066768:C:A
NM_007126.5(VCP):c.2316-8G>A	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV001106973	9	35057227	9	35057230	1106973	1098111		NC_000009.12:35057229:C:T
NM_007126.5(VCP):c.1776T>C (p.Asp592=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001106594	9	35059718	9	35059721	1106594	1098112		NC_000009.12:35059720:A:G
NM_007126.5(VCP):c.577-15C>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001101373	9	35064297	9	35064300	1101373	1098115		NC_000009.12:35064299:G:C
NM_007126.5(VCP):c.1474C>T (p.Leu492=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001100637	9	35060806	9	35060809	1100637	1098113		NC_000009.12:35060808:G:A
NM_007126.5(VCP):c.2109C>T (p.Ile703=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV001096276	9	35059112	9	35059115	1096276	1076437		NC_000009.12:35059114:G:A
NM_007126.5(VCP):c.1839A>C (p.Thr613=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001092902	9	35059655	9	35059658	1092902	1076438		NC_000009.12:35059657:T:G
NM_007126.5(VCP):c.120C>T (p.Ser40=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001090775	9	35068257	9	35068260	1090775	1076444		NC_000009.12:35068259:G:A
NM_007126.5(VCP):c.1611C>G (p.Ala537=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001089780	9	35060394	9	35060397	1089780	1076439		NC_000009.12:35060396:G:C
NM_007126.5(VCP):c.210C>T (p.Ile70=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001089398	9	35067980	9	35067983	1089398	1076442		NC_000009.12:35067982:G:A
NM_007126.5(VCP):c.446-5C>T	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV001079222	9	35065383	9	35065386	1079222	1076441		NC_000009.12:35065385:G:A
NM_007126.5(VCP):c.168A>C (p.Thr56=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV001078388	9	35068022	9	35068025	1078388	1076443		NC_000009.12:35068024:T:G
NM_007126.5(VCP):c.664C>T (p.Leu222=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV001077761	9	35064195	9	35064198	1077761	1076440		NC_000009.12:35064197:G:A
NM_007126.5(VCP):c.2345G>T (p.Gly782Val)	VCP	G737V, G782V	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001058517	9	35057190	9	35057193	1058517	1046162		NC_000009.12:35057192:C:A
NM_007126.5(VCP):c.512G>A (p.Ser171Asn)	VCP	S126N, S171N	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: May 14, 2020)	criteria provided, single submitter	VCV001053574	9	35065312	9	35065315	1053574	1046163		NC_000009.12:35065314:C:T
NM_007126.5(VCP):c.130-3C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001045485	9	35068063	9	35068066	1045485	1029190		NC_000009.12:35068065:G:A
NM_007126.5(VCP):c.331G>A (p.Gly111Ser)	VCP	G66S, G111S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001043684	9	35066786	9	35066789	1043684	1029189		NC_000009.12:35066788:C:T
NM_007126.5(VCP):c.1318G>A (p.Glu440Lys)	VCP	E395K, E440K	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001039996	9	35061053	9	35061056	1039996	1029187		NC_000009.12:35061055:C:T
NM_007126.5(VCP):c.2126G>A (p.Arg709Gln)	VCP	R709Q, R664Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001039720	9	35059095	9	35059098	1039720	1029186		NC_000009.12:35059097:C:T
NM_007126.5(VCP):c.577-2A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001038018	9	35064284	9	35064287	1038018	1029188		NC_000009.12:35064286:T:C
NM_007126.5(VCP):c.268A>G (p.Asn90Asp)	VCP	N45D, N90D	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 19, 2020)	criteria provided, single submitter	VCV001024805	9	35067922	9	35067925	1024805	1008633		NC_000009.12:35067924:T:C
NM_007126.5(VCP):c.1144C>G (p.Gln382Glu)	VCP	Q337E, Q382E	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001022767	9	35061624	9	35061627	1022767	1008631		NC_000009.12:35061626:G:C
NM_007126.5(VCP):c.94A>G (p.Ile32Val)	VCP	I32V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV001019616	9	35068283	9	35068286	1019616	1008635		NC_000009.12:35068285:T:C
NM_007126.5(VCP):c.237T>A (p.Asp79Glu)	VCP	D34E, D79E	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001014881	9	35067953	9	35067956	1014881	1008634		NC_000009.12:35067955:A:T
NM_007126.5(VCP):c.460G>T (p.Val154Phe)	VCP	V109F, V154F	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001013993	9	35065364	9	35065367	1013993	1008632		NC_000009.12:35065366:C:A
NM_007126.5(VCP):c.265C>T (p.Arg89Trp)	VCP	R44W, R89W	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001010487	9	35067925	9	35067928	1010487	993443		NC_000009.12:35067927:G:A
NM_007126.5(VCP):c.401A>G (p.Tyr134Cys)	VCP	Y134C, Y89C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001000668	9	35066716	9	35066719	1000668	993442		NC_000009.12:35066718:T:C
NM_007126.5(VCP):c.294T>A (p.Asp98Glu)	VCP	D53E, D98E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Likely pathogenic(Last reviewed: May 31, 2019)	criteria provided, single submitter	VCV000976025	9	35067896	9	35067899	976025	964331		NC_000009.12:35067898:A:T
NM_007126.5(VCP):c.1864G>T (p.Ala622Ser)	VCP	A577S, A622S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV000972527	9	35059630	9	35059633	972527	955812		NC_000009.12:35059632:C:A
NM_007126.5(VCP):c.2132G>A (p.Arg711Gln)	VCP	R666Q, R711Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV000966733	9	35059089	9	35059092	966733	955811		NC_000009.12:35059091:C:T
NM_007126.5(VCP):c.1106T>C (p.Ile369Thr)	VCP	I369T, I324T	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000963526	9	35061662	9	35061665	963526	946601		NC_000009.12:35061664:A:G
NM_007126.5(VCP):c.1324A>G (p.Met442Val)	VCP	M397V, M442V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000961078	9	35061047	9	35061050	961078	946600		NC_000009.12:35061049:T:C
NM_007126.5(VCP):c.313T>C (p.Cys105Arg)	VCP	C105R, C60R	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000960799	9	35066804	9	35066807	960799	946602		NC_000009.12:35066806:A:G
NM_007126.5(VCP):c.2194C>T (p.Arg732Cys)	VCP	R687C, R732C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: May 24, 2019)	criteria provided, single submitter	VCV000952496	9	35057494	9	35057497	952496	925568		NC_000009.12:35057496:G:A
NM_007126.5(VCP):c.767G>A (p.Arg256Gln)	VCP	R256Q, R211Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Apr 11, 2019)	criteria provided, single submitter	VCV000946240	9	35063019	9	35063022	946240	925569		NC_000009.12:35063021:C:T
NM_007126.5(VCP):c.453T>G (p.Ile151Met)	VCP	I151M, I106M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000942825	9	35065371	9	35065374	942825	934749		NC_000009.12:35065373:A:C
NM_007126.5(VCP):c.523A>G (p.Ile175Val)	VCP	I130V, I175V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000942537	9	35065301	9	35065304	942537	934748		NC_000009.12:35065303:T:C
NM_007126.5(VCP):c.377T>G (p.Ile126Ser)	VCP	I126S, I81S	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 9, 2019)	criteria provided, single submitter	VCV000942237	9	35066740	9	35066743	942237	934750		NC_000009.12:35066742:A:C
NM_007126.5(VCP):c.2242A>T (p.Ser748Cys)	VCP	S748C, S703C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000940463	9	35057446	9	35057449	940463	934747		NC_000009.12:35057448:T:A
NM_007126.5(VCP):c.30T>A (p.Asp10Glu)	VCP	D10E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000931551	9	35068347	9	35068350	931551	919228		NC_000009.12:35068349:A:T
NM_007126.5(VCP):c.130-9T>C	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914689	9	35068069	9	35068072	914689	903400		NC_000009.12:35068071:A:G
NM_007126.5(VCP):c.1293C>T (p.Asp431=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914650	9	35061078	9	35061081	914650	901970		NC_000009.12:35061080:G:A
NM_007126.5(VCP):c.*216G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000914611	9	35056898	9	35056901	914611	901966		NC_000009.12:35056900:C:T
NM_007126.5(VCP):c.*217G>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914610	9	35056897	9	35056900	914610	901965		NC_000009.12:35056899:C:A
NM_007126.5(VCP):c.335A>G (p.Lys112Arg)	VCP	K112R, K67R	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000914194	9	35066782	9	35066785	914194	901975		NC_000009.12:35066784:T:C
NM_007126.5(VCP):c.384T>C (p.Gly128=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000914193	9	35066733	9	35066736	914193	901974		NC_000009.12:35066735:A:G
NM_007126.5(VCP):c.446-4G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914192	9	35065382	9	35065385	914192	903399		NC_000009.12:35065384:C:T
NM_007126.5(VCP):c.591C>G (p.Ser197=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914191	9	35064268	9	35064271	914191	901973		NC_000009.12:35064270:G:C
NM_007126.5(VCP):c.*367G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000914100	9	35056747	9	35056750	914100	901964		NC_000009.12:35056749:C:T
NM_007126.5(VCP):c.697A>G (p.Ile233Val)	VCP	I188V, I233V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000913795	9	35064162	9	35064165	913795	901972		NC_000009.12:35064164:T:C
NM_007126.5(VCP):c.794T>C (p.Phe265Ser)	VCP	F265S, F220S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000913794	9	35062992	9	35062995	913794	901971		NC_000009.12:35062994:A:G
NM_007126.5(VCP):c.*12C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000913746	9	35057102	9	35057105	913746	901969		NC_000009.12:35057104:G:A
NM_007126.5(VCP):c.*15C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000913745	9	35057099	9	35057102	913745	901968		NC_000009.12:35057101:G:A
NM_007126.5(VCP):c.*885G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000913703	9	35056229	9	35056232	913703	903397		NC_000009.12:35056231:C:T
NM_007126.5(VCP):c.812-7C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000912685	9	35062354	9	35062357	912685	903398		NC_000009.12:35062356:G:C
NM_007126.5(VCP):c.*63G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000912643	9	35057051	9	35057054	912643	901967		NC_000009.12:35057053:C:T
NM_007126.5(VCP):c.*1001C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000912608	9	35056113	9	35056116	912608	903396		NC_000009.12:35056115:G:A
NM_007126.5(VCP):c.*1040T>C	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000912607	9	35056074	9	35056077	912607	903395		NC_000009.12:35056076:A:G
NM_007126.5(VCP):c.41C>T (p.Thr14Ile)	VCP	T14I	not specified|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000873235	9	35068336	9	35068339	873235	861363		NC_000009.12:35068338:G:A
NM_007126.5(VCP):c.1996G>A (p.Val666Ile)	VCP	V621I, V666I	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 10, 2019)	criteria provided, single submitter	VCV000847962	9	35059498	9	35059501	847962	836085		NC_000009.12:35059500:C:T
NM_007126.5(VCP):c.995T>C (p.Met332Thr)	VCP	M287T, M332T	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV000846874	9	35062086	9	35062089	846874	836086		NC_000009.12:35062088:A:G
NM_007126.5(VCP):c.2228C>T (p.Ala743Val)	VCP	A698V, A743V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Apr 6, 2020)	criteria provided, single submitter	VCV000837640	9	35057460	9	35057463	837640	836084		NC_000009.12:35057462:G:A
NM_007126.5(VCP):c.648A>G (p.Ile216Met)	VCP	I171M, I216M	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000836876	9	35064211	9	35064214	836876	836087		NC_000009.12:35064213:T:C
NM_007126.5(VCP):c.2345G>C (p.Gly782Ala)	VCP	G782A, G737A	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000835129	9	35057190	9	35057193	835129	836083		NC_000009.12:35057192:C:G
NM_007126.5(VCP):c.390C>G (p.Leu130=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000799309	9	35066727	9	35066730	799309	783401	rs1587128848	NC_000009.12:35066729:G:C
NM_007126.5(VCP):c.372A>G (p.Glu124=)	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000795668	9	35066745	9	35066748	795668	783402	rs1587128887	NC_000009.12:35066747:T:C
NM_007126.5(VCP):c.1696-4A>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000790949	9	35059802	9	35059805	790949	779588	rs963637081	NC_000009.12:35059804:T:C
NM_007126.5(VCP):c.924C>T (p.Ala308=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000767613	9	35062235	9	35062238	767613	700987	rs199504528	NC_000009.12:35062237:G:A
NM_007126.5(VCP):c.732C>T (p.Tyr244=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2018)	criteria provided, conflicting interpretations	VCV000767349	9	35063054	9	35063057	767349	700988	rs201610567	NC_000009.12:35063056:G:A
NM_007126.5(VCP):c.1191A>G (p.Glu397=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Likely benign(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000765862	9	35061577	9	35061580	765862	767389	rs1587122637	NC_000009.12:35061579:T:C
NM_007126.5(VCP):c.618T>C (p.Ile206=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000765640	9	35064241	9	35064244	765640	767392	rs1471384169	NC_000009.12:35064243:A:G
NM_007126.5(VCP):c.1017A>T (p.Ala339=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000765533	9	35062064	9	35062067	765533	767390	rs565534943	NC_000009.12:35062066:T:A
NM_007126.5(VCP):c.1371C>T (p.Ser457=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000764681	9	35060909	9	35060912	764681	767388	rs747614057	NC_000009.12:35060911:G:A
NM_007126.5(VCP):c.709-4A>G	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: May 17, 2018)	criteria provided, single submitter	VCV000760866	9	35063081	9	35063084	760866	775389	rs1587124649	NC_000009.12:35063083:T:C
NM_007126.5(VCP):c.624C>T (p.Gly208=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000753125	9	35064235	9	35064238	753125	767391	rs781273474	NC_000009.12:35064237:G:A
NM_007126.5(VCP):c.18-6T>A	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000751037	9	35068365	9	35068368	751037	775544	rs1587130773	NC_000009.12:35068367:A:T
NM_007126.5(VCP):c.1401C>T (p.Thr467=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000747649	9	35060879	9	35060882	747649	751685	rs916113917	NC_000009.12:35060881:G:A
NM_007126.5(VCP):c.628A>C (p.Arg210=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000743902	9	35064231	9	35064234	743902	751687	rs755168304	NC_000009.12:35064233:T:G
NM_007126.5(VCP):c.2160+8T>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000742604	9	35059053	9	35059056	742604	759748	rs564249854	NC_000009.12:35059055:A:C
NM_007126.5(VCP):c.345T>C (p.His115=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000741897	9	35066772	9	35066775	741897	751688	rs775348132	NC_000009.12:35066774:A:G
NM_007126.5(VCP):c.1476G>A (p.Leu492=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV000733355	9	35060804	9	35060807	733355	737121	rs759475496	NC_000009.12:35060806:C:T
NM_007126.5(VCP):c.1887T>C (p.Ile629=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000733166	9	35059607	9	35059610	733166	737120	rs777402266	NC_000009.12:35059609:A:G
NM_007126.5(VCP):c.2052A>G (p.Gly684=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Feb 1, 2019)	criteria provided, single submitter	VCV000709727	9	35059169	9	35059172	709727	723557	rs753011642	NC_000009.12:35059171:T:C
NM_007126.5(VCP):c.832T>C (p.Leu278=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified	Benign(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000706186	9	35062327	9	35062330	706186	692665	rs200670526	NC_000009.12:35062329:A:G
NM_007126.5(VCP):c.2166A>G (p.Val722=)	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000705822	9	35057522	9	35057525	705822	692664	rs781606619	NC_000009.12:35057524:T:C
NM_007126.5(VCP):c.1180G>A (p.Val394Met)	VCP	V394M, V349M	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000656560	9	35061588	9	35061591	656560	638219	rs1587122661	NC_000009.12:35061590:C:T
NM_007126.5(VCP):c.2266G>A (p.Glu756Lys)	VCP	E711K, E756K	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000653332	9	35057422	9	35057425	653332	638217	rs1587117319	NC_000009.12:35057424:C:T
NM_007126.5(VCP):c.2014T>G (p.Leu672Val)	VCP	L627V, L672V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000647081	9	35059207	9	35059210	647081	638218	rs757829124	NC_000009.12:35059209:A:C
NM_007126.5(VCP):c.512G>T (p.Ser171Ile)	VCP	S126I, S171I	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Mar 22, 2019)	criteria provided, single submitter	VCV000640109	9	35065312	9	35065315	640109	638220	rs200911363	NC_000009.12:35065314:C:A
NM_007126.5(VCP):c.84T>A (p.Val28=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000638960	9	35068293	9	35068296	638960	638221	rs1587130660	NC_000009.12:35068295:A:T
NM_007126.5(VCP):c.340A>G (p.Ile114Val)	VCP	I114V, I69V	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Aug 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000597496	9	35066777	9	35066780	597496	588557	rs549915384	NC_000009.12:35066779:T:C
NM_007126.5(VCP):c.284G>C (p.Arg95Pro)	VCP	R95P, R50P	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000595911	9	35067906	9	35067909	595911	586972	rs758169026	NC_000009.12:35067908:C:G
NM_007126.5(VCP):c.1488T>C (p.Pro496=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2020)	criteria provided, conflicting interpretations	VCV000595430	9	35060517	9	35060520	595430	586492	rs1563976866	NC_000009.12:35060519:A:G
NM_007126.5(VCP):c.1242G>A (p.Leu414=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Oct 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000594371	9	35061129	9	35061132	594371	585434	rs375262833	NC_000009.12:35061131:C:T
NM_007126.5(VCP):c.258A>G (p.Arg86=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2018)	criteria provided, conflicting interpretations	VCV000594266	9	35067932	9	35067935	594266	585329	rs1563980979	NC_000009.12:35067934:T:C
NM_007126.5(VCP):c.1156A>G (p.Lys386Glu)	VCP	K386E, K341E	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Aug 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000594143	9	35061612	9	35061615	594143	585206	rs1563977665	NC_000009.12:35061614:T:C
NM_007126.5(VCP):c.1863C>T (p.Gly621=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2020)	criteria provided, conflicting interpretations	VCV000593323	9	35059631	9	35059634	593323	584387	rs376510669	NC_000009.12:35059633:G:A
NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	NC_000009.12:35067915:G:A
NM_007126.5(VCP):c.320A>T (p.Asp107Val)	VCP	D107V, D62V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000575232	9	35066797	9	35066800	575232	569010	rs1563980440	NC_000009.12:35066799:T:A
NM_007126.5(VCP):c.1984C>T (p.Arg662Cys)	VCP	R662C, R617C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000572697	9	35059510	9	35059513	572697	563947	rs765795425	NC_000009.12:35059512:G:A
NM_007126.5(VCP):c.374G>A (p.Gly125Asp)	VCP	G125D, G80D	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000569394	9	35066743	9	35066746	569394	565887	rs1563980403	NC_000009.12:35066745:C:T
NM_007126.5(VCP):c.2397C>G (p.Asp799Glu)	VCP	D799E, D754E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000568017	9	35057138	9	35057141	568017	563943	rs1329151473	NC_000009.12:35057140:G:C
NM_007126.5(VCP):c.1194+3G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000565903	9	35061571	9	35061574	565903	563957	rs183223259	NC_000009.12:35061573:C:T
NM_007126.5(VCP):c.2316-4A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV000532767	9	35057223	9	35057226	532767	524547	rs755625059	NC_000009.12:35057225:T:C
NM_007126.5(VCP):c.2161-6C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Likely benign(Last reviewed: Mar 12, 2019)	criteria provided, single submitter	VCV000532766	9	35057533	9	35057536	532766	525095	rs199513619	NC_000009.12:35057535:G:A
NM_007126.5(VCP):c.213C>T (p.Val71=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000532765	9	35067977	9	35067980	532765	525108	rs1195805928	NC_000009.12:35067979:G:A
NM_007126.5(VCP):c.552C>T (p.Cys184=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000532764	9	35065272	9	35065275	532764	524557	rs769455914	NC_000009.12:35065274:G:A
NM_007126.5(VCP):c.1950G>A (p.Glu650=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000532763	9	35059544	9	35059547	532763	525101	rs752382520	NC_000009.12:35059546:C:T
NM_007126.5(VCP):c.1329C>T (p.Asn443=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000532762	9	35061042	9	35061045	532762	524550	rs748816624	NC_000009.12:35061044:G:A
NM_007126.5(VCP):c.478G>C (p.Ala160Pro)	VCP	A160P, A115P	not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000532761	9	35065346	9	35065349	532761	524559	rs1554668805	NC_000009.12:35065348:C:G
NM_007126.5(VCP):c.1327A>C (p.Asn443His)	VCP	N443H, N398H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000532760	9	35061044	9	35061047	532760	524552	rs770514866	NC_000009.12:35061046:T:G
NM_007126.5(VCP):c.1360-4C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000532759	9	35060924	9	35060927	532759	524945	rs769279961	NC_000009.12:35060926:G:C
NM_007126.5(VCP):c.479C>T (p.Ala160Val)	VCP	A160V, A115V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000532758	9	35065345	9	35065348	532758	525102	rs1554668804	NC_000009.12:35065347:G:A
NM_007126.5(VCP):c.1896C>A (p.Ala632=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000501835	9	35059598	9	35059601	501835	493259	rs141275388	NC_000009.12:35059600:G:T
NM_007126.5(VCP):c.1875G>T (p.Arg625=)	VCP		not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000501479	9	35059619	9	35059622	501479	492903	rs201410035	NC_000009.12:35059621:C:A
NM_007126.5(VCP):c.576+10C>G	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Jun 27, 2016)	criteria provided, single submitter	VCV000464110	9	35065238	9	35065241	464110	459451	rs757728490	NC_000009.12:35065240:G:C
NM_007126.5(VCP):c.426G>A (p.Ala142=)	VCP		not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2019)	criteria provided, conflicting interpretations	VCV000464109	9	35066691	9	35066694	464109	459155	rs577812326	NC_000009.12:35066693:C:T
NM_007126.5(VCP):c.303-3C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000464108	9	35066817	9	35066820	464108	459547	rs1183711292	NC_000009.12:35066819:G:A
NM_007126.5(VCP):c.2412G>A (p.Leu804=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000464107	9	35057123	9	35057126	464107	459154	rs757712897	NC_000009.12:35057125:C:T
NM_007126.5(VCP):c.1696-7C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000464106	9	35059805	9	35059808	464106	459539	rs1554668202	NC_000009.12:35059807:G:A
NM_007126.5(VCP):c.1202A>G (p.Asn401Ser)	VCP	N401S, N356S	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Benign/Likely benign(Last reviewed: Feb 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000464105	9	35061169	9	35061172	464105	460014	rs148329626	NC_000009.12:35061171:T:C
NM_007126.5(VCP):c.1017A>G (p.Ala339=)	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV000464104	9	35062064	9	35062067	464104	459544	rs565534943	NC_000009.12:35062066:T:C
NM_007126.5(VCP):c.1082-9G>T	VCP		not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464103	9	35061695	9	35061698	464103	459541	rs12349922	NC_000009.12:35061697:C:A
NM_007126.5(VCP):c.278G>A (p.Arg93His)	VCP	R93H, R48H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2021)	criteria provided, conflicting interpretations	VCV000449554	9	35067912	9	35067915	449554	444478	rs779959657	NC_000009.12:35067914:C:T
NM_007126.3(VCP):c.-370G>A	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366727	9	35072720	9	35072723	366727	318546	rs886063895	NC_000009.12:35072722:C:T
NM_007126.5(VCP):c.-267C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366726	9	35072617	9	35072620	366726	312633	rs184152880	NC_000009.12:35072619:G:A
NM_007126.5(VCP):c.-250C>T	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366725	9	35072600	9	35072603	366725	312632	rs886063894	NC_000009.12:35072602:G:A
NM_007126.5(VCP):c.-215A>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366723	9	35072565	9	35072568	366723	312631	rs886063893	NC_000009.12:35072567:T:C
NM_007126.5(VCP):c.-53C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366722	9	35072403	9	35072406	366722	319056	rs369830702	NC_000009.12:35072405:G:A
NM_007126.5(VCP):c.18-5T>C	VCP		not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000366721	9	35068364	9	35068367	366721	318534	rs114256093	NC_000009.12:35068366:A:G
NM_007126.5(VCP):c.185A>G (p.Lys62Arg)	VCP	K62R, K17R	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366720	9	35068005	9	35068008	366720	319050	rs886063892	NC_000009.12:35068007:T:C
NM_007126.5(VCP):c.927C>T (p.Ile309=)	VCP		not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000366719	9	35062232	9	35062235	366719	319044	rs34097935	NC_000009.12:35062234:G:A
NM_007126.5(VCP):c.1092C>T (p.Asp364=)	VCP		not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Benign/Likely benign(Last reviewed: Jun 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000366718	9	35061676	9	35061679	366718	319032	rs61752947	NC_000009.12:35061678:G:A
NM_007126.5(VCP):c.1360-6T>C	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366717	9	35060926	9	35060929	366717	308255	rs370296303	NC_000009.12:35060928:A:G
NM_007126.5(VCP):c.*64C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366715	9	35057050	9	35057053	366715	308247	rs553370942	NC_000009.12:35057052:G:A
NM_007126.5(VCP):c.*153G>T	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign(Last reviewed: Jul 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000366714	9	35056961	9	35056964	366714	318529	rs1053318	NC_000009.12:35056963:C:A
NM_007126.5(VCP):c.*172C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366713	9	35056942	9	35056945	366713	312628	rs886063890	NC_000009.12:35056944:G:C
NM_007126.5(VCP):c.*184G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366712	9	35056930	9	35056933	366712	308246	rs886063889	NC_000009.12:35056932:C:T
NM_007126.5(VCP):c.*347C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366711	9	35056767	9	35056770	366711	312619	rs886063888	NC_000009.12:35056769:G:A
NM_007126.5(VCP):c.*382C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366710	9	35056732	9	35056735	366710	308244	rs749381324	NC_000009.12:35056734:G:A
NM_007126.5(VCP):c.*438A>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366708	9	35056676	9	35056679	366708	308243	rs137953487	NC_000009.12:35056678:T:C
NM_007126.5(VCP):c.*596C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366707	9	35056518	9	35056521	366707	308235	rs55745923	NC_000009.12:35056520:G:A
NM_007126.5(VCP):c.*700C>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366706	9	35056414	9	35056417	366706	318528	rs537730311	NC_000009.12:35056416:G:T
NM_007126.5(VCP):c.*788G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000366705	9	35056326	9	35056329	366705	312609	rs886063887	NC_000009.12:35056328:C:T
NM_007126.5(VCP):c.*906A>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000366704	9	35056208	9	35056211	366704	318524	rs76360394	NC_000009.12:35056210:T:C
NM_007126.5(VCP):c.954C>T (p.Gly318=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia	Uncertain significance(Last reviewed: Dec 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000287400	9	35062127	9	35062130	287400	271637	rs377316335	NC_000009.12:35062129:G:A
NM_007126.5(VCP):c.*4G>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|not specified|Intellectual disability|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2021)	criteria provided, conflicting interpretations	VCV000284304	9	35057110	9	35057113	284304	268541	rs201091341	NC_000009.12:35057112:C:A
NM_007126.5(VCP):c.79A>G (p.Ile27Val)	VCP	I27V	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Intellectual disability|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not specified	Benign(Last reviewed: Jan 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000284302	9	35068298	9	35068301	284302	268539	rs140913250	NC_000009.12:35068300:T:C
NM_007126.5(VCP):c.1584C>T (p.Ala528=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 30, 2020)	criteria provided, conflicting interpretations	VCV000283215	9	35060421	9	35060424	283215	267452	rs147623367	NC_000009.12:35060423:G:A
NM_007126.5(VCP):c.283C>T (p.Arg95Cys)	VCP	R95C, R50C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Spastic paraplegia	Pathogenic/Likely pathogenic(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280124	9	35067907	9	35067910	280124	264531	rs121909332	NC_000009.12:35067909:G:A
NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	NC_000009.12:35065351:G:A
NM_007126.5(VCP):c.811+3G>A	VCP		not specified|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260128	9	35062972	9	35062975	260128	253532	rs514492	NC_000009.12:35062974:C:T
NM_007126.5(VCP):c.1704A>G (p.Gln568=)	VCP		not specified|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Benign/Likely benign(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000260125	9	35059790	9	35059793	260125	253525	rs142577424	NC_000009.12:35059792:T:C
NM_007126.5(VCP):c.1695+8A>G	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|not specified|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000260124	9	35060302	9	35060305	260124	253526	rs684562	NC_000009.12:35060304:T:C
NM_007126.5(VCP):c.1360-14C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|not provided	Benign(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000260122	9	35060934	9	35060937	260122	253527	rs144304208	NC_000009.12:35060936:G:C
NM_007126.5(VCP):c.553G>A (p.Glu185Lys)	VCP	E185K, E140K	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Charcot-Marie-Tooth disease, axonal, type 2y	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000218305	9	35065271	9	35065274	218305	215001	rs864309501	NC_000009.12:35065273:C:T
NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	INCLUSION BODY MYOPATHY WITHOUT EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2020)	no assertion criteria provided	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	NC_000009.12:35067921:T:A
NM_007126.5(VCP):c.463C>G (p.Arg155Gly)	VCP	R155G, R110G	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	VCV000217028	9	35065361	9	35065364	217028	213592	rs121909330	NC_000009.12:35065363:G:C
NM_007126.5(VCP):c.2406T>C (p.Asp802=)	VCP		Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Conflicting interpretations of pathogenicity(Last reviewed: Apr 26, 2021)	criteria provided, conflicting interpretations	VCV000194756	9	35057129	9	35057132	194756	191919	rs145508640	NC_000009.12:35057131:A:G
NM_007126.5(VCP):c.2214A>G (p.Glu738=)	VCP		not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not specified	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194645	9	35057474	9	35057477	194645	191808	rs374391034	NC_000009.12:35057476:T:C
NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Nov 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	NC_000009.12:35065350:C:T
NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	NC_000009.12:35065254:C:T
NM_007126.5(VCP):c.464G>C (p.Arg155Pro)	VCP	R155P, R110P	Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV000008472	9	35065360	9	35065363	8472	23511	rs121909329	NC_000009.12:35065362:C:G
NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	NC_000009.12:35067909:G:C
NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	NC_000009.12:35064166:G:T
NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	NC_000009.12:35065363:G:A
NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided|Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Mar 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	NC_000009.12:35065362:C:T
NM_020821.3(VPS13C):c.7274C>T (p.Thr2425Met)	VPS13C	T2425M, T2382M	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001030584	15	62212469	15	61920270	1030584	1017938		NC_000015.10:61920269:G:A
NM_020821.3(VPS13C):c.1483+1G>A	VPS13C		Parkinson disease 23, autosomal recessive early-onset	Likely pathogenic(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV001030583	15	62283871	15	61991672	1030583	1017939		NC_000015.10:61991671:C:T
NM_020821.3(VPS13C):c.1409G>A (p.Arg470His)	VPS13C	R427H, R470H	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Jan 22, 2020)	criteria provided, single submitter	VCV001029636	15	62283946	15	61991747	1029636	1017940		NC_000015.10:61991746:C:T
NM_020821.3(VPS13C):c.1111C>T (p.Arg371Ter)	VPS13C	R328*, R371*	Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982938	15	62300861	15	62008662	982938	971025		NC_000015.10:62008661:G:A
NM_020821.3(VPS13C):c.5653A>C (p.Asn1885His)	VPS13C	N1842H, N1885H	not specified	Uncertain significance(Last reviewed: May 11, 2020)	criteria provided, single submitter	VCV000932210	15	62228898	15	61936699	932210	920500		NC_000015.10:61936698:T:G
NM_020821.3(VPS13C):c.1102A>G (p.Thr368Ala)	VPS13C	T325A, T368A	not specified	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV000932179	15	62300870	15	62008671	932179	920501		NC_000015.10:62008670:T:C
NM_020821.3(VPS13C):c.9020G>A (p.Arg3007Gln)	VPS13C	R3007Q, R2964Q	Parkinson disease 23, autosomal recessive early-onset	Uncertain significance(Last reviewed: Feb 19, 2018)	no assertion criteria provided	VCV000599078	15	62199548	15	61907349	599078	590310	rs778287890	NC_000015.10:61907348:C:T
NM_020821.3(VPS13C):c.387C>T (p.Gly129=)	VPS13C		Parkinson disease 23, autosomal recessive early-onset|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000547944	15	62320618	15	62028419	547944	538444	rs139665824	NC_000015.10:62028418:G:A
NM_020821.3(VPS13C):c.4165G>C (p.Gly1389Arg)	VPS13C	G1389R, G1346R	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222070	15	62250807	15	61958608	222070	223768	rs369100678	NC_000015.10:61958607:C:G
NM_020821.3(VPS13C):c.9568G>T (p.Glu3190Ter)	VPS13C	E3190*, E3147*	Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222069	15	62174851	15	61882652	222069	223765	rs869312810	NC_000015.10:61882651:C:A
NM_020821.3(VPS13C):c.8445+2T>G	VPS13C		Parkinson disease|Parkinson disease 23, autosomal recessive early-onset	Pathogenic(Last reviewed: Nov 16, 2015)	criteria provided, single submitter	VCV000222067	15	62207830	15	61915631	222067	223766	rs869312809	NC_000015.10:61915630:A:C
NM_018206.6(VPS35):c.1938C>T (p.His646=)	VPS35		not specified|Parkinson disease 17	Benign(Last reviewed: Dec 8, 2020)	criteria provided, single submitter	VCV001166780	16	46696284	16	46662372	1166780	1157736		NC_000016.10:46662371:G:A
NM_018206.6(VPS35):c.1893C>T (p.Ile631=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Mar 3, 2020)	criteria provided, single submitter	VCV001155329	16	46696329	16	46662417	1155329	1146153		NC_000016.10:46662416:G:A
NM_018206.6(VPS35):c.1369-9A>G	VPS35		Parkinson disease 17	Likely benign(Last reviewed: May 29, 2020)	criteria provided, single submitter	VCV001150728	16	46705781	16	46671869	1150728	1146154		NC_000016.10:46671868:T:C
NM_018206.6(VPS35):c.1371G>A (p.Val457=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV001088814	16	46705770	16	46671858	1088814	1082041		NC_000016.10:46671857:C:T
NM_018206.6(VPS35):c.1290C>T (p.Tyr430=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001083536	16	46706255	16	46672343	1083536	1082042		NC_000016.10:46672342:G:A
NM_018206.6(VPS35):c.13C>T (p.Gln5Ter)	VPS35	Q5*	Parkinson disease 17	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001050911	16	46717509	16	46683597	1050911	1049630		NC_000016.10:46683596:G:A
NM_018206.6(VPS35):c.1895T>C (p.Ile632Thr)	VPS35	I632T	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001021992	16	46696327	16	46662415	1021992	1012169		NC_000016.10:46662414:A:G
NM_018206.6(VPS35):c.993G>T (p.Gln331His)	VPS35	Q331H	Parkinson disease 17	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000961428	16	46708494	16	46674582	961428	949404		NC_000016.10:46674581:C:A
NM_018206.6(VPS35):c.506+4A>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000960311	16	46714579	16	46680667	960311	960159		NC_000016.10:46680666:T:G
NM_018206.6(VPS35):c.2350C>A (p.Pro784Thr)	VPS35	P784T	Parkinson disease 17	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000947902	16	46694425	16	46660513	947902	927819		NC_000016.10:46660512:G:T
NM_018206.6(VPS35):c.1900A>G (p.Thr634Ala)	VPS35	T634A	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887867	16	46696322	16	46662410	887867	875299		NC_000016.10:46662409:T:C
NM_018206.6(VPS35):c.2073C>T (p.His691=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000887866	16	46695768	16	46661856	887866	875298		NC_000016.10:46661855:G:A
NM_018206.6(VPS35):c.2211+11T>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000887865	16	46695619	16	46661707	887865	876670		NC_000016.10:46661706:A:G
NM_018206.6(VPS35):c.-35C>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886664	16	46723080	16	46689168	886664	875305		NC_000016.10:46689167:G:C
NM_018206.6(VPS35):c.2353G>C (p.Glu785Gln)	VPS35	E785Q	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886615	16	46694422	16	46660510	886615	875297		NC_000016.10:46660509:C:G
NM_018206.6(VPS35):c.*34A>G	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886614	16	46694350	16	46660438	886614	875296		NC_000016.10:46660437:T:C
NM_018206.6(VPS35):c.*161C>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000886613	16	46694223	16	46660311	886613	875295		NC_000016.10:46660310:G:A
NM_018206.6(VPS35):c.*283C>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886612	16	46694101	16	46660189	886612	875294		NC_000016.10:46660188:G:T
NM_018206.6(VPS35):c.*289C>T	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000886611	16	46694095	16	46660183	886611	875293		NC_000016.10:46660182:G:A
NM_018206.6(VPS35):c.*345T>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000886610	16	46694039	16	46660127	886610	875292		NC_000016.10:46660126:A:C
NM_018206.6(VPS35):c.505G>C (p.Asp169His)	VPS35	D169H	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885653	16	46714584	16	46680672	885653	875304		NC_000016.10:46680671:C:G
NM_018206.6(VPS35):c.648G>A (p.Leu216=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885652	16	46712927	16	46679015	885652	875303		NC_000016.10:46679014:C:T
NM_018206.6(VPS35):c.*422C>A	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000885588	16	46693962	16	46660050	885588	875291		NC_000016.10:46660049:G:T
NM_018206.6(VPS35):c.*575A>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000885587	16	46693809	16	46659897	885587	875290		NC_000016.10:46659896:T:A
NM_018206.6(VPS35):c.1268C>T (p.Pro423Leu)	VPS35	P423L	Parkinson disease 17	Benign(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000884714	16	46706277	16	46672365	884714	875302		NC_000016.10:46672364:G:A
NM_018206.6(VPS35):c.1317T>C (p.Tyr439=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000884713	16	46706228	16	46672316	884713	875301		NC_000016.10:46672315:A:G
NM_018206.6(VPS35):c.1525-5G>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884712	16	46702969	16	46669057	884712	876671		NC_000016.10:46669056:C:A
NM_018206.6(VPS35):c.1809A>T (p.Ala603=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000884711	16	46696913	16	46663001	884711	875300		NC_000016.10:46663000:T:A
NM_018206.6(VPS35):c.1151A>G (p.Asn384Ser)	VPS35	N384S	Parkinson disease 17	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV000855930	16	46708235	16	46674323	855930	843874		NC_000016.10:46674322:T:C
NM_018206.6(VPS35):c.1480T>A (p.Phe494Ile)	VPS35	F494I	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 16, 2019)	criteria provided, single submitter	VCV000838576	16	46705661	16	46671749	838576	843873		NC_000016.10:46671748:A:T
NM_018206.6(VPS35):c.2145A>G (p.Leu715=)	VPS35		Parkinson disease 17|not provided	Benign/Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000707481	16	46695696	16	46661784	707481	693878	rs145033509	NC_000016.10:46661783:T:C
NM_018206.6(VPS35):c.1020A>G (p.Gln340=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000704463	16	46708366	16	46674454	704463	693881	rs188883365	NC_000016.10:46674453:T:C
NM_018206.6(VPS35):c.1420C>G (p.Gln474Glu)	VPS35	Q474E	Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2019)	criteria provided, conflicting interpretations	VCV000651640	16	46705721	16	46671809	651640	644687	rs370401767	NC_000016.10:46671808:G:C
NM_018206.6(VPS35):c.1550T>G (p.Phe517Cys)	VPS35	F517C	Parkinson disease 17	Uncertain significance(Last reviewed: Feb 27, 2018)	criteria provided, single submitter	VCV000579180	16	46702939	16	46669027	579180	570298	rs1567264486	NC_000016.10:46669026:A:C
NM_018206.6(VPS35):c.1313G>A (p.Cys438Tyr)	VPS35	C438Y	Parkinson disease 17	Uncertain significance(Last reviewed: May 7, 2018)	criteria provided, single submitter	VCV000571710	16	46706232	16	46672320	571710	570197	rs745893720	NC_000016.10:46672319:C:T
NM_018206.6(VPS35):c.945A>T (p.Gly315=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000539748	16	46708542	16	46674630	539748	530114	rs144346159	NC_000016.10:46674629:T:A
NM_018206.6(VPS35):c.2359G>A (p.Glu787Lys)	VPS35	E787K	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487679	16	46694416	16	46660504	487679	480750	rs777050595	NC_000016.10:46660503:C:T
NM_018206.6(VPS35):c.2320C>A (p.Leu774Met)	VPS35	L774M	not provided|Parkinson disease 17	Uncertain significance(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000487678	16	46694455	16	46660543	487678	480751	rs192419029	NC_000016.10:46660542:G:T
NM_018206.6(VPS35):c.2210C>T (p.Ala737Val)	VPS35	A737V	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487677	16	46695631	16	46661719	487677	480752	rs749516404	NC_000016.10:46661718:G:A
NM_018206.6(VPS35):c.1819A>G (p.Met607Val)	VPS35	M607V	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487676	16	46696903	16	46662991	487676	480753	rs1555523076	NC_000016.10:46662990:T:C
NM_018206.6(VPS35):c.1796A>G (p.His599Arg)	VPS35	H599R	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487675	16	46696926	16	46663014	487675	480754	rs1434487321	NC_000016.10:46663013:T:C
NM_018206.6(VPS35):c.1679T>C (p.Ile560Thr)	VPS35	I560T	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487674	16	46697043	16	46663131	487674	480755	rs760128592	NC_000016.10:46663130:A:G
NM_018206.6(VPS35):c.1570C>T (p.Arg524Trp)	VPS35	R524W	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487673	16	46702919	16	46669007	487673	480756	rs184277092	NC_000016.10:46669006:G:A
NM_018206.6(VPS35):c.1520A>T (p.Tyr507Phe)	VPS35	Y507F	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487672	16	46705621	16	46671709	487672	480757	rs1555465749	NC_000016.10:46671708:T:A
NM_018206.6(VPS35):c.946C>T (p.Pro316Ser)	VPS35	P316S	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487671	16	46708541	16	46674629	487671	480758	rs770029606	NC_000016.10:46674628:G:A
NM_018206.6(VPS35):c.723T>G (p.Ile241Met)	VPS35	I241M	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487670	16	46711308	16	46677396	487670	480759	rs192783364	NC_000016.10:46677395:A:C
NM_018206.6(VPS35):c.171G>A (p.Met57Ile)	VPS35	M57I	Parkinson disease 17	Uncertain significance(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000487669	16	46716019	16	46682107	487669	480760	rs183554824	NC_000016.10:46682106:C:T
NM_018206.6(VPS35):c.151G>A (p.Gly51Ser)	VPS35	G51S	Parkinson disease 17	Benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000487668	16	46716039	16	46682127	487668	480761	rs193077277	NC_000016.10:46682126:C:T
NM_018206.6(VPS35):c.1938= (p.His646=)	VPS35		Parkinson disease 17	Benign(Last reviewed: Dec 29, 2019)	criteria provided, single submitter	VCV000472501	16	46696284	16	46662372	472501	466454	rs168745	NC_000016.10:46662371:G:G
NM_018206.6(VPS35):c.1881C>T (p.Ala627=)	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000472500	16	46696341	16	46662429	472500	466705	rs138794859	NC_000016.10:46662428:G:A
NM_018206.6(VPS35):c.1391T>C (p.Val464Ala)	VPS35	V464A	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000472499	16	46705750	16	46671838	472499	466476	rs1555465774	NC_000016.10:46671837:A:G
NM_018206.6(VPS35):c.959C>T (p.Ala320Val)	VPS35	A320V	not provided|Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2020)	criteria provided, conflicting interpretations	VCV000450710	16	46708528	16	46674616	450710	445582	rs747944333	NC_000016.10:46674615:G:A
NM_018206.6(VPS35):c.-35C>T	VPS35		Parkinson disease 17	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319299	16	46723080	16	46689168	319299	325368	rs189775907	NC_000016.10:46689167:G:A
NM_018206.6(VPS35):c.-34G>A	VPS35|ORC6		Meier-Gorlin syndrome|Parkinson disease 17	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319298	16	46723079	16	46689167	319298	343011	rs3743928	NC_000016.10:46689166:C:T
NM_018206.6(VPS35):c.-19C>T	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319297	16	46723064	16	46689152	319297	325366	rs573920049	NC_000016.10:46689151:G:A
NM_018206.6(VPS35):c.89T>A (p.Met30Lys)	VPS35	M30K	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319296	16	46717433	16	46683521	319296	335061	rs145147781	NC_000016.10:46683520:A:T
NM_018206.6(VPS35):c.678C>T (p.Arg226=)	VPS35		not provided|Parkinson disease 17	Likely benign(Last reviewed: Sep 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000319295	16	46712897	16	46678985	319295	341511	rs376845827	NC_000016.10:46678984:G:A
NM_018206.6(VPS35):c.851G>A (p.Arg284Gln)	VPS35	R284Q	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319294	16	46710558	16	46676646	319294	343010	rs771276024	NC_000016.10:46676645:C:T
NM_018206.6(VPS35):c.1035G>A (p.Glu345=)	VPS35		not provided|Parkinson disease 17	Conflicting interpretations of pathogenicity(Last reviewed: May 29, 2018)	criteria provided, conflicting interpretations	VCV000319293	16	46708351	16	46674439	319293	335043	rs563975281	NC_000016.10:46674438:C:T
NM_018206.6(VPS35):c.1145A>G (p.Lys382Arg)	VPS35	K382R	Parkinson disease 17|not provided	Benign(Last reviewed: Jun 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000319292	16	46708241	16	46674329	319292	325362	rs116254156	NC_000016.10:46674328:T:C
NM_018206.6(VPS35):c.1488T>C (p.His496=)	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319291	16	46705653	16	46671741	319291	335042	rs776877370	NC_000016.10:46671740:A:G
NM_018206.6(VPS35):c.1912A>T (p.Met638Leu)	VPS35	M638L	Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319290	16	46696310	16	46662398	319290	341506	rs144997996	NC_000016.10:46662397:T:A
NM_018206.6(VPS35):c.2241C>T (p.Ile747=)	VPS35		Parkinson disease 17|not provided	Benign/Likely benign(Last reviewed: Jan 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000319289	16	46694534	16	46660622	319289	325360	rs140543776	NC_000016.10:46660621:G:A
NM_018206.6(VPS35):c.*276A>C	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319285	16	46694108	16	46660196	319285	341503	rs886052009	NC_000016.10:46660195:T:G
NM_018206.6(VPS35):c.*346G>A	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319272	16	46694038	16	46660126	319272	342990	rs545755034	NC_000016.10:46660125:C:T
NM_018206.6(VPS35):c.*354G>C	VPS35		Parkinson disease 17	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319271	16	46694030	16	46660118	319271	342989	rs572048744	NC_000016.10:46660117:C:G
NM_018206.6(VPS35):c.*380G>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319270	16	46694004	16	46660092	319270	341497	rs886052004	NC_000016.10:46660091:C:T
NM_018206.6(VPS35):c.*401G>A	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000319269	16	46693983	16	46660071	319269	342987	rs553790361	NC_000016.10:46660070:C:T
NM_018206.6(VPS35):c.*617A>G	VPS35		Parkinson disease 17	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000319268	16	46693767	16	46659855	319268	341495	rs746602580	NC_000016.10:46659854:T:C
NM_014321.4(ORC6):c.-47G>A	VPS35|ORC6		Parkinson Disease, Dominant|Meier-Gorlin syndrome|not specified|Meier-Gorlin syndrome 3	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000260387	16	46723571	16	46689659	260387	255744	rs144065502	NC_000016.10:46689658:G:A
NM_018206.6(VPS35):c.1576C>T (p.Arg526Cys)	VPS35	R526C	Parkinson disease, late-onset	Uncertain significance(Last reviewed: Jan 22, 2014)	no assertion criteria provided	VCV000096727	16	46702913	16	46669001	96727	102613	rs398124658	NC_000016.10:46669000:G:A
NM_018206.6(VPS35):c.1858G>A (p.Asp620Asn)	VPS35	D620N	Parkinson disease 17	Pathogenic(Last reviewed: Apr 19, 2017)	no assertion criteria provided	VCV000030196	16	46696364	16	46662452	30196	39152	rs188286943	NC_000016.10:46662451:C:T
NM_007013.4(WWP1):c.1879A>T (p.Met627Leu)	WWP1	M627L	Wolff-Parkinson-White pattern	Uncertain significance(Last reviewed: Jul 14, 2017)	no assertion criteria provided	VCV000487621	8	87454888	8	86442659	487621	480701	rs773370868	NC_000008.11:86442658:A:T
